MotifMap M01068

M01068: UF1H3BETA GGYGGGGGWGGGGC


Genome coordinateStrandNormalized LOD scoreZ-scoreBLSBBLSFDRNearest geneDistance (bp)Description
chr17:53439019-53439032-0.9976.0172.712.5730.000NM_001078166687-
chr9:126395938-126395951-0.9635.7322.852.2200.000NM_004959-86418 nuclear receptor subfamily 5, group A, member 1
chr11:113815240-113815253+0.9865.9212.842.1190.000NM_015523-47 small fragment nuclease (DKFZP566E144), mRNA.
chr11:66482795-66482808+0.9525.6362.702.1120.000NM_000920-372 pyruvate carboxylase (PC), nuclear gene encoding
chr3:9419743-9419756+0.9976.0172.742.0940.000NM_0010805175440-
chr7:134845431-134845444+1.0006.0422.232.0920.000NM_001008225-40-
chr15:39739799-39739812+0.8935.1402.782.0750.000NM_001080541-3-
chr1:43888576-43888589+0.9976.0172.572.0560.000NM_014663292 jumonji domain containing 2A (JMJD2A), mRNA.
chr15:61124107-61124120-0.9395.5262.702.0530.000NM_0010180202316-
chr10:70151245-70151258-0.9825.8952.382.0110.000NM_018237368 cell division cycle and apoptosis regulator 1 (CCAR1),
chr10:130003148-130003161-0.9635.7322.441.9970.000NM_002417-188503 antigen identified by monoclonal antibody Ki-67
chr2:136005728-136005741-0.9665.7582.511.9780.000NM_015361275 R3H domain (binds single-stranded nucleic acids)
chr3:62327164-62327177-0.9325.4732.811.9690.000NM_0180086897 zinc finger protein 312 (ZNF312), mRNA.
chr1:109811415-109811428+1.0006.0422.391.9610.000NM_001040709892-
chr11:118489511-118489524-0.9225.3822.851.9580.000NM_0148076308 transmembrane protein 24 (TMEM24), mRNA.
chr10:23318019-23318032+0.9635.7322.611.9570.000NM_17308161153 armadillo repeat containing 3 (ARMC3), mRNA.
chr2:172659083-172659096+0.9495.6102.681.9450.000NM_178120729 distal-less homeo box 1 (DLX1), mRNA.
chr2:25327588-25327601+0.9976.0172.181.9400.000NM_1537591096 DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A),
chr1:38746861-38746874+0.9295.4472.951.9340.000NM_022157351066 Ras-related GTP binding C (RRAGC), mRNA.
chr17:35018281-35018294-0.9976.0172.181.9240.000NM_006160-580 neurogenic differentiation 2 (NEUROD2), mRNA.
chr15:38519158-38519171-0.9665.7582.491.9080.000NM_014952-1445 bromo adjacent homology domain containing 1 (BAHD1),
chr19:45587993-45588006-0.9315.4602.531.8880.000NM_144685-59 homeodomain interacting protein kinase 4 (HIPK4),
chr5:71397688-71397701+0.9275.4252.211.8780.000NM_005909-41086 microtubule-associated protein 1B (MAP1B), transcript
chr7:77005694-77005707+0.9495.6102.531.8740.000NM_0028351023 protein tyrosine phosphatase, non-receptor type 12
chr3:185578476-185578489-0.9285.4342.951.8690.000NM_000460150 thrombopoietin (myeloproliferative leukemia virus
chr2:47601066-47601079-0.8795.0192.611.8680.000NM_02205549908 potassium channel, subfamily K, member 12 (KCNK12),
chr12:6651717-6651730+0.9525.6362.561.8600.000NM_016162-9152 inhibitor of growth family, member 4 (ING4),
chr1:148249117-148249130-0.9665.7582.261.8600.000NM_020205193 zinc finger, A20 domain containing 1 (ZA20D1), mRNA.
chr19:47365990-47366003+0.9976.0171.981.8500.000NM_002698-37520 POU domain, class 2, transcription factor 2 (POU2F2),
chr12:5308714-5308727-0.8935.1402.261.8310.000NM_002527-164713 neurotrophin 3 (NTF3), mRNA.
chr19:50687900-50687913+0.9275.4252.491.8090.000NM_206901414 reticulon 2 (RTN2), transcript variant 3, mRNA.
chr11:57163730-57163743+0.9275.4252.151.7980.000NM_14500810263 yippee-like 4 (Drosophila) (YPEL4), mRNA.
chr17:20000198-20000211-0.9635.7322.271.7980.000NM_001033555304-
chr7:5425903-5425916-1.0006.0421.991.7930.000NM_001080495-7598-
chr10:102560881-102560894+0.8885.0962.421.7900.000NM_00027865523 paired box gene 2 (PAX2), transcript variant b, mRNA.
chr10:93992824-93992837-0.9635.7322.701.7860.000NM_017824-47976 ring finger protein 153 (RNF153), mRNA.
chr12:121577156-121577169-0.9495.6102.951.7820.000NM_023012343 similar to splicing factor, arginine/serine-rich 4
chr13:37341948-37341961+1.0006.0422.071.7820.000NM_016179-13 transient receptor potential cation channel, subfamily
chrX:130020083-130020096-0.9425.5532.421.7800.000NM_144967286 hypothetical protein FLJ30058 (FLJ30058), mRNA.
chr3:57557731-57557744-0.9976.0171.861.7790.000NM_001660387 ADP-ribosylation factor 4 (ARF4), mRNA.
chrX:38939562-38939575+0.9495.6102.381.7750.000NM_021242391645 MID1 interacting protein 1 (gastrulation specific
chr15:81036775-81036788-0.9635.7322.411.7660.000NM_001079534853-
chr5:139069120-139069133+0.9425.5532.531.7660.000NM_01646360518 CXXC finger 5 (CXXC5), mRNA.
chr2:104400016-104400029-0.9635.7322.591.7640.000NM_006236-438285 POU domain, class 3, transcription factor 3 (POU3F3),
chr1:27113193-27113206+0.9285.4342.711.7570.000NM_021969-146 nuclear receptor subfamily 0, group B, member 2
chr2:160838461-160838474-0.9635.7322.401.7520.000NM_000888-73625 integrin, beta 6 (ITGB6), mRNA.
chr17:43977283-43977296+0.9285.4342.581.7500.000NM_002145109 homeo box B2 (HOXB2), mRNA.
chr1:8798712-8798725-0.9295.4472.741.7480.000NM_0121021574 arginine-glutamic acid dipeptide (RE) repeats (RERE),
chr6:72653697-72653710+0.8885.0962.431.7480.000NM_014989426 regulating synaptic membrane exocytosis 1 (RIMS1),
chr1:153369172-153369185+0.9976.0172.091.7430.000NM_1826852299 ephrin-A1 (EFNA1), transcript variant 2, mRNA.
chr16:70904493-70904506-0.9635.7322.401.7400.000NM_031293-140968 polyamine modulated factor 1 binding protein 1
chr3:55491831-55491844-0.9525.6362.741.7330.000NM_0033924540 wingless-type MMTV integration site family, member 5A
chr2:113684082-113684095-0.9665.7582.351.7290.000NM_01245536151 pleckstrin and Sec7 domain containing 4 (PSD4), mRNA.
chr1:26968091-26968104-0.9295.4472.701.7240.000NM_017837-18882 hypothetical protein FLJ20477 (FLJ20477), mRNA.
chrX:102828194-102828207-0.9495.6102.561.7230.000NM_01228658 mortality factor 4 like 2 (MORF4L2), mRNA.
chr18:31178492-31178505+1.0006.0422.431.7200.000NM_006965-89 zinc finger protein 24 (KOX 17) (ZNF24), mRNA.
chr12:6514626-6514639-0.9285.4342.151.7120.000NM_002046808 glyceraldehyde-3-phosphate dehydrogenase (GAPD), mRNA.
chr10:23527789-23527802+0.9665.7582.331.6950.000NM_1781616423 pancreas specific transcription factor, 1a (PTF1A),
chr8:145672112-145672125+0.9295.4472.341.6900.000NM_003923414 forkhead box H1 (FOXH1), mRNA.
chr14:31617112-31617125+0.9495.6102.181.6890.000NM_001173966 Rho GTPase activating protein 5 (ARHGAP5), mRNA.
chr7:22733233-22733246-0.9075.2602.631.6800.000NM_000600-12 interleukin 6 (interferon, beta 2) (IL6), mRNA.
chrX:39850722-39850735-1.0006.0421.681.6770.000NM_020926-9122 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr7:104440399-104440412-0.9665.7582.271.6770.000NM_182931-1374 myeloid/lymphoid or mixed-lineage leukemia 5
chr10:114914318-114914331+0.9635.7322.711.6760.000NM_030756214217 transcription factor 7-like 2 (T-cell specific,
chr2:177338881-177338894-0.9635.7322.481.6700.000NM_194247-446687 heterogeneous nuclear ribonucleoprotein A3 (HNRPA3),
chr12:105602587-105602600-0.9225.3822.291.6600.000NM_03249171 regulatory factor X, 4 (influences HLA class II
chr9:126152407-126152420-0.9976.0172.431.6570.000NM_00279965135 proteasome (prosome, macropain) subunit, beta type, 7
chr11:6624571-6624584+0.9425.5512.541.6550.000NM_0037379079 dachsous 1 (Drosophila) (DCHS1), mRNA.
chr17:53517172-53517185-0.9825.8952.261.6380.000NM_0806771474 dynein light chain 2 (Dlc2), mRNA.
chr10:69992545-69992558-0.9635.7322.261.6370.000NM_0306252226 CXXC finger 6 (CXXC6), mRNA.
chr4:109309597-109309610-0.9665.7581.941.6170.000NM_016269-570 lymphoid enhancer-binding factor 1 (LEF1), mRNA.
chr10:103033868-103033881+1.0006.0421.731.6130.000NM_006562-55161 transcription factor similar to D. melanogaster
chr12:115456320-115456333-0.9976.0172.121.6050.000NM_207436810 FLJ42957 protein (FLJ42957), mRNA.
chr1:16174957-16174970-0.9295.4472.431.6030.000NM_003443144 zinc finger and BTB domain containing 17 (ZBTB17),
chr2:171216577-171216590-0.9825.8952.601.6000.000NM_001003845-63430 Sp5 transcription factor (SP5), mRNA.
chr19:44032043-44032056-0.9635.7321.841.5920.000NM_001533414 heterogeneous nuclear ribonucleoprotein L (HNRPL),
chr1:26608507-26608520+0.9635.7322.911.5920.000NM_024674-1249 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr15:68171359-68171372-0.9495.6102.721.5910.000NM_0050784853 transducin-like enhancer of split 3 (E(sp1) homolog,
chr5:174080854-174080867-1.0006.0422.191.5910.000NM_002449-3227 msh homeo box homolog 2 (Drosophila) (MSX2), mRNA.
chr4:140695840-140695853+0.9665.7582.251.5870.000NM_0306481187 SET domain-containing protein 7 (SET7), mRNA.
chr4:105732364-105732377+0.9225.3822.431.5780.000NM_025212-100448 CXXC finger 4 (CXXC4), mRNA.
chr19:39611101-39611114-0.9635.7322.091.5760.000NM_00549993 SUMO-1 activating enzyme subunit 2 (UBA2), mRNA.
chr5:158056298-158056311-0.9635.7322.701.5760.000NM_024007403049 early B-cell factor (EBF), mRNA.
chr2:60611448-60611461-0.9225.3822.161.5680.000NM_01801422689 B-cell CLL/lymphoma 11A (zinc finger protein)
chr1:197172235-197172248-0.9155.3242.851.5660.000NM_080922297575 protein tyrosine phosphatase, receptor type, C
chrX:39912209-39912222-0.9635.7322.131.5620.000NM_020926-70609 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr2:42138973-42138986+0.9865.9212.271.5550.000NM_1383709816-
chr12:50621539-50621552-0.9635.7322.661.5520.000NM_020328-10114 activin A receptor, type IB (ACVR1B), transcript
chr6:33373498-33373511-0.9665.7581.891.5470.000NM_0047611218 ral guanine nucleotide dissociation stimulator-like 2
chr15:73529865-73529878-0.9225.3822.351.5450.000NM_0154771114 SIN3 homolog A, transcriptional regulator (yeast)
chr6:140244299-140244312+0.9425.5512.301.5430.000NM_006079-506821 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr6:43090134-43090147+1.0006.0422.321.5390.000NM_057161279 kelch domain containing 3 (KLHDC3), mRNA.
chr7:73709649-73709662-0.9635.7322.101.5390.000NM_001518-217 general transcription factor II, i (GTF2I), transcript
chr11:32870280-32870293+0.9495.6102.551.5300.000NM_001076786-988-
chr3:123716254-123716267+0.9425.5512.451.5240.000NM_002264220 karyopherin alpha 1 (importin alpha 5) (KPNA1), mRNA.
chr18:28722164-28722177+0.9285.4342.661.5240.000NM_020805-115192-
chr17:51277961-51277974-0.9635.7322.411.5200.000NM_02121394612 phosphatidylcholine transfer protein (PCTP), mRNA.
chr11:105321490-105321503-0.9275.4252.531.5200.000NM_03242476674-
chrX:39759387-39759400-0.9395.5262.561.5190.000NM_01774582213 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr12:113367788-113367801-0.9285.4342.421.5180.000NM_080717-37158 T-box 5 (TBX5), transcript variant 3, mRNA.
chr12:61615245-61615258-0.9255.4072.191.5170.000NM_020700-313-
chr1:41604704-41604717-1.0006.0421.991.5160.000NM_001956118180 endothelin 2 (EDN2), mRNA.
chr14:56342262-56342275-0.9495.6102.621.5150.000NM_172337-164 orthodenticle homolog 2 (Drosophila) (OTX2),
chr9:127817061-127817074-0.9976.0171.961.5150.000NM_006195267674 pre-B-cell leukemia transcription factor 3 (PBX3),
chr19:45641224-45641237-0.9275.4252.271.5110.000NM_013368-879 SERTA domain containing 3 (SERTAD3), transcript
chr1:41637653-41637666+0.9635.7322.401.5100.000NM_00195685231 endothelin 2 (EDN2), mRNA.
chr16:28212298-28212311-0.9295.4472.171.5070.000NM_0010244011057-
chr2:62786403-62786416+0.9315.4602.141.5060.000NM_015252-134 EH domain binding protein 1 (EHBP1), mRNA.
chrX:64171803-64171816+1.0006.0422.311.4920.000NM_018684-58742 KIAA1166 (KIAA1166), mRNA.
chr20:10222975-10222988+0.9425.5511.981.4900.000NM_13081175598 synaptosomal-associated protein, 25kDa (SNAP25),
chr1:153413748-153413761+0.9495.6101.941.4880.000NM_025058864 tripartite motif-containing 46 (TRIM46), mRNA.
chr9:85784745-85784758+0.9635.7322.081.4880.000NM_031263157 heterogeneous nuclear ribonucleoprotein K (HNRPK),
chr15:41000031-41000044-0.9275.4252.591.4870.000NM_173500268 tau tubulin kinase 2 (TTBK2), mRNA.
chr1:44870671-44870684-0.9165.3382.751.4870.000NM_02458742015 hypothetical protein FLJ22353 (FLJ22353), mRNA.
chr10:114895707-114895720-0.9495.6102.511.4840.000NM_030756195606 transcription factor 7-like 2 (T-cell specific,
chr2:67994825-67994838-0.9185.3512.291.4830.000NM_006333148809 nuclear DNA-binding protein (C1D), transcript variant
chr17:70554844-70554857-0.9865.9211.921.4820.000NM_01535370-
chr7:104491745-104491758-0.9295.4472.291.4760.000NM_01868249972 myeloid/lymphoid or mixed-lineage leukemia 5
chr14:72595296-72595309+0.9275.4252.071.4720.000NM_021239375-
chr11:116690830-116690843+0.9976.0171.861.4680.000NM_0121041352 beta-site APP-cleaving enzyme 1 (BACE1), transcript
chr2:72228509-72228522+0.9665.7582.001.4470.000NM_019885-38 cytochrome P450, family 26, subfamily B, polypeptide 1
chr12:52437077-52437090+0.9976.0172.151.4320.000NM_020898-29591 KIAA1536 protein (KIAA1536), mRNA.
chr8:135794225-135794238-0.9825.8951.651.4190.000NM_020863238 zinc finger protein 406 (ZNF406), mRNA.
chr6:122762888-122762901+0.9976.0171.891.4190.000NM_004506494 heat shock transcription factor 2 (HSF2), mRNA.
chr1:65386911-65386924-0.9665.7581.911.3910.000NM_001002921332 adenylate kinase 3-like 2 (AK3L2), mRNA.
chr11:76861723-76861736+0.9976.0171.771.3830.000NM_002576858 p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog,
chr17:45339969-45339982-0.9825.8951.941.3740.000NM_001077504-59591-
chr17:24965234-24965247-0.9976.0172.471.3680.000NM_0328547386 coronin, actin binding protein 6 (FLJ14871), mRNA.
chrX:48635813-48635826-0.9825.8951.981.3400.000NM_001032381-4226-
chr6:155096447-155096460-1.0006.0421.421.3240.000NM_014892343 RNA binding motif protein 16 (RBM16), mRNA.
chr17:44013910-44013923-0.9976.0171.951.3200.000NM_024015-3168 homeo box B4 (HOXB4), mRNA.
chr7:138695511-138695524-0.9865.9211.471.3180.000NM_016019437 LUC7-like 2 (S. cerevisiae) (LUC7L2), mRNA.
chr11:57299787-57299800+0.9976.0171.871.3180.000NM_00133114077 catenin (cadherin-associated protein), delta 1
chr17:44036776-44036789-0.9825.8952.711.3110.000NM_018952557 homeo box B6 (HOXB6), transcript variant 2, mRNA.
chr1:23767394-23767407+1.0006.0421.421.3080.000NM_002167-8522 inhibitor of DNA binding 3, dominant negative
chr11:73036598-73036611+0.9976.0171.691.3050.000NM_0212001827 pleckstrin homology domain containing, family B
chr19:56888523-56888536-0.9665.7581.631.3000.000NM_00152330510 hyaluronan synthase 1 (HAS1), mRNA.
chr19:18583488-18583501+1.0006.0421.341.2980.000NM_012109-1094 chromosome 19 open reading frame 4 (C19orf4), mRNA.
chr3:152286980-152286993-0.9825.8951.471.2860.000NM_053002-286 TRALPUSH (TRALPUSH), mRNA.
chr1:153514918-153514931+0.9825.8951.891.2740.000NM_0208971020 hyperpolarization activated cyclic nucleotide-gated
chr3:51977527-51977540+0.9976.0171.931.2610.000NM_033008-1018 poly(rC) binding protein 4 (PCBP4), transcript variant
chr9:32541134-32541147-1.0006.0422.111.2600.000NM_0058021467 topoisomerase I binding, arginine/serine-rich
chr19:50188290-50188303+0.9865.9211.941.2520.000NM_006509-8162 v-rel reticuloendotheliosis viral oncogene homolog B,
chr17:58059250-58059263+0.9665.7581.641.2520.000NM_006039856 mannose receptor, C type 2 (MRC2), mRNA.
chr12:54700920-54700933+0.9976.0171.991.2440.000NM_02246564 zinc finger protein, subfamily 1A, 4 (Eos) (ZNFN1A4),
chr2:219452045-219452058-0.9825.8951.711.2360.000NM_025216-1354 wingless-type MMTV integration site family, member 10A
chr14:59785520-59785533-1.0006.0421.361.2280.000NM_177951-198 protein phosphatase 1A (formerly 2C),
chr5:131375440-131375453+1.0006.0422.131.2220.000NM_015256-192 acyl-CoA synthetase long-chain family member 6
chr17:26445806-26445819+0.9665.7582.021.2200.000NM_000267-215 neurofibromin 1 (neurofibromatosis, von Recklinghausen
chr17:7547727-7547740+0.9825.8952.211.2090.000NM_001406-1418 ephrin-B3 (EFNB3), mRNA.
chr12:95112702-95112715+0.9825.8951.561.2060.000NM_005230464 ELK3, ETS-domain protein (SRF accessory protein 2)
chr17:4216018-4216031-0.9665.7581.461.2030.000NM_003342700 ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C.
chr3:47180086-47180099-0.9976.0171.281.2010.000NM_014159-39342 huntingtin interacting protein B (HYPB), transcript
chr1:27159459-27159472-1.0006.0422.111.1960.000NM_15236525 hypothetical protein FLJ34633 (FLJ34633), mRNA.
chr14:74831725-74831738+0.9865.9211.741.1940.000NM_00525216541 v-fos FBJ murine osteosarcoma viral oncogene homolog
chr9:70925605-70925618+0.9665.7581.981.1870.000NM_004817-53204 tight junction protein 2 (zona occludens 2) (TJP2),
chr3:51977494-51977507+0.9976.0171.601.1740.000NM_033008-985 poly(rC) binding protein 4 (PCBP4), transcript variant
chr19:47450438-47450451+1.0006.0421.481.1740.000NM_006494675 Ets2 repressor factor (ERF), mRNA.
chr10:63330419-63330432+0.9665.7582.251.1730.000NM_032199-930-
chr17:44446132-44446145-0.9825.8951.491.1620.000NM_00654616459 IGF-II mRNA-binding protein 1 (IMP-1), mRNA.
chr3:153469335-153469348+1.0006.0421.271.1560.000NM_207292916 muscleblind-like (Drosophila) (MBNL1), transcript
chr4:149585963-149585976-0.9865.9211.341.1530.000NM_000901-2990 nuclear receptor subfamily 3, group C, member 2
chr2:104836745-104836758+1.0006.0421.411.1480.000NM_006236-1556 POU domain, class 3, transcription factor 3 (POU3F3),
chr5:171762905-171762918-0.9665.7582.201.1460.000NM_00101799551227-
chr12:56532994-56533007-0.9825.8951.491.1450.000NM_005730-5980 CTD (carboxy-terminal domain, RNA polymerase II,
chr17:34115617-34115630-0.9976.0171.271.1440.000NM_005937318 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr4:151719967-151719980+0.9695.7821.641.1430.000NM_006439-2686 mab-21-like 2 (C. elegans) (MAB21L2), mRNA.
chr1:22252350-22252363+0.9665.7581.851.1410.000NM_001791743 cell division cycle 42 (GTP binding protein, 25kDa)
chr11:43967491-43967504-0.9665.7581.771.1320.000NM_001031854-58516-
chr5:87887361-87887374-0.9665.7582.751.1270.000NM_153354-286940 hypothetical protein MGC33214 (MGC33214), mRNA.
chr15:87147619-87147632-0.9665.7581.291.1210.000NM_01322741 aggrecan 1 (chondroitin sulfate proteoglycan 1, large
chr19:10574522-10574535+0.9665.7581.401.1120.000NM_005498-15531 adaptor-related protein complex 1, mu 2 subunit
chr11:44613001-44613014+0.9976.0171.671.1000.000NM_00223169384 kangai 1 (suppression of tumorigenicity 6, prostate;
chr12:14304916-14304929-0.9665.7581.841.1000.000NM_018179-104862 activating transcription factor 7 interacting protein
chr19:60878430-60878443-0.9665.7581.261.0970.000NM_013333126 epsin 1 (EPN1), mRNA.
chr11:47164009-47164022+0.9865.9211.571.0830.000NM_016223525 protein kinase C and casein kinase substrate in
chrX:136478511-136478524-0.9825.8952.321.0830.000NM_0034132599 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr19:1706488-1706501+1.0006.0421.261.0790.000NM_0010804881926-
chr9:139328928-139328941-0.9976.0171.521.0780.000NM_001004354-12404 similar to ankyrin-repeat protein Nrarp (MGC61598),
chr12:130946734-130946747+1.0006.0421.981.0680.000NM_0035651602 unc-51-like kinase 1 (C. elegans) (ULK1), mRNA.
chr6:34310960-34310973-0.9825.8951.421.0680.000NM_002131-1568 high mobility group AT-hook 1 (HMGA1), transcript
chr14:100125391-100125404+1.0006.0421.421.0670.000NM_020836-19507 brain-enriched guanylate kinase-associated protein
chr1:19684404-19684417-0.9976.0171.221.0570.000NM_004930175 capping protein (actin filament) muscle Z-line, beta
chr13:19431399-19431412+1.0006.0421.651.0540.000NM_197968689 zinc finger protein 198 (ZNF198), mRNA.
chr17:56829568-56829581+0.9976.0171.381.0530.000NM_005994-2371 T-box 2 (TBX2), mRNA.
chr20:255669-255682-0.9665.7581.751.0490.000NM_0069431530 SRY (sex determining region Y)-box 12 (SOX12), mRNA.
chrX:111213701-111213714-0.9825.8951.541.0450.000NM_001004308892 FLJ46608 protein (FLJ46608), mRNA.
chr12:49444479-49444492+0.9976.0171.231.0420.000NM_005171493 activating transcription factor 1 (ATF1), mRNA.
chr6:140140317-140140330+0.9665.7582.021.0310.000NM_006079-402839 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr9:33808385-33808398+0.9976.0171.451.0290.000NM_0178111303 ubiquitin-conjugating enzyme E2R 2 (UBE2R2), mRNA.
chr11:66940077-66940090+0.9825.8951.481.0220.000NM_020811452-
chr14:66778067-66778080+1.0006.0421.111.0200.000NM_022474393 membrane protein, palmitoylated 5 (MAGUK p55 subfamily
chr1:225130413-225130426-0.9825.8951.331.0160.000NM_0124864930 presenilin 2 (Alzheimer disease 4) (PSEN2), transcript
chr2:178290270-178290283-1.0006.0421.561.0160.000NM_152275-98330 hypothetical protein FLJ13946 (FLJ13946), mRNA.
chr3:170868693-170868706+0.9825.8951.891.0130.000NM_004991-4525 myelodysplasia syndrome 1 (MDS1), mRNA.
chr9:125163676-125163689+0.9976.0171.861.0130.000NM_1736895507 crumbs homolog 2 (Drosophila) (CRB2), mRNA.
chr4:102486828-102486841+0.9665.7581.401.0080.000NM_000944548 protein phosphatase 3 (formerly 2B), catalytic
chr16:30617887-30617900-1.0006.0422.391.0060.000NM_00666224 Snf2-related CBP activator protein (SRCAP), mRNA.
chr1:163780064-163780077-1.0006.0421.381.0040.000NM_001005214296 FLJ25811 protein (FLJ25811), mRNA.
chr6:33518261-33518274-0.9665.7581.850.9990.000NM_152735-11973 zinc finger and BTB domain containing 9 (ZBTB9), mRNA.
chr15:65256169-65256182+0.9695.7821.830.9740.000NM_02466677959 hypothetical protein FLJ11506 (FLJ11506), mRNA.
chrX:101073239-101073252+0.9825.8952.110.9700.000NM_001011657417-
chr10:21855050-21855063-0.9825.8951.200.9690.000NM_207371-433 FLJ45187 protein (FLJ45187), mRNA.
chr16:19087043-19087056-0.9665.7581.150.9620.000NM_0165244 B/K protein (LOC51760), mRNA.
chr11:46098026-46098039+1.0006.0421.370.9590.000NM_0166211535 BRAF35/HDAC2 complex (80 kDa) (BHC80), mRNA.
chr10:73183538-73183551+0.9976.0171.600.9590.000NM_02215319805-
chr20:3670630-3670643+0.9825.8951.700.9560.000NM_0529709374 heat shock 70kD protein 12B (HSPA12B), mRNA.
chrX:24939405-24939418+0.9825.8951.430.9430.000NM_1390584370 aristaless related homeobox (ARX), mRNA.
chr3:49890457-49890470+0.9825.8951.500.9320.000NM_024046-8084 hypothetical protein MGC8407 (MGC8407), mRNA.
chr12:55897319-55897332+0.9665.7581.290.9290.000NM_007224574 neurexophilin 4 (NXPH4), mRNA.
chr19:12755837-12755850-0.9865.9211.630.9270.000NM_002229-7373 jun B proto-oncogene (JUNB), mRNA.
chr17:43153548-43153561-0.9825.8951.730.9260.000NM_013351-11961 T-box 21 (TBX21), mRNA.
chr10:93991054-93991067+0.9825.8951.330.9260.000NM_017824-49746 ring finger protein 153 (RNF153), mRNA.
chr17:34113908-34113921-0.9665.7581.210.9160.000NM_005937-1391 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chrX:40258044-40258057-0.9865.9212.080.9120.000NM_005765-67016 ATPase, H+ transporting, lysosomal accessory protein 2
chr5:141235932-141235945-0.9825.8951.740.9100.000NM_0324202196 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr7:148212760-148212773+1.0006.0421.440.9030.000NM_152998-413 enhancer of zeste homolog 2 (Drosophila) (EZH2),
chr2:165633069-165633082+1.0006.0421.730.9000.000NM_173512-112788 hypothetical protein FLJ39822 (FLJ39822), mRNA.
chr7:5600688-5600701+0.9665.7581.320.8970.000NM_0030881808 fascin homolog 1, actin-bundling protein
chr22:18640395-18640408-1.0006.0421.410.8930.000NM_023004-4579 reticulon 4 receptor (RTN4R), mRNA.
chr1:34020072-34020085-0.9665.7581.730.8900.000NM_145205-78491 HMG2 like (LOC127540), mRNA.
chr13:28110343-28110356-0.9825.8951.270.8890.000NM_015932-20808 chromosome 13 open reading frame 12 (C13orf12), mRNA.
chr19:2425868-2425881+0.9665.7581.470.8880.000NM_015675-1167 growth arrest and DNA-damage-inducible, beta
chr11:22645126-22645139+0.9665.7581.610.8870.000NM_177553-1004 growth arrest-specific 2 (GAS2), transcript variant 2,
chr16:66244269-66244282+1.0006.0421.500.8820.000NM_0010138387838-
chr2:160180239-160180252-0.9825.8951.200.8800.000NM_0134501066 bromodomain adjacent to zinc finger domain, 2B
chrX:68455685-68455698-0.9976.0171.870.8720.000NM_022368-153620 praja 1 (PJA1), mRNA.
chr11:63771621-63771634-1.0006.0421.290.8640.000NM_138689-632-
chr19:47450039-47450052+0.9665.7581.070.8630.000NM_0064941074 Ets2 repressor factor (ERF), mRNA.
chr1:158645095-158645108+0.9865.9211.660.8540.000NM_0203358204-
chr8:10750960-10750973-0.9976.0171.290.8520.000NM_017884-16251 PIN2-interacting protein 1 (PINX1), mRNA.
chr2:63922106-63922119+0.9665.7581.590.8450.000NM_006759-312 UDP-glucose pyrophosphorylase 2 (UGP2), transcript
chr19:18204716-18204729-0.9725.8081.160.8430.000NM_001098818-6468-
chr16:29930388-29930401-0.9665.7581.320.8430.000NM_003586-486 double C2-like domains, alpha (DOC2A), mRNA.
chr8:96809427-96809440-0.9976.0171.510.8430.000NM_001001557432769 growth differentiation factor 6 (GDF6), mRNA.
chr1:203693161-203693174-0.9665.7581.360.8420.000NM_001001552-35357 LEM domain containing 1 (LEMD1), mRNA.
chrX:139300940-139300953+0.9825.8951.310.8420.000NM_005634113951 SRY (sex determining region Y)-box 3 (SOX3), mRNA.
chr1:3681158-3681171+0.9976.0171.470.8390.000NM_02071021770 KIAA1185 protein (KIAA1185), mRNA.
chr14:97746624-97746637+0.9665.7581.320.8250.000NM_182560-500979 hypothetical protein FLJ25773 (FLJ25773), mRNA.
chr1:38482664-38482677-0.9665.7581.530.8220.000NM_002699-197627 POU domain, class 3, transcription factor 1 (POU3F1),
chr1:148126688-148126701-0.9825.8951.850.8210.000NM_175065-598 histone 2, H2ab (HIST2H2AB), mRNA.
chr3:185538768-185538781+0.9976.0171.520.8190.000NM_144635-2084 hypothetical protein MGC21688 (MGC21688), mRNA.
chr1:43946020-43946033-1.0006.0421.460.8090.000NM_174971315 sialyltransferase 6 (N-acetyllacosaminide alpha
chr1:33538974-33538987-0.9665.7581.080.8060.000NM_00108043820312-
chr16:31944030-31944043-0.9665.7581.190.8020.000NM_003414151469 zinc finger protein 267 (ZNF267), transcript variant
chr10:104160365-104160378-0.9665.7581.320.7950.000NM_0027798526 pleckstrin and Sec7 domain containing (PSD), mRNA.
chr16:1980335-1980348-1.0006.0421.300.7910.000NM_004209466 synaptogyrin 3 (SYNGR3), mRNA.
chr11:64237946-64237959-1.0006.0421.260.7900.000NM_0150809290 neurexin 2 (NRXN2), transcript variant alpha-1, mRNA.
chr1:63554803-63554816-0.9665.7582.000.7860.000NM_012183-6415 forkhead box D3 (FOXD3), mRNA.
chr2:219534642-219534655-0.9825.8951.290.7800.000NM_0039362100 cyclin-dependent kinase 5, regulatory subunit 2 (p39)
chr17:53325097-53325110-0.9825.8951.400.7790.000NM_01794910652 CUE domain containing 1 (CUEDC1), mRNA.
chr3:31549823-31549836-1.0006.0421.220.7740.000NM_178862428 source of immunodominant MHC-associated peptides
chr7:960287-960300+0.9665.7581.070.7680.000NM_006869506 centaurin, alpha 1 (CENTA1), mRNA.
chr19:34993956-34993969+0.9665.7581.550.7670.000NM_001238-685 cyclin E1 (CCNE1), transcript variant 1, mRNA.
chr14:37133997-37134010+0.9665.7581.290.7600.000NM_004496243 forkhead box A1 (FOXA1), mRNA.
chr7:93042029-93042042-0.9865.9211.420.7470.000NM_001742-343 calcitonin receptor (CALCR), mRNA.
chr17:46297978-46297991-0.9665.7581.690.7390.000NM_005749-1566 transducer of ERBB2, 1 (TOB1), mRNA.
chrX:152560475-152560488-0.9976.0171.330.7350.000NM_001395-607 dual specificity phosphatase 9 (DUSP9), mRNA.
chr11:56848826-56848839-1.0006.0421.210.7180.000NM_033396163 tankyrase 1 binding protein 1, 182kDa (TNKS1BP1),
chr6:31954816-31954829-0.9865.9211.210.7100.000NM_025257-14 chromosome 6 open reading frame 29 (C6orf29), mRNA.
chr15:71384205-71384218+0.9976.0171.980.7100.000NM_00547764025 hyperpolarization activated cyclic nucleotide-gated
chr8:145137118-145137131-0.9976.0171.050.6900.000NM_0010091841004-
chr9:495350-495363+1.0006.0421.050.6800.000NM_015158747 ankyrin repeat domain 15 (ANKRD15), transcript variant
chr1:46738654-46738667+0.9976.0171.080.6520.000NM_147192-6501 diencephalon/mesencephalon homeobox 1 (DMBX1),
chr1:33420318-33420331+1.0006.0421.660.6380.000NM_018207-464 hypothetical protein FLJ10759 (FLJ10759), mRNA.
chr13:99176967-99176980-1.0006.0421.410.6230.000NM_206808120130 citrate lyase beta like (CLYBL), transcript variant 2,
chr11:118196543-118196556+1.0006.0421.120.5960.000NM_004397-29461 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 (DDX6), mRNA.
chr1:10669451-10669464-0.9976.0171.370.5840.000NM_001079843109843-
chr19:47136402-47136415-1.0006.0421.050.5600.000NM_00642318909 Rab acceptor 1 (prenylated) (RABAC1), mRNA.
chr1:44282227-44282240+0.9976.0171.610.4980.000NM_001024845-12506-
chr22:17333506-17333519+0.9976.0171.130.4930.000NM_016335-29440 proline dehydrogenase (oxidase) 1 (PRODH), nuclear
chr17:44446495-44446508-1.0006.0421.770.4820.000NM_00654616822 IGF-II mRNA-binding protein 1 (IMP-1), mRNA.
chr6:18372494-18372507-0.9665.7581.150.6600.010NM_003472284 DEK oncogene (DNA binding) (DEK), mRNA.
chr6:44313590-44313603-0.9665.7581.190.6500.010NM_007355-9137 heat shock 90kDa protein 1, beta (HSPCB), mRNA.
chr8:42117108-42117121-0.9665.7581.180.6310.010NM_006803-12553 adaptor-related protein complex 3, mu 2 subunit
chr6:43704905-43704918-0.9665.7581.870.6190.010NM_0190969 GTP binding protein 2 (GTPBP2), mRNA.
chr19:11327359-11327372+0.9665.7581.050.6080.010NM_022737352 lipid phosphate phosphatase-related protein type 2
chr17:45993328-45993341-0.9665.7581.110.5950.010NM_198397-20 calcium channel, voltage-dependent, alpha 1G subunit
chr1:233878424-233878437-0.9665.7581.160.5940.010NM_0010987221492-
chr20:656971-656984+0.9665.7581.380.5850.010NM_03340940160 chromosome 20 open reading frame 54 (C20orf54), mRNA.
chrX:99434263-99434276-0.9155.3242.591.3890.013NM_020766114545-
chr8:59876777-59876790-0.9155.3242.121.3790.013NM_003580-141837 neutral sphingomyelinase (N-SMase) activation
chr1:11789056-11789069+0.9165.3382.471.3720.013NM_005957-354 5,10-methylenetetrahydrofolate reductase (NADPH)
chr5:24680894-24680907-0.9325.4732.401.3980.014NM_006727-226 cadherin 10, type 2 (T2-cadherin) (CDH10), mRNA.
chr21:37080775-37080788-0.9295.4472.561.3970.014NM_00506987014 single-minded homolog 2 (Drosophila) (SIM2),
chr10:114914454-114914467-0.9285.4342.391.3920.014NM_030756214353 transcription factor 7-like 2 (T-cell specific,
chr1:37898994-37899007-0.9285.4342.431.3850.014NM_001038633-25916-
chr1:178868210-178868223-0.9325.4732.021.3790.014NM_004736514 xenotropic and polytropic retrovirus receptor (XPR1),
chr19:50975946-50975959-0.9315.4602.231.3770.014NM_001081563-245-
chr2:60637392-60637405-0.9285.4342.041.3740.014NM_022893-3255 B-cell CLL/lymphoma 11A (zinc finger protein)
chr1:149521564-149521577-0.9275.4251.861.3720.014NM_020832249 KIAA1441 protein (KIAA1441), mRNA.
chr17:7181088-7181101-0.9285.4342.241.3690.014NM_014716591 centaurin, beta 1 (CENTB1), mRNA.
chrX:70384993-70385006+0.9825.8951.130.6660.014NM_2015995678 zinc finger protein 261 (ZNF261), transcript variant
chr5:10392237-10392250-0.9825.8951.340.6660.014NM_005885-14491 similar to S. cerevisiae SSM4 (TEB4), mRNA.
chr3:113005006-113005019-0.9825.8951.600.6640.014NM_145753-80394 pleckstrin homology-like domain, family B, member 2
chrX:129044740-129044753-0.9825.8951.220.6570.014NM_00142127407 E74-like factor 4 (ets domain transcription factor)
chr12:70633474-70633487+0.9825.8951.640.6340.014NM_17335314681 tryptophan hydroxylase 2 (TPH2), mRNA.
chr13:71339201-71339214+0.9825.8951.530.6040.014NM_004392130 dachshund homolog 1 (Drosophila) (DACH1), transcript
chr22:25384044-25384057+0.9825.8951.050.5820.014NM_00188636216 crystallin, beta A4 (CRYBA4), mRNA.
chr1:153246784-153246797-0.9225.3822.201.4070.015NM_015872-6664 zinc finger protein 67 homolog (mouse) (ZFP67), mRNA.
chr6:161614330-161614343-0.9635.7321.520.7960.015NM_020133767 1-acylglycerol-3-phosphate O-acyltransferase 4
chr6:43816348-43816361-0.9635.7321.200.7950.015NM_001025366-29483-
chr15:91226908-91226921+0.9635.7321.030.7930.015NM_001042572-17547-
chr2:16685079-16685092-0.9635.7321.800.7880.015NM_03079725498 family with sequence similarity 49, member A (FAM49A),
chr8:143677900-143677913+0.9635.7321.090.7840.015NM_01519314935 activity-regulated cytoskeleton-associated protein
chr17:23903368-23903381+0.9635.7321.690.7820.015NM_005148402 unc-119 homolog (C. elegans) (UNC119), transcript
chr20:3092520-3092533+0.9635.7321.380.7690.015NM_199415-3980 likely ortholog of mouse ubiquitin conjugating enzyme
chr2:236438969-236438982-0.9635.7321.300.7680.015NM_001485302422 gastrulation brain homeo box 2 (GBX2), mRNA.
chr5:37875938-37875951+0.9635.7321.140.7630.015NM_000514-399 glial cell derived neurotrophic factor (GDNF),
chr20:42057076-42057089-0.9635.7321.580.7490.015NM_00109879849226-
chr7:1720046-1720059-0.9635.7321.170.7460.015NM_032302-143891 hypothetical protein MGC10911 (MGC10911), mRNA.
chr1:34415039-34415052-0.9825.8951.250.6810.015NM_032884-719 hypothetical protein MGC15882 (MGC15882), mRNA.
chr17:1848070-1848083-0.9825.8951.380.6700.015NM_17856826858 reticulon 4 receptor-like 1 (RTN4RL1), mRNA.
chr1:66772208-66772221+0.9225.3822.361.4490.016NM_032291-105 hypothetical protein DKFZp761D221 (DKFZp761D221),
chr1:26611755-26611768+0.9295.4472.791.4320.016NM_0246741999 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr12:16649268-16649281+0.9295.4472.411.4320.016NM_0186401430 LIM domain only 3 (rhombotin-like 2) (LMO3),
chr1:241623242-241623255+0.9255.4072.091.4080.016NM_006642137399 serologically defined colon cancer antigen 8
chr17:7699051-7699064+0.9315.4602.471.4030.016NM_20341142 similar to RIKEN cDNA 2600017H02 (LOC92162), mRNA.
chr1:35940920-35940933+0.9585.6861.610.8300.016NM_15237416457 hypothetical protein FLJ38984 (FLJ38984), mRNA.
chr5:134899721-134899734-0.9635.7321.620.8210.016NM_006161-183 neurogenin 1 (NEUROG1), mRNA.
chr10:102939851-102939864+0.9635.7321.450.8150.016NM_00656238856 transcription factor similar to D. melanogaster
chr22:38903151-38903164+0.9635.7321.850.8140.016NM_015088-624-
chr13:50924009-50924022+0.9635.7321.120.8090.016NM_0010399371267-
chr11:122727441-122727454-0.9635.7321.480.8010.016NM_024769-156224 adipocyte-specific adhesion molecule (ASAM), mRNA.
chr11:116563891-116563904+0.9495.6101.730.7650.016NM_0010404558842-
chr17:13375577-13375590-0.9495.6101.850.7650.016NM_00604270392 heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1
chr6:14701531-14701544-0.9495.6101.730.7530.016NM_004233475787 CD83 antigen (activated B lymphocytes, immunoglobulin
chr5:138632094-138632107+0.9495.6102.190.7470.016NM_199189-5497-
chrX:71094664-71094677+0.9495.6101.420.7450.016NM_001024455173812-
chr3:170224278-170224291+0.9495.6101.790.7410.016NM_005241122509 ecotropic viral integration site 1 (EVI1), mRNA.
chr1:234096851-234096864-0.9525.6361.060.7390.016NM_000081-8 Chediak-Higashi syndrome 1 (CHS1), mRNA.
chr14:98669873-98669886+0.9495.6101.500.7380.016NM_022898137702 B-cell CLL/lymphoma 11B (zinc finger protein)
chr20:61600050-61600063-0.9825.8951.030.7110.016NM_001958899 eukaryotic translation elongation factor 1 alpha 2
chr17:75385983-75385996-0.9825.8951.180.7040.016NM_020649-498 chromobox homolog 8 (Pc class homolog, Drosophila)
chr20:35157533-35157546+0.9105.2862.281.4990.017NM_002895291 retinoblastoma-like 1 (p107) (RBL1), transcript
chr5:137099505-137099518-0.8975.1752.491.4670.017NM_017415-143 kelch-like 3 (Drosophila) (KLHL3), mRNA.
chr5:32747066-32747079-0.9495.6101.390.9960.017NM_000908-256 natriuretic peptide receptor C/guanylate cyclase C
chr20:35417051-35417064-0.9495.6101.740.9910.017NM_1982919180 v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene
chr1:109658013-109658026-0.9495.6101.600.9900.017NM_001010985-6827-
chr16:69341850-69341863+0.9525.6361.970.9810.017NM_01805250712 hypothetical protein FLJ10305 (FLJ10305), mRNA.
chr7:106596893-106596906+0.9495.6101.640.9710.017NM_012257297 HMG-box transcription factor 1 (HBP1), mRNA.
chr17:45480168-45480181+0.9635.7321.150.8500.017NM_002204-8462 integrin, alpha 3 (antigen CD49C, alpha 3 subunit of
chr6:149418369-149418382-0.9635.7321.660.8450.017NM_015093-262287 mitogen-activated protein kinase kinase kinase 7
chr11:61491798-61491811+0.9635.7321.680.8370.017NM_002032-90 ferritin, heavy polypeptide 1 (FTH1), mRNA.
chr5:137803146-137803159-0.9635.7321.380.8350.017NM_016606571 chromosome 5 open reading frame 19 (C5orf19), mRNA.
chr12:52863175-52863188-0.9635.7321.920.8340.017NM_0143115849 single-strand selective monofunctional uracil DNA
chr2:156756273-156756286-0.9495.6101.200.7830.017NM_006186141173 nuclear receptor subfamily 4, group A, member 2
chr1:1355908-1355921+0.9495.6101.300.7800.017NM_022834-4764 von Willebrand factor A domain-related protein (WARP),
chr19:3336009-3336022-0.9495.6101.440.7790.017NM_00559718536 nuclear factor I/C (CCAAT-binding transcription
chrX:82647662-82647675+0.9495.6101.260.7700.017NM_000307-2179 POU domain, class 3, transcription factor 4 (POU3F4),
chr8:145234520-145234533+0.9495.6101.550.7690.017NM_0322723327 homolog of yeast MAF1 (MAF1), mRNA.
chr7:27127917-27127930-0.9295.4472.351.4540.018NM_030661-2178 homeo box A3 (HOXA3), transcript variant 1, mRNA.
chr21:37714500-37714513-0.9295.4472.841.4350.018NM_001396128 dual-specificity tyrosine-(Y)-phosphorylation
chr22:35835561-35835574-0.9495.6101.931.0320.018NM_153609-5922 transmembrane protease, serine 6 (TMPRSS6), mRNA.
chr12:3182570-3182583-0.9495.6101.521.0260.018NM_006675125852 transmembrane 4 superfamily member tetraspan NET-5
chr19:11429037-11429050-0.9495.6101.871.0240.018NM_00274321868 protein kinase C substrate 80K-H (PRKCSH), transcript
chr1:201262962-201262975+0.9495.6101.991.0130.018NM_00107980919903-
chr17:70662408-70662421-0.9635.7321.530.8930.018NM_016185-38 hematological and neurological expressed 1 (HN1),
chr5:172416291-172416304-0.9635.7321.390.8890.018NM_153607415 adult retina protein (LOC153222), mRNA.
chr9:95609764-95609777-0.9635.7321.520.8680.018NM_021570147665 BarH-like homeobox 1 (BARX1), mRNA.
chr7:129379815-129379828+0.9495.6101.630.8320.018NM_003344210 ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast)
chr19:12978755-12978768+0.9495.6101.550.8240.018NM_00250111271 nuclear factor I/X (CCAAT-binding transcription
chr11:72020568-72020581-0.9495.6101.600.8060.018NM_00259942492 phosphodiesterase 2A, cGMP-stimulated (PDE2A), mRNA.
chr6:30758362-30758375-0.9495.6101.260.8040.018NM_1334713601-
chr2:236741863-236741876+0.9865.9211.240.4170.018NM_001485-472 gastrulation brain homeo box 2 (GBX2), mRNA.
chr6:35996915-35996928-0.9865.9211.130.4060.018NM_00313719 SFRS protein kinase 1 (SRPK1), mRNA.
chr10:104525916-104525929+0.9085.2672.571.5180.019NM_017787138 chromosome 10 open reading frame 26 (C10orf26), mRNA.
chr1:22291683-22291696+0.9495.6101.611.0630.019NM_00179140076 cell division cycle 42 (GTP binding protein, 25kDa)
chr1:178113345-178113358+0.9495.6101.471.0620.019NM_145034212 AF464140 (LOC163590), mRNA.
chr14:73885338-73885351-0.9495.6101.721.0570.019NM_018228519 chromosome 14 open reading frame 115 (C14orf115),
chr8:21972579-21972592+0.9525.6361.371.0480.019NM_001978-1 erythrocyte membrane protein band 4.9 (dematin)
chr5:139240350-139240363-0.9495.6101.661.0440.019NM_03228984860 pleckstrin and Sec7 domain containing 2 (PSD2), mRNA.
chr2:7691913-7691926+0.9495.6102.561.0440.019NM_014746717039 ring finger protein 144 (RNF144), mRNA.
chr2:79594369-79594382+0.9495.6101.301.0420.019NM_004389835 catenin (cadherin-associated protein), alpha 2
chr1:201808030-201808043-0.9635.7322.260.9270.019NM_001001396-54421 ATPase, Ca++ transporting, plasma membrane 4 (ATP2B4),
chr17:3813711-3813724+0.9555.6601.760.9240.019NM_005173774 ATPase, Ca++ transporting, ubiquitous (ATP2A3),
chr1:153445099-153445112-0.9635.7322.100.9200.019NM_19888385 metaxin 1 (MTX1), transcript variant 2, mRNA.
chr10:78399614-78399627-0.9635.7321.780.9130.019NM_001014797667969-
chr10:94479957-94479970+0.9495.6101.830.8490.019NM_00272940396 hematopoietically expressed homeobox (HHEX), mRNA.
chr12:6907877-6907890-0.9495.6101.210.8440.019NM_001940236 dentatorubral-pallidoluysian atrophy (atrophin-1)
chr5:106743354-106743367-0.9495.6101.610.8440.019NM_001962291141 ephrin-A5 (EFNA5), mRNA.
chrX:128731288-128731301+0.9495.6101.850.8410.019NM_018990-10253 chromosome X open reading frame 9 (CXorf9), mRNA.
chr3:188940280-188940293+0.9665.7581.270.5650.019NM_138931-3338 B-cell CLL/lymphoma 6 (zinc finger protein 51) (BCL6),
chr12:47469897-47469910-0.9665.7581.120.5400.019NM_020983-810 adenylate cyclase 6 (ADCY6), transcript variant 2,
chr16:52516020-52516033+0.9665.7581.270.5350.019NM_001080432220744-
chr1:154397305-154397318-0.9665.7581.040.5260.019NM_0223677393 sema domain, immunoglobulin domain (Ig), transmembrane
chr9:127231176-127231189+0.9665.7581.220.5120.019NM_015635167344 DKFZP434C212 protein (DKFZP434C212), mRNA.
chrX:70390341-70390354-0.9665.7581.210.5080.019NM_201599330 zinc finger protein 261 (ZNF261), transcript variant
chr4:83569225-83569238-0.8935.1401.911.5580.020NM_0313721177 heterogeneous nuclear ribonucleoprotein D-like
chr2:74914555-74914568-1.0006.0421.020.2680.020NM_0001891365 hexokinase 2 (HK2), mRNA.
chr20:29549753-29549766-0.9976.0171.050.2330.020NM_178582-16049 histocompatibility (minor) 13 (HM13), transcript
chrX:136656965-136656978+0.9495.6102.351.3800.021NM_003413181053 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr5:11956536-11956549-0.9495.6101.981.3670.021NM_001332574 catenin (cadherin-associated protein), delta 2 (neural
chr2:138438441-138438454+0.9495.6101.581.0890.021NM_006895263 histamine N-methyltransferase (HNMT), mRNA.
chr17:44161613-44161626+0.9525.6361.671.0810.021NM_006361-503 homeo box B13 (HOXB13), mRNA.
chr17:23926928-23926941+0.9495.6101.901.0720.021NM_0051651150 aldolase C, fructose-bisphosphate (ALDOC), mRNA.
chr17:7061510-7061523+0.9635.7321.140.9440.021NM_000018-2267 acyl-Coenzyme A dehydrogenase, very long chain
chr12:115044040-115044053+0.9635.7321.830.9440.021NM_015335155486 thyroid hormone receptor associated protein 2
chr17:44902800-44902813+0.9635.7321.610.9400.021NM_002507-24766 nerve growth factor receptor (TNFR superfamily, member
chr2:189750945-189750958+0.9635.7321.830.9340.021NM_0003931905 collagen, type V, alpha 2 (COL5A2), mRNA.
chr4:183245751-183245764-0.9495.6102.340.8930.021NM_001080477-236280-
chr2:220084727-220084740+0.9495.6101.150.8910.021NM_018674-2469 amiloride-sensitive cation channel 4, pituitary
chr17:9363839-9363852-0.9495.6101.430.8910.021NM_00485356161 syntaxin 8 (STX8), mRNA.
chr1:44746440-44746453+0.9525.6361.450.8830.021NM_018150102993 hypothetical protein FLJ10597 (FLJ10597), mRNA.
chr1:204068267-204068280+0.9495.6101.680.8730.021NM_15249117601 hypothetical protein FLJ32569 (FLJ32569), mRNA.
chr6:52530849-52530862-0.9495.6101.460.7330.021NM_01228818972 translocation associated membrane protein 2 (TRAM2),
chr7:150283866-150283879-0.9495.6101.140.7290.021NM_172057-18 potassium voltage-gated channel, subfamily H
chr13:60223656-60223669+0.9495.6101.850.7270.021NM_030794354633 tudor domain containing 3 (TDRD3), mRNA.
chr12:92490524-92490537-0.9495.6101.450.7260.021NM_0038772895 suppressor of cytokine signaling 2 (SOCS2), mRNA.
chr22:26167925-26167938+0.9495.6101.460.7240.021NM_002430359561 meningioma (disrupted in balanced translocation) 1
chr12:108634383-108634396-0.9495.6101.900.7230.021NM_032829-22472 hypothetical protein FLJ14721 (FLJ14721), mRNA.
chr17:29929383-29929396+0.9635.7321.080.7160.021NM_2074541118 FLJ44815 protein (FLJ44815), mRNA.
chr1:243386950-243386963-0.9495.6101.270.7160.021NM_0180122140-
chr12:4113902-4113915+0.9635.7321.220.7140.021NM_001759-139197 cyclin D2 (CCND2), mRNA.
chr12:119187398-119187411+0.9495.6101.210.7130.021NM_002859494 paxillin (PXN), mRNA.
chr9:130942158-130942171-0.9525.6361.890.7090.021NM_17800328824 protein phosphatase 2A, regulatory subunit B' (PR 53)
chr7:127784130-127784143-0.9495.6101.490.7080.021NM_018077-12932 RNA binding motif protein 28 (RBM28), mRNA.
chr7:4648308-4648321-0.9635.7321.340.7060.021NM_001037165-40048-
chr20:49080401-49080414+0.9495.6101.820.7000.021NM_172318-7319 potassium voltage-gated channel, subfamily G, member 1
chr1:51560321-51560334+0.9976.0171.170.4260.021NM_001080494205-
chr14:59785642-59785655+0.9976.0171.140.4100.021NM_177951-76 protein phosphatase 1A (formerly 2C),
chr8:142385291-142385304-0.9976.0171.160.4080.021NM_00529361256 G protein-coupled receptor 20 (GPR20), mRNA.
chr16:30015174-30015187-1.0006.0421.170.3810.021NM_031477-152 yippee-like 3 (Drosophila) (YPEL3), mRNA.
chr10:78963367-78963380-0.9976.0171.010.3550.021NM_001014797104216-
chr8:110621309-110621322+0.9425.5511.881.4140.022NM_004215-77 estrogen receptor binding site associated, antigen, 9
chr17:45195819-45195832-0.9425.5512.251.4140.022NM_030802699 C/EBP-induced protein (LOC81558), mRNA.
chr15:63501064-63501077-0.9495.6101.661.1310.022NM_0209621399 likely ortholog of mouse neighbor of Punc E11 (NOPE),
chr3:123716077-123716090-0.9495.6101.931.1260.022NM_002264397 karyopherin alpha 1 (importin alpha 5) (KPNA1), mRNA.
chr16:28179128-28179141-0.9495.6101.901.1250.022NM_001024401-32113-
chr6:140114154-140114167+0.9495.6101.881.1200.022NM_006079-376676 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr14:73885308-73885321-0.9495.6101.681.1170.022NM_018228489 chromosome 14 open reading frame 115 (C14orf115),
chr7:78920920-78920933+0.9495.6101.991.1060.022NM_012301-94 atrophin-1 interacting protein 1 (AIP1), mRNA.
chr12:117930943-117930956-0.9635.7321.570.9990.022NM_19428627264 KIAA1853 protein (KIAA1853), mRNA.
chr5:124737088-124737101-0.9635.7322.410.9920.022NM_020747-628384-
chr1:87548635-87548648+0.9635.7322.200.9820.022NM_006769-18004 LIM domain only 4 (LMO4), mRNA.
chr1:93583971-93583984+0.9635.7321.840.9780.022NM_0019385 down-regulator of transcription 1, TBP-binding
chr2:220145079-220145092-0.9635.7322.030.9760.022NM_002191-19 inhibin, alpha (INHA), mRNA.
chr19:13051483-13051496+0.9495.6101.670.9330.022NM_00558323198 lymphoblastic leukemia derived sequence 1 (LYL1),
chr12:56533141-56533154+0.9495.6101.990.9280.022NM_005730-6127 CTD (carboxy-terminal domain, RNA polymerase II,
chr22:37979469-37979482-0.9495.6101.650.9180.022NM_002608-8533 platelet-derived growth factor beta polypeptide
chr6:25016174-25016187-0.9495.6101.640.9170.022NM_015864-30612 chromosome 6 open reading frame 32 (C6orf32), mRNA.
chr18:10393797-10393810-0.9495.6101.740.9140.022NM_153000-50728 adenomatosis polyposis coli down-regulated 1 (APCDD1),
chr1:203919101-203919114-0.9495.6102.320.9070.022NM_033102-2848 prostein protein (Prostein), mRNA.
chr22:37597924-37597937+0.9495.6101.770.9000.022NM_014292280 chromobox homolog 6 (CBX6), mRNA.
chr5:139052760-139052773-0.9976.0171.090.4650.022NM_01646344158 CXXC finger 5 (CXXC5), mRNA.
chr19:19381665-19381678-0.9976.0171.030.4350.022NM_017660-48632 p66 alpha (p66alpha), mRNA.
chr1:67163457-67163470-0.8945.1492.031.5740.023NM_207014-299 hypothetical protein FLJ23129 (FLJ23129), transcript
chr1:118504022-118504035-0.9155.3242.401.3610.023NM_20699625335 projection protein PF6 (PF6), mRNA.
chr14:41146276-41146289+0.9165.3312.291.3550.023NM_152447-718 leucine rich repeat and fibronectin type III domain
chr11:110888332-110888345-0.9635.7321.641.0260.023NM_017589-58 B-cell translocation gene 4 (BTG4), mRNA.
chr2:236660232-236660245-0.9635.7321.641.0200.023NM_00148581159 gastrulation brain homeo box 2 (GBX2), mRNA.
chr20:21450544-21450557-0.9635.7321.791.0120.023NM_002509-7880 NK2 transcription factor related, locus 2 (Drosophila)
chr1:144181684-144181697-0.8194.5132.851.6110.024NM_03230560 hypothetical protein MGC3200 (MGC3200), mRNA.
chr6:43090161-43090174+0.9495.6101.560.9640.024NM_057161306 kelch domain containing 3 (KLHDC3), mRNA.
chr11:66931435-66931448+0.9525.6361.750.9480.024NM_1985173547 FLJ00332 protein (FLJ00332), mRNA.
chr3:183809493-183809506-0.9495.6101.960.9460.024NM_014616-184392-
chr3:49893416-49893429-0.9635.7321.730.5940.024NM_024046-11043 hypothetical protein MGC8407 (MGC8407), mRNA.
chr14:103766809-103766822+0.9635.7321.070.5850.024NM_01565692096-
chr2:121367383-121367396-0.9635.7321.150.5850.024NM_005270101156 GLI-Kruppel family member GLI2 (GLI2), transcript
chr1:203530488-203530501-0.9635.7321.120.5790.024NM_03095227018 likely ortholog of rat SNF1/AMP-activated protein
chr1:24108096-24108109+0.9635.7321.030.5730.024NM_0018414308 cannabinoid receptor 2 (macrophage) (CNR2), mRNA.
chr10:80651305-80651318-0.9825.8951.100.3490.024NM_02033859529 retinoic acid induced 17 (RAI17), mRNA.
chr8:122298949-122298962-0.9825.8951.210.3420.024NM_021021-405039 syntrophin, beta 1 (dystrophin-associated protein A1,
chr3:172661065-172661078+0.8734.9682.181.6100.025NM_015028-519-
chr10:21848772-21848785-0.9495.6102.191.4520.025NM_2073715845 FLJ45187 protein (FLJ45187), mRNA.
chr1:23543169-23543182-0.9495.6101.871.4500.025NM_005826202 heterogeneous nuclear ribonucleoprotein R (HNRPR),
chr17:45410094-45410107+0.9495.6102.391.4450.025NM_0019345065 distal-less homeobox 4 (DLX4), transcript variant 2,
chr18:71699817-71699830+0.9295.4472.231.3630.025NM_001037331-431240-
chr1:29435469-29435482+0.9305.4521.941.3620.025NM_133178-65 protein tyrosine phosphatase, receptor type, U
chr18:31178064-31178077+0.9285.4342.431.3530.025NM_006965339 zinc finger protein 24 (KOX 17) (ZNF24), mRNA.
chr11:74947972-74947985+0.9295.4472.261.3480.025NM_001235-2746 serine (or cysteine) proteinase inhibitor, clade H
chr10:99084857-99084870+0.9285.4342.171.3460.025NM_012083-409 frequently rearranged in advanced T-cell lymphomas 2
chrX:39808225-39808238+0.9285.4341.991.3440.025NM_01774533375 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr12:55309253-55309266+0.9285.4342.181.3430.025NM_0134497177 bromodomain adjacent to zinc finger domain, 2A
chr3:184898568-184898581-0.9275.4251.831.3420.025NM_018023368 YEATS domain containing 2 (YEATS2), mRNA.
chr5:137702041-137702054+0.9285.4342.091.3400.025NM_016605274 chromosome 5 open reading frame 6 (C5orf6), mRNA.
chr6:91180398-91180411+0.9305.4522.481.3370.025NM_021813-117216 BTB and CNC homology 1, basic leucine zipper
chrX:19216268-19216281-0.9495.6101.991.1420.025NM_000284-55604 pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1),
chr4:80155725-80155738-0.9495.6101.691.1420.025NM_001040202-76119-
chr19:36099071-36099084+0.9495.6102.381.1370.025NM_020856432959 zinc finger protein 537 (ZNF537), mRNA.
chr4:187884877-187884890+0.9635.7321.771.0610.025NM_005245-2896 FAT tumor suppressor homolog 1 (Drosophila) (FAT),
chr16:71662208-71662221-0.9635.7321.651.0520.025NM_006885-22433 AT-binding transcription factor 1 (ATBF1), mRNA.
chr2:120985476-120985489-0.9635.7321.761.0490.025NM_002193166107 inhibin, beta B (activin AB beta polypeptide) (INHBB),
chr6:33496673-33496686+0.9635.7321.260.6330.025NM_006772948-
chr12:113599273-113599286+0.9635.7321.230.6320.025NM_0059967079 T-box 3 (ulnar mammary syndrome) (TBX3), transcript
chr1:46460234-46460247-0.9635.7321.530.6180.025NM_00101361518741-
chr20:662905-662918-0.9635.7321.140.6180.025NM_03340934226 chromosome 20 open reading frame 54 (C20orf54), mRNA.
chr16:2998431-2998444-0.9635.7321.090.6170.025NM_020982-3676 claudin 9 (CLDN9), mRNA.
chr16:27028918-27028931+0.9635.7321.530.6170.025NM_18283143489 TNT protein (TNT), mRNA.
chr20:34357491-34357504+0.9825.8951.020.4180.025NM_014902-126 discs, large (Drosophila) homolog-associated protein 4
chr11:62163369-62163382-0.9825.8951.120.4040.025NM_1983357311 glucosidase, alpha; neutral AB (GANAB), mRNA.
chr17:40806661-40806674-0.9825.8951.020.4040.025NM_19928252119 Rho GTPase activating protein 27 (ARHGAP27), mRNA.
chr1:9395962-9395975+0.9825.8951.320.3980.025NM_025106120491 SPRY domain-containing SOCS box protein SSB-1 (SSB1),
chr13:25322516-25322529-0.9825.8951.050.3670.025NM_001007538200682-
chr15:38517368-38517381+0.8935.1402.411.6120.026NM_014952-3235 bromo adjacent homology domain containing 1 (BAHD1),
chr17:64922692-64922705-0.8935.1412.951.6040.026NM_002758359 mitogen-activated protein kinase kinase 6 (MAP2K6),
chr1:33602181-33602194-0.9635.7321.891.0950.026NM_19804011600 polyhomeotic-like 2 (Drosophila) (PHC2), transcript
chr19:63776347-63776360-0.9635.7321.711.0800.026NM_003422407 zinc finger protein 42 (myeloid-specific retinoic
chr14:59166704-59166717+0.9555.6601.551.0790.026NM_206852569 reticulon 1 (RTN1), transcript variant 3, mRNA.
chr8:102032248-102032261+0.9635.7321.491.0780.026NM_1456901199 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
chr2:8631241-8631254+0.9635.7321.120.6640.026NM_002166-108223 inhibitor of DNA binding 2, dominant negative
chr2:218052234-218052247-0.9635.7321.210.6560.026NM_022648464772 tensin (TNS), mRNA.
chr17:53116020-53116033+0.9635.7321.400.6510.026NM_016070166378 mitochondrial ribosomal protein S23 (MRPS23), nuclear
chr14:102127229-102127242+0.9635.7321.290.6450.026NM_015156-1657 REST corepressor 1 (RCOR1), mRNA.
chrX:129017834-129017847-0.9635.7321.290.6410.026NM_00142154313 E74-like factor 4 (ets domain transcription factor)
chr17:4216046-4216059+0.9635.7321.750.6380.026NM_003342672 ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C.
chr5:160908634-160908647-0.9635.7321.050.6380.026NM_021911-926 gamma-aminobutyric acid (GABA) A receptor, beta 2
chr3:57140195-57140208-0.9635.7321.840.6370.026NM_00108097334248-
chr3:195233430-195233443-0.9495.6101.230.5980.026NM_005524-103098 hairy and enhancer of split 1, (Drosophila) (HES1),
chr6:88902241-88902254-0.9495.6101.340.5910.026NM_0160839534 cannabinoid receptor 1 (brain) (CNR1), transcript
chr3:171633582-171633595+0.9495.6101.610.5860.026NM_00560214323 claudin 11 (oligodendrocyte transmembrane protein)
chr1:7664633-7664646-0.9495.6101.230.5760.026NM_004781-89183 vesicle-associated membrane protein 3 (cellubrevin)
chr5:171018889-171018902+0.9495.6101.240.5740.026NM_003862239717 fibroblast growth factor 18 (FGF18), transcript
chr2:96793440-96793453-0.9825.8951.010.4400.026NM_0201843174 cyclin M4 (CNNM4), mRNA.
chr8:93178477-93178490+0.9635.7322.201.3950.027NM_175635-1858 core-binding factor, runt domain, alpha subunit 2;
chr1:154629100-154629113+0.9635.7322.051.3860.027NM_02040723573 Rhesus blood group, B glycoprotein (RHBG), mRNA.
chrX:39898749-39898762-0.9635.7321.851.3840.027NM_020926-57149 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr11:66162955-66162968-0.9635.7322.261.3820.027NM_002896341 RNA binding motif protein 4 (RBM4), mRNA.
chr10:80562754-80562767+0.9635.7321.921.3710.027NM_020338-29022 retinoic acid induced 17 (RAI17), mRNA.
chr7:51118338-51118351+0.9165.3382.491.1990.027NM_015198233652 cordon-bleu homolog (mouse) (COBL), mRNA.
chr17:45410069-45410082-0.9225.3822.161.1930.027NM_0019345040 distal-less homeobox 4 (DLX4), transcript variant 2,
chr2:20511621-20511634-0.9165.3312.161.1870.027NM_0040401405 ras homolog gene family, member B (RHOB), mRNA.
chr12:53108654-53108667-0.9225.3892.441.1830.027NM_002205-9337 integrin, alpha 5 (fibronectin receptor, alpha
chr17:17568840-17568853-0.9525.6361.831.1690.027NM_03066543428 retinoic acid induced 1 (RAI1), mRNA.
chr6:34091540-34091553-0.9225.3821.641.0600.027NM_000841117881 glutamate receptor, metabotropic 4 (GRM4), mRNA.
chr3:18367890-18367903+0.9225.3822.091.0590.027NM_00297172454 special AT-rich sequence binding protein 1 (binds to
chr3:138966285-138966298-0.9155.3241.571.0520.027NM_004189116 SRY (sex determining region Y)-box 14 (SOX14), mRNA.
chr18:21183462-21183475-0.9225.3892.211.0480.027NM_0154612652 zinc finger protein 521 (ZNF521), mRNA.
chr11:66794433-66794446-0.9225.3821.861.0460.027NM_0016194052 adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA.
chr8:22608773-22608786+0.9225.3891.551.0400.027NM_004430-2013 early growth response 3 (EGR3), mRNA.
chr12:52020592-52020605-0.9155.3241.701.0370.027NM_152860-4788 Sp7 transcription factor (SP7), mRNA.
chr7:100594929-100594942-0.9295.4471.990.9970.027NM_003378643 VGF nerve growth factor inducible (VGF), mRNA.
chr17:7682608-7682621-0.9275.4251.780.9910.027NM_001080424-1252-
chr14:23084175-23084188-0.9295.4471.820.9880.027NM_024328-10796-
chr12:47790290-47790303+0.9255.4071.900.9860.027NM_018113657 lipocalin-interacting membrane receptor (LIMR), mRNA.
chr17:33839046-33839059+0.9255.4071.630.9850.027NM_01459877615-
chr19:10214723-10214736+0.9275.4251.500.9830.027NM_015956-8817 mitochondrial ribosomal protein L4 (MRPL4), nuclear
chr15:68162961-68162974-0.9285.4341.780.9720.027NM_00507813251 transducin-like enhancer of split 3 (E(sp1) homolog,
chr12:50549426-50549439-0.9255.4071.710.9710.027NM_182608-18485 hypothetical protein DKFZp686O1689 (DKFZp686O1689),
chr17:7174414-7174427+0.9395.5261.740.8660.027NM_032442-1052 G protein pathway suppressor 2 (GPS2), transcript
chr5:10406813-10406826-0.9425.5511.290.8660.027NM_00588585 similar to S. cerevisiae SSM4 (TEB4), mRNA.
chr9:117878729-117878742-0.9295.4471.840.8660.027NM_002581-77063 pregnancy-associated plasma protein A, pappalysin 1
chr6:94185564-94185577+0.9255.4071.890.8660.027NM_004440429 EphA7 (EPHA7), mRNA.
chr12:54869236-54869249+0.9285.4341.180.8600.027NM_003075308 SWI/SNF related, matrix associated, actin dependent
chr14:69419128-69419141+0.9275.4251.350.8600.027NM_0221373332 SPARC related modular calcium binding 1 (SMOC1), mRNA.
chrX:117994243-117994256-0.9315.4601.950.8560.027NM_0247781602 ring finger protein 127 (RNF127), mRNA.
chr19:9981285-9981298+0.9285.4341.260.8540.027NM_015719862 collagen, type V, alpha 3 (COL5A3), mRNA.
chr17:53515730-53515743+0.9425.5531.110.8520.027NM_08067732 dynein light chain 2 (Dlc2), mRNA.
chr10:99071253-99071266-0.9285.4341.800.8490.027NM_0054792341 frequently rearranged in advanced T-cell lymphomas
chr5:96477895-96477908+0.9295.4472.100.8490.027NM_15323426300 chromosome 5 open reading frame 11 (C5orf11), mRNA.
chr7:72971688-72971701-0.9295.4471.710.8460.027NM_18250458363 Williams-Beuren syndrome critical region 28 (WBSCR28),
chr12:22588422-22588435+0.9255.4071.490.8460.027NM_014802297 KIAA0528 gene product (KIAA0528), mRNA.
chr12:3167993-3168006+0.9295.4471.930.8450.027NM_006675111275 transmembrane 4 superfamily member tetraspan NET-5
chr6:31696768-31696781-0.9425.5511.370.8440.027NM_080686439 HLA-B associated transcript 2 (BAT2), transcript
chr9:128467417-128467430+0.9425.5531.740.8440.027NM_00231650898 LIM homeobox transcription factor 1, beta (LMX1B),
chr3:9414925-9414938-0.9295.4472.020.8430.027NM_001080517622-
chr11:22807964-22807977-0.9395.5261.570.8430.027NM_005256155133 growth arrest-specific 2 (GAS2), transcript variant 1,
chr1:153303167-153303180+0.9315.4601.500.8420.027NM_182690430 ephrin-A4 (EFNA4), transcript variant 3, mRNA.
chr16:30445416-30445429-0.9255.4071.490.8390.027NM_024671-5 hypothetical protein FLJ23436 (FLJ23436), mRNA.
chr12:4248792-4248805-0.9315.4601.410.8360.027NM_001759-4307 cyclin D2 (CCND2), mRNA.
chrX:54851441-54851454+0.9305.4521.610.8350.027NM_01459919 melanoma antigen, family D, 2 (MAGED2), transcript
chr8:24826536-24826549+0.9635.7321.440.6990.027NM_005382-576 neurofilament 3 (150kDa medium) (NEF3), mRNA.
chr8:123868377-123868390-0.9635.7321.640.6910.027NM_0149435395 zinc fingers and homeoboxes 2 (ZHX2), mRNA.
chr9:71787023-71787036+0.9635.7321.300.6860.027NM_153267-61217 MAM domain containing 2 (MAMDC2), mRNA.
chr9:132387663-132387676-0.9635.7321.080.6800.027NM_003934-57018-
chr11:65443039-65443052-0.9585.6861.330.6790.027NM_03145068 basophilic leukemia expressed protein BLES03 (Bles03),
chr19:39089145-39089158+0.9635.7321.270.6780.027NM_024076109638 potassium channel tetramerisation domain containing 15
chr12:54843668-54843681+0.9635.7321.910.6750.027NM_0794235401 myosin, light polypeptide 6, alkali, smooth muscle and
chr5:171145412-171145425+0.9635.7321.100.6720.027NM_012300221070 F-box and WD-40 domain protein 11 (FBXW11), transcript
chr17:69121088-69121101-0.9525.6361.240.6320.027NM_019064-175280 sidekick homolog 2 (chicken) (SDK2), mRNA.
chr9:21325472-21325485+0.9495.6101.550.6280.027NM_018847-43 kelch-like 9 (Drosophila) (KLHL9), mRNA.
chr7:150411326-150411339-0.9495.6101.280.6250.027NM_031434-305 chromosome 7 open reading frame 21 (C7orf21), mRNA.
chr5:158060201-158060214-0.9495.6101.210.6240.027NM_024007399146 early B-cell factor (EBF), mRNA.
chr6:34311339-34311352-0.9495.6101.060.6210.027NM_002131-1189 high mobility group AT-hook 1 (HMGA1), transcript
chrX:50467357-50467370-0.9495.6101.800.6120.027NM_020717106427-
chr2:114364386-114364399+0.9525.6361.060.6100.027NM_005721479 ARP3 actin-related protein 3 homolog (yeast) (ACTR3),
chr14:101033775-101033788-0.9495.6101.270.6010.027NM_001362-63566 deiodinase, iodothyronine, type III (DIO3), mRNA.
chr2:172458579-172458592-0.8524.7992.591.6470.028NM_003705400 solute carrier family 25 (mitochondrial carrier,
chr3:125697807-125697820-0.9135.3122.631.6220.028NM_007064-88312 serine/threonine kinase with Dbl- and pleckstrin
chr11:119712180-119712193+0.8975.1751.981.4190.028NM_015313-876 Rho guanine nucleotide exchange factor (GEF) 12
chr18:33218174-33218187+0.9005.1992.261.4140.028NM_020180181767 bruno-like 4, RNA binding protein (Drosophila)
chr3:185555219-185555232+0.9225.3821.811.2840.028NM_0043666742 chloride channel 2 (CLCN2), mRNA.
chr10:64698098-64698111+0.9155.3242.411.2840.028NM_004241890 jumonji domain containing 1C (JMJD1C), mRNA.
chr1:206395429-206395442-0.9225.3822.201.2790.028NM_02517988859 plexin A2 (PLXNA2), mRNA.
chr9:35679986-35679999-0.9225.3822.361.2740.028NM_21367467 tropomyosin 2 (beta) (TPM2), transcript variant 2,
chr19:14405819-14405832-0.9325.4731.351.0310.028NM_002741753 protein kinase N1 (PKN1), transcript variant 2, mRNA.
chr5:172683741-172683754-0.9285.4341.781.0290.028NM_0037145371 stanniocalcin 2 (STC2), mRNA.
chr5:33927507-33927520+0.9295.4472.261.0290.028NM_030955374 a disintegrin-like and metalloprotease (reprolysin
chr1:203685829-203685842-0.9285.4341.551.0260.028NM_001001552-28025 LEM domain containing 1 (LEMD1), mRNA.
chr19:38408651-38408664-0.9285.4341.631.0230.028NM_019849-103 solute carrier family 7, (neutral amino acid
chr20:31737365-31737378-0.9305.4521.681.0170.028NM_005225489 E2F transcription factor 1 (E2F1), mRNA.
chr1:153319795-153319808-0.9325.4731.981.0170.028NM_0049521923 ephrin-A3 (EFNA3), mRNA.
chr17:24013373-24013386+0.9265.4151.901.0140.028NM_00317044 suppressor of Ty 6 homolog (S. cerevisiae) (SUPT6H),
chrX:153016174-153016187-0.9265.4151.481.0120.028NM_004992149 methyl CpG binding protein 2 (Rett syndrome) (MECP2),
chr1:223906465-223906478-0.9295.4471.591.0110.028NM_0010084931003-
chr3:187137999-187138012-0.9295.4471.631.0080.028NM_004593451 splicing factor, arginine/serine-rich 10 (transformer
chr17:21220511-21220524+0.9315.4601.361.0040.028NM_021012319 potassium inwardly-rectifying channel, subfamily J,
chr9:20596320-20596333+0.9275.4252.101.0010.028NM_00452916130 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr19:45016009-45016022+0.9305.4521.581.0000.028NM_004714672 dual-specificity tyrosine-(Y)-phosphorylation
chr7:27136941-27136954-0.9425.5511.640.9990.028NM_002141-17 homeo box A4 (HOXA4), mRNA.
chr6:15353407-15353420+0.9395.5261.580.9950.028NM_004973-999 Jumonji, AT rich interactive domain 2 (JARID2), mRNA.
chr19:39437273-39437286+0.9425.5531.520.9930.028NM_01468677 KIAA0355 (KIAA0355), mRNA.
chr1:43770487-43770500+0.9425.5511.370.9860.028NM_0028401453 protein tyrosine phosphatase, receptor type, F
chr11:118433163-118433176-0.9425.5531.790.9830.028NM_006389-41 hypoxia up-regulated 1 (HYOU1), mRNA.
chr22:40107307-40107320-0.9425.5531.650.9760.028NM_003216-502 thyrotrophic embryonic factor (TEF), mRNA.
chr20:47238312-47238325+0.9305.4521.450.8330.028NM_017454-1 staufen, RNA binding protein (Drosophila) (STAU),
chr16:48426304-48426317+0.9285.4341.510.8320.028NM_015069-7885 zinc finger protein 423 (ZNF423), mRNA.
chr19:51854628-51854641+0.9275.4291.400.8310.028NM_145056-4874 thymus expressed gene 3-like (MGC15476), mRNA.
chr13:49993984-49993997+0.9295.4471.740.8310.028NM_198989321902 deleted in lymphocytic leukemia 7 (DLEU7), mRNA.
chr7:127958906-127958919-0.9315.4601.150.8300.028NM_01839654987 methyltransferase like 2 (METTL2), mRNA.
chr12:50516397-50516410-0.9275.4251.470.8290.028NM_001013690-13922-
chr19:52307072-52307085-0.9275.4251.500.8260.028NM_0151681777-
chr6:30631689-30631702-0.9295.4471.510.8260.028NM_001077497-946-
chr4:153675906-153675919+0.9315.4601.450.8210.028NM_033632-284 F-box and WD-40 domain protein 7 (archipelago homolog,
chrX:44945272-44945285+0.9255.4071.590.8200.028NM_024689-182 chromosome X open reading frame 36 (CXorf36), mRNA.
chr6:43255856-43255869+0.9315.4601.780.8190.028NM_015089-1944 p53-associated parkin-like cytoplasmic protein (PARC),
chr17:7773492-7773505+0.9315.4601.310.8170.028NM_004732-14 potassium voltage-gated channel, shaker-related
chr10:126127364-126127377+0.9295.4472.150.8120.028NM_022126-12938 phospholysine phosphohistidine inorganic pyrophosphate
chr17:75529181-75529194-0.9275.4291.560.8120.028NM_01902095061 TBC1 domain family, member 16 (TBC1D16), mRNA.
chr1:45046189-45046202+0.9325.4731.790.8110.028NM_001013632-645-
chr19:40223985-40223998+0.9305.4521.810.8110.028NM_182983835 hepsin (transmembrane protease, serine 1) (HPN),
chr9:83494570-83494583-0.9255.4071.630.8110.028NM_005077-1154 transducin-like enhancer of split 1 (E(sp1) homolog,
chr3:50216031-50216044-0.9285.4341.900.8050.028NM_006841-1578 solute carrier family 38, member 3 (SLC38A3), mRNA.
chr1:41601371-41601384+0.9285.4341.460.8050.028NM_012236-120996 sex comb on midleg homolog 1 (Drosophila) (SCMH1),
chr9:115422843-115422856+0.9325.4732.270.8050.028NM_14448926922 regulator of G-protein signalling 3 (RGS3), transcript
chr9:139330403-139330416+0.9305.4521.360.8040.028NM_001004354-13879 similar to ankyrin-repeat protein Nrarp (MGC61598),
chr12:47679665-47679678-0.9315.4601.260.8010.028NM_015086-310-
chr1:154700388-154700401+0.9495.6101.600.6650.028NM_006365-34580 transcriptional activator of the c-fos promoter
chr1:12447350-12447363+0.9495.6101.890.6610.028NM_004753153057 dehydrogenase/reductase (SDR family) member 3 (DHRS3),
chr12:119017439-119017452-0.9495.6101.320.6570.028NM_00686121543 RAB35, member RAS oncogene family (RAB35), mRNA.
chr1:174932119-174932132+0.9495.6101.830.6500.028NM_020318233289 pappalysin 2 (PAPPA2), transcript variant 1, mRNA.
chr15:87219477-87219490-0.9525.6361.600.6480.028NM_17823220297 hyaluronan and proteoglycan link protein 3 (HAPLN3),
chr3:50277373-50277386+0.9525.6361.610.6450.028NM_001005914-2571-
chr12:49444099-49444112-0.9665.7581.270.4900.028NM_005171113 activating transcription factor 1 (ATF1), mRNA.
chr5:87890140-87890153-0.8935.1402.841.6500.029NM_153354-289719 hypothetical protein MGC33214 (MGC33214), mRNA.
chr15:58832107-58832120-0.9135.3122.561.4100.029NM_134260-125083 RAR-related orphan receptor A (RORA), transcript
chr1:42920735-42920748-0.9115.2932.481.4010.029NM_004559182 nuclease sensitive element binding protein 1 (NSEP1),
chr16:85653929-85653942-0.9495.6101.791.2040.029NM_024735320935 F-box protein 31 (FBXO31), mRNA.
chr17:18074623-18074636+0.9555.6602.001.1260.029NM_0041405062 lethal giant larvae homolog 1 (Drosophila) (LLGL1),
chr3:49482356-49482369-0.9635.7321.421.1260.029NM_004393-113 dystroglycan 1 (dystrophin-associated glycoprotein 1)
chr18:40516972-40516985+0.9635.7321.951.1190.029NM_015559-18395 SET binding protein 1 (SETBP1), mRNA.
chr10:45330443-45330456+0.9635.7322.431.1130.029NM_00100226620382 c-mir, cellular modulator of immune recognition (MIR),
chrX:70239967-70239980-0.9635.7321.801.1020.029NM_0010252653178-
chr19:13025861-13025874-0.9225.3821.611.0210.029NM_00558348820 lymphoblastic leukemia derived sequence 1 (LYL1),
chr11:61273745-61273758+0.9225.3821.941.0150.029NM_013279-5592 chromosome 11 open reading frame 9 (C11orf9), mRNA.
chr8:72919300-72919313+0.9225.3891.741.0110.029NM_005098-15 musculin (activated B-cell factor-1) (MSC), mRNA.
chr3:38182291-38182304+0.9155.3242.471.0100.029NM_005109361 oxidative-stress responsive 1 (OSR1), mRNA.
chr1:27212099-27212112-0.9265.4152.060.8990.029NM_052943-185 family with sequence similarity 46, member B (FAM46B),
chr17:58908454-58908467+0.9425.5531.500.8980.029NM_000789388 angiotensin I converting enzyme (peptidyl-dipeptidase
chr2:43312083-43312096-0.9295.4471.690.8970.029NM_006887-4834 zinc finger protein 36, C3H type-like 2 (ZFP36L2),
chr8:92122343-92122356+0.9325.4732.030.8930.029NM_018710-119 hypothetical protein DKFZp762O076 (DKFZp762O076),
chr12:95113779-95113792-0.9255.4072.200.8910.029NM_0052301541 ELK3, ETS-domain protein (SRF accessory protein 2)
chr20:45419750-45419763-0.9315.4601.770.8890.029NM_183048-869 protein kinase C binding protein 1 (PRKCBP1),
chrX:132931904-132931917+0.9255.4071.960.8870.029NM_00448415428 glypican 3 (GPC3), mRNA.
chr12:112441855-112441868-0.9285.4341.790.8860.029NM_022363-47595 LIM homeobox 5 (LHX5), mRNA.
chr6:45738896-45738909-0.9255.4071.980.8850.029NM_004348241104 runt-related transcription factor 2 (RUNX2), mRNA.
chr11:29995155-29995168+0.9425.5531.260.8850.029NM_002233-91 potassium voltage-gated channel, shaker-related
chr1:36394836-36394849-0.9285.4341.410.8790.029NM_018067546 hypothetical protein FLJ10350 (FLJ10350), mRNA.
chr19:3335925-3335938-0.9395.5261.180.8760.029NM_00559718452 nuclear factor I/C (CCAAT-binding transcription
chr15:71763518-71763531+0.9275.4251.700.8750.029NM_001024736-57-
chr6:6997118-6997131+0.9315.4601.280.8750.029NM_001003698-56045 ras responsive element binding protein 1 (RREB1),
chr2:71672962-71672975-0.9275.4291.790.8740.029NM_003494138794 dysferlin, limb girdle muscular dystrophy 2B
chr16:14631658-14631671+0.9425.5531.860.8710.029NM_002582-118 poly(A)-specific ribonuclease (deadenylation nuclease)
chr14:73620364-73620377+0.9295.4472.340.8710.029NM_005589585 aldehyde dehydrogenase 6 family, member A1 (ALDH6A1),
chr11:10272367-10272380-0.9255.4071.340.8690.029NM_030962-55 Charcot-Marie-Tooth neuropathy 4B2 (autosomal
chr19:51608798-51608811-0.9295.4471.530.8670.029NM_032040-117 coiled-coil domain containing 8 (CCDC8), mRNA.
chr17:6862786-6862799-0.9155.3241.320.8620.029NM_1748934038 hypothetical protein MGC49942 (MGC49942), mRNA.
chr5:140872984-140872997+0.9155.3241.720.8590.029NM_01892924092 protocadherin gamma subfamily C, 5 (PCDHGC5),
chr2:74454271-74454284+0.9215.3811.680.8520.029NM_023019716 dynactin 1 (p150, glued homolog, Drosophila) (DCTN1),
chrX:149210328-149210341-0.9155.3242.020.8440.029NM_005491-153950 chromosome X open reading frame 6 (CXorf6), mRNA.
chr10:71871491-71871504-0.9395.5262.000.7960.029NM_018055-62 nodal homolog (mouse) (NODAL), mRNA.
chr1:154326417-154326430+0.9425.5511.250.7950.029NM_001093725-8004-
chr3:62027293-62027306-0.9425.5511.630.7880.029NM_020685-253043 chromosome 3 open reading frame 14 (C3orf14), mRNA.
chr2:159021844-159021857+0.9365.5031.440.7750.029NM_003628222 plakophilin 4 (PKP4), mRNA.
chr2:12774413-12774426+0.9425.5531.450.7680.029NM_021643-146 tribbles homolog 2 (Drosophila) (TRIB2), mRNA.
chr17:52984006-52984019-0.9635.7321.230.5630.029NM_170721294733 musashi homolog 2 (Drosophila) (MSI2), transcript
chr2:32436634-32436647+0.9495.6101.760.5580.029NM_0162521134 baculoviral IAP repeat-containing 6 (apollon) (BIRC6),
chr10:76839422-76839435+0.9495.6101.490.5580.029NM_032772-7991 zinc finger protein 503 (ZNF503), mRNA.
chr3:185515351-185515364+0.9495.6101.010.5570.029NM_182917-337 eukaryotic translation initiation factor 4 gamma, 1
chrX:129019455-129019468-0.9495.6101.020.5570.029NM_00142152692 E74-like factor 4 (ets domain transcription factor)
chr17:35752011-35752024-0.9495.6101.260.5530.029NM_001024809243-
chr1:47651192-47651205-0.9495.6101.310.5490.029NM_012186-3039 forkhead box E3 (FOXE3), mRNA.
chr17:11442995-11443008+0.9635.7321.340.5490.029NM_001372622 dynein, axonemal, heavy polypeptide 9 (DNAH9),
chr2:20509892-20509905-0.9635.7321.370.5470.029NM_004040-324 ras homolog gene family, member B (RHOB), mRNA.
chr19:52353184-52353197+0.9495.6101.800.5460.029NM_00550027300 SUMO-1 activating enzyme subunit 1 (SAE1), mRNA.
chr3:182912014-182912027-0.9525.6361.370.5440.029NM_003106-302 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr4:95592040-95592053+0.9525.6361.320.5400.029NM_00645779 LIM protein (similar to rat protein kinase C-binding
chr22:40083601-40083614-0.9635.7321.030.5350.029NM_003216-24208 thyrotrophic embryonic factor (TEF), mRNA.
chr10:102404058-102404071-0.9495.6101.570.5350.029NM_003988-91300 paired box gene 2 (PAX2), transcript variant c, mRNA.
chr17:29929959-29929972-0.9495.6101.200.5320.029NM_207454542 FLJ44815 protein (FLJ44815), mRNA.
chr2:176748780-176748793+0.9495.6101.430.5250.029NM_00689811829 homeo box D3 (HOXD3), mRNA.
chr9:130188127-130188140-0.9635.7321.220.5250.029NM_03091414766 chromosome 9 open reading frame 74 (C9orf74), mRNA.
chr6:34629176-34629189+0.9495.6101.370.5250.029NM_0123912893 SAM pointed domain containing ets transcription factor
chr8:80798169-80798182+0.9495.6101.020.5240.029NM_00104070844484-
chr11:73037479-73037492-0.9495.6101.510.5240.029NM_0212002708 pleckstrin homology domain containing, family B
chr5:72565869-72565882-0.9635.7321.110.5230.029NM_15321766139 hypothetical protein MGC13034 (MGC13034), mRNA.
chr2:197737471-197737484-0.9635.7321.090.5180.029NM_15369733536 hypothetical protein DKFZp434D2328 (LOC91526), mRNA.
chr1:14897363-14897376+0.9495.6101.310.5100.029NM_01520999663-
chr7:150538576-150538589-0.9635.7321.100.5040.029NM_00569216674 ATP-binding cassette, sub-family F (GCN20), member 2
chr22:23176891-23176904+0.9635.7321.100.5040.029NM_00067517899 adenosine A2a receptor (ADORA2A), mRNA.
chr1:199929799-199929812+0.9635.7321.450.5040.029NM_02044345826 neuron navigator 1 (NAV1), mRNA.
chr3:46878309-46878322+0.9635.7321.230.5030.029NM_0002581668 myosin, light polypeptide 3, alkali; ventricular,
chr16:73739923-73739936-0.9635.7321.641.4020.030NM_153688101 zinc finger protein 1 homolog (mouse) (ZFP1), mRNA.
chr4:163304665-163304678-0.9395.5261.961.2970.030NM_020116-29 follistatin-like 5 (FSTL5), mRNA.
chr9:37017730-37017743+0.9425.5532.141.2770.030NM_0167346746 paired box gene 5 (B-cell lineage specific activator)
chr7:150283977-150283990-0.9425.5511.761.2740.030NM_172057-129 potassium voltage-gated channel, subfamily H
chr16:2504450-2504463+0.9525.6361.561.2570.030NM_001694596 ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
chr18:20972479-20972492+0.9495.6102.341.2420.030NM_015461213635 zinc finger protein 521 (ZNF521), mRNA.
chr19:47367708-47367721+0.9225.3822.201.2170.030NM_002698-39238 POU domain, class 2, transcription factor 2 (POU2F2),
chrX:139160199-139160212+0.9225.3822.221.2160.030NM_005634254692 SRY (sex determining region Y)-box 3 (SOX3), mRNA.
chr4:114190216-114190229-0.9225.3821.851.2000.030NM_020977-3 ankyrin 2, neuronal (ANK2), transcript variant 2,
chr15:32425332-32425345-0.9295.4472.061.1990.030NM_17574174 nuclear protein in testis (NUT), mRNA.
chr12:14302265-14302278+0.9295.4472.531.1980.030NM_018179-107513 activating transcription factor 7 interacting protein
chr3:49133283-49133296-0.9305.4521.961.1970.030NM_006677-66-
chr22:34476089-34476102-0.9255.4072.621.1970.030NM_03064232324 apolipoprotein L, 5 (APOL5), mRNA.
chr1:6767394-6767407-0.9285.4341.991.1900.030NM_015215-477-
chr22:39362391-39362404+0.9275.4251.961.1890.030NM_020831245 megakaryoblastic leukemia (translocation) 1 (MKL1),
chr1:153244291-153244304+0.9285.4341.941.1860.030NM_015872-9157 zinc finger protein 67 homolog (mouse) (ZFP67), mRNA.
chr15:70554938-70554951+0.9295.4472.421.1840.030NM_0057441317 ariadne homolog, ubiquitin-conjugating enzyme E2
chr10:112826676-112826689+0.9255.4072.271.1830.030NM_000681-135 adrenergic, alpha-2A-, receptor (ADRA2A), mRNA.
chr2:69724384-69724397-0.9315.4601.761.1830.030NM_01491197 AP2 associated kinase 1 (AAK1), mRNA.
chr11:71964961-71964974-0.9285.4342.611.1800.030NM_00259998099 phosphodiesterase 2A, cGMP-stimulated (PDE2A), mRNA.
chrX:68279883-68279896-0.9155.3241.901.1660.030NM_00103239622114-
chr19:60515509-60515522+0.9225.3822.111.1610.030NM_00108548813011-
chr17:35716997-35717010+0.9155.3241.991.1580.030NM_000964-1875 retinoic acid receptor, alpha (RARA), mRNA.
chr3:142586271-142586284+0.9155.3242.101.1530.030NM_00108041260626-
chr1:222687547-222687560+0.9155.3242.071.1510.030NM_025160788 WD repeat domain 26 (WDR26), mRNA.
chr15:41669629-41669642-0.9225.3821.951.1490.030NM_020990-2815 creatine kinase, mitochondrial 1 (ubiquitous) (CKMT1),
chr20:32611659-32611672-0.9225.3822.441.1340.030NM_0325141579 microtubule-associated protein 1 light chain 3 alpha
chr11:124100762-124100775+0.9225.3822.201.0940.030NM_006176-14090 neurogranin (protein kinase C substrate, RC3) (NRGN),
chr3:65558632-65558645+0.9165.3381.841.0900.030NM_001033057440917-
chr3:50248582-50248595-0.9165.3382.291.0850.030NM_00207031 guanine nucleotide binding protein (G protein), alpha
chr6:35418293-35418306+0.9425.5532.311.0330.030NM_00623880 peroxisome proliferative activated receptor, delta
chr1:40611914-40611927+0.9395.5261.751.0190.030NM_022733-301 hypothetical protein AL133206 (LOC64744), mRNA.
chr1:154097023-154097036+0.9425.5511.891.0000.030NM_1522801199 synaptotagmin XI (SYT11), mRNA.
chr5:141212919-141212932-0.9495.6101.040.6950.030NM_03242025209 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr7:100038733-100038746+0.9495.6101.550.6680.030NM_002593907 procollagen C-endopeptidase enhancer (PCOLCE), mRNA.
chr12:102848260-102848273-0.8975.1752.791.4610.031NM_00329941 tumor rejection antigen (gp96) 1 (TRA1), mRNA.
chr15:39574319-39574332-0.9115.2931.871.4360.031NM_0022201005 inositol 1,4,5-trisphosphate 3-kinase A (ITPKA), mRNA.
chr10:77397540-77397553+0.9225.3822.381.3330.031NM_032024185115 chromosome 10 open reading frame 11 (C10orf11), mRNA.
chr8:65452480-65452493-0.9155.3242.211.3160.031NM_152414-202788 basic helix-loop-helix domain containing, class B, 5
chr9:82603012-82603025+0.9225.3822.641.3090.031NM_005077890404 transducin-like enhancer of split 1 (E(sp1) homolog,
chr3:9414372-9414385+0.9315.4601.811.2990.031NM_00108051769-
chr11:129270418-129270431-0.9285.4341.771.2950.031NM_006165-2304 nuclear factor related to kappa B binding protein
chr6:106581753-106581766+0.9315.4602.331.2870.031NM_001198-59035 PR domain containing 1, with ZNF domain (PRDM1),
chr5:133830070-133830083+0.9285.4342.021.2820.031NM_080656-54582 similar to RIKEN cDNA A430101B06 gene (MGC13017),
chr12:5460243-5460256+0.9285.4342.211.2810.031NM_002527-13184 neurotrophin 3 (NTF3), mRNA.
chr8:116750926-116750939-0.9315.4601.621.2770.031NM_014112-524 trichorhinophalangeal syndrome I (TRPS1), mRNA.
chr8:89407798-89407811+0.9315.4601.711.2760.031NM_0059411035 matrix metalloproteinase 16 (membrane-inserted)
chr12:55807784-55807797-0.9265.4152.091.0630.031NM_002332-665 low density lipoprotein-related protein 1
chr7:87344037-87344050-0.9255.4071.601.0620.031NM_018843-433 mitochondrial carrier family protein (MCFP), mRNA.
chr11:64283262-64283275-0.9275.4251.741.0600.031NM_0056091501 phosphorylase, glycogen; muscle (McArdle syndrome,
chr19:12947324-12947337+0.9305.4521.661.0600.031NM_1526545992 hypothetical protein FLJ38607 (FLJ38607), mRNA.
chr2:37405213-37405226+0.9275.4251.141.0570.031NM_005813-7487 protein kinase C, nu (PRKCN), mRNA.
chr10:105031705-105031718+0.9295.4472.011.0540.031NM_0327274895 internexin neuronal intermediate filament protein,
chr17:42164896-42164909-0.9275.4252.231.0540.031NM_03075386185 wingless-type MMTV integration site family, member 3
chr15:42617468-42617481-0.9295.4471.801.0510.031NM_0037581010 eukaryotic translation initiation factor 3, subunit 1
chr11:118406742-118406755-0.9325.4731.991.0480.031NM_00146758 solute carrier family 37 (glycerol-6-phosphate
chr19:47446873-47446886+0.9275.4251.801.0460.031NM_0064944240 Ets2 repressor factor (ERF), mRNA.
chr8:130628416-130628429-0.9295.4471.771.0430.031NM_031415239900 melanoma-derived leucine zipper, extra-nuclear factor
chr17:26083051-26083064+0.9285.4341.581.0400.031NM_01598692766 cytokine receptor-like factor 3 (CRLF3), mRNA.
chr3:124188510-124188523+0.9295.4471.881.0380.031NM_00103170240756-
chr10:125263198-125263211+0.9275.4251.751.0380.031NM_153442-152563 G protein-coupled receptor 26 (GPR26), mRNA.
chr17:34604445-34604458+0.9285.4342.291.0370.031NM_0007232982 calcium channel, voltage-dependent, beta 1 subunit
chr5:82805113-82805126-0.9295.4471.921.0350.031NM_0043851874 chondroitin sulfate proteoglycan 2 (versican) (CSPG2),
chr2:219572931-219572944-0.9225.3821.580.9920.031NM_057094-6560 crystallin, beta A2 (CRYBA2), transcript variant 3,
chr8:142384527-142384540+0.9225.3821.560.9910.031NM_00529362020 G protein-coupled receptor 20 (GPR20), mRNA.
chr5:176492437-176492450+0.9225.3821.570.9860.031NM_022455-995 nuclear receptor binding SET domain protein 1 (NSD1),
chr3:172659494-172659507+0.9155.3241.980.9780.031NM_0150281052-
chr3:23933599-23933612+0.9225.3822.220.9710.031NM_00294856 ribosomal protein L15 (RPL15), mRNA.
chr5:113725861-113725874-0.9225.3892.120.9690.031NM_02161446 potassium intermediate/small conductance
chr12:55922672-55922685-0.9225.3821.680.9670.031NM_020142-1930 NADH:ubiquinone oxidoreductase MLRQ subunit homolog
chr12:46864104-46864117-0.9285.4342.130.9300.031NM_001013635538-
chr3:130516630-130516643+0.9295.4471.300.9300.031NM_0060261177 H1 histone family, member X (H1FX), mRNA.
chr6:37245549-37245562-0.9425.5511.270.9270.031NM_002648-315 pim-1 oncogene (PIM1), mRNA.
chr1:203985794-203985807-0.9285.4371.710.9260.031NM_022731122 nuclear ubiquitous casein kinase and cyclin-dependent
chr4:144476973-144476986+0.9255.4071.530.9250.031NM_002039-427 GRB2-associated binding protein 1 (GAB1), transcript
chr8:117588081-117588094-0.9295.4472.240.9250.031NM_003756249162 eukaryotic translation initiation factor 3, subunit 3
chr17:7731404-7731417+0.9295.4471.620.9230.031NM_001005273-1330 chromodomain helicase DNA binding protein 3 (CHD3),
chr19:50975968-50975981+0.9255.4071.920.9170.031NM_001081563-267-
chr11:127622035-127622048-0.9295.4471.780.9170.031NM_005238275336 v-ets erythroblastosis virus E26 oncogene homolog 1
chr11:3786352-3786365-0.9425.5531.550.9130.031NM_01448992 FGF receptor activating protein 1 (FRAG1), mRNA.
chr5:172193920-172193933+0.9425.5531.540.9130.031NM_00103171173-
chr8:144983280-144983293-0.9425.5531.400.9120.031NM_014281245 fuse-binding protein-interacting repressor (SIAHBP1),
chr5:87815801-87815814-0.9295.4471.890.9090.031NM_153354-215380 hypothetical protein MGC33214 (MGC33214), mRNA.
chr9:138141520-138141533+0.9285.4341.310.9040.031NM_1528339032-
chr11:32873453-32873466-0.9315.4601.910.9020.031NM_0010767862185-
chr22:26396857-26396870-0.9395.5261.200.9020.031NM_002430130629 meningioma (disrupted in balanced translocation) 1
chr1:206211704-206211717-0.9275.4291.830.9010.031NM_001773-60398 CD34 antigen (CD34), mRNA.
chr17:40661469-40661482+0.9225.3821.560.8950.031NM_0058926494 formin-like 1 (FMNL1), mRNA.
chrX:53281030-53281043+0.9165.3381.520.8930.031NM_004187-9701 Jumonji, AT rich interactive domain 1C (RBP2-like)
chr17:2546190-2546203-0.9225.3821.540.8910.031NM_01522915487 KIAA0664 protein (KIAA0664), mRNA.
chr9:109131874-109131887+0.9155.3242.260.8900.031NM_00287446609 RAD23 homolog B (S. cerevisiae) (RAD23B), mRNA.
chr1:42921006-42921019+0.9165.3311.770.8890.031NM_004559453 nuclease sensitive element binding protein 1 (NSEP1),
chr1:178435013-178435026-0.9225.3891.440.8820.031NM_033343-30952 LIM homeobox 4 (LHX4), mRNA.
chr20:30759817-30759830-0.9155.3241.830.8700.031NM_05304135658 COMM domain containing 7 (COMMD7), mRNA.
chr2:42574664-42574677+0.9425.5531.110.8180.031NM_13332977 potassium voltage-gated channel, subfamily G, member 3
chr16:65761890-65761903-0.9425.5531.450.8120.031NM_003946-3381 nucleolar protein 3 (apoptosis repressor with CARD
chr11:116520434-116520447-0.9635.7322.181.4560.032NM_002572284 platelet-activating factor acetylhydrolase, isoform
chr9:35663875-35663888-0.9225.3822.141.1310.032NM_00121660 carbonic anhydrase IX (CA9), mRNA.
chr9:117444451-117444464-0.9225.3892.171.1250.032NM_017418500633 deleted in esophageal cancer 1 (DEC1), mRNA.
chr3:178560511-178560524-0.9165.3311.971.1250.032NM_024665-162777 transducin (beta)-like 1X-linked receptor 1 (TBL1XR1),
chrX:19672457-19672470+0.9225.3892.621.1240.032NM_00102466655333-
chr15:38318645-38318658+0.9225.3822.001.1160.032NM_020168-623 p21(CDKN1A)-activated kinase 6 (PAK6), mRNA.
chr9:124001109-124001122+0.9225.3821.731.1150.032NM_01436829731 LIM homeobox 6 (LHX6), transcript variant 1, mRNA.
chr4:146013569-146013582+0.9225.3822.441.1040.032NM_002940-224937 ATP-binding cassette, sub-family E (OABP), member 1
chr8:65308923-65308936-0.9155.3242.471.1000.032NM_152414-346345 basic helix-loop-helix domain containing, class B, 5
chrX:68220617-68220630-0.9285.4341.510.7980.032NM_00103239681380-
chr1:59091550-59091563-0.9255.4071.450.7940.032NM_002228-69177 v-jun sarcoma virus 17 oncogene homolog (avian) (JUN),
chr11:6396493-6396506-0.9295.4471.700.7930.032NM_001164383 amyloid beta (A4) precursor protein-binding, family B,
chr19:10894676-10894689-0.9265.4151.400.7930.032NM_138358-5648 hypothetical protein BC011833 (LOC90580), mRNA.
chr22:24468770-24468783+0.9295.4471.300.7890.032NM_032608750 myosin XVIIIB (MYO18B), mRNA.
chr19:41119221-41119234+0.9305.4521.230.7880.032NM_024509-541 leucine rich repeat and fibronectin type III domain
chr3:195943262-195943275+0.9305.4521.440.7870.032NM_15369055451 family with sequence similarity 43, member A (FAM43A),
chr10:110768792-110768805-0.9295.4471.310.7870.032NM_020383904400 X-prolyl aminopeptidase (aminopeptidase P) 1, soluble
chr1:224802976-224802989+0.9255.4071.610.7860.032NM_001003665-48 similar to hypothetical protein Y97E10AL.1
chr1:21831288-21831301+0.9295.4471.480.7850.032NM_00288537098 RAP1, GTPase activating protein 1 (RAP1GA1), mRNA.
chr1:118529411-118529424-0.9295.4471.770.7830.032NM_206996-54 projection protein PF6 (PF6), mRNA.
chr3:47004416-47004429-0.9285.4341.740.7820.032NM_0151758339-
chr6:83130182-83130195-0.9265.4151.350.7800.032NM_00667024 trophoblast glycoprotein (TPBG), mRNA.
chr7:97681160-97681173-0.9325.4731.640.7790.032NM_1774551758 class II bHLH protein MIST1 (MIST1), mRNA.
chr3:26640561-26640574+0.9275.4251.960.7790.032NM_0529531357 leucine rich repeat containing 3B (LRRC3B), mRNA.
chr7:100591121-100591134+0.9295.4471.850.7780.032NM_0033784451 VGF nerve growth factor inducible (VGF), mRNA.
chr10:126772155-126772168-0.9275.4291.440.7770.032NM_022802-65712 C-terminal binding protein 2 (CTBP2), transcript
chr5:134855252-134855265+0.9265.4151.820.7760.032NM_001099221-39264-
chr4:74343274-74343287+0.9305.4521.220.7760.032NM_03221792 ankyrin repeat domain 17 (ANKRD17), transcript variant
chr17:45408173-45408186+0.9285.4341.340.7740.032NM_0019343144 distal-less homeobox 4 (DLX4), transcript variant 2,
chr11:118693087-118693100+0.9315.4601.180.7730.032NM_006500-37 melanoma cell adhesion molecule (MCAM), mRNA.
chr11:1549062-1549075-0.9285.4341.420.7730.032NM_004420664 dual specificity phosphatase 8 (DUSP8), mRNA.
chr18:29415951-29415964-0.9295.4471.680.7680.032NM_0306323512-
chr8:127639956-127639969-0.9425.5531.840.7530.032NM_174911-308 breast cancer membrane protein 101 (NSE2), mRNA.
chrX:119328324-119328337-0.9425.5511.400.7440.032NM_017938992 hypothetical protein FLJ20716 (FLJ20716), mRNA.
chr11:31789851-31789864-0.9425.5531.460.7390.032NM_001604-396 paired box gene 6 (aniridia, keratitis) (PAX6), mRNA.
chr7:4965378-4965391+0.9425.5531.340.7360.032NM_198403-8 monocyte to macrophage differentiation-associated 2
chr18:5532986-5532999-0.9495.6101.000.4880.032NM_0123071000 erythrocyte membrane protein band 4.1-like 3
chr14:88498297-88498310+0.9495.6101.250.4880.032NM_198310137666 tetratricopeptide repeat domain 8 (TTC8), transcript
chr3:32859260-32859273-0.9495.6101.140.4780.032NM_00103911124846-
chr5:170781490-170781503+0.9495.6101.320.4710.032NM_0038622318 fibroblast growth factor 18 (FGF18), transcript
chr17:68831972-68831985+0.9495.6101.520.4700.032NM_012121-12234 CDC42 effector protein (Rho GTPase binding) 4
chr2:104828029-104828042-0.9495.6102.281.2910.033NM_006236-10272 POU domain, class 3, transcription factor 3 (POU3F3),
chr16:8285888-8285901+0.9495.6102.061.2860.033NM_024109-337040 hypothetical protein MGC2654 (MGC2654), mRNA.
chr20:51477361-51477374-0.9495.6102.091.2780.033NM_006526155682 zinc finger protein 217 (ZNF217), mRNA.
chr6:149681053-149681066+0.9495.6101.791.2730.033NM_015093397 mitogen-activated protein kinase kinase kinase 7
chr14:93274044-93274057+0.9525.6362.101.2700.033NM_17801350475 proline rich membrane anchor 1 (PRIMA1), mRNA.
chr10:102762467-102762480-0.9155.3241.901.2590.033NM_03242915612 leucine zipper, putative tumor suppressor 2 (LZTS2),
chr8:102033864-102033877-0.9155.3241.921.2560.033NM_145690-417 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
chr1:38341407-38341420+0.9155.3242.061.2400.033NM_002699-56370 POU domain, class 3, transcription factor 1 (POU3F1),
chr19:45641126-45641139+0.9295.4472.271.2310.033NM_013368-781 SERTA domain containing 3 (SERTAD3), transcript
chr19:54780211-54780224-0.9295.4471.891.2270.033NM_0009512031 proline rich Gla (G-carboxyglutamic acid) 2 (PRRG2),
chr7:140417684-140417697-0.9275.4252.091.2260.033NM_053035-56468 mitochondrial ribosomal protein S33 (MRPS33), nuclear
chr1:41642898-41642911+0.9285.4342.171.2250.033NM_00195679986 endothelin 2 (EDN2), mRNA.
chr2:241345600-241345613+0.9285.4341.881.2220.033NM_00432162697 kinesin family member 1A (KIF1A), mRNA.
chr11:16126957-16126970-0.9295.4472.191.2120.033NM_017508254011-
chr17:39994420-39994433+0.9295.4472.051.2100.033NM_0014664069 frizzled homolog 2 (Drosophila) (FZD2), mRNA.
chr17:18027731-18027744+0.9275.4252.221.2060.033NM_017758239 hypothetical protein FLJ20308 (FLJ20308), mRNA.
chr12:45052495-45052508-0.9275.4251.701.2050.033NM_018976319 solute carrier family 38, member 2 (SLC38A2), mRNA.
chr1:162813331-162813344-0.9295.4471.731.2050.033NM_00258517870 pre-B-cell leukemia transcription factor 1 (PBX1),
chr10:28074538-28074551+0.9295.4471.841.2000.033NM_173576215 chromosome 10 open reading frame 48 (C10orf48), mRNA.
chr4:169789858-169789871+0.9635.7322.051.1920.033NM_016081135166 palladin (KIAA0992), mRNA.
chr20:30871623-30871636+0.9635.7321.951.1850.033NM_012325288 microtubule-associated protein, RP/EB family, member 1
chr8:25371905-25371918-0.9635.7321.861.1820.033NM_017634-68 potassium channel tetramerisation domain containing 9
chr8:23442404-23442417-0.9425.5512.191.0370.033NM_016612196 mitochondrial solute carrier protein (MSCP), mRNA.
chr13:57102109-57102122-0.9425.5531.941.0360.033NM_001040429-1581-
chr16:29598431-29598444+0.9285.4341.690.9640.033NM_014298589 quinolinate phosphoribosyltransferase
chr4:41578921-41578934-0.9275.4251.660.9590.033NM_018126-52905 transmembrane protein 33 (TMEM33), mRNA.
chr12:3128206-3128219+0.9255.4072.090.9560.033NM_00667571488 transmembrane 4 superfamily member tetraspan NET-5
chr7:129380180-129380193-0.9295.4471.920.9550.033NM_182697-155 ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast)
chrX:136334613-136334626+0.9295.4471.570.9550.033NM_003413-141299 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr16:1980396-1980409+0.9255.4071.480.9540.033NM_004209527 synaptogyrin 3 (SYNGR3), mRNA.
chr3:23822358-23822371+0.9275.4251.640.9510.033NM_18266615 ubiquitin-conjugating enzyme E2E 1 (UBC4/5 homolog,
chr3:129699468-129699481-0.9255.4071.510.9500.033NM_032638-4750 GATA binding protein 2 (GATA2), mRNA.
chr1:23623839-23623852+0.9425.5531.720.9490.033NM_0031969 transcription elongation factor A (SII), 3 (TCEA3),
chr10:102517739-102517752-0.9285.4342.140.9490.033NM_00027822381 paired box gene 2 (PAX2), transcript variant b, mRNA.
chr20:51728139-51728152+0.9295.4472.140.9470.033NM_006526-95096 zinc finger protein 217 (ZNF217), mRNA.
chr8:53789585-53789598+0.9315.4601.900.9450.033NM_014781-6 RB1-inducible coiled-coil 1 (RB1CC1), mRNA.
chr20:55274721-55274734-0.9265.4152.010.9450.033NM_001719-13 bone morphogenetic protein 7 (osteogenic protein 1)
chr1:87569841-87569854+0.9255.4071.550.9420.033NM_0067693202 LIM domain only 4 (LMO4), mRNA.
chr17:7138216-7138229-0.9285.4341.510.9400.033NM_015982382 germ cell specific Y-box binding protein (YBX2), mRNA.
chr13:87123243-87123256+0.9285.4342.120.9400.033NM_015567472 SLIT and NTRK-like family, member 5 (SLITRK5), mRNA.
chr13:40138360-40138373-0.9285.4341.350.9390.033NM_002015374 forkhead box O1A (rhabdomyosarcoma) (FOXO1A), mRNA.
chr1:32574009-32574022+0.9315.4601.350.9380.033NM_023009401 MARCKS-like protein (MLP), mRNA.
chr3:195175962-195175975+0.9295.4472.400.9380.033NM_005524-160566 hairy and enhancer of split 1, (Drosophila) (HES1),
chr20:30813791-30813804+0.9425.5531.310.9340.033NM_17584939 DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B),
chr19:50196516-50196529-0.9425.5531.370.9340.033NM_00650964 v-rel reticuloendotheliosis viral oncogene homolog B,
chr19:50039833-50039846+0.9155.3241.440.9280.033NM_002856-1300 poliovirus receptor-related 2 (herpesvirus entry
chr16:20819123-20819136-0.9185.3512.170.9280.033NM_17347538 hypothetical protein MGC48972 (MGC48972), mRNA.
chr22:26528052-26528065-0.9155.3241.620.9280.033NM_002430-566 meningioma (disrupted in balanced translocation) 1
chr2:162738245-162738258+0.9155.3242.460.9240.033NM_002054-21242 glucagon (GCG), mRNA.
chr17:7697794-7697807-0.9225.3891.560.9230.033NM_203411-1215 similar to RIKEN cDNA 2600017H02 (LOC92162), mRNA.
chr5:133830435-133830448-0.9155.3291.500.9210.033NM_080656-54947 similar to RIKEN cDNA A430101B06 gene (MGC13017),
chr17:59130584-59130597-0.9225.3821.600.9190.033NM_030576667 hypothetical protein MGC10986 (MGC10986), mRNA.
chr15:94677391-94677404+0.9225.3891.980.9070.033NM_0210052541 nuclear receptor subfamily 2, group F, member 2
chr17:35757565-35757578+0.9225.3821.410.9060.033NM_0010248095797-
chr8:64680594-64680607-0.9275.4252.231.3180.034NM_152758437019 YTH domain family 3 (YTHDF3), mRNA.
chr17:4818143-4818156-0.9305.4522.211.3160.034NM_004890-6287 sperm associated antigen 7 (SPAG7), mRNA.
chr1:26591965-26591978-0.9285.4342.731.3110.034NM_024674-17791 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr20:33487579-33487592-0.9275.4252.451.3110.034NM_0005571862 growth differentiation factor 5 (cartilage-derived
chr15:75500539-75500552+0.9295.4471.991.3010.034NM_018200341 high-mobility group 20A (HMG20A), mRNA.
chr1:202031837-202031850-0.9295.4472.051.0960.034NM_014827563 KIAA0663 gene product (KIAA0663), mRNA.
chrX:46503559-46503572+0.9315.4601.481.0930.034NM_032591-143 solute carrier family 9 (sodium/hydrogen exchanger),
chr17:7249507-7249520-0.9315.4601.521.0920.034NM_152766-1365 hypothetical protein MGC40107 (MGC40107), mRNA.
chr9:132805151-132805164-0.9255.4071.331.0920.034NM_032843-1093 fibrinogen C domain containing 1 (FIBCD1), mRNA.
chr11:95714864-95714877+0.9295.4471.811.0920.034NM_0324271128 mastermind-like 2 (Drosophila) (MAML2), mRNA.
chr1:27774411-27774424+0.9285.4341.741.0830.034NM_00102988228319-
chr15:38419768-38419781-0.9285.4342.431.0820.034NM_207380-2142 FLJ43339 protein (FLJ43339), mRNA.
chr10:62883015-62883028-0.9295.4472.251.0790.034NM_178505199 transmembrane protein 26 (TMEM26), mRNA.
chr12:48019148-48019161+0.9275.4251.611.0780.034NM_001008223-1910-
chr20:43468610-43468623-0.9275.4251.841.0770.034NM_00104822459-
chr11:117997270-117997283-0.9325.4731.761.0740.034NM_01515714947 pleckstrin homology-like domain, family B, member 1
chr7:127788149-127788162+0.9295.4471.961.0700.034NM_018077-16951 RNA binding motif protein 28 (RBM28), mRNA.
chr11:30564123-30564136-0.9315.4601.601.0680.034NM_001584-5507 chromosome 11 open reading frame 8 (C11orf8), mRNA.
chr9:4206802-4206815+0.9635.7321.120.4950.034NM_152629-64619 GLIS family zinc finger 3 (GLIS3), mRNA.
chr11:124808008-124808021-0.9635.7321.140.4930.034NM_00510363325 fasciculation and elongation protein zeta 1 (zygin I)
chr14:23065008-23065021+0.9635.7321.050.4890.034NM_024328-29963-
chr6:163754986-163754999-0.9635.7321.130.4860.034NM_206853-579 quaking homolog, KH domain RNA binding (mouse) (QKI),
chr3:197120124-197120137-0.9665.7581.080.4280.034NM_005781153 activated Cdc42-associated kinase 1 (ACK1), mRNA.
chr1:16215228-16215241-0.9665.7581.020.4060.034NM_0144242310 heat shock 27kDa protein family, member 7
chr16:1150021-1150034+0.9665.7581.050.4020.034NM_0210986879 calcium channel, voltage-dependent, alpha 1H subunit
chrX:130021139-130021152+0.9665.7581.680.4020.034NM_1449671342 hypothetical protein FLJ30058 (FLJ30058), mRNA.
chr5:124118355-124118368+0.8935.1402.951.5240.035NM_020747-9651-
chr10:63333813-63333826-0.8975.1752.471.3840.035NM_0321992464-
chr2:219659705-219659718+0.9395.5262.591.1970.035NM_002181-26272 Indian hedgehog homolog (Drosophila) (IHH), mRNA.
chr17:800293-800306+0.9355.4961.961.1840.035NM_02246329467 nucleoredoxin (NXN), mRNA.
chr10:102749211-102749224+0.9425.5511.661.1700.035NM_0324292356 leucine zipper, putative tumor suppressor 2 (LZTS2),
chr3:137398185-137398198-0.9285.4342.391.1660.035NM_018133-807 hypothetical protein FLJ10546 (FLJ10546), mRNA.
chr17:2443980-2443993-0.9315.4602.191.1620.035NM_000430394 platelet-activating factor acetylhydrolase, isoform
chr17:46060361-46060374+0.9285.4341.681.1570.035NM_003786-6766 ATP-binding cassette, sub-family C (CFTR/MRP), member
chr17:30331857-30331870-0.9255.4071.801.1480.035NM_013975306 ligase III, DNA, ATP-dependent (LIG3), transcript
chr2:63132134-63132147-0.9315.4601.841.1470.035NM_014562765 orthodenticle homolog 1 (Drosophila) (OTX1), mRNA.
chr15:21444169-21444182-0.9255.4072.011.1450.035NM_019066-1901 MAGE-like 2 (MAGEL2), mRNA.
chr17:32223623-32223636+0.9255.4072.181.1430.035NM_005568-144889 LIM homeobox 1 (LHX1), mRNA.
chrX:9391251-9391264+0.9295.4472.051.1410.035NM_005647-1688 transducin (beta)-like 1X-linked (TBL1X), mRNA.
chr9:35529120-35529133+0.9285.4341.961.1400.035NM_00109995124776-
chr19:40462085-40462098-0.9285.4341.891.1380.035NM_021175-3065 hepcidin antimicrobial peptide (HAMP), mRNA.
chr1:50287244-50287257-0.9295.4472.161.1360.035NM_021952-59881 ELAV (embryonic lethal, abnormal vision,
chr1:242681855-242681868-0.9425.5531.921.0960.035NM_001126181 adenylosuccinate synthase (ADSS), mRNA.
chr1:243092976-243092989-0.9385.5231.641.0740.035NM_0045011474 heterogeneous nuclear ribonucleoprotein U (scaffold
chr12:52167255-52167268-0.9225.3892.030.8310.035NM_00630112283 mitogen-activated protein kinase kinase kinase 12
chr19:53649474-53649487-0.9165.3381.670.8260.035NM_013348-1004 potassium inwardly-rectifying channel, subfamily J,
chr1:31973592-31973605+0.9225.3821.530.8260.035NM_00170328643 brain-specific angiogenesis inhibitor 2 (BAI2), mRNA.
chr6:33703837-33703850+0.9155.3242.020.8110.035NM_0022246798 inositol 1,4,5-triphosphate receptor, type 3 (ITPR3),
chr15:87718474-87718487-0.9155.3242.180.8090.035NM_002693-39444 polymerase (DNA directed), gamma (POLG), mRNA.
chr16:620921-620934-0.9225.3821.560.8070.035NM_0532848 WAP, follistatin/kazal, immunoglobulin, kunitz and
chr5:138610180-138610193-0.9165.3381.780.8050.035NM_199189-27411-
chr7:43249900-43249913+0.9165.3382.010.8050.035NM_015052131277 NEDD4-like ubiquitin-protein ligase 1 (NEDL1), mRNA.
chr19:45798133-45798146+0.9165.3381.500.8000.035NM_001042545-884-
chr11:32405001-32405014-0.9225.3821.520.8000.035NM_0003788662 Wilms tumor 1 (WT1), transcript variant A, mRNA.
chr5:61064457-61064470+0.9225.3821.750.8000.035NM_17366795164 hypothetical protein FLJ37543 (FLJ37543), mRNA.
chr15:87706921-87706934-0.9115.2931.681.3960.036NM_002693-27891 polymerase (DNA directed), gamma (POLG), mRNA.
chr17:4826199-4826212+0.9055.2412.581.3920.036NM_0150995456 calmodulin binding transcription activator 2 (CAMTA2),
chr12:4893527-4893540+0.9135.3122.841.3850.036NM_0002174293 potassium voltage-gated channel, shaker-related
chr1:35795953-35795966+0.9075.2602.491.3840.036NM_01428473 neurochondrin (NCDN), mRNA.
chr1:153443816-153443829-0.9525.6362.231.3190.036NM_007112498 thrombospondin 3 (THBS3), mRNA.
chr10:100019261-100019274-0.9225.3892.160.9600.036NM_032211-1264 lysyl oxidase-like 4 (LOXL4), mRNA.
chr16:52121553-52121566-0.9225.3821.730.9600.036NM_022476-26882 fused toes homolog (mouse) (FTS), mRNA.
chr7:96298663-96298676-0.9155.3242.150.9570.036NM_006304-121524 split hand/foot malformation (ectrodactyly) type 1
chr4:94968971-94968984+0.9225.3821.580.9530.036NM_005172-30 atonal homolog 1 (Drosophila) (ATOH1), mRNA.
chr1:25124392-25124405-0.9165.3382.300.9520.036NM_0043504965 runt-related transcription factor 3 (RUNX3), mRNA.
chr16:48450264-48450277-0.9165.3381.680.9430.036NM_015069-31845 zinc finger protein 423 (ZNF423), mRNA.
chr1:107589267-107589280+0.9225.3821.810.9420.036NM_014917105099-
chr8:28803816-28803829+0.9225.3822.490.9340.036NM_024567-228 hypothetical protein FLJ21616 (FLJ21616), mRNA.
chr17:19206277-19206290-0.9665.7581.000.4560.036NM_015681342 B9 protein (EPPB9), mRNA.
chr5:50729848-50729861+0.9425.5512.561.3630.037NM_00220215233 ISL1 transcription factor, LIM/homeodomain, (islet-1)
chr17:1848246-1848259+0.9295.4472.271.2560.037NM_17856826682 reticulon 4 receptor-like 1 (RTN4RL1), mRNA.
chr19:12694111-12694124-0.9315.4602.321.2530.037NM_013433-33 transportin 2 (importin 3, karyopherin beta 2b)
chr2:203901174-203901187+0.9275.4251.981.2520.037NM_00575926 abl interactor 2 (ABI2), mRNA.
chr10:31649421-31649434+0.9285.4342.081.2510.037NM_0307511373 transcription factor 8 (represses interleukin 2
chr17:1249787-1249800-0.9315.4601.761.2490.037NM_006761480 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
chr11:11820077-11820090+0.9285.4342.011.2450.037NM_017944631 ubiquitin specific protease 47 (USP47), mRNA.
chr20:10567631-10567644-0.9295.4472.841.2450.037NM_00021434959 jagged 1 (Alagille syndrome) (JAG1), mRNA.
chr9:129588734-129588747+0.9275.4251.621.2430.037NM_001261676 cyclin-dependent kinase 9 (CDC2-related kinase)
chr15:95127598-95127611-0.9275.4252.011.2420.037NM_17349915 spermatogenesis-related protein 8 (MGC44294), mRNA.
chr14:22840678-22840691+0.9425.5531.931.2310.037NM_004050-5098 BCL2-like 2 (BCL2L2), mRNA.
chr15:86890843-86890856-0.9425.5532.121.2250.037NM_01799645 de-etiolated 1 (DET1), mRNA.
chrX:30581506-30581519-0.9425.5512.421.2230.037NM_203391145 glycerol kinase (GK), transcript variant 1, mRNA.
chr1:109853923-109853936+0.9425.5531.681.2070.037NM_020703-64-
chr12:48047460-48047473+0.9395.5261.631.2060.037NM_023071605 spermatogenesis associated, serine-rich 2 (SPATS2),
chr1:114249358-114249371-0.9295.4471.781.1330.037NM_022836-103 DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae)
chrX:122694373-122694386+0.9285.4342.181.1330.037NM_001081550212-
chr1:111936954-111936967-0.9275.4292.511.1270.037NM_001010935-26874-
chr5:140996599-140996612-0.9265.4151.991.1260.037NM_003883-3 histone deacetylase 3 (HDAC3), mRNA.
chr1:75372810-75372823+0.9315.4602.151.1240.037NM_0010019336203 LIM homeobox 8 (LHX8), mRNA.
chr15:82945465-82945478+0.9285.4342.081.1220.037NM_181877312 zinc finger protein 29 (ZFP29), mRNA.
chr6:108585520-108585533-0.9315.4601.591.1210.037NM_003269-8335 nuclear receptor subfamily 2, group E, member 1
chr11:118298025-118298038-0.9285.4341.531.1190.037NM_182557-11202 B-cell CLL/lymphoma 9-like (BCL9L), mRNA.
chr1:181075330-181075343+0.9295.4471.931.1120.037NM_001357356 DEAH (Asp-Glu-Ala-His) box polypeptide 9 (DHX9),
chr19:34995379-34995392+0.9285.4341.421.1090.037NM_05718278 cyclin E1 (CCNE1), transcript variant 2, mRNA.
chr6:13380823-13380836+0.9255.4071.921.1080.037NM_01649555770 TBC1 domain family, member 7 (TBC1D7), mRNA.
chr15:38516203-38516216-0.9275.4252.051.1000.037NM_014952-4400 bromo adjacent homology domain containing 1 (BAHD1),
chrX:103298410-103298423-0.9285.4341.991.1000.037NM_207318553-
chr6:42183077-42183090+0.9165.3381.300.7990.037NM_000409-47975 guanylate cyclase activator 1A (retina) (GUCA1A),
chr6:101948514-101948527+0.9225.3891.430.7960.037NM_021956-5061 glutamate receptor, ionotropic, kainate 2 (GRIK2),
chr22:42140678-42140691-0.9225.3821.440.7920.037NM_0010443702814-
chr4:77764719-77764732+0.9225.3821.540.7870.037NM_020859189542 Shroom-related protein (ShrmL), mRNA.
chr14:77611232-77611245+0.9155.3241.110.7830.037NM_020421275105 aarF domain containing kinase 1 (ADCK1), mRNA.
chr19:10404685-10404698+0.9155.3241.310.7820.037NM_006202-19852 phosphodiesterase 4A, cAMP-specific (phosphodiesterase
chr8:22715244-22715257-0.9225.3891.770.7810.037NM_004430-108484 early growth response 3 (EGR3), mRNA.
chr22:40346916-40346929+0.9225.3821.510.7800.037NM_015704-54-
chr11:8848829-8848842-0.9155.3241.880.7800.037NM_00541840245 suppression of tumorigenicity 5 (ST5), transcript
chr10:80561215-80561228-0.9155.3241.460.7780.037NM_020338-30561 retinoic acid induced 17 (RAI17), mRNA.
chr19:50446606-50446619+0.9155.3231.430.7740.037NM_03141724 MAP/microtubule affinity-regulating kinase 4 (MARK4),
chr4:175987005-175987018+0.9165.3311.350.7740.037NM_00104254335-
chr10:78400860-78400873-0.9155.3241.580.7710.037NM_001014797666723-
chr4:85639269-85639282-0.9165.3311.770.7690.037NM_006168-858 NK6 transcription factor related, locus 1 (Drosophila)
chr20:44344824-44344837-0.8935.1412.441.4320.038NM_021248-31083 cadherin-like 22 (CDH22), mRNA.
chr7:69878090-69878103+0.8935.1402.361.4230.038NM_022479-357535 Williams-Beuren syndrome chromosome region 17
chr9:88707954-88707967-0.9635.7321.911.2660.038NM_00204843970 growth arrest-specific 1 (GAS1), mRNA.
chr15:39007268-39007281-0.9635.7321.931.2620.038NM_019074-1471 delta-like 4 (Drosophila) (DLL4), mRNA.
chr3:126074962-126074975-0.9635.7322.111.2580.038NM_00221313872 integrin, beta 5 (ITGB5), mRNA.
chr7:138695633-138695646+0.9635.7321.471.2340.038NM_016019559 LUC7-like 2 (S. cerevisiae) (LUC7L2), mRNA.
chr5:124270233-124270246-0.9425.5512.191.1330.038NM_020747-161529-
chr11:65944111-65944124-0.9425.5531.671.1300.038NM_178864-840 HLH-PAS transcription factor NXF (NXF), mRNA.
chr5:174080724-174080737+0.9425.5532.171.1200.038NM_002449-3357 msh homeo box homolog 2 (Drosophila) (MSX2), mRNA.
chr20:60246995-60247008+0.9425.5531.601.1190.038NM_144498120 oxysterol binding protein-like 2 (OSBPL2), transcript
chr3:195330319-195330332-0.9395.5262.361.1150.038NM_005524-6209 hairy and enhancer of split 1, (Drosophila) (HES1),
chr11:111288610-111288623-0.9435.5591.871.1040.038NM_0015411 heat shock 27kDa protein 2 (HSPB2), mRNA.
chr14:20563859-20563872+0.9315.4601.440.7660.038NM_201537-84 NDRG family member 2 (NDRG2), transcript variant 4,
chr16:65491576-65491589+0.9285.4341.790.7660.038NM_00406218691 cadherin 16, KSP-cadherin (CDH16), mRNA.
chr15:64466286-64466299-0.9315.4601.200.7650.038NM_002755-293 mitogen-activated protein kinase kinase 1 (MAP2K1),
chr5:72565851-72565864-0.9315.4601.430.7640.038NM_15321766121 hypothetical protein MGC13034 (MGC13034), mRNA.
chr1:18551876-18551889+0.9255.4071.400.7630.038NM_152375-128035 hypothetical protein FLJ38753 (FLJ38753), mRNA.
chr5:141118534-141118547+0.9325.4731.660.7620.038NM_022481-76550 ARF-GAP, RHO-GAP, ankyrin repeat and plekstrin
chr7:103417419-103417432-0.9265.4151.380.7620.038NM_173054-221 reelin (RELN), transcript variant 2, mRNA.
chr1:116187239-116187252-0.9285.4341.450.7600.038NM_005599-1969 nescient helix loop helix 2 (NHLH2), mRNA.
chr5:140032980-140032993-0.9295.4471.530.7580.038NM_194249375 dead end homolog 1 (zebrafish) (DND1), mRNA.
chr20:60377150-60377163+0.9275.4251.320.7580.038NM_005560-1387 laminin, alpha 5 (LAMA5), mRNA.
chr3:150286769-150286782-0.9275.4291.580.7580.038NM_003071262 SWI/SNF related, matrix associated, actin dependent
chrX:152643425-152643438-0.9255.4071.390.7570.038NM_000033-5 ATP-binding cassette, sub-family D (ALD), member 1
chr1:210525988-210526001-0.9255.4071.370.7560.038NM_006243586 protein phosphatase 2, regulatory subunit B (B56),
chr6:131076163-131076176-0.9275.4251.660.7530.038NM_052913276308 KIAA1913 (KIAA1913), mRNA.
chr3:160964415-160964428+0.9255.4071.490.7520.038NM_000882-224808 interleukin 12A (natural killer cell stimulatory
chr1:172104398-172104411-0.9285.4341.440.7500.038NM_032522343 zinc finger and BTB domain containing 37 (ZBTB37),
chr11:62239183-62239196-0.9285.4341.520.7480.038NM_0122027574 guanine nucleotide binding protein (G protein), gamma
chr1:151967132-151967145-0.9315.4601.210.7460.038NM_02301541 hypothetical protein FLJ21919 (FLJ21919), mRNA.
chr2:144806550-144806563-0.9315.4601.170.7450.038NM_024659-51 glycosyltransferase-like 1 (GTDC1), mRNA.
chr11:69162397-69162410-0.9325.4731.500.7440.038NM_053056-2557 cyclin D1 (PRAD1: parathyroid adenomatosis 1) (CCND1),
chr11:111288535-111288548+0.9325.4731.850.7420.038NM_001541-74 heat shock 27kDa protein 2 (HSPB2), mRNA.
chr8:124478168-124478181+0.9325.4731.560.7420.038NM_014109-300 ATPase family, AAA domain containing 2 (ATAD2), mRNA.
chr11:113633631-113633644-0.9285.4341.420.7420.038NM_006169-38014 nicotinamide N-methyltransferase (NNMT), mRNA.
chr20:43435769-43435782+0.9275.4251.300.7400.038NM_0144774602 chromosome 20 open reading frame 10 (C20orf10), mRNA.
chr22:20251946-20251959-0.9305.4521.350.7380.038NM_19815789 ubiquitin-conjugating enzyme E2L 3 (UBE2L3),
chr9:95968779-95968792+0.9315.4601.510.7370.038NM_15242282312 protein tyrosine phosphatase domain containing 1
chr15:91417418-91417431-0.9255.4071.370.7370.038NM_02021116019 RGM domain family, member A (RGMA), mRNA.
chr10:104374373-104374386-0.9295.4472.110.7340.038NM_030912-19769 tripartite motif-containing 8 (TRIM8), mRNA.
chr19:53365417-53365430+0.9425.5531.370.7270.038NM_000234-45 ligase I, DNA, ATP-dependent (LIG1), mRNA.
chr16:47873288-47873301-0.9425.5531.360.7270.038NM_004352-104 cerebellin 1 precursor (CBLN1), mRNA.
chr11:106967153-106967166-0.9425.5531.060.7230.038NM_018712-34 ELMO domain containing 1 (ELMOD1), mRNA.
chr20:36777834-36777847-0.9425.5511.660.7200.038NM_080552-8585 vesicular inhibitory amino acid transporter (VIAAT),
chr9:139315588-139315601-0.9395.5261.020.7160.038NM_001004354936 similar to ankyrin-repeat protein Nrarp (MGC61598),
chr5:113724846-113724859-0.9395.5261.690.7160.038NM_021614-969 potassium intermediate/small conductance
chr12:129212261-129212274-0.9425.5511.360.7150.038NM_007197-624 frizzled homolog 10 (Drosophila) (FZD10), mRNA.
chr5:138767470-138767483-0.9395.5261.150.7110.038NM_016459-13966 proapoptotic caspase adaptor protein (PACAP), mRNA.
chr14:23907898-23907911-0.9425.5511.110.7090.038NM_004554904 nuclear factor of activated T-cells, cytoplasmic,
chr6:36272984-36272997-0.9425.5531.630.7090.038NM_015695556-
chr17:7055806-7055819+0.9425.5511.130.7070.038NM_000018-7971 acyl-Coenzyme A dehydrogenase, very long chain
chr2:161058631-161058644+0.9425.5531.380.7010.038NM_016839-80 RNA binding motif, single stranded interacting protein
chr17:51277966-51277979-0.8334.6322.411.5410.039NM_02121394617 phosphatidylcholine transfer protein (PCTP), mRNA.
chr11:66033381-66033394+0.9425.5511.150.5950.039NM_024649-1214 Bardet-Biedl syndrome 1 (BBS1), mRNA.
chr11:9642176-9642189+0.9425.5531.060.5910.039NM_01505572 SWAP-70 protein (SWAP70), mRNA.
chr19:16801195-16801208+0.9425.5531.300.5900.039NM_01526077 SIN3 homolog B, transcriptional regulator (yeast)
chr16:66022444-66022457-0.9425.5531.350.5860.039NM_0001967 hydroxysteroid (11-beta) dehydrogenase 2 (HSD11B2),
chr11:33752666-33752679-0.9395.5261.270.5800.039NM_033406-19 F-box protein 3 (FBXO3), transcript variant 2, mRNA.
chr1:10624835-10624848+0.9435.5591.210.5670.039NM_001079843154459-
chr4:6253295-6253308-0.9425.5531.110.5670.039NM_144720-76 multiple coiled-coil GABABR1-binding protein
chr2:26015000-26015013+0.9015.2112.331.1930.040NM_00225443947 kinesin family member 3C (KIF3C), mRNA.
chr8:75046694-75046707-0.8955.1612.731.1750.040NM_005648206 transcription elongation factor B (SIII), polypeptide
chr20:44091463-44091476+0.9315.4601.320.7320.040NM_020708318 solute carrier family 12, (potassium-chloride
chr2:10101117-10101130-0.9265.4151.220.7310.040NM_00359784 TGFB inducible early growth response 2 (TIEG2), mRNA.
chr1:8860740-8860753+0.9285.4341.070.7290.040NM_001428627 enolase 1, (alpha) (ENO1), mRNA.
chr20:30508858-30508871+0.9275.4251.250.7290.040NM_08061625991 chromosome 20 open reading frame 112 (C20orf112),
chr13:78131092-78131105-0.9255.4071.530.7280.040NM_024546223 chromosome 13 open reading frame 7 (C13orf7), mRNA.
chr16:29950012-29950025+0.9305.4521.460.7260.040NM_031478-325 hypothetical protein DKFZp434I2117 (DKFZP434I2117),
chr6:44149124-44149137-0.9265.4151.180.7250.040NM_03211154045 mitochondrial ribosomal protein L14 (MRPL14), nuclear
chr9:111850719-111850732+0.9255.4071.350.7250.040NM_00100406522 A kinase (PRKA) anchor protein 2 (AKAP2), mRNA.
chr2:219533908-219533921-0.9305.4521.650.7240.040NM_0039361366 cyclin-dependent kinase 5, regulatory subunit 2 (p39)
chr12:50872160-50872173-0.9285.4341.550.7240.040NM_182507-109 hypothetical protein LOC144501 (LOC144501), mRNA.
chr17:52001955-52001968-0.9295.4471.510.7240.040NM_005450-24219 noggin (NOG), mRNA.
chr12:6921507-6921520-0.9255.4071.360.7210.040NM_138425-1857 likely ortholog of mouse gene rich cluster, C10 gene
chr1:210381638-210381651-0.9265.4151.220.7210.040NM_016448105984 RA-regulated nuclear matrix-associated protein (RAMP),
chr9:34558997-34559010+0.9275.4251.650.7200.040NM_00184220725 ciliary neurotrophic factor receptor (CNTFR),
chr8:22129505-22129518-0.9295.4471.360.7200.040NM_00109933516291-
chr12:77781495-77781508-0.9295.4471.420.7200.040NM_005639-353819 synaptotagmin I (SYT1), mRNA.
chr22:27994496-27994509-0.9295.4471.320.7170.040NM_005243579 Ewing sarcoma breakpoint region 1 (EWSR1), transcript
chrX:129230266-129230279-0.9325.4731.570.7150.040NM_017666288 suppressor of hairy wing homolog 3 (Drosophila)
chr19:45631877-45631890-0.9305.4521.230.7140.040NM_013376-8105 SERTA domain containing 1 (SERTAD1), mRNA.
chr15:65146118-65146131-0.9255.4071.280.7110.040NM_005902969 SMAD, mothers against DPP homolog 3 (Drosophila)
chr6:157050040-157050053+0.9255.4071.210.7110.040NM_017519-90638 AT rich interactive domain 1B (SWI1-like) (ARID1B),
chr19:7896813-7896826-0.9285.4341.180.7100.040NM_206833216 cortexin 1 (CTXN1), mRNA.
chr19:51166583-51166596-0.9295.4471.550.7090.040NM_0025161914 neuro-oncological ventral antigen 2 (NOVA2), mRNA.
chr3:23996842-23996855+0.9295.4472.150.7090.040NM_00512635132 nuclear receptor subfamily 1, group D, member 2
chr17:39990414-39990427-0.9315.4601.180.7080.040NM_00146663 frizzled homolog 2 (Drosophila) (FZD2), mRNA.
chr7:72574299-72574312+0.9295.4471.120.7070.040NM_032408245 bromodomain adjacent to zinc finger domain, 1B
chr6:41645650-41645663+0.9295.4471.310.7060.040NM_13845723608 forkhead box P4 (FOXP4), mRNA.
chr10:124884722-124884735+0.9265.4151.420.7050.040NM_005519-12806-
chr15:62540274-62540287+0.9285.4341.210.7040.040NM_015042-38298-
chr20:22507058-22507071+0.9285.4341.640.7040.040NM_0217846043 forkhead box A2 (FOXA2), transcript variant 1, mRNA.
chr1:31999226-31999239+0.9315.4601.470.7030.040NM_0017033009 brain-specific angiogenesis inhibitor 2 (BAI2), mRNA.
chr2:96138197-96138210-0.9255.4071.460.7030.040NM_0006827418 adrenergic, alpha-2B-, receptor (ADRA2B), mRNA.
chr2:59960683-59960696+0.9495.6102.491.3490.041NM_018014673454 B-cell CLL/lymphoma 11A (zinc finger protein)
chr9:35819424-35819437-0.9425.5531.731.2360.041NM_00104259011-
chr2:176710420-176710433+0.9125.3051.931.1880.041NM_0195587797 homeo box D8 (HOXD8), mRNA.
chr19:45656064-45656077+0.9115.2932.141.1840.041NM_0007137453 biliverdin reductase B (flavin reductase (NADPH))
chr5:56568601-56568614+0.9135.3122.191.1840.041NM_02291363000 vasculin (DKFZp761C169), mRNA.
chr9:130211291-130211304+0.9075.2602.331.1790.041NM_016174-11547 cerebral endothelial cell adhesion molecule 1
chr10:102548626-102548639+0.9135.3121.931.1790.041NM_00027853268 paired box gene 2 (PAX2), transcript variant b, mRNA.
chr1:26610985-26610998+0.9055.2412.611.1730.041NM_0246741229 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr2:177127579-177127592-0.9085.2662.761.1690.041NM_006554285296 metaxin 2 (MTX2), mRNA.
chr6:90596680-90596693-0.9095.2731.731.1670.041NM_012115401 CASP8 associated protein 2 (CASP8AP2), mRNA.
chr19:15421491-15421504-0.9425.5531.280.6330.041NM_021241271-
chr19:40318032-40318045+0.9425.5511.410.6260.041NM_139284-88 leucine-rich repeat LGI family, member 4 (LGI4), mRNA.
chr19:44595035-44595048-0.9435.5591.840.6050.041NM_022835-455 likely ortholog of mouse common-site lymphoma/leukemia
chr11:2247105-2247118+0.9425.5531.250.6010.041NM_0051701653 achaete-scute complex-like 2 (Drosophila) (ASCL2),
chr19:48950570-48950583+0.9425.5531.480.5550.041NM_019108412 hypothetical protein FLJ12886 (FLJ12886), mRNA.
chr17:35027931-35027944+0.9425.5531.280.5450.041NM_032192-8674 protein phosphatase 1, regulatory (inhibitor) subunit
chr4:103967864-103967877-0.9425.5511.120.5430.041NM_181891-21 ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog,
chr2:175060058-175060071-0.9425.5531.220.5430.041NM_152529-1 G protein-coupled receptor 155 (GPR155), mRNA.
chr18:42591079-42591092+0.9425.5511.530.5420.041NM_013305-42 sialyltransferase 8E (alpha-2,
chr17:74387503-74387516-0.9495.6101.250.4330.041NM_025090-38939 ubiquitin specific protease 36 (USP36), mRNA.
chr11:114197862-114197875-0.9635.7321.110.4330.041NM_001077639-226168-
chr4:37873149-37873162-0.9635.7321.150.4150.041NM_006607234798 pituitary tumor-transforming 2 (PTTG2), mRNA.
chr1:167352075-167352088-0.9635.7321.180.4130.041NM_0016779604 ATPase, Na+/K+ transporting, beta 1 polypeptide
chr17:44137120-44137133+0.9495.6101.230.4120.041NM_03239117761 small nuclear protein PRAC (PRAC), mRNA.
chr4:111769610-111769623+0.9635.7321.000.4110.041NM_000325-5907 paired-like homeodomain transcription factor 2
chr12:55309810-55309823-0.9495.6101.020.4070.041NM_0134496620 bromodomain adjacent to zinc finger domain, 2A
chr19:2258157-2258170-0.9525.6361.030.4060.041NM_152988-21372 SPPL2b (SPPL2B), mRNA.
chr6:133773794-133773807-0.9665.7581.030.3580.041NM_172105169706 eyes absent homolog 4 (Drosophila) (EYA4), transcript
chr9:71564532-71564545-0.9425.5531.190.6650.042NM_001099666164-
chr11:66915989-66916002+0.9425.5531.110.6610.042NM_00458490 RAD9 homolog A (S. pombe) (RAD9A), mRNA.
chr1:206419991-206420004-0.9395.5261.390.6610.042NM_02517964297 plexin A2 (PLXNA2), mRNA.
chr3:142688455-142688468+0.9425.5531.220.6580.042NM_006506-61 RAS p21 protein activator 2 (RASA2), mRNA.
chr5:137396725-137396738+0.9395.5261.270.6560.042NM_016603-106 chromosome 5 open reading frame 5 (C5orf5), mRNA.
chr10:72662279-72662292+0.9425.5511.590.6350.042NM_17074420024 unc-5 homolog B (C. elegans) (UNC5B), mRNA.
chr14:21081841-21081854+0.9295.4471.250.6310.042NM_005407-6664 sal-like 2 (Drosophila) (SALL2), mRNA.
chr10:103283231-103283244-0.9255.4071.740.6300.042NM_01327454732 polymerase (DNA directed), lambda (POLL), mRNA.
chr6:155008-155021+0.9285.4341.070.6290.042NM_020185-81993 dual specificity phosphatase 22 (DUSP22), mRNA.
chr3:9417509-9417522-0.9295.4471.510.6260.042NM_0010805173206-
chr5:107744597-107744610-0.9265.4151.380.6250.042NM_022824413 F-box and leucine-rich repeat protein 17 (FBXL17),
chr9:70584873-70584886-0.9255.4071.450.6240.042NM_138333189 chromosome 9 open reading frame 42 (C9orf42), mRNA.
chr16:2767216-2767229-0.9285.4341.310.6220.042NM_00710882 transcription elongation factor B (SIII), polypeptide
chrX:68302030-68302043-0.9255.4071.510.6220.042NM_145119-33 praja 1 (PJA1), mRNA.
chr1:178490144-178490157-0.9285.4341.150.6200.042NM_03334324179 LIM homeobox 4 (LHX4), mRNA.
chr11:124129694-124129707-0.9275.4251.380.6170.042NM_014312-2375 V-set and immunoglobulin domain containing 2 (VSIG2),
chr8:37713595-37713608+0.9255.4071.200.6140.042NM_001003790334 chromosome 8 open reading frame 2 (C8orf2), transcript
chr16:2761113-2761126+0.9295.4471.880.6130.042NM_0071086185 transcription elongation factor B (SIII), polypeptide
chr8:145090962-145090975+0.9295.4471.700.6120.042NM_201381-69 plectin 1, intermediate filament binding protein
chr19:17595382-17595395+0.9285.4341.640.6120.042NM_00108042165019-
chr1:202273812-202273825+0.9275.4251.340.6120.042NM_1825793199 hypothetical protein FLJ40343 (FLJ40343), mRNA.
chr19:36533256-36533269-0.9305.4521.090.6120.042NM_020856-1226 zinc finger protein 537 (ZNF537), mRNA.
chr1:65547515-65547528-0.9325.4731.310.6110.042NM_01478744597-
chr10:73704388-73704401-0.9255.4071.300.6090.042NM_019058805 DNA-damage-inducible transcript 4 (DDIT4), mRNA.
chr17:68832061-68832074-0.9285.4341.290.6090.042NM_012121-12323 CDC42 effector protein (Rho GTPase binding) 4
chr6:36870135-36870148+0.9275.4251.050.6090.042NM_02093945063 copine V (CPNE5), mRNA.
chr16:2953475-2953488-0.9315.4601.310.6080.042NM_024507-643 kringle containing transmembrane protein 2 (KREMEN2),
chr2:219470585-219470598-0.9265.4151.420.6080.042NM_02521617186 wingless-type MMTV integration site family, member 10A
chr11:61274124-61274137-0.9285.4341.680.6060.042NM_013279-5213 chromosome 11 open reading frame 9 (C11orf9), mRNA.
chr8:145393290-145393303+0.9315.4601.040.6040.042NM_001080514-115-
chrX:129056670-129056683+0.9285.4341.830.6030.042NM_00142115477 E74-like factor 4 (ets domain transcription factor)
chr22:29772846-29772859+0.9275.4291.050.6020.042NM_006932-34359 smoothelin (SMTN), transcript variant 3, mRNA.
chr3:158637215-158637228-0.9285.4341.900.6020.042NM_00285214 pentaxin-related gene, rapidly induced by IL-1 beta
chr5:72180176-72180189-0.9275.4251.090.6000.042NM_153188590 transportin 1 (TNPO1), transcript variant 2, mRNA.
chrX:16874619-16874632+0.9425.5531.020.5280.042NM_001080975-16-
chr19:16296388-16296401+0.9425.5531.680.5270.042NM_016270-163 Kruppel-like factor 2 (lung) (KLF2), mRNA.
chr3:136843726-136843739-0.9425.5511.230.5210.042NM_002718-323431 protein phosphatase 2 (formerly 2A), regulatory
chr15:41855679-41855692-0.9425.5511.290.5130.042NM_0251651115 elongation factor RNA polymerase II-like 3 (ELL3),
chr15:88406333-88406346-0.9425.5511.340.5130.042NM_00216840379 isocitrate dehydrogenase 2 (NADP+), mitochondrial
chr3:51976551-51976564-0.9395.5261.130.5090.042NM_033008-42 poly(rC) binding protein 4 (PCBP4), transcript variant
chr11:108800963-108800976-0.9395.5261.080.5080.042NM_2076452978 similar to expressed sequence AI593442 (LOC399947),
chr10:114648809-114648822+0.9495.6101.060.4620.042NM_030756-51292 transcription factor 7-like 2 (T-cell specific,
chr2:149349999-149350012+0.9525.6361.030.4600.042NM_004522810-
chr18:33300379-33300392+0.9495.6101.300.4600.042NM_02018099562 bruno-like 4, RNA binding protein (Drosophila)
chr5:154217694-154217707-0.9495.6101.190.4380.042NM_004779-597 CCR4-NOT transcription complex, subunit 8 (CNOT8),
chr17:7271349-7271362-0.9665.7581.290.3990.042NM_1757341790 hypothetical protein LOC201243 (LOC201243), mRNA.
chr4:113552761-113552774-0.9665.7581.020.3760.042NM_02514434560 lymphocyte alpha-kinase (LAK), mRNA.
chr2:30875266-30875279+0.8945.1492.231.4420.043NM_1445758549 calpain 13 (CAPN13), mRNA.
chr3:50398403-50398416-0.9135.3122.421.3590.043NM_007024-26460 placental protein 6 (PL6), mRNA.
chr6:26263842-26263855-0.9055.2412.761.3520.043NM_005321-596 histone 1, H1e (HIST1H1E), mRNA.
chr1:46369889-46369902-0.9135.3122.261.3410.043NM_0036291012 phosphoinositide-3-kinase, regulatory subunit,
chr17:24644860-24644873-0.9125.3052.311.3350.043NM_020772343 82-kD FMRP Interacting Protein (182-FIP), mRNA.
chr4:147795569-147795582-0.9635.7322.501.2930.043NM_00457516174 POU domain, class 4, transcription factor 2 (POU4F2),
chr11:72143506-72143519+0.9635.7322.621.2870.043NM_001040118-27685-
chr9:102155046-102155059-0.9425.5511.551.1660.043NM_017746-51 testis expressed sequence 10 (TEX10), mRNA.
chr1:154878473-154878486+0.9265.4151.430.6990.043NM_021948209 brevican (BCAN), transcript variant 1, mRNA.
chr20:17610558-17610571+0.9315.4601.070.6980.043NM_001042576370-
chr15:62714133-62714146-0.9275.4251.210.6960.043NM_00253768374 ornithine decarboxylase antizyme 2 (OAZ2), mRNA.
chr17:76929458-76929471-0.9285.4341.530.6950.043NM_178520-10389 hypothetical protein FLJ38792 (FLJ38792), mRNA.
chr16:73325906-73325919-0.9285.4341.070.6940.043NM_152649-33616 hypothetical protein FLJ34389 (FLJ34389), mRNA.
chr1:53358403-53358416+0.9295.4471.410.6940.043NM_00667122434 solute carrier family 1 (glutamate transporter),
chr12:46576806-46576819-0.9275.4251.160.6930.043NM_0003768275 vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR),
chr1:179721369-179721382+0.9305.4521.090.6930.043NM_0007212130 calcium channel, voltage-dependent, alpha 1E subunit
chr1:15726194-15726207+0.9315.4601.200.6920.043NM_015291355-
chr5:149575887-149575900+0.9255.4071.510.6920.043NM_01422826274 solute carrier family 6 (neurotransmitter transporter,
chr3:126576584-126576597-0.9315.4601.130.6900.043NM_021964304 zinc finger protein 148 (pHZ-52) (ZNF148), mRNA.
chr16:68531353-68531366-0.9255.4071.550.6850.043NM_182619-10858 secretory protein LOC348174 (LOC348174), mRNA.
chr8:55532893-55532906+0.9315.4601.610.6840.043NM_022454-55 SRY (sex determining region Y)-box 17 (SOX17), mRNA.
chr12:52437178-52437191-0.9325.4731.840.6820.043NM_020898-29692 KIAA1536 protein (KIAA1536), mRNA.
chrX:56275455-56275468-0.9275.4291.220.6800.043NM_007250-77 Kruppel-like factor 8 (KLF8), mRNA.
chr1:64012095-64012108+0.9295.4471.240.6790.043NM_001083592-83-
chr2:111594691-111594704+0.9275.4251.430.6790.043NM_207002-171 BCL2-like 11 (apoptosis facilitator) (BCL2L11),
chr17:24945110-24945123-0.9255.4071.620.6780.043NM_152345557 hypothetical protein FLJ25555 (FLJ25555), mRNA.
chr19:43571807-43571820+0.9285.4341.200.6720.043NM_001039616-872-
chr20:603939-603952-0.9265.4151.420.6690.043NM_033129884 scratch homolog 2, zinc finger protein (Drosophila)
chr20:30516909-30516922-0.9635.7321.070.4660.043NM_08061617940 chromosome 20 open reading frame 112 (C20orf112),
chr10:104175376-104175389-0.9635.7321.360.4640.043NM_0243265897-
chr14:103079157-103079170+0.9635.7321.140.4590.043NM_15230713995 hypothetical protein FLJ40452 (FLJ40452), mRNA.
chr19:1213583-1213596+0.9635.7321.080.4560.043NM_001280-6664 cold inducible RNA binding protein (CIRBP), mRNA.
chr11:61039923-61039936+0.9635.7321.060.4450.043NM_14501734855 IIIG9 protein (FLJ32771), mRNA.
chr1:59395339-59395352-0.9635.7321.140.4450.043NM_018291-139889 hypothetical protein FLJ10986 (FLJ10986), mRNA.
chr10:115011067-115011080-0.9635.7321.270.4370.043NM_004132-291608 hyaluronan binding protein 2 (HABP2), mRNA.
chr12:120440702-120440715+0.9635.7321.060.4360.043NM_00100536662045-
chr5:14453497-14453510+0.9635.7321.220.4350.043NM_019018-181335 hypothetical protein FLJ11127 (FLJ11127), mRNA.
chr9:109223889-109223902-0.9495.6101.050.3940.043NM_00423567687 Kruppel-like factor 4 (gut) (KLF4), mRNA.
chr8:10683913-10683926+0.9495.6101.430.3930.043NM_01788450796 PIN2-interacting protein 1 (PINX1), mRNA.
chr8:142438307-142438320-0.9495.6101.300.3910.043NM_0052938240 G protein-coupled receptor 20 (GPR20), mRNA.
chr12:131155428-131155441-0.9525.6361.050.3770.043NM_17506639378 DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 (DDX51),
chr17:67924141-67924154+0.9495.6101.240.3670.043NM_000346295485 SRY (sex determining region Y)-box 9 (campomelic
chr1:44844268-44844281-0.8734.9742.331.5970.044NM_02458768418 hypothetical protein FLJ22353 (FLJ22353), mRNA.
chr20:35157528-35157541+0.8564.8252.281.4790.044NM_002895296 retinoblastoma-like 1 (p107) (RBL1), transcript
chr6:108988668-108988681-0.8624.8772.011.4700.044NM_0014556 forkhead box O3A (FOXO3A), transcript variant 1, mRNA.
chr16:1142574-1142587+0.9255.4071.080.6660.044NM_001005407-568-
chr2:216657135-216657148-0.9275.4251.410.6650.044NM_1383902348 hypothetical protein BC008604 (LOC92691), mRNA.
chr4:146964132-146964145+0.9285.4342.040.6650.044NM_178835114925 hypothetical protein LOC152485 (LOC152485), mRNA.
chr17:35757626-35757639+0.9255.4071.030.6620.044NM_0010248095858-
chr2:232235430-232235443-0.9265.4151.370.6620.044NM_001099285-45949-
chr7:98038431-98038444-0.9275.4251.180.6610.044NM_002523-46014 neuronal pentraxin II (NPTX2), mRNA.
chr2:45731255-45731268-0.9285.4341.250.6600.044NM_005400-1192 protein kinase C, epsilon (PRKCE), mRNA.
chr18:975508-975521-0.9295.4471.900.6600.044NM_00111780311 adenylate cyclase activating polypeptide 1 (pituitary)
chr19:14090098-14090111+0.9305.4521.360.6590.044NM_002730-539 protein kinase, cAMP-dependent, catalytic, alpha
chr4:83625637-83625650-0.9275.4251.790.6590.044NM_02120454950 E-1 enzyme (MASA), mRNA.
chr11:64150960-64150973+0.9255.4071.310.6580.044NM_13873416403 neurexin 2 (NRXN2), transcript variant beta, mRNA.
chr4:42353989-42354002+0.9255.4071.730.6570.044NM_006095-342 ATPase, aminophospholipid transporter (APLT), Class I,
chr5:60664930-60664943+0.9315.4601.150.6560.044NM_001048249-170871-
chr5:172598443-172598456-0.9265.4151.150.6520.044NM_004387-3575 NK2 transcription factor related, locus 5 (Drosophila)
chr19:9907832-9907845-0.9305.4521.210.6500.044NM_058164238 olfactomedin 2 (OLFM2), mRNA.
chr17:38181342-38181355-0.9275.4251.310.6470.044NM_0323532462 hypothetical protein MGC10540 (MGC10540), mRNA.
chr9:139604936-139604949+0.9315.4601.010.6460.044NM_138462-178 zinc finger, MYND domain containing 19 (ZMYND19),
chr2:63973944-63973957-0.9295.4471.630.6420.044NM_00675951526 UDP-glucose pyrophosphorylase 2 (UGP2), transcript
chr19:1201688-1201701-0.9315.4601.060.6410.044NM_1774012236-
chr2:200036638-200036651+0.9305.4521.070.6400.044NM_015265-3192 SATB family member 2 (SATB2), mRNA.
chr17:33838744-33838757+0.9285.4341.480.6390.044NM_01459877313-
chr1:26729074-26729087+0.9315.4601.470.6380.044NM_002953338 ribosomal protein S6 kinase, 90kDa, polypeptide 1
chr20:538983-538996+0.9255.4071.910.6370.044NM_004609-73 transcription factor 15 (basic helix-loop-helix)
chr1:93686835-93686848+0.9315.4601.370.6370.044NM_017737508 chromosome 1 open reading frame 39 (C1orf39), mRNA.
chr11:17720452-17720465+0.9285.4341.550.6370.044NM_0049766462 potassium voltage-gated channel, Shaw-related
chr4:53493665-53493678-0.9295.4471.690.6370.044NM_02394070513 RAS-like, family 11, member B (RASL11B), mRNA.
chr11:65028328-65028341+0.9275.4291.520.6350.044NM_020680-20696 SCY1-like 1 (S. cerevisiae) (SCYL1), mRNA.
chr3:116606760-116606773+0.9275.4251.780.6350.044NM_002045-218282 growth associated protein 43 (GAP43), mRNA.
chr7:100238525-100238538+0.9285.4341.420.6340.044NM_00444424554 EphB4 (EPHB4), mRNA.
chr6:34310995-34311008-0.9285.4341.340.6340.044NM_002131-1533 high mobility group AT-hook 1 (HMGA1), transcript
chr11:65381917-65381930+0.9635.7321.901.3220.045NM_005507463 cofilin 1 (non-muscle) (CFL1), mRNA.
chr12:108399279-108399292-0.9635.7321.881.3180.045NM_031954259 potassium channel tetramerisation domain containing 10
chr10:47128263-47128276+0.9635.7322.231.3170.045NM_001630-88563 annexin A8 (ANXA8), mRNA.
chr8:20704690-20704703-0.9635.7322.311.3000.045NM_021020-547607 leucine zipper, putative tumor suppressor 1 (LZTS1),
chr8:127639411-127639424-0.8975.1751.711.2270.045NM_174911237 breast cancer membrane protein 101 (NSE2), mRNA.
chr2:232359595-232359608-0.9425.5531.370.6980.045NM_022730289 COP9 constitutive photomorphogenic homolog subunit 7B
chr2:160469555-160469568-0.9425.5531.560.6890.045NM_002349-47 lymphocyte antigen 75 (LY75), mRNA.
chrX:39841728-39841741+0.9395.5261.100.6830.045NM_020926-128 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr11:72731977-72731990+0.9425.5511.050.6800.045NM_152222-32976 tumor necrosis factor receptor superfamily, member
chr2:208284342-208284355+0.9425.5531.020.6780.045NM_152523-67 hypothetical protein FLJ40432 (FLJ40432), mRNA.
chr2:99472915-99472928-0.9425.5511.130.6760.045NM_016316-3 REV1-like (yeast) (REV1L), mRNA.
chr1:19155796-19155809-0.9425.5531.190.6740.045NM_170726-54137 aldehyde dehydrogenase 4 family, member A1 (ALDH4A1),
chr17:27616905-27616918-0.9425.5531.100.6730.045NM_138328-303 rhomboid, veinlet-like 4 (Drosophila) (RHBDL4), mRNA.
chr6:1077030-1077043-0.9635.7321.010.3930.045NM_033260-180545 forkhead box Q1 (FOXQ1), mRNA.
chr2:225613378-225613391-0.9635.7321.040.3930.045NM_0146892196-
chr19:54296614-54296627-0.9635.7321.050.3890.045NM_022165-12716 lin-7 homolog B (C. elegans) (LIN7B), mRNA.
chr2:119316552-119316565+0.9635.7321.540.3840.045NM_0014265677 engrailed homolog 1 (EN1), mRNA.
chr14:69197928-69197941-0.9635.7321.170.3780.045NM_01473449962 KIAA0247 (KIAA0247), mRNA.
chr17:12635078-12635091+0.8795.0192.391.4950.046NM_0148591624 KIAA0672 gene product (KIAA0672), mRNA.
chr2:30875267-30875280+0.8334.6382.231.4230.046NM_1445758548 calpain 13 (CAPN13), mRNA.
chr7:92301254-92301267+0.8975.1752.351.3190.046NM_001259-106 cyclin-dependent kinase 6 (CDK6), mRNA.
chr9:128428875-128428888-0.9135.3122.101.2320.046NM_00231612356 LIM homeobox transcription factor 1, beta (LMX1B),
chr3:49178567-49178580+0.9125.3052.251.2210.046NM_022903222 hypothetical protein FLJ12800 (FLJ12800), mRNA.
chr14:72563253-72563266-0.9125.3052.121.2180.046NM_021260339 zinc finger, FYVE domain containing 1 (ZFYVE1),
chr8:26205486-26205499+0.9125.3052.001.2070.046NM_002717635 protein phosphatase 2 (formerly 2A), regulatory
chr10:63479077-63479090+0.8975.1752.501.1570.046NM_032199147728-
chr12:47879123-47879136-0.8955.1612.531.1510.046NM_006009-9995 tubulin, alpha 3 (TUBA3), mRNA.
chr4:54789097-54789110-0.8965.1661.771.1510.046NM_006206-1007 platelet-derived growth factor receptor, alpha
chr15:91416415-91416428-0.8955.1612.041.1490.046NM_02021117022 RGM domain family, member A (RGMA), mRNA.
chr9:95626656-95626669+0.9225.3821.750.7650.046NM_021570130773 BarH-like homeobox 1 (BARX1), mRNA.
chr20:29567308-29567321-0.9225.3821.410.7550.046NM_1785811506 histocompatibility (minor) 13 (HM13), transcript
chr5:89636510-89636523-0.9155.3242.440.7500.046NM_004365104849 centrin, EF-hand protein, 3 (CDC31 homolog, yeast)
chr1:18977828-18977841+0.9225.3821.590.7490.046NM_15223280914 taste receptor, type 1, member 2 (TAS1R2), mRNA.
chr2:20248075-20248088+0.9225.3891.390.7440.046NM_00299740333 syndecan 1 (SDC1), mRNA.
chr1:33587760-33587773-0.9305.4521.090.5990.046NM_004427326 polyhomeotic-like 2 (Drosophila) (PHC2), transcript
chr1:52791595-52791608+0.9315.4601.270.5990.046NM_015269-264-
chr10:80875221-80875234-0.9265.4151.220.5980.046NM_153367165 chromosome 10 open reading frame 56 (C10orf56), mRNA.
chr15:66694126-66694139+0.9285.4341.470.5960.046NM_00609135599 coronin, actin binding protein, 2B (CORO2B), mRNA.
chr19:38481303-38481316-0.9275.4291.640.5930.046NM_0043643857 CCAAT/enhancer binding protein (C/EBP), alpha (CEBPA),
chr1:112082694-112082707-0.9265.4151.330.5930.046NM_019099851 hypothetical protein LOC55924 (LOC55924), transcript
chr1:22433180-22433193-0.9285.4341.350.5930.046NM_030761-90983 wingless-type MMTV integration site family, member 4
chr2:62276700-62276713+0.9255.4071.260.5910.046NM_00657734 UDP-GlcNAc:betaGal
chr12:117337262-117337275+0.9295.4471.530.5900.046NM_02249138621 likely ortholog of mouse Sds3 (SDS3), mRNA.
chr17:38080793-38080806+0.9285.4341.550.5890.046NM_0249271702 hypothetical protein FLJ21019 (FLJ21019), mRNA.
chr22:41030087-41030100-0.9275.4291.340.5890.046NM_181492-88698 transcription factor 20 (AR1) (TCF20), transcript
chr5:168611307-168611320-0.9295.4471.640.5890.046NM_00306249247 slit homolog 3 (Drosophila) (SLIT3), mRNA.
chr10:79780196-79780209-0.9275.4251.170.5880.046NM_033022316716 ribosomal protein S24 (RPS24), transcript variant 1,
chr1:54713232-54713245+0.9285.4341.310.5870.046NM_001009955-68552-
chr8:13003531-13003544-0.9295.4471.270.5850.046NM_00609431649 deleted in liver cancer 1 (DLC1), transcript variant
chr14:54807783-54807796-0.9315.4601.530.5840.046NM_01794351 F-box protein 34 (FBXO34), mRNA.
chr18:33181380-33181393-0.9275.4251.110.5820.046NM_020180218561 bruno-like 4, RNA binding protein (Drosophila)
chr6:42016570-42016583-0.9295.4471.460.5780.046NM_001760960 cyclin D3 (CCND3), mRNA.
chr5:107036317-107036330-0.9315.4601.430.5780.046NM_001962-1822 ephrin-A5 (EFNA5), mRNA.
chr11:61377887-61377900-0.9295.4471.080.5730.046NM_00426525698 fatty acid desaturase 2 (FADS2), mRNA.
chr5:60663281-60663294+0.9285.4371.280.5720.046NM_001048249-169222-
chr8:11512828-11512841+0.9305.4521.100.5690.046NM_002052-86234 GATA binding protein 4 (GATA4), mRNA.
chr3:182655964-182655977+0.9495.6101.090.3650.046NM_003106-256352 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr1:154984059-154984072+0.9495.6101.210.3510.046NM_0044944101 hepatoma-derived growth factor (high-mobility group
chr5:141198394-141198407+0.8464.7462.021.4230.047NM_03242039734 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr7:41694747-41694760-0.9125.3052.361.3260.047NM_00219214484 inhibin, beta A (activin A, activin AB alpha
chr7:27119588-27119601+0.9055.2412.701.3140.047NM_153632553 homeo box A3 (HOXA3), transcript variant 3, mRNA.
chr1:120412654-120412667-0.9135.3121.771.3130.047NM_0244081145 Notch homolog 2 (Drosophila) (NOTCH2), mRNA.
chr19:36329032-36329045-0.9105.2872.181.3130.047NM_020856202998 zinc finger protein 537 (ZNF537), mRNA.
chr5:131632938-131632951-0.9125.3052.061.1590.048NM_00368711752 PDZ and LIM domain 4 (PDLIM4), mRNA.
chr14:102286307-102286320+0.9055.2412.171.1590.048NM_003300-27162 TNF receptor-associated factor 3 (TRAF3), transcript
chr18:43447648-43447661+0.9085.2671.981.1520.048NM_005901263276 SMAD, mothers against DPP homolog 2 (Drosophila)
chr2:128415991-128416004-0.9135.3122.491.1470.048NM_031445-57087 hypothetical protein MGC4268 (MGC4268), mRNA.
chr11:40271462-40271475-0.9055.2412.321.1430.048NM_020929778 netrin-G1 ligand (NGL-1), mRNA.
chr2:200178858-200178871+0.9095.2732.061.1420.048NM_015265-145412 SATB family member 2 (SATB2), mRNA.
chr9:130573958-130573971-0.8965.1662.231.0500.048NM_00633661 chromosome 9 open reading frame 60 (C9orf60), mRNA.
chr1:44592133-44592146-0.8955.1612.611.0500.048NM_0240661393-
chr19:45795962-45795975+0.9425.5531.240.4930.048NM_0010425441081-
chr17:4856383-4856396+0.9395.5261.090.4830.048NM_00661214483 kinesin family member 1C (KIF1C), mRNA.
chr2:164302057-164302070-0.8404.6962.701.5300.049NM_018086-1298 fidgetin (FIGN), mRNA.
chr16:65987969-65987982+0.8384.6772.531.5110.049NM_016140-3047 brain specific protein (CGI-38), mRNA.
chr20:31517153-31517166-0.8734.9742.951.4280.049NM_003098-21794 syntrophin, alpha 1 (dystrophin-associated protein A1,
chr3:18440327-18440340+0.8965.1662.101.1240.049NM_00297117 special AT-rich sequence binding protein 1 (binds to
chr17:37560326-37560339+0.8965.1662.371.1180.049NM_004583222 RAB5C, member RAS oncogene family (RAB5C), transcript
chr4:158361149-158361162+0.8975.1752.081.0950.049NM_001083620-21-
chr6:127509917-127509930-0.8955.1612.091.0880.049NM_03278428276 thrombospondin, type I, domain containing 2 (THSD2),
chr10:102459383-102459396-0.9225.3821.830.7270.049NM_003988-35975 paired box gene 2 (PAX2), transcript variant c, mRNA.
chr15:41769461-41769474-0.9225.3821.050.7190.049NM_001015001-2815-
chr12:121450563-121450576-0.9155.3241.460.7130.049NM_00295622506 restin (Reed-Steinberg cell-expressed intermediate
chr6:139654975-139654988+0.9155.3241.340.7100.049NM_153235-126-
chr3:46886247-46886260+0.9225.3821.450.7010.049NM_000258-6270 myosin, light polypeptide 3, alkali; ventricular,
chr18:51405449-51405462+0.9155.3241.660.7000.049NM_0031991409 transcription factor 4 (TCF4), mRNA.
chr17:7284263-7284276-0.8664.9172.341.5330.050NM_004112950 fibroblast growth factor 11 (FGF11), mRNA.
chr1:51215719-51215732+0.9135.3122.391.2920.050NM_0786267589 cyclin-dependent kinase inhibitor 2C (p18, inhibits
chr12:102982675-102982688+0.9085.2662.191.2880.050NM_013320318 host cell factor C2 (HCFC2), mRNA.
chr11:46490811-46490824-0.9095.2732.431.2810.050NM_01774978679 hypothetical protein FLJ20294 (FLJ20294), mRNA.
chr1:154980868-154980881-0.9135.3122.541.2710.050NM_145729-3321 mitochondrial ribosomal protein L24 (MRPL24), nuclear
chr11:61059446-61059459+0.9085.2672.201.2670.050NM_00420045428 synaptotagmin VII (SYT7), mRNA.
chr18:34470194-34470207+0.8955.1612.491.2440.050NM_020180-1070253 bruno-like 4, RNA binding protein (Drosophila)
chr13:71336870-71336883-0.9105.2861.991.0620.050NM_0043922461 dachshund homolog 1 (Drosophila) (DACH1), transcript
chr11:31623999-31624012-0.9125.3052.441.0530.050NM_019040136226 elongation protein 4 homolog (S. cerevisiae) (ELP4),
chr1:47775164-47775177+0.9135.3122.411.0530.050NM_004474100988 forkhead box D2 (FOXD2), mRNA.
chr16:68767210-68767223+0.9125.3051.311.0510.050NM_1736191881 hypothetical protein MGC34761 (MGC34761), mRNA.
chr14:23109301-23109314+0.9135.3121.921.0500.050NM_080545-2182 adaptor-related protein complex 1, gamma 2 subunit
chrX:49013221-49013234-0.9085.2671.981.0500.050NM_03321560-
chr9:2612087-2612100-0.9055.2411.841.0440.050NM_003383394 very low density lipoprotein receptor (VLDLR), mRNA.
chr20:51642456-51642469-0.9125.3051.571.0370.050NM_006526-9413 zinc finger protein 217 (ZNF217), mRNA.
chr11:19356736-19356749+0.9125.3051.861.0350.050NM_024680-137653 FLJ23311 protein (FLJ23311), mRNA.
chr4:154293654-154293667+0.9635.7321.590.3580.050NM_015271-51314 tripartite motif-containing 2 (TRIM2), mRNA.
chr5:49998958-49998971-0.9635.7321.100.3550.050NM_024615488 poly (ADP-ribose) polymerase family, member 8 (PARP8),
chr17:3791943-3791956-0.9635.7321.100.3520.050NM_00517322542 ATPase, Ca++ transporting, ubiquitous (ATP2A3),
chr8:30133345-30133358-0.9635.7321.450.3470.050NM_00657190 dynactin 6 (DCTN6), mRNA.
chrX:39899268-39899281+0.9665.7581.140.3020.050NM_020926-57668 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr2:148495026-148495039-0.9085.2662.411.2650.051NM_181741-237 origin recognition complex, subunit 4-like (yeast)
chr1:202277096-202277109-0.9135.3122.411.2620.051NM_182579-85 hypothetical protein FLJ40343 (FLJ40343), mRNA.
chr1:8000404-8000417-0.9125.3052.451.2590.051NM_0189488539 mitogen-inducible gene 6 (MIG-6), mRNA.
chr7:21434332-21434345-0.9135.3122.131.2590.051NM_003112218 Sp4 transcription factor (SP4), mRNA.
chr19:45801621-45801634-0.9085.2672.141.2560.051NM_0010425452604-
chr12:53032386-53032399-0.9085.2662.471.2540.051NM_02037012139 G protein-coupled receptor 84 (GPR84), mRNA.
chr20:30632731-30632744-0.9125.3051.781.2500.051NM_001010976-6111-
chr12:52939298-52939311-0.9125.3052.231.1330.051NM_01211720853 chromobox homolog 5 (HP1 alpha homolog, Drosophila)
chr9:108821033-108821046-0.9135.3122.091.1330.051NM_021224155934 zinc finger protein 462 (ZNF462), mRNA.
chr20:38838899-38838912-0.9075.2602.141.1310.051NM_005461-87609 v-maf musculoaponeurotic fibrosarcoma oncogene homolog
chrX:70391153-70391166-0.9085.2662.271.1280.051NM_005096-5 zinc finger protein 261 (ZNF261), transcript variant
chr1:23758656-23758669-0.9085.2672.201.1170.051NM_002167216 inhibitor of DNA binding 3, dominant negative
chr13:29779514-29779527+0.9085.2671.441.1160.051NM_03211670 katanin p60 subunit A-like 1 (KATNAL1), mRNA.
chr5:64813566-64813579+0.9085.2661.871.1110.051NM_197941-106 similar to ADAMTS-10 precursor (A disintegrin and
chr20:2677432-2677445+0.9135.3122.251.1070.051NM_01960951850 carboxypeptidase X (M14 family) (CPXM), mRNA.
chr20:51659746-51659759-0.9085.2661.741.0980.051NM_006526-26703 zinc finger protein 217 (ZNF217), mRNA.
chr7:129038763-129038776-0.9085.2662.191.0940.051NM_00501172 nuclear respiratory factor 1 (NRF1), mRNA.
chr6:26165344-26165357+0.9125.3052.331.0930.051NM_005319-666 histone 1, H1c (HIST1H1C), mRNA.
chr19:50665338-50665351+0.9125.3051.941.0900.051NM_0067322345 FBJ murine osteosarcoma viral oncogene homolog B
chr9:109085601-109085614-0.9135.3122.021.0850.051NM_002874336 RAD23 homolog B (S. cerevisiae) (RAD23B), mRNA.
chr1:200342218-200342231-0.9105.2862.171.0790.051NM_004767-16334 G-protein coupled receptor 37 like 1 (GPR37L1), mRNA.
chr15:38187293-38187306-0.9085.2661.991.0770.051NM_0010039401074 Bcl2 modifying factor (BMF), transcript variant 1,
chr1:143921637-143921650+0.9135.3121.451.0750.051NM_2034581269 similar to NOTCH2 protein (N2N), mRNA.
chr19:50150465-50150478+0.9085.2671.851.0680.051NM_00129487 cleft lip and palate associated transmembrane protein
chr3:64247128-64247141+0.9225.3822.030.6930.051NM_198859-60957 prickle-like 2 (Drosophila) (PRICKLE2), mRNA.
chr1:204974092-204974105+0.9225.3821.230.6850.051NM_00057238370 interleukin 10 (IL10), mRNA.
chr10:115104785-115104798+0.9635.7322.251.3530.052NM_004132-197890 hyaluronan binding protein 2 (HABP2), mRNA.
chr1:38003586-38003599+0.8945.1512.111.1970.052NM_173641-175 hypothetical protein FLJ33655 (FLJ33655), mRNA.
chrX:100220978-100220991+0.8935.1402.191.1850.052NM_021637559 transmembrane protein 35 (TMEM35), mRNA.
chr12:47772228-47772241-0.8945.1512.341.1740.052NM_0210442641 desert hedgehog homolog (Drosophila) (DHH), mRNA.
chr4:16779440-16779453-0.8935.1411.811.1690.052NM_001290-270015 LIM domain binding 2 (LDB2), mRNA.
chr19:4860901-4860914+0.9225.3891.000.6300.052NM_001048201491-
chr13:108812196-108812209-0.9165.3311.030.6290.052NM_003749424719 insulin receptor substrate 2 (IRS2), mRNA.
chr10:102719203-102719216-0.9165.3381.320.6280.052NM_017893-2973 sema domain, immunoglobulin domain (Ig), transmembrane
chr9:70584685-70584698-0.9225.3821.460.6220.052NM_1383331 chromosome 9 open reading frame 42 (C9orf42), mRNA.
chr9:98091568-98091581-0.9155.3241.210.6200.052NM_00019712687 hydroxysteroid (17-beta) dehydrogenase 3 (HSD17B3),
chr1:154980862-154980875-0.9225.3821.500.6190.052NM_145729-3315 mitochondrial ribosomal protein L24 (MRPL24), nuclear
chr10:70257211-70257224-0.9165.3381.130.6140.052NM_152709-76-
chr22:25383383-25383396+0.9165.3381.110.6140.052NM_00188635555 crystallin, beta A4 (CRYBA4), mRNA.
chr22:38637686-38637699-0.9225.3821.050.6130.052NM_00481010754 GRB2-related adaptor protein 2 (GRAP2), mRNA.
chr11:63338018-63338031-0.9225.3821.430.6110.052NM_138471619 hypothetical protein BC007540 (LOC144097), mRNA.
chr12:6751719-6751732+0.9225.3891.140.6100.052NM_002286-112 lymphocyte-activation gene 3 (LAG3), mRNA.
chr1:34405133-34405146-0.9155.3241.420.6090.052NM_052896-1103 CUB and Sushi multiple domains 2 (CSMD2), mRNA.
chr16:50032457-50032470+0.9155.3242.020.6040.052NM_002968-289773 sal-like 1 (Drosophila) (SALL1), mRNA.
chr19:34708139-34708152-0.9165.3311.490.6010.052NM_006627-80802 processing of precursor 4, ribonuclease P/MRP subunit
chrX:23953389-23953402+0.9255.4071.700.5660.052NM_0306241835-
chr16:19779117-19779130+0.9255.4071.050.5660.052NM_01623524535 G protein-coupled receptor, family C, group 5, member
chr13:79357153-79357166+0.9295.4471.500.5660.052NM_019080403965-
chr1:112334012-112334025-0.9325.4731.130.5650.052NM_172198-712 potassium voltage-gated channel, Shal-related
chr5:146242714-146242727-0.9295.4471.840.5630.052NM_181675-4213 protein phosphatase 2 (formerly 2A), regulatory
chr1:180627749-180627762+0.9285.4341.160.5620.052NM_002065-176 glutamate-ammonia ligase (glutamine synthase) (GLUL),
chr22:40703376-40703389-0.9325.4731.350.5600.052NM_019106534 septin 3 (SEPT3), transcript variant B, mRNA.
chr22:36621097-36621110+0.9295.4471.150.5600.052NM_033386-11095 MICAL-like 1 (MICAL-L1), mRNA.
chr6:35335740-35335753-0.9285.4341.020.5590.052NM_003427352 zinc finger protein 76 (expressed in testis) (ZNF76),
chr3:44015638-44015651-0.9315.4601.140.5540.052NM_016006308359 abhydrolase domain containing 5 (ABHD5), mRNA.
chr17:40605995-40606008-0.9295.4471.300.5530.052NM_14460812048 hypothetical protein MGC39389 (FLJ32384), mRNA.
chr1:158303585-158303598-0.9295.4471.660.5490.052NM_0022413000 potassium inwardly-rectifying channel, subfamily J,
chr17:77440924-77440937-0.9295.4471.550.5460.052NM_0057821834 THO complex 4 (THOC4), mRNA.
chr1:154881636-154881649+0.9295.4471.240.5460.052NM_0219483372 brevican (BCAN), transcript variant 1, mRNA.
chr7:128257527-128257540+0.9315.4601.150.5460.052NM_001458-92 filamin C, gamma (actin binding protein 280) (FLNC),
chrX:128941583-128941596+0.9315.4601.660.5440.052NM_021946-2667 BCL6 co-repressor-like 1 (BCORL1), mRNA.
chr14:74956040-74956053-0.9305.4521.200.5440.052NM_130469-12450 jun dimerization protein 2 (JDP2), mRNA.
chr11:46257153-46257166+0.9275.4251.340.5390.052NM_0528541449 cAMP responsive element binding protein 3-like 1
chr1:44249623-44249636+0.9325.4731.310.5380.052NM_0069345961 solute carrier family 6 (neurotransmitter transporter,
chrX:48822416-48822429-0.9255.4071.420.5370.052NM_0010298962092-
chr6:90178629-90178642-0.9315.4601.210.5370.052NM_021244-145 Ras-related GTP binding D (RRAGD), mRNA.
chr10:105304982-105304995+0.9265.4151.230.5370.052NM_00421061044 neuralized-like (Drosophila) (NEURL), mRNA.
chr12:6668565-6668578+0.9265.4151.520.5360.052NM_001039918223-
chr12:6449740-6449753-0.9265.4151.190.5350.052NM_014231364 vesicle-associated membrane protein 1 (synaptobrevin
chr1:196151975-196151988+0.9265.4151.220.5340.052NM_020204-1065 LIM homeobox 9 (LHX9), mRNA.
chr2:42030655-42030668+0.9285.4341.760.5340.052NM_138370-98502-
chr16:3014106-3014119+0.8885.0962.191.3850.053NM_024339112 hypothetical protein MGC2655 (MGC2655), mRNA.
chr9:134979331-134979344-0.8935.1412.251.3700.053NM_0062667051 ral guanine nucleotide dissociation stimulator
chr1:74124610-74124623-0.9255.4071.090.5310.053NM_003838-311804 fucose-1-phosphate guanylyltransferase (FPGT), mRNA.
chr10:22865732-22865745-0.9295.4471.500.5300.053NM_005028177758 phosphatidylinositol-4-phosphate 5-kinase, type II,
chr14:22564592-22564605-0.9295.4471.090.5290.053NM_0027979357 proteasome (prosome, macropain) subunit, beta type, 5
chr12:64643466-64643479+0.9285.4341.570.5270.053NM_003484139059-
chr1:232987971-232987984-0.9325.4731.590.5270.053NM_182972-176077 interferon regulatory factor 2 binding protein 2
chr12:97421819-97421832+0.9295.4471.340.5270.053NM_001032283-11621-
chr6:69734911-69734924+0.9285.4341.360.5210.053NM_001704330853 brain-specific angiogenesis inhibitor 3 (BAI3), mRNA.
chr8:142586513-142586526-0.9265.4151.220.5200.053NM_207414-1 FLJ43860 protein (FLJ43860), mRNA.
chr4:128353332-128353345+0.9295.4471.010.5190.053NM_015693-420138 PDZ domain containing 6 (PDZK6), mRNA.
chr6:42017137-42017150+0.9285.4341.070.5180.053NM_001760393 cyclin D3 (CCND3), mRNA.
chr12:53112458-53112471+0.9275.4251.360.5170.053NM_002205-13141 integrin, alpha 5 (fibronectin receptor, alpha
chr5:176176703-176176716+0.9275.4251.100.5170.053NM_1333696637-
chr9:36153301-36153314-0.9285.4341.150.5160.053NM_005893-5990 calicin (CCIN), mRNA.
chr1:204748027-204748040+0.9255.4071.210.5160.053NM_182663625 Ras association (RalGDS/AF-6) domain family 5
chr9:34968166-34968179-0.9295.4471.290.5130.053NM_012266-11519 DnaJ (Hsp40) homolog, subfamily B, member 5 (DNAJB5),
chr10:70103379-70103392+0.9275.4291.120.5130.053NM_018237-47498 cell division cycle and apoptosis regulator 1 (CCAR1),
chr22:49086690-49086703+0.9285.4341.090.5100.053NM_012401-11354-
chr14:52486797-52486810-0.9305.4521.090.5100.053NM_006832663 pleckstrin homology domain containing, family C (with
chr2:204106450-204106463-0.9295.4471.580.5100.053NM_2135891853 Ras association (RalGDS/AF-6) and pleckstrin homology
chr2:218582835-218582848+0.9285.4341.150.5090.053NM_198483-63350 FLJ46536 protein (FLJ46536), mRNA.
chr12:107515191-107515204+0.9295.4471.360.5080.053NM_181724722 hypothetical protein LOC338773 (LOC338773), mRNA.
chr17:70265612-70265625+0.9285.4341.280.5040.053NM_0042529333 solute carrier family 9 (sodium/hydrogen exchanger),
chr11:17490282-17490295-0.9285.4341.300.5030.053NM_00570932257 Usher syndrome 1C (autosomal recessive, severe)
chr19:38430249-38430262-0.9285.4341.150.5020.053NM_019849-21701 solute carrier family 7, (neutral amino acid
chr12:101931176-101931189+0.9315.4601.240.5020.053NM_00431655682 achaete-scute complex-like 1 (Drosophila) (ASCL1),
chr4:126455709-126455722+0.9255.4071.240.5020.053NM_024582-1208 fat-like cadherin FATJ (FATJ), mRNA.
chr3:13896633-13896646-0.9255.4071.060.5010.053NM_004625-14 wingless-type MMTV integration site family, member 7A
chr11:6456342-6456355-0.9285.4341.080.5000.053NM_012192-2811 fracture callus 1 homolog (rat) (FXC1), mRNA.
chr19:6375405-6375418-0.9315.4601.080.5000.053NM_003685400 KH-type splicing regulatory protein (FUSE binding
chr3:49106165-49106178-0.8574.8351.851.4610.054NM_017730343 FLJ20259 protein (FLJ20259), transcript variant 1,
chr9:75494488-75494501+0.8955.1612.521.0320.054NM_000700537987 annexin A1 (ANXA1), mRNA.
chr12:56110940-56110953+0.8965.1661.511.0170.054NM_005538-3770 inhibin, beta C (INHBC), mRNA.
chr1:38924784-38924797+0.8975.1751.851.0080.054NM_022157173143 Ras-related GTP binding C (RRAGC), mRNA.
chr14:63733479-63733492+0.8734.9682.321.4590.055NM_182913-17033 spectrin repeat containing, nuclear envelope 2
chr20:938424-938437-0.9225.3821.370.6660.055NM_001040007-7520-
chr4:54670573-54670586+0.9185.3511.380.6640.055NM_1332679718 homeobox protein GSH-2 (GSH-2), mRNA.
chr1:154723592-154723605-0.9165.3381.430.6630.055NM_00592013561 MADS box transcription enhancer factor 2, polypeptide
chr15:86597863-86597876-0.9225.3821.460.6590.055NM_0010123382802-
chr5:157558509-157558522+0.9185.3511.720.6570.055NM_014666-339763 enthoprotin (ENTH), mRNA.
chr7:69675187-69675200+0.9225.3821.210.6560.055NM_022479-560438 Williams-Beuren syndrome chromosome region 17
chr16:1172542-1172555-0.9155.3241.080.6530.055NM_02109829400 calcium channel, voltage-dependent, alpha 1H subunit
chr11:69364783-69364796-0.9225.3821.250.6510.055NM_005247-21654 fibroblast growth factor 3 (murine mammary tumor virus
chr17:35140104-35140117+0.9185.3511.420.6480.055NM_032339210 chromosome 17 open reading frame 37 (C17orf37), mRNA.
chr17:35532338-35532351-0.9225.3821.110.6460.055NM_001012241122-
chr1:59019896-59019909-0.9225.3821.610.6460.055NM_0022282477 v-jun sarcoma virus 17 oncogene homolog (avian) (JUN),
chr22:37544665-37544678-0.9225.3821.210.6450.055NM_005740-24558 dynein, axonemal, light polypeptide 4 (DNAL4), mRNA.
chr1:65414486-65414499-0.9225.3821.120.6450.055NM_00100292127907 adenylate kinase 3-like 2 (AK3L2), mRNA.
chr16:71645188-71645201+0.9185.3511.120.6400.055NM_006885-5413 AT-binding transcription factor 1 (ATBF1), mRNA.
chr6:37259075-37259088+0.9225.3891.420.6380.055NM_00264813211 pim-1 oncogene (PIM1), mRNA.
chr1:47716648-47716661+0.9225.3821.990.6380.055NM_00447442472 forkhead box D2 (FOXD2), mRNA.
chr7:134116703-134116716-0.9155.3241.980.6370.055NM_0331572092 caldesmon 1 (CALD1), transcript variant 3, mRNA.
chr2:155264249-155264262-0.9225.3821.120.6350.055NM_0022391010 potassium inwardly-rectifying channel, subfamily J,
chr9:81881344-81881357+0.8194.5132.311.4850.056NM_007005504746 transducin-like enhancer of split 4 (E(sp1) homolog,
chr8:26205521-26205534+0.9105.2861.841.0330.056NM_002717670 protein phosphatase 2 (formerly 2A), regulatory
chr17:2443894-2443907-0.9085.2661.871.0330.056NM_000430308 platelet-activating factor acetylhydrolase, isoform
chr1:142627924-142627937+0.9095.2731.421.0310.056NM_178230447679 cyclophilin-LC (COAS2), mRNA.
chr12:52709549-52709562+0.9125.3051.921.0270.056NM_0045031188 homeo box C6 (HOXC6), transcript variant 1, mRNA.
chr17:44917131-44917144-0.9125.3051.991.0270.056NM_002507-10435 nerve growth factor receptor (TNFR superfamily, member
chr10:102375290-102375303+0.9135.3121.951.0110.056NM_01790289759 hypoxia-inducible factor 1, alpha subunit inhibitor
chr2:60631039-60631052-0.9135.3122.061.0060.056NM_0180143098 B-cell CLL/lymphoma 11A (zinc finger protein)
chr2:177785970-177785983+0.9085.2661.891.0040.056NM_194247402 heterogeneous nuclear ribonucleoprotein A3 (HNRPA3),
chr7:116195513-116195526-0.8955.1612.280.9990.056NM_006136-94186 capping protein (actin filament) muscle Z-line, alpha
chr17:29964498-29964511-0.8975.1751.680.9920.056NM_20731332717 hypothetical protein LOC124842 (LOC124842), mRNA.
chr19:12765514-12765527-0.8965.1662.210.9910.056NM_0022292304 jun B proto-oncogene (JUNB), mRNA.
chr11:64267370-64267383-0.8995.1871.830.9780.056NM_001098671836-
chr15:71113751-71113764-0.8955.1612.120.9670.056NM_002499-18077 neogenin homolog 1 (chicken) (NEO1), mRNA.
chr21:46849715-46849728+0.9155.3241.430.5990.056NM_006272-252 S100 calcium binding protein, beta (neural) (S100B),
chr14:64252083-64252096+0.9225.3821.430.5980.056NM_01554911237-
chr8:114519000-114519013+0.9165.3311.630.5930.056NM_198123-582 CUB and Sushi multiple domains 3 (CSMD3), transcript
chr6:37044478-37044491-0.9165.3311.200.5920.056NM_15337014391 protease inhibitor 16 (PI16), mRNA.
chr1:153248012-153248025-0.9225.3891.250.5870.056NM_015872-5436 zinc finger protein 67 homolog (mouse) (ZFP67), mRNA.
chrX:152569690-152569703+0.9225.3821.360.5860.056NM_0013958608 dual specificity phosphatase 9 (DUSP9), mRNA.
chr6:44150957-44150970+0.9225.3891.460.5850.056NM_03211152212 mitochondrial ribosomal protein L14 (MRPL14), nuclear
chr12:52497376-52497389+0.9155.3241.920.5850.056NM_020898-89890 KIAA1536 protein (KIAA1536), mRNA.
chrX:152683232-152683245-0.9155.3241.390.5780.056NM_005393427 plexin B3 (PLXNB3), mRNA.
chr10:7489210-7489223-0.9155.3241.500.5730.056NM_0010298804246-
chr15:64780487-64780500+0.9165.3381.110.5720.056NM_005585-1101 SMAD, mothers against DPP homolog 6 (Drosophila)
chr7:99908082-99908095+0.9225.3821.370.5710.056NM_0309356756 TSC-22-like (THG-1), mRNA.
chrX:68692468-68692481+0.9165.3311.190.5710.056NM_01568650765 transmembrane protein 28 (TMEM28), mRNA.
chr9:124067213-124067226+0.9395.5261.240.4630.056NM_033117-302 RNA binding motif protein 18 (RBM18), mRNA.
chr22:40996695-40996708+0.9425.5531.110.4520.056NM_181492-55306 transcription factor 20 (AR1) (TCF20), transcript
chr22:44059440-44059453+0.9425.5531.030.4450.056NM_006953-13 uroplakin 3A (UPK3A), mRNA.
chr3:72614907-72614920+0.9395.5261.100.4350.056NM_012234-36443 RING1 and YY1 binding protein (RYBP), mRNA.
chr10:50238028-50238041+0.9425.5511.660.4320.056NM_00108052031885-
chr3:40403632-40403645-0.9425.5531.520.4310.056NM_00124835 ectonucleoside triphosphate diphosphohydrolase 3
chr3:184454548-184454561-0.9425.5531.020.4280.056NM_032047922 UDP-GlcNAc:betaGal
chr11:63758538-63758551-0.9425.5531.040.4210.056NM_003377-204 vascular endothelial growth factor B (VEGFB), mRNA.
chr8:145119726-145119739-0.9425.5531.100.4210.056NM_201378-98 plectin 1, intermediate filament binding protein
chr5:138802759-138802772+0.9425.5531.140.4040.056NM_152686279 hypothetical protein MGC29463 (MGC29463), mRNA.
chr11:22808013-22808026-0.9395.5261.180.4010.056NM_005256155182 growth arrest-specific 2 (GAS2), transcript variant 1,
chr8:98950420-98950433-0.9525.6361.060.3290.056NM_03058333 matrilin 2 (MATN2), transcript variant 2, mRNA.
chr6:149634818-149634831-0.9495.6101.120.3220.056NM_015093-45838 mitogen-activated protein kinase kinase kinase 7
chr2:2312084-2312097+0.9495.6101.400.3180.056NM_0150251968-
chr6:41229419-41229432+0.9525.6361.120.3030.056NM_178174629 triggering receptor expressed on myeloid cells-like 1
chr22:20126264-20126277+0.8244.5581.981.4020.057NM_01509424671 hypermethylated in cancer 2 (HIC2), mRNA.
chr14:73863078-73863091-0.8945.1492.951.3630.058NM_018228-21741 chromosome 14 open reading frame 115 (C14orf115),
chr17:7531321-7531334-0.9135.3122.090.9990.058NM_000546321 tumor protein p53 (Li-Fraumeni syndrome) (TP53), mRNA.
chr19:12760672-12760685+0.9085.2662.040.9950.058NM_002229-2538 jun B proto-oncogene (JUNB), mRNA.
chr19:51155909-51155922-0.9055.2411.830.9930.058NM_00251612588 neuro-oncological ventral antigen 2 (NOVA2), mRNA.
chr1:28935797-28935810+0.9055.2412.220.9880.058NM_016258174 YTH domain family 2 (YTHDF2), mRNA.
chr5:87473901-87473914-0.9085.2661.850.9870.058NM_153354126520 hypothetical protein MGC33214 (MGC33214), mRNA.
chr17:24973534-24973547-0.9105.2861.740.9780.058NM_032854-914 coronin, actin binding protein 6 (FLJ14871), mRNA.
chr17:44928403-44928416+0.9095.2731.690.9770.058NM_002507837 nerve growth factor receptor (TNFR superfamily, member
chr12:47637146-47637159-0.9135.3122.170.9750.058NM_001659431 ADP-ribosylation factor 3 (ARF3), mRNA.
chr1:29113610-29113623+0.9085.2661.880.9750.058NM_20334327495 erythrocyte membrane protein band 4.1 (elliptocytosis
chr6:41579712-41579725+0.9135.3122.180.9740.058NM_001012426-42330-
chr2:74916241-74916254+0.9075.2601.660.9720.058NM_0001893051 hexokinase 2 (HK2), mRNA.
chr20:34636312-34636325-0.9085.2661.820.9710.058NM_021809988 TGFB-induced factor 2 (TALE family homeobox) (TGIF2),
chr7:19123656-19123669+0.9085.2661.470.9670.058NM_000474164 twist homolog 1 (acrocephalosyndactyly 3;
chr10:23503844-23503857+0.9265.4151.080.4990.058NM_178161-17522 pancreas specific transcription factor, 1a (PTF1A),
chr11:2245582-2245595-0.9275.4251.250.4980.058NM_0051703176 achaete-scute complex-like 2 (Drosophila) (ASCL2),
chr10:79837249-79837262+0.9285.4341.060.4970.058NM_033022373769 ribosomal protein S24 (RPS24), transcript variant 1,
chr11:46100865-46100878+0.9265.4151.270.4960.058NM_016621-1304 BRAF35/HDAC2 complex (80 kDa) (BHC80), mRNA.
chr1:26019507-26019520+0.9315.4601.500.4940.058NM_001099626-299-
chr22:40897534-40897547-0.9285.4341.290.4940.058NM_001025161-40707-
chr1:159433453-159433466-0.9295.4471.450.4930.058NM_0050992015 a disintegrin-like and metalloprotease (reprolysin
chr22:18104416-18104429-0.9265.4151.300.4890.058NM_00040713450 glycoprotein Ib (platelet), beta polypeptide (GP1BB),
chr17:64020411-64020424-0.9265.4151.110.4890.058NM_212472373 protein kinase, cAMP-dependent, regulatory, type I,
chr2:111851013-111851026-0.9295.4471.300.4870.058NM_138621256151 BCL2-like 11 (apoptosis facilitator) (BCL2L11),
chr7:148026661-148026674-0.9265.4151.000.4850.058NM_003592-105 cullin 1 (CUL1), mRNA.
chr20:34807944-34807957+0.9255.4071.150.4840.058NM_032013-49 NDRG family member 3 (NDRG3), transcript variant 1,
chr22:41010153-41010166+0.9255.4071.160.4840.058NM_181492-68764 transcription factor 20 (AR1) (TCF20), transcript
chr1:39320286-39320299-0.9255.4071.070.4810.058NM_012090681 microtubule-actin crosslinking factor 1 (MACF1),
chr1:44171937-44171950+0.9265.4151.150.4800.058NM_057091458 artemin (ARTN), transcript variant 2, mRNA.
chr7:72884654-72884667+0.9285.4341.120.4800.058NM_0013051625 claudin 4 (CLDN4), mRNA.
chr2:84986229-84986242+0.9255.4071.260.4800.058NM_02110355 thymosin, beta 10 (TMSB10), mRNA.
chr20:57051246-57051259-0.9265.4151.220.4780.058NM_01604550 chromosome 20 open reading frame 45 (C20orf45), mRNA.
chr22:20108717-20108730-0.9275.4251.050.4780.058NM_0150947124 hypermethylated in cancer 2 (HIC2), mRNA.
chr11:72092309-72092322+0.9295.4471.170.4760.058NM_0152429535 centaurin, delta 2 (CENTD2), transcript variant 2,
chr1:29087420-29087433+0.9255.4071.060.4750.058NM_2033431305 erythrocyte membrane protein band 4.1 (elliptocytosis
chr5:129268337-129268350+0.9255.4071.000.4710.058NM_17585615-
chr1:196470571-196470584+0.9295.4471.140.4700.058NM_1334942366 NIMA (never in mitosis gene a)-related kinase 7
chr15:87707403-87707416-0.9295.4471.150.4690.058NM_002693-28373 polymerase (DNA directed), gamma (POLG), mRNA.
chr5:59223663-59223676+0.9295.4471.290.4690.058NM_006203-305631 phosphodiesterase 4D, cAMP-specific (phosphodiesterase
chr10:104392620-104392633+0.9315.4601.420.4680.058NM_030912-1522 tripartite motif-containing 8 (TRIM8), mRNA.
chr1:8797675-8797688-0.8935.1412.601.3150.059NM_0121022611 arginine-glutamic acid dipeptide (RE) repeats (RERE),
chr11:34263348-34263361+0.8935.1402.241.3000.059NM_14580472030 ankyrin repeat and BTB (POZ) domain containing 2
chr7:75796741-75796754-0.8885.0962.551.2890.059NM_00154026982 heat shock 27kDa protein 1 (HSPB1), mRNA.
chr5:157643280-157643293+0.8945.1492.471.2770.059NM_014666-424534 enthoprotin (ENTH), mRNA.
chr8:95723182-95723195+0.8945.1511.771.2740.059NM_017697684 hypothetical protein FLJ20171 (FLJ20171), mRNA.
chr14:51190086-51190099+0.8935.1402.461.2720.059NM_1523301860 chromosome 14 open reading frame 31 (C14orf31), mRNA.
chr1:224253804-224253817+0.8945.1492.321.2190.059NM_152608-115 hypothetical protein FLJ35382 (FLJ35382), mRNA.
chr18:46976084-46976097-0.8945.1492.411.2140.059NM_0166261604 ring finger and KH domain containing 2 (RKHD2), mRNA.
chr1:61664740-61664753-0.8915.1232.391.2070.059NM_032027298943 beta-amyloid binding protein precursor (BBP), mRNA.
chr17:38433263-38433276+0.9635.7321.110.3280.059NM_0054402579 ras homolog gene family, member N (ARHN), mRNA.
chr7:99905522-99905535+0.9635.7321.170.3100.059NM_001004323-5692 hypothetical gene supported by BC031966 (MGC43036),
chr5:141207422-141207435-0.9635.7321.190.3040.059NM_03242030706 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr17:39386588-39386601-0.9495.6101.240.2980.059NM_002722-11229 pancreatic polypeptide (PPY), mRNA.
chr1:98283695-98283708+0.9165.3381.050.5570.060NM_000110-124492 dihydropyrimidine dehydrogenase (DPYD), mRNA.
chr19:54258968-54258981+0.9225.3821.150.5560.060NM_006179-31 neurotrophin 5 (neurotrophin 4/5) (NTF5), mRNA.
chr11:16591390-16591403-0.9155.3241.340.5520.060NM_014267-125280 small acidic protein (SMAP), mRNA.
chr12:6703397-6703410+0.9165.3381.030.5490.060NM_01631915 COP9 constitutive photomorphogenic homolog subunit 7A
chr12:42515629-42515642-0.9155.3241.170.5450.060NM_032256-500 hypothetical protein DKFZp434K2435 (DKFZp434K2435),
chr7:100040376-100040389+0.9225.3891.050.5430.060NM_0025932550 procollagen C-endopeptidase enhancer (PCOLCE), mRNA.
chrX:39758313-39758326-0.9165.3381.360.5370.060NM_01774583287 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr7:13995101-13995114-0.9185.3511.410.5370.060NM_004956188 ets variant gene 1 (ETV1), mRNA.
chr9:118007426-118007439-0.9225.3821.450.5360.060NM_00258151634 pregnancy-associated plasma protein A, pappalysin 1
chr9:132808967-132808980+0.9165.3381.520.5350.060NM_032843-4909 fibrinogen C domain containing 1 (FIBCD1), mRNA.
chr2:42961002-42961015-0.9225.3821.050.5350.060NM_012205-87783 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), mRNA.
chr11:63829558-63829571-0.9165.3311.200.5340.060NM_00445138 estrogen-related receptor alpha (ESRRA), mRNA.
chr7:28417111-28417124-0.9425.5531.340.3930.060NM_182898-1458 cAMP responsive element binding protein 5 (CREB5),
chr4:174692299-174692312+0.9425.5511.070.3870.060NM_021973-4346 heart and neural crest derivatives expressed 2
chr21:45887955-45887968+0.9425.5531.130.3860.060NM_194255-101176 solute carrier family 19 (folate transporter), member
chr5:148740728-148740741-0.9395.5261.080.3850.060NM_014443-1697 interleukin 17B (IL17B), mRNA.
chr6:83959776-83959789-0.9425.5531.050.3760.060NM_015599-122 phosphoglucomutase 3 (PGM3), mRNA.
chr16:4314189-4314202+0.9425.5511.010.3700.060NM_032575-7937 GLIS family zinc finger 2 (GLIS2), mRNA.
chr2:45015874-45015887+0.9225.3891.250.5320.061NM_005413-6567 sine oculis homeobox homolog 3 (Drosophila) (SIX3),
chr14:22546329-22546342+0.9225.3821.640.5270.061NM_0219442863 chromosome 14 open reading frame 93 (C14orf93), mRNA.
chr1:238882676-238882689-0.9225.3821.050.5270.061NM_022469-40591 gremlin 2 homolog, cysteine knot superfamily (Xenopus
chr12:71593766-71593779+0.9225.3821.710.5260.061NM_013381641136 thyrotropin-releasing hormone degrading ectoenzyme
chr10:73115736-73115749+0.9155.3241.780.5210.061NM_02215387607-
chr12:52841178-52841191-0.9155.3241.540.5190.061NM_01431127846 single-strand selective monofunctional uracil DNA
chr5:63838461-63838474-0.9225.3821.280.5190.061NM_001029875353-
chr16:48450258-48450271-0.9225.3891.450.5170.061NM_015069-31839 zinc finger protein 423 (ZNF423), mRNA.
chr12:120745609-120745622-0.9225.3821.150.5150.061NM_019034-29632 ras homolog gene family, member F (in filopodia)
chr3:38472008-38472021+0.9185.3511.450.5150.061NM_0011061314 activin A receptor, type IIB (ACVR2B), mRNA.
chr3:14864638-14864651+0.9225.3821.080.5140.061NM_15253628928 FYVE, RhoGEF and PH domain containing 5 (FGD5), mRNA.
chr16:580055-580068+0.9165.3381.420.5090.061NM_021168-25 RAB40C, member RAS oncogene family (RAB40C), mRNA.
chr4:115740100-115740113+0.9155.3241.010.5090.061NM_003360-22772 UDP glycosyltransferase 8 (UDP-galactose ceramide
chr2:26552742-26552755+0.9225.3821.260.5050.061NM_0048021672 otoferlin (OTOF), transcript variant 2, mRNA.
chr4:154124650-154124663-0.9155.3241.120.5050.061NM_03339341165 KIAA1727 protein (KIAA1727), mRNA.
chr1:202949232-202949245+0.9225.3821.290.5040.061NM_201630-28012 leucine rich repeat neuronal 5 (LRRN5), transcript
chr11:69127553-69127566-0.9155.3241.480.5020.061NM_053056-37401 cyclin D1 (PRAD1: parathyroid adenomatosis 1) (CCND1),
chr17:35501972-35501985+0.9225.3821.210.5000.061NM_0217248527 nuclear receptor subfamily 1, group D, member 1
chr11:77577109-77577122-0.8975.1751.500.9610.063NM_001029859203-
chr8:41303972-41303985-0.9005.1992.160.9440.063NM_003012-17835 secreted frizzled-related protein 1 (SFRP1), mRNA.
chr1:53949208-53949221-0.9635.7321.110.2830.063NM_14719323257 GLIS family zinc finger 1 (GLIS1), mRNA.
chr11:6516367-6516380+0.9635.7321.200.2730.063NM_144666-27444 hypothetical protein FLJ32752 (FLJ32752), mRNA.
chr8:76482589-76482602-0.8795.0191.971.2930.065NM_004133-132069 hepatocyte nuclear factor 4, gamma (HNF4G), mRNA.
chr17:7284139-7284152-0.8795.0192.141.2910.065NM_004112826 fibroblast growth factor 11 (FGF11), mRNA.
chr7:41694753-41694766-0.8795.0272.361.2910.065NM_00219214478 inhibin, beta A (activin A, activin AB alpha
chr9:130211285-130211298+0.8795.0272.311.2900.065NM_016174-11553 cerebral endothelial cell adhesion molecule 1
chr4:109282474-109282487+0.8795.0192.521.2800.065NM_01626926553 lymphoid enhancer-binding factor 1 (LEF1), mRNA.
chr5:61068177-61068190-0.8935.1402.461.2660.065NM_17366798884 hypothetical protein FLJ37543 (FLJ37543), mRNA.
chr1:199127743-199127756+0.8935.1401.721.2470.065NM_018265551 hypothetical protein FLJ10901 (FLJ10901), mRNA.
chr15:69626570-69626583-0.8945.1492.431.2370.065NM_001093733-205424-
chr17:2042073-2042086-0.8885.0962.601.2350.065NM_017575111746 chromosome 17 open reading frame 31 (C17orf31), mRNA.
chr17:76987494-76987507+0.8965.1661.640.8940.065NM_00108051933-
chr1:6443162-6443175-0.8975.1751.860.8870.065NM_0037905680 tumor necrosis factor receptor superfamily, member 25
chr7:14908677-14908690-0.8995.1872.170.8860.065NM_145695-61264 diacylglycerol kinase, beta 90kDa (DGKB), transcript
chr5:167650832-167650845+0.8955.1611.760.8770.065NM_015238-738 KIBRA protein (KIBRA), mRNA.
chr12:44670625-44670638-0.8975.1751.860.8720.065NM_00471943 splicing factor, arginine/serine-rich 2, interacting
chr12:117903917-117903930-0.8965.1662.030.8630.065NM_194286238 KIAA1853 protein (KIAA1853), mRNA.
chr17:30054542-30054555+0.8955.1611.980.8610.065NM_207313122761 hypothetical protein LOC124842 (LOC124842), mRNA.
chr2:158374030-158374043-0.8995.1871.830.8570.065NM_00110529006 activin A receptor, type I (ACVR1), mRNA.
chr9:36476106-36476119-0.8955.1611.620.8490.065NM_194330-84911 ring finger protein 38 (RNF38), transcript variant 5,
chr2:200030586-200030599+0.8965.1662.030.8390.065NM_0152652860 SATB family member 2 (SATB2), mRNA.
chr14:68219148-68219161-0.8975.1751.500.8380.065NM_004926110390 zinc finger protein 36, C3H type-like 1 (ZFP36L1),
chr12:131646584-131646597-0.9425.5531.050.3630.065NM_012226-58792 purinergic receptor P2X, ligand-gated ion channel, 2
chr17:45632770-45632783+0.9425.5531.150.3560.065NM_0000881229 collagen, type I, alpha 1 (COL1A1), mRNA.
chr11:226472-226485-0.9425.5531.120.3420.065NM_012239-111 sirtuin (silent mating type information regulation 2
chr7:69675383-69675396+0.9495.6101.010.2580.065NM_022479-560242 Williams-Beuren syndrome chromosome region 17
chr1:21523656-21523669-0.9525.6361.010.2370.065NM_001397-34162 endothelin converting enzyme 1 (ECE1), mRNA.
chr1:154947554-154947567-0.9495.6101.110.2320.065NM_001878-5555 cellular retinoic acid binding protein 2 (CRABP2),
chr12:120532-120545-0.9495.6101.360.2190.065NM_01523263829-
chrX:39764108-39764121-0.9495.6101.300.2140.065NM_01774577492 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr6:8554716-8554729+0.9495.6101.060.2100.065NM_015948-174092 solute carrier family 35, member B3 (SLC35B3), mRNA.
chr11:118283722-118283735-0.8754.9882.221.3420.066NM_1825573101 B-cell CLL/lymphoma 9-like (BCL9L), mRNA.
chr12:2942981-2942994+0.9055.2411.620.9550.066NM_2014433858 TEA domain family member 4 (TEAD4), transcript variant
chr3:195139188-195139201+0.9125.3051.970.9540.066NM_005524-197340 hairy and enhancer of split 1, (Drosophila) (HES1),
chr11:61005264-61005277+0.9075.2601.940.9530.066NM_145017196 IIIG9 protein (FLJ32771), mRNA.
chr2:50053558-50053571-0.9075.2602.130.9520.066NM_138735374840 neurexin 1 (NRXN1), transcript variant beta, mRNA.
chr3:182920935-182920948-0.9135.3122.010.9490.066NM_0031068619 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr2:58728625-58728638-0.9105.2861.880.9490.066NM_018062-406607 Fanconi anemia, complementation group L (FANCL), mRNA.
chr1:201411618-201411631-0.9135.3121.670.9480.066NM_004997-53 myosin binding protein H (MYBPH), mRNA.
chr14:74491180-74491193+0.9055.2411.760.9350.066NM_002632864 placental growth factor, vascular endothelial growth
chr19:1202051-1202064+0.8965.1661.090.9270.066NM_1774012599-
chr14:67051302-67051315-0.8965.1662.000.9120.066NM_182526472 hypothetical protein FLJ33387 (FLJ33387), mRNA.
chr3:49424017-49424030+0.8975.1751.700.9080.066NM_001664513 ras homolog gene family, member A (RHOA), mRNA.
chr13:19430936-19430949+0.8975.1751.680.9070.066NM_197968226 zinc finger protein 198 (ZNF198), mRNA.
chr10:103862342-103862355-0.9165.3381.570.4920.066NM_0038932350 LIM domain binding 1 (LDB1), mRNA.
chr16:25970026-25970039+0.9155.3241.050.4920.066NM_006040359278 heparan sulfate (glucosamine) 3-O-sulfotransferase 4
chr3:197104449-197104462-0.9225.3821.080.4890.066NM_0010109382380-
chr12:97747348-97747361+0.9155.3241.560.4880.066NM_181869184239 apoptotic protease activating factor (APAF1),
chr9:70925963-70925976-0.9225.3891.440.4870.066NM_004817-52846 tight junction protein 2 (zona occludens 2) (TJP2),
chr1:203464138-203464151-0.9225.3821.530.4840.066NM_014858524 cerebral protein 11 (HUCEP11), mRNA.
chr19:13208026-13208039+0.9165.3381.470.4790.066NM_00490785844 immediate early response 2 (IER2), mRNA.
chr9:123070155-123070168-0.9225.3821.350.4780.066NM_19825254 gelsolin (amyloidosis, Finnish type) (GSN), transcript
chr9:129869282-129869295-0.9225.3821.550.4780.066NM_197956-70 chromosome 9 open reading frame 90 (C9orf90), mRNA.
chr1:86395078-86395091+0.9155.3241.280.4750.066NM_152890-369 collagen, type XXIV, alpha 1 (COL24A1), mRNA.
chr5:153134752-153134765+0.9225.3821.780.4720.066NM_005927-263900 microfibrillar-associated protein 3 (MFAP3), mRNA.
chr2:204716573-204716586-0.9185.3511.500.4700.066NM_012092206925 inducible T-cell co-stimulator (ICOS), mRNA.
chr17:58058204-58058217-0.9225.3821.240.4680.066NM_006039-190 mannose receptor, C type 2 (MRC2), mRNA.
chr14:22607794-22607807-0.8835.0532.561.3130.067NM_144985-12919 cadherin-like 24 (CDH24), mRNA.
chr14:36052800-36052813+0.8024.3722.211.4080.068NM_0033175854 thyroid transcription factor 1 (TITF1), mRNA.
chr7:100317909-100317922+0.8835.0532.221.2280.068NM_1828007338 arsenate resistance protein ARS2 (ARS2), transcript
chr3:9414518-9414531-0.9135.3121.610.8990.068NM_001080517215-
chr19:13978020-13978033+0.9135.3121.830.8980.068NM_00291877 regulatory factor X, 1 (influences HLA class II
chr12:1801377-1801390+0.9055.2411.700.8980.068NM_0010390291521-
chr20:15978596-15978609+0.9135.3121.750.8980.068NM_024704523482 chromosome 20 open reading frame 23 (C20orf23), mRNA.
chr14:64416477-64416490+0.9085.2671.760.8970.068NM_145165-34316 churchill domain containing 1 (CHURC1), mRNA.
chr1:32889231-32889244+0.9095.2732.050.8960.068NM_005610-80 retinoblastoma binding protein 4 (RBBP4), mRNA.
chr5:53849303-53849316-0.9085.2671.910.8910.068NM_052870-137 sorting nexin associated golgi protein 1 (SNAG1),
chr7:113513116-113513129+0.9135.3121.910.8910.068NM_002711-166816 protein phosphatase 1, regulatory (inhibitor) subunit
chr18:58569950-58569963+0.9085.2661.720.8860.068NM_19444936336 pleckstrin homology domain containing, family E (with
chr6:24828027-24828040-0.9075.2601.790.8850.068NM_030939-645 chromosome 6 open reading frame 62 (C6orf62), mRNA.
chr16:29791577-29791590+0.9085.2661.660.8780.068NM_006319-9498 CDP-diacylglycerol--inositol 3-phosphatidyltransferase
chr1:46726471-46726484+0.9135.3121.840.8770.068NM_147192-18684 diencephalon/mesencephalon homeobox 1 (DMBX1),
chr1:204301627-204301640-0.9095.2731.340.8770.068NM_000707-88840 arginine vasopressin receptor 1B (AVPR1B), mRNA.
chr19:11429069-11429082-0.9085.2671.580.8750.068NM_00274321900 protein kinase C substrate 80K-H (PRKCSH), transcript
chr3:49881613-49881626-0.9135.3122.090.8730.068NM_024046760 hypothetical protein MGC8407 (MGC8407), mRNA.
chr3:51973300-51973313-0.9095.2731.320.8710.068NM_033010-1352 poly(rC) binding protein 4 (PCBP4), transcript variant
chr12:52984530-52984543+0.9055.2412.330.8700.068NM_006163-8719 nuclear factor (erythroid-derived 2), 45kDa (NFE2),
chr19:10779906-10779919+0.9055.2411.590.8660.068NM_00685828077 interleukin 1 receptor-like 1 ligand (IL1RL1LG), mRNA.
chr14:20563014-20563027-0.9085.2661.520.8620.068NM_20153890 NDRG family member 2 (NDRG2), transcript variant 5,
chr1:158603215-158603228-0.9085.2671.710.8610.068NM_005598-183 nescient helix loop helix 1 (NHLH1), mRNA.
chr12:121000655-121000668-0.9085.2671.700.8610.068NM_014938-388 Mlx interactor (MONDOA), mRNA.
chr2:202545874-202545887-0.9125.3052.310.8590.068NM_003507-61581 frizzled homolog 7 (Drosophila) (FZD7), mRNA.
chr12:119311633-119311646+0.9125.3051.490.8580.068NM_002442-20292 musashi homolog 1 (Drosophila) (MSI1), mRNA.
chr20:44093831-44093844+0.9085.2671.420.8510.068NM_0207082686 solute carrier family 12, (potassium-chloride
chr17:43978985-43978998-0.9085.2661.600.8500.068NM_002145-1593 homeo box B2 (HOXB2), mRNA.
chr9:1908297-1908310-0.9135.3121.420.8500.068NM_003070-96945 SWI/SNF related, matrix associated, actin dependent
chr9:126309812-126309825+0.9075.2602.070.8490.068NM_004959-292 nuclear receptor subfamily 5, group A, member 1
chr11:66253129-66253142+0.9135.3122.240.8430.068NM_006946-7683 spectrin, beta, non-erythrocytic 2 (SPTBN2), mRNA.
chr12:111304604-111304617+0.9055.2411.850.8410.068NM_00097027222 ribosomal protein L6 (RPL6), mRNA.
chr21:33320032-33320045-0.9085.2671.680.8410.068NM_00580623 oligodendrocyte lineage transcription factor 2
chr19:44266672-44266685+0.9075.2601.790.8390.068NM_001004318-13 FLJ16165 protein (FLJ16165), mRNA.
chr12:6750279-6750292+0.9115.2931.740.8380.068NM_002286-1552 lymphocyte-activation gene 3 (LAG3), mRNA.
chr18:28702286-28702299-0.9135.3122.050.8350.068NM_020805-95314-
chr9:102442120-102442133+0.9285.4341.080.4650.068NM_00101811662063-
chrX:132843839-132843852-0.9295.4471.190.4570.068NM_004484103493 glypican 3 (GPC3), mRNA.
chrX:69592212-69592225-0.9325.4731.680.4560.068NM_0207303426-
chr2:167857583-167857596-0.9265.4151.340.4550.068NM_152381389462-
chr10:101287305-101287318+0.9275.4291.520.4530.068NM_1452854725 NK2 transcription factor related, locus 3 (Drosophila)
chr16:30033501-30033514+0.9255.4071.060.4490.068NM_024307-1122 hypothetical protein MGC4171 (MGC4171), mRNA.
chr13:40136935-40136948-0.9255.4071.730.4480.068NM_0020151799 forkhead box O1A (rhabdomyosarcoma) (FOXO1A), mRNA.
chr6:112930524-112930537-0.9295.4471.080.4480.068NM_001013734155399-
chr14:72428430-72428443-0.9295.4471.110.4450.068NM_0120742132 D4, zinc and double PHD fingers, family 3 (DPF3),
chr9:128466324-128466337-0.9295.4471.270.4440.068NM_00231649805 LIM homeobox transcription factor 1, beta (LMX1B),
chr9:132358709-132358722-0.9265.4151.180.4410.068NM_05401248894 argininosuccinate synthetase (ASS), transcript variant
chr7:72763771-72763784-0.9285.4341.180.4390.068NM_0046038153 syntaxin 1A (brain) (STX1A), mRNA.
chr1:31943645-31943658+0.9275.4291.410.4380.068NM_001856-1290 collagen, type XVI, alpha 1 (COL16A1), mRNA.
chr9:27358658-27358671-0.9255.4071.470.4370.068NM_020641-71521-
chr2:64487225-64487238+0.9295.4471.390.4360.068NM_014181-47841 HSPC159 protein (HSPC159), mRNA.
chr17:31243358-31243371+0.9635.7321.050.2400.068NM_002985-11868 chemokine (C-C motif) ligand 5 (CCL5), mRNA.
chr10:25035188-25035201-0.8885.0962.391.1650.069NM_02082417362 Rho GTPase activating protein 21 (ARHGAP21), mRNA.
chr17:40182771-40182784-0.8945.1491.941.1600.069NM_002390-9223 a disintegrin and metalloproteinase domain 11
chr1:41617759-41617772+0.8885.0962.041.1600.069NM_001956105125 endothelin 2 (EDN2), mRNA.
chr10:76255907-76255920+0.8935.1402.051.1590.069NM_012330-378 MYST histone acetyltransferase (monocytic leukemia) 4
chr2:172458767-172458780-0.8945.1492.291.1560.069NM_003705212 solute carrier family 25 (mitochondrial carrier,
chrX:129047475-129047488-0.8935.1411.971.1420.069NM_00142124672 E74-like factor 4 (ets domain transcription factor)
chr6:100717819-100717832+0.8935.1401.681.1370.069NM_032503-168984 G protein-coupled receptor 145 (GPR145), mRNA.
chr9:128185793-128185806+0.8935.1401.731.1350.069NM_03344656944-
chr19:47282763-47282776+0.8935.1412.191.1340.069NM_02275216505 zinc finger protein 574 (ZNF574), mRNA.
chr1:32311342-32311355+0.9085.2661.950.9330.069NM_018056326 hypothetical protein FLJ10315 (FLJ10315), mRNA.
chr5:149089930-149089943-0.9085.2671.770.9330.069NM_133263-27 peroxisome proliferative activated receptor, gamma,
chr16:30583272-30583285-0.9135.3121.520.9320.069NM_02403113630 hypothetical protein MGC3121 (MGC3121), mRNA.
chr19:13924270-13924283+0.9105.2861.450.9300.069NM_13835351-
chr13:78259013-78259026-0.9095.2732.700.9270.069NM_024546-127698 chromosome 13 open reading frame 7 (C13orf7), mRNA.
chr4:124585289-124585302+0.9055.2411.820.9270.069NM_00584145256 sprouty homolog 1, antagonist of FGF signaling
chr11:66801599-66801612+0.9135.3121.340.9240.069NM_00161911218 adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA.
chr6:10498526-10498539-0.9085.2672.110.9240.069NM_00103228022067-
chr9:97248440-97248453+0.9135.3121.620.9180.069NM_00108360760862-
chr1:153194323-153194336-0.9105.2861.410.9170.069NM_020524868 pre-B-cell leukemia transcription factor interacting
chr19:11451352-11451365+0.9105.2861.510.9160.069NM_0014201451 ELAV (embryonic lethal, abnormal vision,
chr12:47499043-47499056+0.9055.2411.620.9130.069NM_000725364 calcium channel, voltage-dependent, beta 3 subunit
chr16:68544298-68544311+0.9125.3051.170.9110.069NM_1826192087 secretory protein LOC348174 (LOC348174), mRNA.
chr7:151792198-151792211+0.9125.3051.320.9030.069NM_00102986619043-
chr3:166396929-166396942+0.9085.2661.650.9020.069NM_014926234 SLIT and NTRK-like family, member 3 (SLITRK3), mRNA.
chr19:47371139-47371152-0.9085.2661.970.9010.069NM_13332842514 death effector domain containing 2 (DEDD2), mRNA.
chr17:53420810-53420823+0.9105.2861.680.9000.069NM_007146-196 zinc finger protein 161 (ZNF161), mRNA.
chr2:210744415-210744428+0.8604.8612.011.3670.070NM_152519-119 hypothetical protein FLJ23861 (FLJ23861), mRNA.
chr19:60865637-60865650-0.9325.4731.090.4320.070NM_0072798509 U2 (RNU2) small nuclear RNA auxiliary factor 2
chr12:51902060-51902073+0.9315.4601.140.4280.070NM_001042728-1643-
chr4:16503916-16503929-0.9285.4341.310.4250.070NM_0012905509 LIM domain binding 2 (LDB2), mRNA.
chr10:5444634-5444647-0.9275.4291.030.4240.070NM_001047160216-
chr19:12947270-12947283-0.9265.4151.040.4230.070NM_1526545938 hypothetical protein FLJ38607 (FLJ38607), mRNA.
chr14:68125819-68125832-0.9325.4731.060.4230.070NM_004926203719 zinc finger protein 36, C3H type-like 1 (ZFP36L1),
chr17:1875694-1875707-0.9265.4151.300.4190.070NM_178568-766 reticulon 4 receptor-like 1 (RTN4RL1), mRNA.
chr11:33752660-33752673-0.9265.4151.170.4190.070NM_033406-13 F-box protein 3 (FBXO3), transcript variant 2, mRNA.
chrX:62891343-62891356+0.9325.4731.400.4190.070NM_015185375-
chr12:51778118-51778131-0.9265.4151.290.4180.070NM_002178515 insulin-like growth factor binding protein 6 (IGFBP6),
chr14:25060784-25060797-0.9275.4291.210.4160.070NM_014178-471849 syntaxin binding protein 6 (amisyn) (STXBP6), mRNA.
chr12:117299073-117299086+0.9275.4291.050.4130.070NM_022491432 likely ortholog of mouse Sds3 (SDS3), mRNA.
chr12:51556704-51556717-0.9275.4291.020.4120.070NM_173352-27659 keratin 5b (K5B), mRNA.
chr1:224441142-224441155-0.9275.4291.440.4110.070NM_022735-96 acyl-Coenzyme A binding domain containing 3 (ACBD3),
chr9:16380186-16380199+0.9295.4471.290.4090.070NM_017637480600 basonuclin 2 (BNC2), mRNA.
chr17:38974064-38974077-0.9295.4471.250.4070.070NM_0019864767 ets variant gene 4 (E1A enhancer binding protein,
chr19:9908398-9908411+0.9275.4251.350.4070.070NM_058164-328 olfactomedin 2 (OLFM2), mRNA.
chr20:61479313-61479326-0.9275.4251.000.4060.070NM_000744-16121 cholinergic receptor, nicotinic, alpha polypeptide 4
chr10:73411130-73411143-0.9255.4071.100.4060.070NM_00427317104 carbohydrate (chondroitin 6) sulfotransferase 3
chr11:109731144-109731157+0.9295.4471.190.4020.070NM_002906-58497 radixin (RDX), mRNA.
chrX:68080377-68080390-0.9295.4471.120.4020.070NM_004429114921 ephrin-B1 (EFNB1), mRNA.
chr1:6471425-6471438-0.9255.4071.260.4010.070NM_0010426641802-
chrX:128743035-128743048+0.9315.4601.020.4000.070NM_0189901494 chromosome X open reading frame 9 (CXorf9), mRNA.
chr2:112655975-112655988+0.9255.4071.300.4000.070NM_15321443642 hypothetical protein FLJ37440 (FLJ37440), mRNA.
chr12:52025469-52025482-0.8734.9681.981.3980.071NM_152860-9665 Sp7 transcription factor (SP7), mRNA.
chr19:54185031-54185044-0.8664.9162.561.3940.071NM_0021033330 glycogen synthase 1 (muscle) (GYS1), mRNA.
chr2:218510555-218510568+0.8714.9562.131.3720.071NM_0226486451 tensin (TNS), mRNA.
chr7:78919639-78919652+0.8614.8682.111.3080.071NM_0123011187 atrophin-1 interacting protein 1 (AIP1), mRNA.
chr14:74814864-74814877-0.8945.1492.161.0640.071NM_005252-320 v-fos FBJ murine osteosarcoma viral oncogene homolog
chr12:5568727-5568740+0.8935.1401.771.0610.071NM_00252795300 neurotrophin 3 (NTF3), mRNA.
chr2:25336089-25336102-0.8935.1411.511.0530.071NM_153759-7405 DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A),
chr6:42015664-42015677-0.8945.1492.161.0520.071NM_0017601866 cyclin D3 (CCND3), mRNA.
chr20:30410593-30410606-0.8935.1402.081.0500.071NM_015338879 additional sex combs like 1 (Drosophila) (ASXL1),
chr10:130566147-130566160-0.8945.1491.831.0500.071NM_002412-589209 O-6-methylguanine-DNA methyltransferase (MGMT), mRNA.
chr1:26310217-26310230+0.8925.1302.411.0490.071NM_152835-596 casein kinase (LOC149420), mRNA.
chr9:37024164-37024177-0.8925.1302.701.0490.071NM_016734312 paired box gene 5 (B-cell lineage specific activator)
chr15:62952470-62952483+0.8915.1231.751.0420.071NM_02520131382 PH domain-containing protein (pp9099), mRNA.
chr11:61274025-61274038-0.8945.1492.641.0400.071NM_013279-5312 chromosome 11 open reading frame 9 (C11orf9), mRNA.
chr1:22549814-22549827+0.8935.1402.251.0380.071NM_001083621-101017-
chr11:17677849-17677862+0.8945.1491.961.0340.071NM_002478-19737 myogenic factor 3 (MYOD1), mRNA.
chr16:28791978-28791991-0.8955.1581.740.7850.071NM_004320-5232 ATPase, Ca++ transporting, cardiac muscle, fast twitch
chr4:152155884-152155897+0.8975.1752.230.7840.071NM_006726445 LPS-responsive vesicle trafficking, beach and anchor
chr3:49877890-49877903-0.8955.1612.270.7830.071NM_0240464483 hypothetical protein MGC8407 (MGC8407), mRNA.
chr6:3172334-3172347-0.8975.1751.500.7810.071NM_178012536 tubulin, beta polypeptide paralog (MGC8685), mRNA.
chr1:156279830-156279843-0.8955.1612.140.7740.071NM_01824050243 kin of IRRE like (Drosophila) (KIRREL), mRNA.
chr1:43196503-43196516-0.8975.1751.380.7710.071NM_006516585 solute carrier family 2 (facilitated glucose
chr12:10266817-10266830+0.8734.9742.201.3000.072NM_03141210161 GABA(A) receptor-associated protein like 1
chr10:119547134-119547147+0.8945.1492.461.1280.072NM_014904248970 RAB11 family interacting protein 2 (class I)
chr9:76302780-76302793+0.8935.1401.991.1260.072NM_006914808 RAR-related orphan receptor B (RORB), mRNA.
chr10:125191033-125191046+0.8945.1492.431.1210.072NM_153442-224728 G protein-coupled receptor 26 (GPR26), mRNA.
chr17:43486964-43486977+0.8935.1441.971.1200.072NM_0032046319 nuclear factor (erythroid-derived 2)-like 1 (NFE2L1),
chr12:3469907-3469920+0.8935.1401.931.1200.072NM_019854-679 HMT1 hnRNP methyltransferase-like 4 (S. cerevisiae)
chrX:152790147-152790160+0.8935.1401.921.1180.072NM_0004254358 L1 cell adhesion molecule (hydrocephalus, stenosis of
chr3:51508826-51508839-0.8945.1492.051.1140.072NM_014703215 Vpr-binding protein (VprBP), mRNA.
chr8:118881106-118881119-0.8935.1402.461.1070.072NM_080651278995 thyroid hormone receptor associated protein 6
chr12:112785042-112785055-0.8885.0962.031.1070.072NM_016196103457 RNA binding motif protein 19 (RBM19), mRNA.
chr16:72322778-72322791+0.8945.1492.711.1000.072NM_002811-565304 proteasome (prosome, macropain) 26S subunit,
chr12:4889235-4889248-0.8925.1302.171.0990.072NM_0002171 potassium voltage-gated channel, shaker-related
chr2:26250430-26250443+0.8935.1411.851.0990.072NM_000183-70590 hydroxyacyl-Coenzyme A
chr5:132052517-132052530+0.8935.1402.521.0970.072NM_17234815345 interleukin 4 (IL4), transcript variant 2, mRNA.
chr12:106239348-106239361+0.8935.1401.781.0940.072NM_0010180723121-
chr10:102300879-102300892+0.8885.0962.191.0910.072NM_01790215348 hypoxia-inducible factor 1, alpha subunit inhibitor
chr7:20832579-20832592+0.8885.0962.351.0900.072NM_198956-39549 Sp8 transcription factor (SP8), transcript variant 2,
chr10:76255701-76255714+0.8945.1462.091.0900.072NM_012330-584 MYST histone acetyltransferase (monocytic leukemia) 4
chr6:114399341-114399354-0.8935.1402.081.0860.072NM_001527-294 histone deacetylase 2 (HDAC2), mRNA.
chr1:31310832-31310845-0.8935.1442.131.0830.072NM_001020658319-
chr1:40136530-40136543-0.8945.1492.601.0820.072NM_0010330813744-
chr2:134042601-134042614+0.8935.1442.081.0810.072NM_207363-100-
chr5:124105621-124105634-0.8885.0962.261.0810.072NM_0207473083-
chr12:51900448-51900461+0.8945.1511.791.0770.072NM_001042728-31-
chr15:68176251-68176264+0.8975.1752.010.8230.072NM_005078-39 transducin-like enhancer of split 3 (E(sp1) homolog,
chrX:24197011-24197024-0.8955.1612.700.8210.072NM_003410117382 zinc finger protein, X-linked (ZFX), mRNA.
chr9:139181824-139181837-0.8975.1751.440.8160.072NM_0010136532488-
chr9:37241457-37241470-0.8955.1612.400.8150.072NM_032226131088 zinc finger, CCHC domain containing 7 (ZCCHC7), mRNA.
chr1:44888545-44888558-0.8955.1581.790.8130.072NM_02458724141 hypothetical protein FLJ22353 (FLJ22353), mRNA.
chr5:43229312-43229325-0.9285.4341.170.3970.072NM_1533611328 hypothetical protein MGC42105 (MGC42105), mRNA.
chr12:105873665-105873678+0.9265.4151.030.3970.072NM_152261-70 hypothetical protein MGC17943 (MGC17943), mRNA.
chr17:12140318-12140331-0.9275.4251.430.3970.072NM_003010275558 mitogen-activated protein kinase kinase 4 (MAP2K4),
chr4:18008491-18008504-0.9295.4471.470.3940.072NM_153686-376017 transcription factor MLR1 (MLR1), mRNA.
chr6:106880033-106880046-0.9255.4071.170.3930.072NM_004849355 APG5 autophagy 5-like (S. cerevisiae) (APG5L), mRNA.
chr19:51130240-51130253+0.9285.4341.060.3920.072NM_001029861-20364-
chr1:91342883-91342896-0.9295.4471.610.3870.072NM_201269-82624 zinc finger motif enhancer binding protein 2 (Zep-2),
chr5:176869468-176869481-0.9305.4521.180.3850.072NM_024872-9 docking protein 3 (DOK3), mRNA.
chr10:111748584-111748597-0.9275.4251.090.3850.072NM_019903-7032 adducin 3 (gamma) (ADD3), transcript variant 2, mRNA.
chr17:24098289-24098302+0.9275.4291.380.3840.072NM_0042953239 TNF receptor-associated factor 4 (TRAF4), transcript
chr11:61099740-61099753+0.9315.4601.040.3820.072NM_0042005134 synaptotagmin VII (SYT7), mRNA.
chr22:30072785-30072798-0.9255.4071.020.3810.072NM_032051-536 zinc finger protein 278 (ZNF278), transcript variant
chr5:68063361-68063374+0.9285.4341.200.3770.072NM_024055-362113 solute carrier family 30 (zinc transporter), member 5
chr8:22606668-22606681+0.9285.4371.120.3740.072NM_00443092 early growth response 3 (EGR3), mRNA.
chr14:69386912-69386925-0.9255.4071.060.3740.072NM_001034852-28884-
chr3:27732178-27732191-0.9315.4601.180.3730.072NM_0054426611 eomesodermin homolog (Xenopus laevis) (EOMES), mRNA.
chr6:31728451-31728464-0.9275.4291.130.3720.072NM_0807025 HLA-B associated transcript 3 (BAT3), transcript
chr20:275710-275723-0.9315.4601.020.3720.072NM_024958-2083 chromosome 20 open reading frame 98 (C20orf98), mRNA.
chr17:46598764-46598777-0.9255.4071.120.3700.072NM_001018139-16-
chrX:130240860-130240873-0.9285.4341.180.3690.072NM_00155510076 immunoglobulin superfamily, member 1 (IGSF1),
chr1:12599417-12599430+0.9315.4601.000.3670.072NM_004753990 dehydrogenase/reductase (SDR family) member 3 (DHRS3),
chr9:101708706-101708719+0.9425.5531.250.3290.072NM_01791919 syntaxin 17 (STX17), mRNA.
chr2:99791444-99791457-0.9425.5511.180.3180.072NM_001025108297033-
chr12:52025463-52025476-0.9425.5511.010.3120.072NM_152860-9659 Sp7 transcription factor (SP7), mRNA.
chr1:222687640-222687653-0.8935.1411.910.9910.073NM_025160695 WD repeat domain 26 (WDR26), mRNA.
chr17:46152227-46152240+0.8945.1492.000.9910.073NM_016424351 cisplatin resistance-associated overexpressed protein
chr22:30069341-30069354-0.8945.1492.330.9890.073NM_0143232908 zinc finger protein 278 (ZNF278), transcript variant
chr6:89147853-89147866+0.8885.0961.820.9870.073NM_033181-236078 cannabinoid receptor 1 (brain) (CNR1), transcript
chr20:51367450-51367463-0.8885.0962.180.9820.073NM_006526265593 zinc finger protein 217 (ZNF217), mRNA.
chr1:26609709-26609722+0.8895.1041.990.9810.073NM_024674-47 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr11:128091348-128091361-0.8935.1442.600.9720.073NM_00201722249 Friend leukemia virus integration 1 (FLI1), mRNA.
chr15:62779048-62779061-0.8935.1411.690.9670.073NM_0025373459 ornithine decarboxylase antizyme 2 (OAZ2), mRNA.
chr2:42102308-42102321-0.9125.3051.340.7990.073NM_138370-26849-
chr18:58345002-58345015-0.9085.2671.360.7980.073NM_017742-12792 zinc finger, CCHC domain containing 2 (ZCCHC2), mRNA.
chr10:99664742-99664755-0.9085.2662.410.7970.073NM_00101091764856-
chr7:35460691-35460704+0.9085.2662.010.7950.073NM_020417-200924 T-box 20 (TBX20), mRNA.
chr12:52155396-52155409+0.9135.3121.680.7930.073NM_00109862023335-
chr19:14089230-14089243+0.9085.2661.370.7910.073NM_002730329 protein kinase, cAMP-dependent, catalytic, alpha
chr7:150308842-150308855-0.9125.3051.380.7910.073NM_172056-2895 potassium voltage-gated channel, subfamily H
chr2:208284648-208284661+0.9085.2671.820.7910.073NM_152523239 hypothetical protein FLJ40432 (FLJ40432), mRNA.
chr4:53938392-53938405+0.9055.2411.710.7900.073NM_030917-128 FIP1 like 1 (S. cerevisiae) (FIP1L1), mRNA.
chr15:86626853-86626866-0.9085.2661.510.7880.073NM_001007156-26188-
chr19:19506510-19506523+0.9115.2931.020.7870.073NM_153221-3464 cartilage intermediate layer protein 2 (CILP2), mRNA.
chr19:47350096-47350109-0.9055.2411.680.7870.073NM_002698-21626 POU domain, class 2, transcription factor 2 (POU2F2),
chr9:88752065-88752078-0.9085.2661.630.7870.073NM_002048-141 growth arrest-specific 1 (GAS1), mRNA.
chr9:37909590-37909603+0.9135.3121.350.7820.073NM_033412-15240 mitochondrial carrier triple repeat 1 (MCART1), mRNA.
chr9:35105911-35105924-0.9085.2671.840.7800.073NM_025182-18 KIAA1539 (KIAA1539), mRNA.
chr2:208828123-208828136-0.9085.2671.520.7800.073NM_005896-72 isocitrate dehydrogenase 1 (NADP+), soluble (IDH1),
chr2:27047134-27047147-0.9085.2661.390.7770.073NM_012326205 microtubule-associated protein, RP/EB family, member 3
chr15:73123420-73123433-0.9055.2412.090.7770.073NM_02182320540 hypothetical protein MDS018 (MDS018), mRNA.
chr17:2535214-2535227+0.9055.2412.000.7750.073NM_01522926463 KIAA0664 protein (KIAA0664), mRNA.
chr12:123064682-123064695+0.9125.3051.580.7750.073NM_15243741159 hypothetical protein DKFZp761B128 (DKFZp761B128),
chr4:90446838-90446851-0.9085.2661.730.7740.073NM_1982811346 hypothetical protein LOC285513 (LOC285513), mRNA.
chr11:27634635-27634648-0.9075.2602.040.7730.073NM_1707352614 brain-derived neurotrophic factor (BDNF), transcript
chr10:73690600-73690613-0.9055.2411.310.7710.073NM_019058-12983 DNA-damage-inducible transcript 4 (DDIT4), mRNA.
chr2:174905421-174905434+0.9085.2661.550.7710.073NM_024583-63192 secernin 3 (SCRN3), mRNA.
chr1:159368439-159368452-0.9085.2661.470.7700.073NM_001039712441-
chr16:48052324-48052337+0.9075.2601.610.7700.073NM_14460287115 hypothetical protein MGC32905 (MGC33367), mRNA.
chr19:60680003-60680016+0.9135.3121.470.7690.073NM_033113592-
chr16:30867409-30867422+0.9055.2411.960.7670.073NM_152288-407 hypothetical protein MGC13024 (MGC13024), mRNA.
chr2:43307828-43307841+0.9135.3121.600.7670.073NM_006887-579 zinc finger protein 36, C3H type-like 2 (ZFP36L2),
chrX:105307957-105307970+0.8935.1412.421.0270.074NM_15242382 melanoma associated antigen (mutated) 1-like 1
chr11:66765204-66765217+0.8935.1402.391.0240.074NM_001619-25177 adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA.
chr7:25955969-25955982-0.8945.1492.321.0160.074NM_004289-202316 nuclear factor (erythroid-derived 2)-like 3 (NFE2L3),
chr9:111849962-111849975+0.8885.0962.171.0140.074NM_001004065-735 A kinase (PRKA) anchor protein 2 (AKAP2), mRNA.
chr6:140140276-140140289+0.8935.1402.091.0130.074NM_006079-402798 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr17:75420341-75420354-0.8945.1491.261.0090.074NM_0036557467 chromobox homolog 4 (Pc class homolog, Drosophila)
chr4:16399807-16399820+0.8945.1492.191.0090.074NM_001290109618 LIM domain binding 2 (LDB2), mRNA.
chr2:151042283-151042296-0.8945.1491.871.0080.074NM_00516810143 ras homolog gene family, member E (ARHE), mRNA.
chr11:121517683-121517696-0.8885.0962.381.0030.074NM_001001786-25550 BRCC2 mRNA (BRCC2), mRNA.
chr13:22172927-22172940-0.8935.1412.441.0020.074NM_000231-480064 sarcoglycan, gamma (35kDa dystrophin-associated
chr12:48780369-48780382-0.8935.1441.781.0010.074NM_005276-3599 glycerol-3-phosphate dehydrogenase 1 (soluble) (GPD1),
chr4:113372788-113372801+0.9285.4341.050.3660.074NM_018569458 chromosome 4 open reading frame 16 (C4orf16), mRNA.
chr20:54012102-54012115-0.9255.4071.020.3660.074NM_0806171317 cerebellin 4 precursor (CBLN4), mRNA.
chr16:56591955-56591968+0.9315.4601.000.3650.074NM_020807-692-
chr1:204797152-204797165+0.9255.4071.080.3590.074NM_182665137 Ras association (RalGDS/AF-6) domain family 5
chr11:19369803-19369816+0.9275.4251.190.3510.074NM_024680-150720 FLJ23311 protein (FLJ23311), mRNA.
chr7:127788014-127788027+0.9325.4731.280.3500.074NM_018077-16816 RNA binding motif protein 28 (RBM28), mRNA.
chr19:52937932-52937945+0.9315.4601.040.3490.074NM_015710-2588 glioma tumor suppressor candidate region gene 2
chr21:37160372-37160385+0.9295.4471.240.3470.074NM_000411124001 holocarboxylase synthetase
chr9:18370488-18370501-0.9295.4471.100.3470.074NM_052866-93579 ADAMTS-like 1 (ADAMTSL1), transcript variant 2, mRNA.
chr4:25877963-25877976+0.9275.4291.120.3460.074NM_005349-52367 recombining binding protein suppressor of hairless
chr3:178989431-178989444-0.9295.4471.190.3460.074NM_024665-591697 transducin (beta)-like 1X-linked receptor 1 (TBL1XR1),
chr6:38715423-38715436-0.9255.4071.100.3420.074NM_001099272479-
chr18:30057348-30057361+0.9295.4471.010.3410.074NM_00378796 nucleolar protein 4 (NOL4), mRNA.
chrX:39752828-39752841+0.9315.4601.130.3400.074NM_01774588772 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr12:5015509-5015522+0.9255.4071.260.3360.074NM_002234-7737 potassium voltage-gated channel, shaker-related
chrX:45515478-45515491-0.9325.4731.030.3360.074NM_024689-570388 chromosome X open reading frame 36 (CXorf36), mRNA.
chr12:48246363-48246376-0.9255.4071.320.3350.074NM_001012300126-
chr18:44698635-44698648-0.9255.4071.080.3340.074NM_00590432444 SMAD, mothers against DPP homolog 7 (Drosophila)
chr1:155076535-155076548+0.9395.5261.080.2970.074NM_01421518755 insulin receptor-related receptor (INSRR), mRNA.
chr17:74611583-74611596+0.9395.5261.000.2940.074NM_00104257329069-
chr1:36559579-36559592+0.9395.5291.010.2890.074NM_0181662763 hypothetical protein FLJ10647 (FLJ10647), mRNA.
chr4:119493392-119493405+0.9425.5531.120.2860.074NM_003619-22 protease, serine, 12 (neurotrypsin, motopsin)
chr17:7196139-7196152+0.9425.5531.080.2850.074NM_001002914307 potassium channel tetramerisation domain containing 11
chr7:12217429-12217442-0.8604.8611.941.2960.075NM_01837478 hypothetical protein FLJ11273 (FLJ11273), mRNA.
chr18:54679851-54679864+0.8574.8352.591.2890.075NM_018181-1090 zinc finger protein 532 (ZNF532), mRNA.
chr6:72654903-72654916-0.9225.3821.190.4660.075NM_0149891632 regulating synaptic membrane exocytosis 1 (RIMS1),
chr7:129205943-129205956+0.9155.3241.060.4630.075NM_001040110148888-
chr4:13514874-13514887+0.9155.3241.670.4590.075NM_148894-276448 family with sequence similarity 44, member A (FAM44A),
chr11:121098680-121098693+0.9165.3381.080.4570.075NM_003105270650 sortilin-related receptor, L(DLR class) A
chr7:75981352-75981365-0.9225.3821.270.4540.075NM_1826843771 uroplakin 3B (UPK3B), transcript variant 2, mRNA.
chr8:9793314-9793327+0.9185.3511.450.4480.075NM_012331-155822 methionine sulfoxide reductase A (MSRA), mRNA.
chr15:75713604-75713617-0.9155.3241.150.4460.075NM_032808-1840 leucine rich repeat neuronal 6A (LRRN6A), mRNA.
chr3:185801691-185801704-0.9165.3381.320.4450.075NM_00444339510 EphB3 (EPHB3), mRNA.
chr15:65386900-65386913+0.9155.3241.260.4450.075NM_02278452752 hypothetical protein FLJ12476 (FLJ12476), mRNA.
chr17:67119355-67119368-0.9155.3241.100.4430.075NM_000346-509301 SRY (sex determining region Y)-box 9 (campomelic
chr22:49255416-49255429-0.9225.3821.440.4400.075NM_0029724904 SET binding factor 1 (SBF1), transcript variant 1,
chr11:16790513-16790526-0.9225.3821.060.4400.075NM_01426773843 small acidic protein (SMAP), mRNA.
chr1:64709832-64709845+0.8394.6832.131.3070.076NM_020925868 KIAA1573 protein (KIAA1573), mRNA.
chr1:40929935-40929948+0.8744.9812.451.2700.076NM_01422383 nuclear transcription factor Y, gamma (NFYC), mRNA.
chr10:103316416-103316429-0.9135.3121.580.8320.076NM_01327421547 polymerase (DNA directed), lambda (POLL), mRNA.
chr3:52248227-52248240-0.9085.2672.090.8310.076NM_007284-4 PTK9L protein tyrosine kinase 9-like (A6-related
chr11:13256617-13256630+0.9055.2411.650.8300.076NM_001178816 aryl hydrocarbon receptor nuclear translocator-like
chr12:52698212-52698225+0.9135.3121.600.8280.076NM_1536931403 homeo box C6 (HOXC6), transcript variant 2, mRNA.
chr20:44327070-44327083-0.9055.2411.390.8240.076NM_021248-13329 cadherin-like 22 (CDH22), mRNA.
chr20:49847648-49847661-0.9125.3052.270.8190.076NM_0204364773 sal-like 4 (Drosophila) (SALL4), mRNA.
chr1:43784252-43784265+0.9085.2661.710.8190.076NM_00284015218 protein tyrosine phosphatase, receptor type, F
chr17:35009259-35009272-0.9135.3121.840.8160.076NM_0061608442 neurogenic differentiation 2 (NEUROD2), mRNA.
chr11:44312982-44312995+0.9135.3121.950.8150.076NM_021926-24690 aristaless-like homeobox 4 (ALX4), mRNA.
chr11:124665162-124665175-0.9085.2671.730.8140.076NM_022062125493 PBX/knotted 1 homeobox 2 (PKNOX2), mRNA.
chr1:10881153-10881166-0.9055.2411.250.8120.076NM_17350765692 hypothetical protein FLJ37118 (FLJ37118), mRNA.
chr6:111243522-111243535-0.9085.2661.810.8080.076NM_015076-417 cyclin-dependent kinase (CDC2-like) 11 (CDK11), mRNA.
chr10:62531943-62531956+0.9125.3051.600.8040.076NM_001032380-100739-
chr16:67709526-67709539-0.9135.3121.820.8010.076NM_00532910682 hyaluronan synthase 3 (HAS3), transcript variant 1,
chr8:110621304-110621317+0.8334.6322.031.3890.077NM_004215-82 estrogen receptor binding site associated, antigen, 9
chr14:73863077-73863090-0.8334.6382.951.3420.077NM_018228-21742 chromosome 14 open reading frame 115 (C14orf115),
chr18:33141444-33141457-0.8534.8062.471.3170.077NM_020180258497 bruno-like 4, RNA binding protein (Drosophila)
chr8:10260177-10260190-0.8604.8611.961.2630.077NM_198464-160214 tryptophan/serine protease (UNQ9391), mRNA.
chr17:1567291-1567304+0.8604.8612.381.2550.077NM_152348811 hypothetical protein FLJ33817 (FLJ33817), mRNA.
chr1:164064084-164064097+0.8594.8561.951.2530.077NM_012474670 uridine-cytidine kinase 2 (UCK2), mRNA.
chr16:2758638-2758651-0.8524.7992.381.3870.078NM_0071088660 transcription elongation factor B (SIII), polypeptide
chr1:202301318-202301331+0.8374.6692.011.3400.078NM_005686-7451 SRY (sex determining region Y)-box 13 (SOX13), mRNA.
chr5:137702297-137702310+0.8815.0382.551.0490.078NM_016605530 chromosome 5 open reading frame 6 (C5orf6), mRNA.
chr14:77415015-77415028-0.8754.9881.701.0460.078NM_02042178888 aarF domain containing kinase 1 (ADCK1), mRNA.
chr2:202949740-202949753-0.8965.1662.130.7580.078NM_001204-76 bone morphogenetic protein receptor, type II
chr19:60851700-60851713+0.8965.1661.260.7490.078NM_0133011034 protein predicted by clone 23882 (HSU79303), mRNA.
chr12:101372919-101372932+0.8955.1612.090.7490.078NM_00061825535 insulin-like growth factor 1 (somatomedin C) (IGF1),
chr1:24179174-24179187-0.8975.1751.590.7460.078NM_006625234 FUS interacting protein (serine-arginine rich) 1
chr1:7025256-7025269+0.8975.1751.250.7410.078NM_015215257385-
chr7:6380641-6380654+0.8975.1751.620.7400.078NM_19882990 ras-related C3 botulinum toxin substrate 1 (rho
chr1:60255761-60255774-0.8955.1612.070.7400.078NM_15237756253 hypothetical protein MGC34837 (MGC34837), mRNA.
chr2:43307312-43307325+0.8975.1752.040.7350.078NM_006887-63 zinc finger protein 36, C3H type-like 2 (ZFP36L2),
chr6:155096888-155096901+0.9005.1991.300.7300.078NM_014892784 RNA binding motif protein 16 (RBM16), mRNA.
chr12:14301801-14301814+0.8975.1752.330.7080.078NM_018179-107977 activating transcription factor 7 interacting protein
chr10:93358405-93358418-0.8955.1611.520.7020.078NM_00539824433 protein phosphatase 1, regulatory (inhibitor) subunit
chr5:50710215-50710228-0.8965.1662.080.7000.078NM_002202-4400 ISL1 transcription factor, LIM/homeodomain, (islet-1)
chr11:46273563-46273576+0.9395.5261.030.2190.078NM_05285417859 cAMP responsive element binding protein 3-like 1
chr11:124723570-124723583+0.9425.5511.100.2070.078NM_005103147763 fasciculation and elongation protein zeta 1 (zygin I)
chr9:868200-868213-0.9395.5261.150.2000.078NM_02195136610 doublesex and mab-3 related transcription factor 1
chr1:153309123-153309136+0.8524.7942.291.3410.079NM_1826906386 ephrin-A4 (EFNA4), transcript variant 3, mRNA.
chr7:29097393-29097406+0.8955.1611.950.6900.079NM_01902955285 carboxypeptidase, vitellogenic-like (CPVL), transcript
chr1:41020853-41020866-0.8975.1751.610.6890.079NM_004700-1318 potassium voltage-gated channel, KQT-like subfamily,
chr16:49237529-49237542+0.8975.1751.670.6880.079NM_18285435138 selectin ligand interactor cytoplasmic-1 (SLIC1),
chr10:63327717-63327730+0.9015.2111.740.6840.079NM_032199-3632-
chr17:37373172-37373185+0.8955.1611.640.6820.079NM_033133987 2',3'-cyclic nucleotide 3' phosphodiesterase (CNP),
chr19:2001870-2001883+0.8965.1661.340.6760.079NM_017572373 MAP kinase interacting serine/threonine kinase 2
chr12:55314732-55314745+0.9035.2251.360.6760.079NM_0134491698 bromodomain adjacent to zinc finger domain, 2A
chr7:99865055-99865068-0.8975.1752.440.6750.079NM_019606-310 hypothetical protein FLJ20257 (FLJ20257), mRNA.
chr22:40258240-40258253-0.9225.3821.080.4320.079NM_13833812170 polymerase (RNA) III (DNA directed) polypeptide H
chrX:70388236-70388249-0.9165.3311.380.4290.079NM_2015992435 zinc finger protein 261 (ZNF261), transcript variant
chr12:119900572-119900585-0.9225.3891.090.4290.079NM_000545-260 transcription factor 1, hepatic; LF-B1, hepatic
chr17:56810668-56810681-0.9225.3821.100.4290.079NM_005994-21271 T-box 2 (TBX2), mRNA.
chr19:13044276-13044289+0.9225.3891.180.4280.079NM_00558330405 lymphoblastic leukemia derived sequence 1 (LYL1),
chr11:62277937-62277950-0.9155.3291.150.4220.079NM_024784253 zinc finger and BTB domain containing 3 (ZBTB3), mRNA.
chr18:33088205-33088218-0.9165.3381.320.4210.079NM_020180311736 bruno-like 4, RNA binding protein (Drosophila)
chr1:47707186-47707199-0.9225.3891.100.4200.079NM_00447433010 forkhead box D2 (FOXD2), mRNA.
chr12:52710357-52710370-0.9165.3381.250.4160.079NM_0045031996 homeo box C6 (HOXC6), transcript variant 1, mRNA.
chr10:118721856-118721869+0.9155.3241.140.4160.079NM_01833033010 KIAA1598 (KIAA1598), mRNA.
chr6:39283397-39283410+0.9165.3381.590.4130.079NM_00374021832 potassium channel, subfamily K, member 5 (KCNK5),
chr5:112566964-112566977-0.9225.3821.700.4130.079NM_00238791547 mutated in colorectal cancers (MCC), mRNA.
chrX:136479043-136479056+0.9165.3381.230.4060.079NM_0034133131 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr13:47705251-47705264-0.9425.5531.380.2350.079NM_02199942 integral membrane protein 2B (ITM2B), mRNA.
chr5:139069544-139069557-0.8664.9172.531.2570.080NM_01646360942 CXXC finger 5 (CXXC5), mRNA.
chr15:34964595-34964608-0.8734.9682.421.2500.080NM_172315213200 Meis1, myeloid ecotropic viral integration site 1
chr1:59795200-59795213-0.8795.0192.391.1420.081NM_015888-257821 hook homolog 1 (Drosophila) (HOOK1), mRNA.
chr20:13251516-13251529-0.8825.0451.891.0770.081NM_080826101198-
chr3:27902362-27902375-0.8795.0192.451.0730.081NM_005442-163573 eomesodermin homolog (Xenopus laevis) (EOMES), mRNA.
chr9:115697333-115697346-0.8935.1401.830.8650.081NM_13337419050-
chr11:65950394-65950407+0.8885.0962.100.8640.081NM_1788645443 HLH-PAS transcription factor NXF (NXF), mRNA.
chr17:34136644-34136657-0.8885.0962.480.8570.081NM_00593721345 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr3:50468758-50468771+0.8935.1401.690.8560.081NM_00100550547138-
chr10:79787115-79787128+0.8945.1462.140.8560.081NM_033022323635 ribosomal protein S24 (RPS24), transcript variant 1,
chr2:176738702-176738715-0.8935.1411.880.8550.081NM_0068981751 homeo box D3 (HOXD3), mRNA.
chr8:10459348-10459361-0.8935.1401.920.8540.081NM_19846438957 tryptophan/serine protease (UNQ9391), mRNA.
chr17:35719376-35719389-0.8945.1491.930.8530.081NM_000964504 retinoic acid receptor, alpha (RARA), mRNA.
chr1:66772187-66772200+0.8915.1231.860.8490.081NM_032291-126 hypothetical protein DKFZp761D221 (DKFZp761D221),
chr10:43873002-43873015-0.8945.1491.400.8470.081NM_000609327546 chemokine (C-X-C motif) ligand 12 (stromal
chr5:139264315-139264328-0.8925.1302.130.8460.081NM_032289108825 pleckstrin and Sec7 domain containing 2 (PSD2), mRNA.
chr17:44932320-44932333+0.8935.1401.680.8430.081NM_0025074754 nerve growth factor receptor (TNFR superfamily, member
chr1:161646863-161646876-0.8885.0961.920.8400.081NM_14569788616 cell division cycle associated 1 (CDCA1), transcript
chr1:212644822-212644835-0.8885.0961.890.8390.081NM_020197123723 SET and MYND domain containing 2 (SMYD2), mRNA.
chr18:18067600-18067613+0.8885.0961.360.8390.081NM_00525764286 GATA binding protein 6 (GATA6), mRNA.
chr4:109474324-109474337+0.8945.1491.840.8390.081NM_016269-165297 lymphoid enhancer-binding factor 1 (LEF1), mRNA.
chr2:210744136-210744149-0.8925.1302.040.8380.081NM_152519160 hypothetical protein FLJ23861 (FLJ23861), mRNA.
chr12:53065947-53065960+0.8935.1441.570.8370.081NM_015481-1199 zinc finger protein 385 (ZNF385), mRNA.
chr12:7982234-7982247-0.8935.1411.880.8360.081NM_006931-2096 solute carrier family 2 (facilitated glucose
chr2:30398970-30398983-0.8915.1231.670.8360.081NM_03091591169 likely ortholog of mouse limb-bud and heart gene
chr11:64240337-64240350-0.9125.3051.430.7650.081NM_0150806899 neurexin 2 (NRXN2), transcript variant alpha-1, mRNA.
chr19:46310651-46310664-0.9075.2601.550.7640.081NM_000774-1442 cytochrome P450, family 2, subfamily F, polypeptide 1
chr2:44762199-44762212+0.9085.2661.440.7630.081NM_005413-260242 sine oculis homeobox homolog 3 (Drosophila) (SIX3),
chr20:60364817-60364830-0.9085.2661.560.7580.081NM_00556010946 laminin, alpha 5 (LAMA5), mRNA.
chr9:132808973-132808986+0.9135.3121.430.7560.081NM_032843-4915 fibrinogen C domain containing 1 (FIBCD1), mRNA.
chr5:148738930-148738943+0.9085.2671.620.7540.081NM_014443101 interleukin 17B (IL17B), mRNA.
chrX:152797299-152797312+0.9085.2661.740.7530.081NM_001039768-1922-
chr5:138657194-138657207+0.9085.2661.700.7530.081NM_01883440 matrin 3 (MATR3), mRNA.
chr10:103567901-103567914-0.9085.2661.760.7520.081NM_012215264 meningioma expressed antigen 5 (hyaluronidase)
chr1:199864361-199864374-0.9085.2661.480.7500.081NM_020443-19612 neuron navigator 1 (NAV1), mRNA.
chr3:183039673-183039686+0.9125.3051.430.7490.081NM_003106127357 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr8:144312614-144312627-0.9135.3121.100.7480.081NM_002347502 lymphocyte antigen 6 complex, locus H (LY6H), mRNA.
chr1:54642488-54642501-0.9125.3051.950.7480.081NM_0180702079 single stranded DNA binding protein 3 (SSBP3), mRNA.
chr7:129207944-129207957+0.9085.2662.070.7460.081NM_001040110150889-
chr22:49255285-49255298-0.9085.2662.030.7430.081NM_0029725035 SET binding factor 1 (SBF1), transcript variant 1,
chr10:104426102-104426115-0.9135.3121.520.7420.081NM_03091231960 tripartite motif-containing 8 (TRIM8), mRNA.
chr5:17271383-17271396+0.9125.3051.430.7420.081NM_006317733 brain abundant, membrane attached signal protein 1
chr11:65162722-65162735+0.9055.2411.210.7410.081NM_006747651 signal-induced proliferation-associated gene 1
chr7:101130445-101130458+0.9135.3121.240.7410.081NM_138403-71327 myosin light chain 2, precursor lymphocyte-specific
chr9:121171053-121171066+0.9085.2661.700.7390.081NM_014618507 deleted in bladder cancer 1 (DBC1), mRNA.
chr5:176806988-176807001+0.9135.3121.770.7370.081NM_030567686 hypothetical protein MGC10772 (MGC10772), mRNA.
chr3:50333698-50333711+0.9125.3051.420.7360.081NM_033158205 hyaluronoglucosaminidase 2 (HYAL2), transcript variant
chr7:150576140-150576153-0.9135.3121.240.7350.081NM_001003801542 SWI/SNF related, matrix associated, actin dependent
chr10:102575951-102575964-0.9135.3121.240.7350.081NM_00027880593 paired box gene 2 (PAX2), transcript variant b, mRNA.
chr1:120637045-120637058-0.9095.2731.050.7350.081NM_001004340100372 Fc-gamma receptor I B2 (LOC440607), mRNA.
chr17:51592304-51592317+0.9055.2411.190.7350.081NM_1532286569 hypothetical protein FLJ38335 (FLJ38335), mRNA.
chr7:35338061-35338074+0.9055.2411.390.7340.081NM_020417-78294 T-box 20 (TBX20), mRNA.
chr7:41631563-41631576-0.9135.3121.500.7320.081NM_00219277668 inhibin, beta A (activin A, activin AB alpha
chr17:4683836-4683849-0.9055.2411.440.7310.081NM_170663585 misshapen/NIK-related kinase (MINK), transcript
chr9:91411598-91411611-0.9085.2661.850.7310.081NM_0067051950 growth arrest and DNA-damage-inducible, gamma
chr16:24359127-24359140-0.9105.2861.500.7280.081NM_032626-99182 retinoblastoma binding protein 6 (RBBP6), transcript
chr15:49173760-49173773-0.9055.2411.220.7280.081NM_20738111005 FLJ41287 protein (FLJ41287), mRNA.
chr20:42008872-42008885+0.9055.2411.310.7280.081NM_0010987981022-
chr12:46581881-46581894+0.9075.2601.560.7270.081NM_0003763200 vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR),
chr11:73034957-73034970-0.9055.2411.770.7230.081NM_021200186 pleckstrin homology domain containing, family B
chr19:40473644-40473657+0.9075.2601.650.7220.081NM_002361-1134 myelin associated glycoprotein (MAG), transcript
chr20:44290596-44290609+0.9135.3121.150.7220.081NM_02124823145 cadherin-like 22 (CDH22), mRNA.
chr3:195904746-195904759+0.9075.2601.510.7220.081NM_15369016935 family with sequence similarity 43, member A (FAM43A),
chr14:23907685-23907698+0.9135.3121.530.7210.081NM_004554691 nuclear factor of activated T-cells, cytoplasmic,
chr10:102417986-102417999-0.9095.2731.940.7200.081NM_003988-77372 paired box gene 2 (PAX2), transcript variant c, mRNA.
chr2:231589017-231589030-0.9075.2601.060.7190.081NM_002807-40736 proteasome (prosome, macropain) 26S subunit,
chr17:56110174-56110187+0.9145.3161.340.7190.081NM_001099432320-
chr17:8476355-8476368-0.9135.3121.890.7180.081NM_005964-1594 myosin, heavy polypeptide 10, non-muscle (MYH10),
chrX:68414864-68414877+0.9135.3121.560.7170.081NM_022368-112799 praja 1 (PJA1), mRNA.
chr17:66511867-66511880-0.9125.3052.250.7150.081NM_000891834696 potassium inwardly-rectifying channel, subfamily J,
chr17:7681080-7681093+0.9085.2661.150.7120.081NM_001080424-2780-
chr4:1742120-1742133+0.9075.2601.310.7100.081NM_000142-23201 fibroblast growth factor receptor 3 (achondroplasia,
chr10:35419031-35419044-0.9115.2931.290.7090.081NM_003591269 cullin 2 (CUL2), mRNA.
chr3:170863541-170863554-0.9135.3121.230.7090.081NM_004991627 myelodysplasia syndrome 1 (MDS1), mRNA.
chr17:24519317-24519330+0.9125.3051.510.7080.081NM_07847112216 myosin XVIIIA (MYO18A), transcript variant 1, mRNA.
chrX:39622307-39622320-0.9085.2661.520.7060.081NM_017745219293 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr9:99541887-99541900-0.9075.2601.490.7050.081NM_000380-42427 xeroderma pigmentosum, complementation group A (XPA),
chr8:81560836-81560849-0.9115.2931.260.7050.081NM_023929-67 zinc finger and BTB domain containing 10 (ZBTB10),
chr1:243090553-243090566-0.9075.2601.750.7030.081NM_0045013897 heterogeneous nuclear ribonucleoprotein U (scaffold
chr13:43909116-43909129-0.9135.3121.560.7030.081NM_006022-137 transforming growth factor beta 1 induced transcript 4
chr3:138965651-138965664-0.9055.2411.770.7030.081NM_004189-518 SRY (sex determining region Y)-box 14 (SOX14), mRNA.
chr1:200477411-200477424+0.9075.2601.490.7020.081NM_00101740427605-
chrX:68007162-68007175-0.9075.2601.560.7020.081NM_00442941706 ephrin-B1 (EFNB1), mRNA.
chr3:143229924-143229937-0.9095.2732.280.7010.081NM_006286-22857 transcription factor Dp-2 (E2F dimerization partner 2)
chr6:80771292-80771305+0.9085.2661.570.7000.081NM_003318314 TTK protein kinase (TTK), mRNA.
chr1:35507471-35507484+0.8754.9881.861.1330.082NM_005095416 zinc finger protein 262 (ZNF262), mRNA.
chr3:46879992-46880005-0.8825.0502.191.1310.082NM_000258-15 myosin, light polypeptide 3, alkali; ventricular,
chr14:35504168-35504181+0.8795.0192.351.1290.082NM_032352138920 breast cancer metastasis-suppressor 1-like (BRMS1L),
chr9:126567711-126567724+0.8795.0272.791.1280.082NM_0014895686 nuclear receptor subfamily 6, group A, member 1
chr18:44695278-44695291+0.8945.1492.560.9650.082NM_00590435801 SMAD, mothers against DPP homolog 7 (Drosophila)
chr3:125692821-125692834-0.8915.1231.860.9650.082NM_007064-93298 serine/threonine kinase with Dbl- and pleckstrin
chr8:97236534-97236547-0.8935.1411.660.9620.082NM_0010015575662 growth differentiation factor 6 (GDF6), mRNA.
chr22:39049672-39049685+0.8945.1492.590.9590.082NM_000026-22737 adenylosuccinate lyase (ADSL), mRNA.
chr1:45386174-45386187+0.8885.0962.400.9570.082NM_02088358663-
chr2:174654607-174654620-0.8935.1402.280.9570.082NM_003111-116298 Sp3 transcription factor (SP3), mRNA.
chr5:178983592-178983605+0.8945.1492.130.9560.082NM_005520-316 heterogeneous nuclear ribonucleoprotein H1 (H)
chr15:41572380-41572393-0.8935.1442.030.9540.082NM_00565717648 tumor protein p53 binding protein, 1 (TP53BP1), mRNA.
chr4:83512825-83512838+0.8935.1401.620.9530.082NM_0010038101348 heterogeneous nuclear ribonucleoprotein D (AU-rich
chr17:7328654-7328667-0.8885.0962.480.9490.082NM_000937332 polymerase (RNA) II (DNA directed) polypeptide A,
chr1:28937095-28937108+0.8935.1401.970.9490.082NM_0162581472 YTH domain family 2 (YTHDF2), mRNA.
chr18:46978132-46978145-0.8945.1511.570.9480.082NM_016626-444 ring finger and KH domain containing 2 (RKHD2), mRNA.
chr17:24644896-24644909-0.8945.1492.410.9450.082NM_020772307 82-kD FMRP Interacting Protein (182-FIP), mRNA.
chr1:158461562-158461575-0.8945.1511.910.9370.082NM_00376819911 phosphoprotein enriched in astrocytes 15 (PEA15),
chr2:208284786-208284799+0.8945.1491.910.9350.082NM_152523377 hypothetical protein FLJ40432 (FLJ40432), mRNA.
chr17:35485081-35485094+0.9135.3121.930.6990.082NM_00325012495 thyroid hormone receptor, alpha (erythroblastic
chr1:16901889-16901902+0.9135.3121.680.6980.082NM_017940-89320-
chr5:148619684-148619697+0.9085.2661.490.6930.082NM_152406-11867-
chr3:10480947-10480960+0.9135.3121.830.6930.082NM_001683-14401 ATPase, Ca++ transporting, plasma membrane 2 (ATP2B2),
chr11:6418838-6418851-0.9075.2601.810.6920.082NM_000613-69 hemopexin (HPX), mRNA.
chr8:20136361-20136374-0.9055.2411.570.6920.082NM_02102020722 leucine zipper, putative tumor suppressor 1 (LZTS1),
chr10:43212343-43212356+0.9085.2661.000.6910.082NM_001098208-58-
chr11:72170027-72170040+0.9115.2931.220.6900.082NM_00664512371 START domain containing 10 (STARD10), mRNA.
chr12:55930860-55930873-0.9125.3051.620.6880.082NM_145064376 SH3 and cysteine rich domain 3 (STAC3), mRNA.
chr15:39945986-39945999+0.9075.2601.060.6880.082NM_01664227581 spectrin, beta, non-erythrocytic 5 (SPTBN5), mRNA.
chr2:216985727-216985740+0.9075.2601.810.6880.082NM_014140-996 SWI/SNF related, matrix associated, actin dependent
chrX:128484105-128484118+0.9085.2671.400.6860.082NM_0030691017 SWI/SNF related, matrix associated, actin dependent
chr2:70020755-70020768+0.9095.2731.580.6850.082NM_15279222146 hypothetical protein FLJ25084 (FLJ25084), mRNA.
chr1:38985713-38985726+0.9085.2671.500.6850.082NM_022157112214 Ras-related GTP binding C (RRAGC), mRNA.
chr11:47165139-47165152+0.9075.2601.470.6840.082NM_016223-605 protein kinase C and casein kinase substrate in
chr5:141238724-141238737+0.9135.3121.580.6830.082NM_002587-596 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr20:60482730-60482743+0.9125.3051.220.6830.082NM_0804731691 GATA binding protein 5 (GATA5), mRNA.
chr6:17320970-17320983-0.9135.3121.460.6830.082NM_153020-69841 RNA binding motif protein 24 (RBM24), mRNA.
chrX:132930795-132930808+0.9075.2602.120.6830.082NM_00448416537 glypican 3 (GPC3), mRNA.
chr7:27167676-27167689+0.9135.3121.870.6820.082NM_1527393998 homeo box A9 (HOXA9), transcript variant 1, mRNA.
chr6:170437546-170437559-0.9135.3121.180.6810.082NM_0056184076 delta-like 1 (Drosophila) (DLL1), mRNA.
chr2:16108674-16108687-0.9135.3121.630.6810.082NM_005378110640 v-myc myelocytomatosis viral related oncogene,
chr12:47739059-47739072-0.9115.2932.200.6800.082NM_003482-3685 myeloid/lymphoid or mixed-lineage leukemia 2 (MLL2),
chrX:67969643-67969656+0.9135.3121.860.6800.082NM_0044294187 ephrin-B1 (EFNB1), mRNA.
chr12:23262065-23262078-0.9075.2621.630.6800.082NM_178010366710 SRY (sex determining region Y)-box 5 (SOX5),
chr14:56392644-56392657-0.9085.2661.980.6790.082NM_021728-45707 orthodenticle homolog 2 (Drosophila) (OTX2),
chr1:39229332-39229345+0.9135.3121.710.6770.082NM_024595-72 hypothetical protein FLJ12666 (FLJ12666), mRNA.
chr9:115382973-115382986-0.9075.2601.140.6760.082NM_021106312 regulator of G-protein signalling 3 (RGS3), transcript
chr6:33044987-33045000+0.9095.2731.150.6760.082NM_005104672 bromodomain containing 2 (BRD2), mRNA.
chr11:74419048-74419061+0.9075.2601.520.6730.082NM_00665641550 sialidase 3 (membrane sialidase) (NEU3), mRNA.
chr3:32587388-32587401+0.9085.2671.630.6710.082NM_016141-42 dynein, cytoplasmic, light intermediate polypeptide 1
chr1:44739310-44739323+0.9135.3121.860.6710.082NM_01815095863 hypothetical protein FLJ10597 (FLJ10597), mRNA.
chr16:65790435-65790448-0.9055.2411.420.6700.082NM_0247126 engulfment and cell motility 3 (ced-12 homolog, C.
chr1:154386418-154386431+0.9075.2601.170.6690.082NM_022367-3494 sema domain, immunoglobulin domain (Ig), transmembrane
chr22:41025920-41025933+0.9145.3161.090.6670.082NM_181492-84531 transcription factor 20 (AR1) (TCF20), transcript
chr14:54808129-54808142+0.9135.3121.420.6670.082NM_017943397 F-box protein 34 (FBXO34), mRNA.
chr5:52811892-52811905-0.9185.3511.120.3950.082NM_006350-360 follistatin (FST), transcript variant FST317, mRNA.
chr10:97105674-97105687+0.9225.3821.290.3940.082NM_020992-64903 PDZ and LIM domain 1 (elfin) (PDLIM1), mRNA.
chr7:100596769-100596782+0.9165.3381.210.3920.082NM_003378-1197 VGF nerve growth factor inducible (VGF), mRNA.
chr11:129799942-129799955-0.9225.3821.180.3920.082NM_0070373807 a disintegrin-like and metalloprotease (reprolysin
chr17:24918293-24918306-0.9165.3381.370.3900.082NM_198147-119 hypothetical protein LOC116236 (LOC116236), mRNA.
chrX:68078162-68078175-0.9165.3311.110.3900.082NM_004429112706 ephrin-B1 (EFNB1), mRNA.
chrX:150620331-150620344+0.9155.3241.370.3870.082NM_0240822996 proline rich Gla (G-carboxyglutamic acid) 3
chr3:48663084-48663097-0.9225.3821.230.3860.082NM_00140712268 cadherin, EGF LAG seven-pass G-type receptor 3
chr9:109769947-109769960+0.9225.3821.120.3840.082NM_004235-478371 Kruppel-like factor 4 (gut) (KLF4), mRNA.
chr1:153559389-153559402-0.9165.3381.090.3810.082NM_0010395171173-
chr12:119521401-119521414+0.9225.3821.020.3790.082NM_198202-17817 processing of precursor 5, ribonuclease P/MRP subunit
chr8:145460058-145460071-0.9165.3381.340.3790.082NM_001080514.R2-1253-
chr11:125510954-125510967+0.9165.3381.280.3760.082NM_016952-72557 cell adhesion molecule-related/down-regulated by
chr22:37162586-37162599-0.9225.3821.010.3740.082NM_0049817393 potassium inwardly-rectifying channel, subfamily J,
chr16:29995040-29995053+0.9165.3381.650.3690.082NM_002720255 protein phosphatase 4 (formerly X), catalytic subunit
chr9:14312437-14312450-0.9255.4071.150.3270.082NM_005596-8492 nuclear factor I/B (NFIB), mRNA.
chr11:60654491-60654504+0.9265.4151.020.3260.082NM_01420728048 CD5 antigen (p56-62) (CD5), mRNA.
chr14:68046855-68046868+0.9255.4071.350.3220.082NM_004926282683 zinc finger protein 36, C3H type-like 1 (ZFP36L1),
chr3:69872131-69872144+0.9265.4151.170.3210.082NM_198159908 microphthalmia-associated transcription factor (MITF),
chr1:35103906-35103919+0.9285.4341.540.3190.082NM_138428-5974 hypothetical protein BC011880 (LOC113444), mRNA.
chr12:99378760-99378773-0.9275.4251.120.3170.082NM_005123-12950 nuclear receptor subfamily 1, group H, member 4
chr1:38242286-38242299-0.9275.4251.180.3110.082NM_0044681535 four and a half LIM domains 3 (FHL3), mRNA.
chr14:35814927-35814940+0.9275.4251.150.3070.082NM_01658644669 MAP3K12 binding inhibitory protein 1 (MBIP), mRNA.
chr1:52824859-52824872+0.9295.4471.090.3060.082NM_015696-15673 glutathione peroxidase 7 (GPX7), mRNA.
chr2:219801301-219801314-0.9255.4071.050.3030.082NM_0240851304 hypothetical protein FLJ22169 (FLJ22169), mRNA.
chr9:97228586-97228599+0.8945.1491.920.9330.083NM_00108360780716-
chr8:27150059-27150072-0.8885.0962.090.9310.083NM_03079521761 stathmin-like 4 (STMN4), mRNA.
chr5:137854734-137854747+0.8915.1232.390.9300.083NM_00196425754 early growth response 1 (EGR1), mRNA.
chr6:90596511-90596524+0.8895.1041.370.9300.083NM_012115232 CASP8 associated protein 2 (CASP8AP2), mRNA.
chr10:99240666-99240679+0.8945.1491.970.9270.083NM_0223627489 MMS19-like (MET18 homolog, S. cerevisiae) (MMS19L),
chrX:135556653-135556666+0.8915.1232.500.9270.083NM_000074-1249 tumor necrosis factor (ligand) superfamily, member 5
chr17:59428597-59428610+0.8935.1412.090.9260.083NM_0008739418 intercellular adhesion molecule 2 (ICAM2), mRNA.
chr1:216856936-216856949+0.8935.1442.110.9260.083NM_003238270545 transforming growth factor, beta 2 (TGFB2), mRNA.
chr1:153798434-153798447-0.8935.1411.850.9250.083NM_018489514 ash1 (absent, small, or homeotic)-like (Drosophila)
chr4:4568457-4568470-0.8885.0961.760.9240.083NM_01693026219 syntaxin 18 (STX18), mRNA.
chr11:3812582-3812595+0.8935.1401.890.9230.083NM_0016656207 ras homolog gene family, member G (rho G) (RHOG),
chr3:186787034-186787047-0.8945.1491.510.9230.083NM_021627409 SUMO1/sentrin/SMT3 specific protease 2 (SENP2), mRNA.
chr1:54617032-54617045+0.8945.1492.230.9220.083NM_01807027535 single stranded DNA binding protein 3 (SSBP3), mRNA.
chr1:112273916-112273929-0.8945.1492.330.9150.083NM_00498059384 potassium voltage-gated channel, Shal-related
chrX:106581844-106581857-0.8915.1231.680.9150.083NM_002764-176471 phosphoribosyl pyrophosphate synthetase 1 (PRPS1),
chr4:53218882-53218895+0.8935.1411.890.9080.083NM_0228321315 ubiquitin specific protease 46 (USP46), mRNA.
chr16:49707743-49707756-0.8935.1401.700.9070.083NM_00296834941 sal-like 1 (Drosophila) (SALL1), mRNA.
chr2:160277479-160277492+0.8935.1401.460.9040.083NM_022826323 axotrophin (AXOT), mRNA.
chr22:40107955-40107968+0.8925.1301.760.9030.083NM_003216146 thyrotrophic embryonic factor (TEF), mRNA.
chr9:34169281-34169294+0.8945.1492.170.9030.083NM_016525370 ubiquitin associated protein 1 (UBAP1), mRNA.
chr4:134290685-134290698+0.8885.0962.030.9020.083NM_032961865 protocadherin 10 (PCDH10), transcript variant 1, mRNA.
chr11:114880476-114880489-0.8334.6322.371.2880.084NM_014333-25 immunoglobulin superfamily, member 4 (IGSF4), mRNA.
chr12:5406401-5406414-0.8334.6382.361.2390.084NM_002527-67026 neurotrophin 3 (NTF3), mRNA.
chrX:69558504-69558517+0.8935.1402.170.8970.084NM_017711-1112 glycerophosphodiester phosphodiesterase domain
chr2:43008969-43008982-0.8945.1492.330.8970.084NM_012205-135750 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), mRNA.
chr4:24082994-24083007-0.8935.1441.880.8970.084NM_001358112288 DEAH (Asp-Glu-Ala-His) box polypeptide 15 (DHX15),
chr8:23766751-23766764-0.8935.1441.880.8950.084NM_0031551514 stanniocalcin 1 (STC1), mRNA.
chr2:60637553-60637566+0.8935.1401.870.8890.084NM_022893-3416 B-cell CLL/lymphoma 11A (zinc finger protein)
chr16:11255866-11255879-0.8885.0961.990.8890.084NM_0037451674 suppressor of cytokine signaling 1 (SOCS1), mRNA.
chr4:158112010-158112023-0.8945.1511.070.8870.084NM_016205-14 platelet derived growth factor C (PDGFC), mRNA.
chr20:21035041-21035054-0.8945.1492.400.8840.084NM_018474-19505 chromosome 20 open reading frame 19 (C20orf19), mRNA.
chr10:119349842-119349855+0.8885.0961.570.8840.084NM_00409857996 empty spiracles homolog 2 (Drosophila) (EMX2), mRNA.
chr1:176962264-176962277+0.8885.0961.970.8810.084NM_0180371362 Ral GEF with PH domain and SH3 binding motif 2
chr1:211580626-211580639-0.8915.1232.610.8800.084NM_012424289506 ribosomal protein S6 kinase, 52kDa, polypeptide 1
chr7:100599175-100599188+0.8935.1402.250.8770.084NM_003378-3603 VGF nerve growth factor inducible (VGF), mRNA.
chr6:41654402-41654415+0.8945.1491.890.8740.084NM_13845732360 forkhead box P4 (FOXP4), mRNA.
chr2:206259335-206259348-0.8915.1231.290.8710.084NM_2012793966 neuropilin 2 (NRP2), transcript variant 3, mRNA.
chr12:54766343-54766356-0.8935.1402.150.8680.084NM_0019826284 v-erb-b2 erythroblastic leukemia viral oncogene
chr14:23905377-23905390+0.9265.4151.110.2990.084NM_004554-1617 nuclear factor of activated T-cells, cytoplasmic,
chr13:45322577-45322590-0.9315.4601.310.2950.084NM_1988491270 similar to seven in absentia 2 (LOC283514), mRNA.
chr10:73705616-73705629+0.9255.4071.130.2900.084NM_0190582033 DNA-damage-inducible transcript 4 (DDIT4), mRNA.
chr12:26158684-26158697-0.9265.4151.440.2900.084NM_03076210429 basic helix-loop-helix domain containing, class B, 3
chr19:44640646-44640659-0.9295.4471.110.2880.084NM_00316912582 suppressor of Ty 5 homolog (S. cerevisiae) (SUPT5H),
chr8:26569577-26569590+0.9255.4071.280.2850.084NM_00138678339 dihydropyrimidinase-like 2 (DPYSL2), mRNA.
chr10:113395720-113395733+0.9285.4341.020.2830.084NM_020918537788 glycerol-3-phosphate acyltransferase, mitochondrial
chrX:19095530-19095543-0.9325.4731.000.2810.084NM_005756-44932 G protein-coupled receptor 64 (GPR64), mRNA.
chr5:139015519-139015532-0.9285.4341.070.2750.084NM_0164636917 CXXC finger 5 (CXXC5), mRNA.
chr16:2758639-2758652-0.8224.5392.381.3730.085NM_0071088659 transcription elongation factor B (SIII), polypeptide
chr14:20628193-20628206-0.8384.6772.311.2930.085NM_0164238446 zinc finger protein 219 (ZNF219), mRNA.
chr11:46490812-46490825-0.8364.6592.431.2560.085NM_01774978678 hypothetical protein FLJ20294 (FLJ20294), mRNA.
chr5:92957573-92957586+0.8394.6832.561.2550.085NM_00565412874 nuclear receptor subfamily 2, group F, member 1
chr1:199902068-199902081-0.9155.3241.550.3640.085NM_02044318095 neuron navigator 1 (NAV1), mRNA.
chr12:48421869-48421882+0.9165.3311.190.3630.085NM_001098576110-
chr3:50145230-50145243-0.9155.3241.160.3590.085NM_004186-22522 sema domain, immunoglobulin domain (Ig), short basic
chr6:43199315-43199328+0.9165.3381.300.3540.085NM_15288247408 PTK7 protein tyrosine kinase 7 (PTK7), transcript
chr3:197850899-197850912-0.9165.3381.050.3490.085NM_198565-54 ELLP3030 (UNQ3030), mRNA.
chr7:129700412-129700425-0.9165.3381.130.3430.085NM_0018696552 carboxypeptidase A2 (pancreatic) (CPA2), mRNA.
chr12:110944868-110944881+0.9155.3241.310.3400.085NM_0068179433 chromosome 12 open reading frame 8 (C12orf8), mRNA.
chr5:167824297-167824310-0.9155.3241.070.3400.085NM_002887-21644 arginyl-tRNA synthetase (RARS), mRNA.
chr2:20288471-20288484-0.9165.3381.080.3380.085NM_002997-63 syndecan 1 (SDC1), mRNA.
chr3:10570701-10570714+0.9165.3381.020.3360.085NM_001683-104155 ATPase, Ca++ transporting, plasma membrane 2 (ATP2B2),
chr18:5886385-5886398+0.9155.3241.340.3350.085NM_001080209-4282-
chr11:114880471-114880484-0.8524.7992.371.2930.086NM_014333-20 immunoglobulin superfamily, member 4 (IGSF4), mRNA.
chr10:104014297-104014310-0.8754.9882.720.9990.086NM_00419319098 golgi-specific brefeldin A resistance factor 1 (GBF1),
chr7:40753156-40753169-0.8795.0272.360.9990.086NM_024728612156 chromosome 7 open reading frame 10 (C7orf10), mRNA.
chr5:148877961-148877974-0.8754.9882.380.9970.086NM_00102510533239-
chr1:35795947-35795960+0.8835.0532.490.9930.086NM_01428467 neurochondrin (NCDN), mRNA.
chr7:129208017-129208030+0.8835.0602.410.9930.086NM_001040110150962-
chr9:130187878-130187891-0.8815.0392.400.9900.086NM_03091414517 chromosome 9 open reading frame 74 (C9orf74), mRNA.
chr10:80653166-80653179-0.8795.0271.910.9770.086NM_02033861390 retinoic acid induced 17 (RAI17), mRNA.
chr7:35203914-35203927-0.8754.9882.070.9700.086NM_00107765355853-
chrX:53365097-53365110-0.8795.0272.220.9680.086NM_015075-37576-
chr10:103530843-103530856-0.8464.7452.641.2490.087NM_0069932305 nucleophosmin/nucleoplasmin, 3 (NPM3), mRNA.
chr17:44017268-44017281-0.9285.4341.210.2530.087NM_024015-6526 homeo box B4 (HOXB4), mRNA.
chr9:93317526-93317539+0.9255.4071.070.2530.087NM_005384-91561 nuclear factor, interleukin 3 regulated (NFIL3), mRNA.
chr6:108098853-108098866+0.9295.4471.230.2460.087NM_198081101295 sex comb on midleg-like 4 (Drosophila) (SCML4), mRNA.
chr3:27550875-27550888+0.9295.4471.180.2410.087NM_003615-77626 solute carrier family 4, sodium bicarbonate
chr12:52699217-52699230-0.9285.4341.140.2390.087NM_1536932408 homeo box C6 (HOXC6), transcript variant 2, mRNA.
chr1:46643787-46643800+0.9265.4151.000.2390.087NM_00144111308 fatty acid amide hydrolase (FAAH), mRNA.
chr1:165565266-165565279+0.9315.4601.230.2390.087NM_002697108599 POU domain, class 2, transcription factor 1 (POU2F1),
chr9:124186460-124186473-0.9295.4471.130.2370.087NM_08059113510 prostaglandin-endoperoxide synthase 1 (prostaglandin
chr2:118659605-118659618+0.9315.4601.210.2220.087NM_01613397185 insulin induced gene 2 (INSIG2), mRNA.
chr17:8744947-8744960-0.9295.4471.310.1820.087NM_01430811612 phosphoinositide-3-kinase, regulatory subunit,
chr4:114900527-114900540+0.8244.5582.951.3290.088NM_1721271650 calcium/calmodulin-dependent protein kinase (CaM
chr17:43988157-43988170+0.8955.1542.020.6650.088NM_002145-10765 homeo box B2 (HOXB2), mRNA.
chr9:130491121-130491134+0.8965.1661.270.6600.088NM_003011-461 SET translocation (myeloid leukemia-associated) (SET),
chr19:15171833-15171846+0.8965.1661.240.6560.088NM_000435959 Notch homolog 3 (Drosophila) (NOTCH3), mRNA.
chr2:232281868-232281881+0.8975.1751.300.6540.088NM_002823489 prothymosin, alpha (gene sequence 28) (PTMA), mRNA.
chr4:142272898-142272911-0.8975.1751.810.6530.088NM_0207241168-
chr2:232281042-232281055-0.8975.1751.920.6420.088NM_001099285-337-
chr13:110164914-110164927+0.8975.1751.320.6390.088NM_005537-346 inhibitor of growth family, member 1 (ING1),
chr17:43253589-43253602+0.8965.1661.440.6350.088NM_145798557 oxysterol binding protein-like 7 (OSBPL7), transcript
chr11:130822856-130822869+0.8955.1611.900.6350.088NM_00104820977375-
chr3:89660280-89660293-0.8955.1611.800.6340.088NM_182644420878 EphA3 (EPHA3), transcript variant 2, mRNA.
chrX:128484649-128484662-0.8724.9621.821.1860.089NM_003069473 SWI/SNF related, matrix associated, actin dependent
chr7:77164324-77164337+0.9085.2661.370.6660.090NM_198467728 round spermatid basic protein 1-like (RSBN1L), mRNA.
chrX:68287199-68287212-0.9085.2662.090.6660.090NM_00103239614798-
chr7:151792068-151792081+0.9055.2411.460.6640.090NM_00102986618913-
chr11:119072417-119072430-0.9125.3051.490.6640.090NM_20328532228 poliovirus receptor-related 1 (herpesvirus entry
chr1:149165499-149165512-0.9085.2661.570.6630.090NM_01243287 SET domain, bifurcated 1 (SETDB1), mRNA.
chr1:27299271-27299284+0.9085.2661.320.6620.090NM_00304754717 solute carrier family 9 (sodium/hydrogen exchanger),
chr1:117255163-117255176-0.9055.2411.100.6620.090NM_0204401051 prostaglandin F2 receptor negative regulator (PTGFRN),
chr5:140843758-140843771+0.9125.3051.300.6590.090NM_032406-1067 protocadherin gamma subfamily C, 4 (PCDHGC4),
chr16:29949980-29949993+0.9085.2661.240.6570.090NM_031478-293 hypothetical protein DKFZp434I2117 (DKFZP434I2117),
chr9:83748161-83748174+0.9075.2601.020.6560.090NM_001001670-45246 FLJ46321 protein (FLJ46321), mRNA.
chr1:33120596-33120609-0.9085.2661.550.6530.090NM_002143-3989 hippocalcin (HPCA), mRNA.
chr15:39496515-39496528+0.9085.2671.110.6530.090NM_0151387 KIAA0252 (KIAA0252), mRNA.
chr6:112929754-112929767-0.9085.2661.870.6520.090NM_001013734154629-
chr18:58005418-58005431+0.9115.2931.250.6510.090NM_02085414 KIAA1468 (KIAA1468), mRNA.
chr17:34081363-34081376+0.9085.2662.040.6500.090NM_005937-33936 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr2:202024688-202024701+0.9115.2931.420.6470.090NM_018571151 amyotrophic lateral sclerosis 2 (juvenile) chromosome
chr6:37259069-37259082+0.9075.2601.460.6450.090NM_00264813205 pim-1 oncogene (PIM1), mRNA.
chr3:171558032-171558045-0.9085.2661.290.6450.090NM_005414-78 SKI-like (SKIL), mRNA.
chr5:71235615-71235628+0.9135.3122.230.6450.090NM_004291184965 cocaine- and amphetamine-regulated transcript (CART),
chr20:38949587-38949600-0.9105.2861.740.6440.090NM_003286-141189 topoisomerase (DNA) I (TOP1), mRNA.
chr14:36121364-36121377+0.9085.2671.920.6430.090NM_014360173 NK2 transcription factor related, locus 8 (Drosophila)
chr20:22512961-22512974-0.9135.3121.110.6430.090NM_021784140 forkhead box A2 (FOXA2), transcript variant 1, mRNA.
chr2:42128644-42128657+0.9085.2671.080.6410.090NM_138370-513-
chr15:35180087-35180100+0.9085.2661.480.6400.090NM_170677-91 Meis1, myeloid ecotropic viral integration site 1
chrX:17303018-17303031-0.9055.2411.630.6380.090NM_198270-346 Nance-Horan syndrome (congenital cataracts and dental
chr19:60656072-60656085-0.9055.2411.300.6370.090NM_0247108752 hypothetical protein FLJ23469 (FLJ23469), mRNA.
chr1:16354220-16354233-0.9085.2671.880.6360.090NM_004431931 EphA2 (EPHA2), mRNA.
chr20:47238370-47238383-0.9145.3151.280.6340.090NM_017454-59 staufen, RNA binding protein (Drosophila) (STAU),
chr1:26126709-26126722-0.8584.8431.991.2310.091NM_203399-20754 stathmin 1/oncoprotein 18 (STMN1), transcript variant
chr11:122940676-122940689+0.8574.8351.741.2180.091NM_02071639038-
chr12:50546113-50546126-0.8594.8512.281.1710.091NM_182608-21798 hypothetical protein DKFZp686O1689 (DKFZp686O1689),
chr18:28604608-28604621+0.8935.1401.900.8320.091NM_0208052364-
chr19:40958833-40958846-0.8945.1511.400.8310.091NM_052948617 sorting nexin 26 (SNX26), mRNA.
chr4:105635623-105635636+0.8945.1491.570.8290.091NM_025212-3707 CXXC finger 4 (CXXC4), mRNA.
chr17:35014187-35014200+0.8925.1302.100.8280.091NM_0061603514 neurogenic differentiation 2 (NEUROD2), mRNA.
chr5:149942084-149942097+0.8935.1442.070.8230.091NM_007286-58249 synaptopodin (SYNPO), mRNA.
chr7:44803144-44803157+0.8945.1491.430.8190.091NM_021130478 peptidylprolyl isomerase A (cyclophilin A) (PPIA),
chr13:44812777-44812790+0.8925.1301.680.8180.091NM_003295520 tumor protein, translationally-controlled 1 (TPT1),
chr14:56421389-56421402-0.8935.1411.990.8150.091NM_021728-74452 orthodenticle homolog 2 (Drosophila) (OTX2),
chr19:44585381-44585394-0.8885.0961.930.8130.091NM_003407-3846 zinc finger protein 36, C3H type, homolog (mouse)
chr10:89858052-89858065+0.8935.1401.800.8090.091NM_000314244977 phosphatase and tensin homolog (mutated in multiple
chr2:219779825-219779838+0.8915.1231.610.8080.091NM_138802143 hypothetical protein BC018415 (LOC130617), mRNA.
chrX:108755106-108755119-0.8885.0962.060.8040.091NM_012282-57 KCNE1-like (KCNE1L), mRNA.
chr12:5567291-5567304-0.8945.1492.000.8040.091NM_00252793864 neurotrophin 3 (NTF3), mRNA.
chr19:47693845-47693858-0.8935.1401.250.8030.091NM_00102491230634-
chr1:31147778-31147791+0.8935.1401.850.8020.091NM_0146546289-
chr17:35521339-35521352+0.8935.1401.720.7970.091NM_021724-10840 nuclear receptor subfamily 1, group D, member 1
chr19:51149675-51149688+0.8895.1042.050.7920.091NM_00251618822 neuro-oncological ventral antigen 2 (NOVA2), mRNA.
chr17:34871447-34871460+0.8885.0962.150.7910.091NM_016507-271 CDC2-related protein kinase 7 (CRK7), mRNA.
chr5:67548110-67548123+0.8885.0961.990.7910.091NM_181523-10008 phosphoinositide-3-kinase, regulatory subunit,
chr1:58583916-58583929-0.8945.1491.560.7890.091NM_021080-95117 disabled homolog 1 (Drosophila) (DAB1), mRNA.
chr7:155813684-155813697+0.8945.1491.580.7890.091NM_030936-312378 ring finger protein 32 (RNF32), mRNA.
chr1:20751299-20751312+0.8885.0962.030.7870.091NM_207334-120 family with sequence similarity 43, member B (FAM43B),
chr10:103862202-103862215-0.8885.0961.750.7860.091NM_0038932490 LIM domain binding 1 (LDB1), mRNA.
chr15:75712373-75712386+0.8915.1231.560.7840.091NM_032808-609 leucine rich repeat neuronal 6A (LRRN6A), mRNA.
chr1:27925507-27925520+0.8915.1231.600.7830.091NM_152660530 hypothetical protein MGC34648 (MGC34648), mRNA.
chr9:97213408-97213421+0.8915.1231.380.7830.091NM_000136-93596 Fanconi anemia, complementation group C (FANCC), mRNA.
chr17:32241087-32241100+0.8895.1042.170.7830.091NM_005568-127425 LIM homeobox 1 (LHX1), mRNA.
chr11:124445876-124445889-0.8935.1411.100.7800.091NM_1982777534 solute carrier family 37 (glycerol-3-phosphate
chr1:23366632-23366645-0.8885.0961.740.7800.091NM_0336311293 leucine zipper protein 1 (LUZP1), mRNA.
chr12:4260365-4260378-0.8935.1412.180.7780.091NM_0017597266 cyclin D2 (CCND2), mRNA.
chr11:72720142-72720155-0.8935.1402.380.7770.091NM_01478622925 Rho guanine nucleotide exchange factor (GEF) 17
chr12:108019695-108019708-0.8895.1041.570.7760.091NM_080911-3 uracil-DNA glycosylase (UNG), nuclear gene encoding
chr17:43301561-43301574-0.8915.1231.990.7750.091NM_199262-13322 Sp6 transcription factor (SP6), mRNA.
chr2:196733314-196733327+0.8935.1402.220.7750.091NM_00422611206 serine/threonine kinase 17b (apoptosis-inducing)
chr1:153312803-153312816-0.8945.1491.780.7720.091NM_004952-5069 ephrin-A3 (EFNA3), mRNA.
chr1:10576333-10576346+0.8945.1492.000.7710.091NM_004565118843 peroxisomal biogenesis factor 14 (PEX14), mRNA.
chr5:174803837-174803850-0.8915.1231.770.7710.091NM_000794-68 dopamine receptor D1 (DRD1), mRNA.
chr11:18769134-18769147+0.8945.1491.740.7700.091NM_032781831 protein tyrosine phosphatase, non-receptor type 5
chr2:223196098-223196111+0.8885.0961.970.7680.091NM_00568732973 phenylalanine-tRNA synthetase-like, beta subunit
chrX:77469802-77469815+0.8935.1402.280.7670.091NM_006639-59 cysteinyl leukotriene receptor 1 (CYSLTR1), mRNA.
chr17:34122269-34122282+0.8975.1751.140.6200.091NM_0059376970 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr10:104377670-104377683-0.8965.1661.840.6160.091NM_030912-16472 tripartite motif-containing 8 (TRIM8), mRNA.
chr2:220081794-220081807+0.8965.1661.110.6110.091NM_018674-5402 amiloride-sensitive cation channel 4, pituitary
chrX:16715172-16715185-0.8975.1751.670.6110.091NM_018360791 chromosome X open reading frame 15 (CXorf15), mRNA.
chr6:42529424-42529437-0.9125.3051.590.6330.092NM_033502-1663 transcriptional regulating factor 1 (TRERF1),
chr13:73606678-73606691-0.9105.2861.330.6330.092NM_007249-611 Kruppel-like factor 12 (KLF12), transcript variant 1,
chr6:151083440-151083453-0.9125.3051.030.6320.092NM_001029884120848-
chr18:17200246-17200259-0.9075.2621.090.6320.092NM_052911234445 establishment factor-like protein (EFO1), mRNA.
chr1:207132579-207132592+0.9055.2411.050.6320.092NM_025179-648291 plexin A2 (PLXNA2), mRNA.
chrX:23954067-23954080+0.9135.3121.550.6310.092NM_0306241157-
chr12:13584858-13584871-0.9095.2731.660.6310.092NM_182558-163946 hypothetical protein FLJ33810 (FLJ33810), mRNA.
chr2:104030075-104030088-0.9125.3051.710.6310.092NM_006236-808226 POU domain, class 3, transcription factor 3 (POU3F3),
chr12:112785143-112785156-0.9145.3151.420.6290.092NM_016196103356 RNA binding motif protein 19 (RBM19), mRNA.
chr2:25954744-25954757+0.9105.2861.470.6280.092NM_01826372 additional sex combs like 2 (Drosophila) (ASXL2),
chr10:80343530-80343543+0.9085.2671.850.6280.092NM_020338-248246 retinoic acid induced 17 (RAI17), mRNA.
chrX:53366461-53366474-0.9085.2671.230.6250.092NM_015075-38940-
chr18:53862303-53862316+0.9085.2671.270.6250.092NM_015277-375 neural precursor cell expressed, developmentally
chr7:123460735-123460748-0.9085.2671.280.6220.092NM_003117108270 sperm adhesion molecule 1 (PH-20 hyaluronidase, zona
chr19:54643056-54643069-0.9055.2411.210.6210.092NM_0179163823 hypothetical protein FLJ20643 (FLJ20643), mRNA.
chr7:69321493-69321506-0.9085.2671.630.6200.092NM_015570619338 autism susceptibility candidate 2 (AUTS2), mRNA.
chr22:18118943-18118956+0.9085.2671.590.6170.092NM_080647-5183 T-box 1 (TBX1), transcript variant C, mRNA.
chr17:41242820-41242833+0.9075.2601.460.6170.092NM_00438225471 corticotropin releasing hormone receptor 1 (CRHR1),
chr17:27619168-27619181+0.9075.2601.540.6170.092NM_1383281960 rhomboid, veinlet-like 4 (Drosophila) (RHBDL4), mRNA.
chr16:53294500-53294513-0.9135.3121.720.6170.092NM_005853-228012 iroquois homeobox protein 5 (IRX5), mRNA.
chr11:15267085-15267098-0.9075.2601.680.6160.092NM_001042536174125-
chr10:107013895-107013908+0.9095.2731.830.6160.092NM_014978623146 sortilin-related VPS10 domain containing receptor 3
chr2:152663325-152663338-0.9135.3121.410.6120.092NM_001005746140-
chr7:93767512-93767525-0.9075.2601.710.6120.092NM_000089-94197 collagen, type I, alpha 2 (COL1A2), mRNA.
chrX:40828941-40828954-0.9095.2732.430.6120.092NM_001039590-791-
chr12:6745932-6745945-0.9105.2861.100.6110.092NM_002824230 parathymosin (PTMS), mRNA.
chr6:42183056-42183069+0.9075.2601.130.6100.092NM_000409-47996 guanylate cyclase activator 1A (retina) (GUCA1A),
chr1:43170523-43170536-0.9055.2411.580.6100.092NM_00651626565 solute carrier family 2 (facilitated glucose
chr12:131658169-131658182-0.9115.2931.370.6100.092NM_012226-47207 purinergic receptor P2X, ligand-gated ion channel, 2
chr1:158599733-158599746-0.9055.2411.390.6080.092NM_005598-3665 nescient helix loop helix 1 (NHLH1), mRNA.
chr11:63552727-63552740-0.9085.2661.440.6080.092NM_01767042926 OTU domain, ubiquitin aldehyde binding 1 (OTUB1),
chr22:36096657-36096670+0.9075.2601.550.6080.092NM_05290656794-
chr22:36227428-36227441+0.9055.2411.910.6060.092NM_002405-15097 manic fringe homolog (Drosophila) (MFNG), mRNA.
chr1:51198428-51198441+0.9085.2671.670.6040.092NM_00705196 Fas (TNFRSF6) associated factor 1 (FAF1), transcript
chr11:118298097-118298110+0.9135.3121.340.6020.092NM_182557-11274 B-cell CLL/lymphoma 9-like (BCL9L), mRNA.
chr14:20974869-20974882+0.9135.3121.790.6020.092NM_020920375-
chr11:61277900-61277913+0.9085.2661.000.6020.092NM_013279-1437 chromosome 11 open reading frame 9 (C11orf9), mRNA.
chr1:26819589-26819602-0.8965.1661.740.5940.092NM_00100666574759-
chr1:39443021-39443034-0.8965.1661.720.5940.092NM_012090123416 microtubule-actin crosslinking factor 1 (MACF1),
chr1:155280952-155280965-0.8965.1662.090.5880.092NM_014784834 Rho guanine nucleotide exchange factor (GEF) 11
chr2:202811308-202811321-0.8975.1751.520.5820.092NM_001005781259-
chr11:63769701-63769714-0.8955.1611.130.5790.092NM_1386891288-
chr4:149585156-149585169+0.8975.1751.000.5780.092NM_000901-2183 nuclear receptor subfamily 3, group C, member 2
chr16:66671156-66671169-0.8975.1751.300.5770.092NM_173164-5620 nuclear factor of activated T-cells, cytoplasmic,
chrX:70232609-70232622+0.8975.1751.260.5740.092NM_005938-42 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr22:40941992-40942005+0.8975.1751.180.5740.092NM_181492-603 transcription factor 20 (AR1) (TCF20), transcript
chr22:20126265-20126278+0.7994.3531.981.3880.093NM_01509424672 hypermethylated in cancer 2 (HIC2), mRNA.
chr10:64698103-64698116+0.7994.3532.641.3320.094NM_004241885 jumonji domain containing 1C (JMJD1C), mRNA.
chr11:18612480-18612493-0.9075.2601.610.5990.094NM_194285116 hypothetical protein FLJ39441 (FLJ39441), mRNA.
chrX:85290069-85290082+0.9125.3051.550.5960.094NM_053281-112 dachshund homolog 2 (Drosophila) (DACH2), mRNA.
chr19:43392214-43392227-0.9085.2671.150.5960.094NM_00464714414 D4, zinc and double PHD fingers family 1 (DPF1), mRNA.
chr22:20316938-20316951-0.9055.2411.050.5950.094NM_152612-48 hypothetical protein FLJ36046 (FLJ36046), mRNA.
chrX:153262824-153262837+0.9135.3121.880.5950.094NM_0001171943 emerin (Emery-Dreifuss muscular dystrophy) (EMD),
chr2:219572277-219572290+0.9055.2411.430.5920.094NM_057094-5906 crystallin, beta A2 (CRYBA2), transcript variant 3,
chr1:93317779-93317792+0.9135.3121.390.5900.094NM_007358448 likely ortholog of mouse metal response element
chr16:66476204-66476217-0.9135.3121.350.5890.094NM_19844322 MRCC2446 (UNQ2446), mRNA.
chr19:50044078-50044091+0.9085.2661.000.5880.094NM_0010427242945-
chr9:111753342-111753355+0.9135.3122.050.5870.094NM_001004065-97355 A kinase (PRKA) anchor protein 2 (AKAP2), mRNA.
chr9:128209716-128209729-0.9125.3051.340.5870.094NM_03344680867-
chr12:120211077-120211090+0.9135.3121.750.5820.094NM_1722267811 calcium/calmodulin-dependent protein kinase kinase 2,
chr1:107484570-107484583+0.9055.2411.330.5820.094NM_014917402-
chr17:35473765-35473778+0.9085.2661.610.5800.094NM_0032501179 thyroid hormone receptor, alpha (erythroblastic
chr10:75303537-75303550+0.9135.3121.210.5800.094NM_001222807 calcium/calmodulin-dependent protein kinase (CaM
chr10:99538912-99538925+0.9125.3051.010.5780.094NM_003015-17152 secreted frizzled-related protein 5 (SFRP5), mRNA.
chr20:61039895-61039908-0.9085.2671.210.5770.094NM_017896109 chromosome 20 open reading frame 11 (C20orf11), mRNA.
chr11:124538079-124538092-0.9085.2661.320.5770.094NM_022062-1590 PBX/knotted 1 homeobox 2 (PKNOX2), mRNA.
chr2:71069095-71069108+0.9075.2601.180.5760.094NM_1445826414 testis expressed sequence 261 (TEX261), mRNA.
chr10:80204935-80204948-0.9085.2671.190.5740.094NM_020338-386841 retinoic acid induced 17 (RAI17), mRNA.
chr14:76455295-76455308-0.9105.2861.350.5730.094NM_00108100292765-
chrX:130250403-130250416-0.9125.3051.560.5730.094NM_001555533 immunoglobulin superfamily, member 1 (IGSF1),
chr21:33420025-33420038-0.9075.2601.280.5720.094NM_13898355682 oligodendrocyte transcription factor 1 (OLIG1), mRNA.
chr7:150390622-150390635-0.9085.2661.270.5710.094NM_0030403050 solute carrier family 4, anion exchanger, member 2
chr20:773172-773185+0.9075.2601.740.5710.094NM_031424-13 chromosome 20 open reading frame 55 (C20orf55),
chr4:158111781-158111794+0.9135.3121.070.5710.094NM_016205215 platelet derived growth factor C (PDGFC), mRNA.
chr1:158461028-158461041+0.9075.2601.420.5700.094NM_00376819377 phosphoprotein enriched in astrocytes 15 (PEA15),
chr17:33861742-33861755+0.9135.3121.390.5700.094NM_014598100311-
chr2:23772141-23772154-0.9115.2931.110.5700.094NM_017552231297-
chr17:43317445-43317458+0.9125.3051.560.5680.094NM_003110-10970 Sp2 transcription factor (SP2), mRNA.
chr4:185631467-185631480-0.9055.2411.390.5670.094NM_0021991253 interferon regulatory factor 2 (IRF2), mRNA.
chr2:18447706-18447719-0.8204.5262.361.2720.095NM_020905157675 retinol dehydrogenase 14 (all-trans and 9-cis)
chr12:5460238-5460251+0.8294.6052.211.2280.095NM_002527-13189 neurotrophin 3 (NTF3), mRNA.
chr19:18583483-18583496+0.8334.6391.341.2140.095NM_012109-1099 chromosome 19 open reading frame 4 (C19orf4), mRNA.
chr16:29597941-29597954-0.8384.6772.061.1840.096NM_01429899 quinolinate phosphoribosyltransferase
chr11:58146664-58146677+0.8434.7212.421.1830.096NM_00061443 ciliary neurotrophic factor (CNTF), mRNA.
chr10:63330431-63330444+0.8424.7142.711.1790.096NM_032199-918-
chr16:45281017-45281030+0.9165.3381.070.3310.096NM_01432158 origin recognition complex, subunit 6 homolog-like
chr9:36858932-36858945+0.9155.3241.000.3310.096NM_016734165544 paired box gene 5 (B-cell lineage specific activator)
chr3:125397968-125397981+0.9225.3821.010.3290.096NM_001024660101793-
chr2:30294097-30294110+0.9225.3821.100.3140.096NM_030915-13704 likely ortholog of mouse limb-bud and heart gene
chr14:75465096-75465109-0.9155.3241.020.3140.096NM_00323952146 transforming growth factor, beta 3 (TGFB3), mRNA.
chr1:230308231-230308244-0.9155.3241.270.3040.096NM_020808409635 signal-induced proliferation-associated 1 like 2
chr5:151284062-151284075+0.9165.3311.100.3010.096NM_000171534 glycine receptor, alpha 1 (startle
chr9:118383138-118383151+0.8795.0192.580.9610.097NM_001099679-106164-
chr6:123359802-123359815+0.8795.0192.190.9610.097NM_001010852621-
chr17:68851143-68851156+0.8795.0191.530.9590.097NM_012121-31405 CDC42 effector protein (Rho GTPase binding) 4
chr10:105386495-105386508+0.8754.9881.580.9540.097NM_004210142557 neuralized-like (Drosophila) (NEURL), mRNA.
chr11:16025477-16025490-0.8795.0271.900.9540.097NM_017508355491-
chr11:64156836-64156849+0.8775.0082.320.9520.097NM_13873410527 neurexin 2 (NRXN2), transcript variant beta, mRNA.
chr16:20818635-20818648+0.8795.0192.390.9500.097NM_173475526 hypothetical protein MGC48972 (MGC48972), mRNA.
chr5:173467217-173467230+0.8815.0381.840.9480.097NM_01598061987 HMP19 protein (HMP19), mRNA.
chr14:22974757-22974770-0.8795.0271.660.9460.097NM_000257-47 myosin, heavy polypeptide 7, cardiac muscle, beta
chr3:138064388-138064401-0.8754.9881.520.9440.097NM_006153725 NCK adaptor protein 1 (NCK1), mRNA.
chr6:127882233-127882246-0.8795.0272.350.9350.097NM_001012279-2693-
chr11:133323516-133323529-0.8795.0271.740.9340.097NM_0149878574-
chr1:159369079-159369092+0.8945.1491.420.7630.097NM_00103971123-
chrX:51653215-51653228+0.8945.1491.840.7620.097NM_001005333-123 melanoma antigen, family D, 1 (MAGED1), transcript
chr14:23022675-23022688-0.8945.1492.030.7610.097NM_00104263514037-
chr7:23477388-23477401+0.8935.1401.900.7590.097NM_006547-868 IGF-II mRNA-binding protein 3 (IMP-3), mRNA.
chr11:916518-916531-0.8915.1231.660.7590.097NM_012305777 adaptor-related protein complex 2, alpha 2 subunit
chr14:98781868-98781881+0.8945.1461.520.7590.097NM_02289825707 B-cell CLL/lymphoma 11B (zinc finger protein)
chr19:14026766-14026779-0.8885.0961.370.7570.097NM_00484323604 interleukin 27 receptor, alpha (IL27RA), mRNA.
chr5:141153285-141153298-0.8935.1401.810.7560.097NM_03242084843 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr11:3775214-3775227+0.8885.0961.720.7560.097NM_016320254 nucleoporin 98kDa (NUP98), transcript variant 1, mRNA.
chr8:10708805-10708818+0.8885.0961.780.7550.097NM_01788425904 PIN2-interacting protein 1 (PINX1), mRNA.
chr19:15209633-15209646+0.8885.0961.660.7530.097NM_024794-5402 abhydrolase domain containing 9 (ABHD9), mRNA.
chr11:19757352-19757365+0.8885.0961.480.7530.097NM_18296465964 neuron navigator 2 (NAV2), transcript variant 1, mRNA.
chr19:47194002-47194015-0.8945.1491.920.7500.097NM_152296-3780 ATPase, Na+/K+ transporting, alpha 3 polypeptide
chr1:23797698-23797711-0.8885.0962.020.7500.097NM_002167-38826 inhibitor of DNA binding 3, dominant negative
chr17:4844641-4844654+0.8935.1441.780.7480.097NM_0066122741 kinesin family member 1C (KIF1C), mRNA.
chr8:93215817-93215830+0.8945.1491.570.7480.097NM_175635-39198 core-binding factor, runt domain, alpha subunit 2;
chr1:31618632-31618645-0.8935.1411.930.7470.097NM_004102-122 fatty acid binding protein 3, muscle and heart
chr3:128361307-128361320+0.8935.1401.470.7470.097NM_001007534-33257-
chr19:50664950-50664963-0.8885.0961.750.7460.097NM_0067321957 FBJ murine osteosarcoma viral oncogene homolog B
chr10:112514724-112514737-0.8935.1441.700.7440.097NM_014456-106762 programmed cell death 4 (neoplastic transformation
chr14:23117967-23117980+0.8915.1231.780.7430.097NM_032452-133 junctophilin 4 (JPH4), mRNA.
chr5:137701969-137701982-0.8945.1491.870.7400.097NM_016605202 chromosome 5 open reading frame 6 (C5orf6), mRNA.
chr1:114854468-114854481-0.8945.1491.620.7390.097NM_015906836 tripartite motif-containing 33 (TRIM33), transcript
chr8:96834448-96834461-0.8885.0961.900.7370.097NM_001001557407748 growth differentiation factor 6 (GDF6), mRNA.
chr12:84200006-84200019-0.8935.1412.380.7370.097NM_0069822090 cartilage paired-class homeoprotein 1 (CART1), mRNA.
chr6:112461913-112461926-0.8885.0961.280.7350.097NM_003880-19958 WNT1 inducible signaling pathway protein 3 (WISP3),
chr6:3403063-3403076-0.8935.1441.500.7340.097NM_021945-12846 chromosome 6 open reading frame 85 (C6orf85), mRNA.
chr20:44410219-44410232+0.8945.1461.930.7330.097NM_01594516252 solute carrier family 35, member C2 (SLC35C2),
chr8:77851718-77851731+0.8885.0962.030.7330.097NM_02472195748 zinc finger homeodomain 4 (ZFHX4), mRNA.
chr1:54574148-54574161+0.8945.1491.450.7320.097NM_01807070419 single stranded DNA binding protein 3 (SSBP3), mRNA.
chr4:147077364-147077377-0.8935.1411.370.7320.097NM_1788351693 hypothetical protein LOC152485 (LOC152485), mRNA.
chr16:54784178-54784191-0.8935.1401.400.7310.097NM_020988629 guanine nucleotide binding protein (G protein), alpha
chr8:95976695-95976708-0.8915.1231.310.7300.097NM_057749-37 cyclin E2 (CCNE2), transcript variant 1, mRNA.
chr12:119311483-119311496+0.8885.0961.550.7290.097NM_002442-20142 musashi homolog 1 (Drosophila) (MSI1), mRNA.
chr5:175976284-175976297-0.8895.1041.840.7280.097NM_052899-6547 G protein-regulated inducer of neurite outgrowth 1
chr6:33496870-33496883-0.8945.1491.200.7280.097NM_0067721145-
chr17:24643932-24643945-0.8885.0961.370.7270.097NM_0207721271 82-kD FMRP Interacting Protein (182-FIP), mRNA.
chr17:45655543-45655556+0.8935.1411.150.7270.097NM_000088-21544 collagen, type I, alpha 1 (COL1A1), mRNA.
chr3:73129127-73129140+0.8945.1491.750.7260.097NM_174907418 protein phosphatase 4, regulatory subunit 2 (PPP4R2),
chr1:65503968-65503981+0.8885.0961.590.7260.097NM_0147871050-
chr7:149735914-149735927-0.8915.1231.880.7230.097NM_17368028675 hypothetical protein MGC33584 (MGC33584), mRNA.
chr6:35124220-35124233-0.8935.1411.320.7230.097NM_01867992945 t-complex 11 (mouse) (TCP11), mRNA.
chr5:140997830-140997843+0.8935.1442.000.7220.097NM_1738281153 chromosome 5 open reading frame 16 (C5orf16), mRNA.
chr11:61091066-61091079+0.8885.0961.750.7210.097NM_00420013808 synaptotagmin VII (SYT7), mRNA.
chr1:154215002-154215015-0.8915.1231.460.7160.097NM_004723-427 rho/rac guanine nucleotide exchange factor (GEF) 2
chr2:207716857-207716870-0.8935.1412.150.7150.097NM_00370922002 Kruppel-like factor 7 (ubiquitous) (KLF7), mRNA.
chr12:112210799-112210812-0.8915.1232.020.7140.097NM_02495946509 solute carrier family 24 (sodium/potassium/calcium
chr9:128525265-128525278-0.8945.1491.200.7120.097NM_014007-81817 zinc finger protein 297B (ZNF297B), mRNA.
chr13:34414297-34414310+0.8885.0961.830.7100.097NM_015678-59 neurobeachin (NBEA), mRNA.
chr5:115938713-115938726-0.8885.0961.370.7100.097NM_020796-263 sema domain, transmembrane domain (TM), and
chr19:51133139-51133152-0.8945.1492.030.7080.097NM_001029861-23263-
chr12:55315789-55315802+0.8885.0961.970.7080.097NM_013449641 bromodomain adjacent to zinc finger domain, 2A
chr11:114570738-114570751+0.8885.0961.610.7080.097NM_001098517309713-
chr10:21849424-21849437-0.8945.1491.740.7060.097NM_2073715193 FLJ45187 protein (FLJ45187), mRNA.
chr7:6527603-6527616-0.8885.0961.770.7050.097NM_006854-37378 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein
chr1:153924352-153924365-0.8935.1411.250.7050.097NM_139119837 YY1 associated protein (YAP), transcript variant 3,
chr2:157177890-157177903-0.8945.1492.100.7040.097NM_000408176844 glycerol-3-phosphate dehydrogenase 2 (mitochondrial)
chr7:29326044-29326057-0.8895.1041.350.7030.097NM_004067125498 chimerin (chimaerin) 2 (CHN2), mRNA.
chr17:24347599-24347612+0.8935.1401.920.7010.097NM_0010986359608-
chr12:54606755-54606768+0.8935.1402.160.7010.097NM_0323451209 PYM protein (PYM), mRNA.
chr20:229977-229990-0.8935.1411.810.7000.097NM_0330893873 zinc finger, CCHC domain containing 3 (ZCCHC3), mRNA.
chr2:15867024-15867037+0.8935.1401.980.7000.097NM_005378-131010 v-myc myelocytomatosis viral related oncogene,
chr7:100237648-100237661-0.8955.1611.060.5660.097NM_00444425431 EphB4 (EPHB4), mRNA.
chr6:37549178-37549191-0.8955.1611.230.5530.097NM_13849326500-
chr10:124050927-124050940-0.8955.1581.480.5500.097NM_14458730216 chromosome 10 open reading frame 87 (C10orf87), mRNA.
chr1:148389529-148389542+0.8965.1661.450.5470.097NM_016274835 CK2 interacting protein 1; HQ0024c protein (CKIP-1),
chr1:211552920-211552933-0.8955.1611.790.5420.097NM_012424261800 ribosomal protein S6 kinase, 52kDa, polypeptide 1
chr5:153184782-153184795-0.9155.3241.070.2990.097NM_005927-213870 microfibrillar-associated protein 3 (MFAP3), mRNA.
chr11:46268915-46268928+0.9155.3241.450.2970.097NM_05285413211 cAMP responsive element binding protein 3-like 1
chr8:145613773-145613786+0.9155.3241.140.2880.097NM_130849-692 solute carrier family 39 (zinc transporter), member 4
chr17:16329066-16329079+0.9155.3241.390.2860.097NM_2073876823 FLJ35696 protein (FLJ35696), mRNA.
chr17:46062315-46062328+0.9155.3241.220.2850.097NM_003786-4812 ATP-binding cassette, sub-family C (CFTR/MRP), member
chr5:139104372-139104385+0.9165.3381.310.2830.097NM_032289-51118 pleckstrin and Sec7 domain containing 2 (PSD2), mRNA.
chr1:21768176-21768189+0.9155.3241.290.2820.097NM_00047859831 alkaline phosphatase, liver/bone/kidney (ALPL), mRNA.
chr9:111973822-111973835-0.9155.3241.220.2760.097NM_00101299335913-
chr7:127835874-127835887+0.9155.3241.150.2750.097NM_1832431403 IMP (inosine monophosphate) dehydrogenase 1 (IMPDH1),
chr17:59269923-59269936-0.9225.3821.270.2710.097NM_0010984264160-
chr9:130945954-130945967-0.9165.3311.070.2690.097NM_17800332620 protein phosphatase 2A, regulatory subunit B' (PR 53)
chr8:95723181-95723194+0.7994.3531.771.2370.098NM_017697683 hypothetical protein FLJ20171 (FLJ20171), mRNA.
chr7:129199249-129199262+0.8534.8061.921.1980.098NM_001040110142194-
chr17:23329122-23329135-0.8524.7992.811.1910.098NM_016231-64593 nemo like kinase (NLK), mRNA.
chr2:74520648-74520661-0.8504.7802.161.2180.099NM_001015056570-
chr14:21064256-21064269+0.9085.2661.420.5630.099NM_00540710921 sal-like 2 (Drosophila) (SALL2), mRNA.
chr17:34081433-34081446-0.9125.3051.650.5620.099NM_005937-33866 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr19:13478314-13478327+0.9085.2671.120.5600.099NM_000068-40 calcium channel, voltage-dependent, P/Q type, alpha 1A
chr3:55495335-55495348-0.9055.2411.840.5600.099NM_0033921036 wingless-type MMTV integration site family, member 5A
chr14:63078967-63078980-0.9085.2671.780.5590.099NM_006246865 protein phosphatase 2, regulatory subunit B (B56),
chr12:114302505-114302518+0.9135.3121.150.5580.099NM_016569-696153 T-box 3 (ulnar mammary syndrome) (TBX3), transcript
chr3:185516362-185516375+0.9135.3121.030.5570.099NM_182917674 eukaryotic translation initiation factor 4 gamma, 1
chr2:42649841-42649854+0.9135.3121.050.5570.099NM_020744766 metastasis associated family, member 3 (MTA3), mRNA.
chr5:123171309-123171322-0.9085.2661.120.5560.099NM_001044723295717-
chr1:116005483-116005496-0.9075.2601.210.5550.099NM_13895919486 vang-like 1 (van gogh, Drosophila) (VANGL1), mRNA.
chrX:153256228-153256241-0.9115.2931.180.5540.099NM_001456-3383 filamin A, alpha (actin binding protein 280) (FLNA),
chr16:47873327-47873340-0.9085.2671.120.5540.099NM_004352-143 cerebellin 1 precursor (CBLN1), mRNA.
chr10:21854998-21855011-0.9085.2671.140.5530.099NM_207371-381 FLJ45187 protein (FLJ45187), mRNA.
chr11:118305348-118305361+0.9085.2671.550.5530.099NM_182557-18525 B-cell CLL/lymphoma 9-like (BCL9L), mRNA.
chr20:48094126-48094139+0.9135.3121.050.5530.099NM_00598561292 snail homolog 1 (Drosophila) (SNAI1), mRNA.
chr8:38444880-38444893+0.9085.2671.100.5530.099NM_023105629 fibroblast growth factor receptor 1 (fms-related
chrX:39900294-39900307-0.9085.2661.320.5530.099NM_020926-58694 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr16:66051044-66051057-0.9085.2671.240.5520.099NM_00469121546 ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d
chr9:128454538-128454551+0.9085.2671.650.5520.099NM_00231638019 LIM homeobox transcription factor 1, beta (LMX1B),
chr9:83793394-83793407+0.9075.2601.150.5510.099NM_001001670-13 FLJ46321 protein (FLJ46321), mRNA.
chr3:151171430-151171443+0.9085.2671.230.5510.099NM_0530241 profilin 2 (PFN2), transcript variant 1, mRNA.
chr16:4528573-4528586+0.9085.2671.400.5500.099NM_013399244 chromosome 16 open reading frame 5 (C16orf5), mRNA.
chr11:2235073-2235086+0.9135.3121.010.5500.099NM_00517013685 achaete-scute complex-like 2 (Drosophila) (ASCL2),
chr17:19231146-19231159-0.9115.2931.310.5480.099NM_002404-60 microfibrillar-associated protein 4 (MFAP4), mRNA.
chr1:27770822-27770835-0.9085.2661.410.5480.099NM_00102988231908-
chr2:86295818-86295831+0.9075.2601.270.5480.099NM_14564415827 mitochondrial ribosomal protein L35 (MRPL35), nuclear
chr10:22650074-22650087-0.9085.2661.180.5470.099NM_00518028 B lymphoma Mo-MLV insertion region (mouse) (BMI1),
chr22:27939548-27939561+0.9055.2411.410.5470.099NM_1334557695 EMI domain containing 1 (EMID1), mRNA.
chr4:57300371-57300384-0.9125.3051.250.5470.099NM_139212-58049 homeodomain-only protein (HOP), transcript variant 3,
chr1:87152882-87152895+0.9085.2671.470.5430.099NM_01226232 heparan sulfate 2-O-sulfotransferase 1 (HS2ST1), mRNA.
chr12:4255300-4255313-0.9085.2661.800.5420.099NM_0017592201 cyclin D2 (CCND2), mRNA.
chr9:131048713-131048726-0.9135.3121.230.5420.099NM_203434-68352 immediate early response 5-like (IER5L), mRNA.
chr18:13454779-13454792-0.9135.3121.050.5420.099NM_001003674-146787 chromosome 18 open reading frame 1 (C18orf1),
chrX:128766528-128766541-0.9135.3121.820.5410.099NM_01899024987 chromosome X open reading frame 9 (CXorf9), mRNA.
chr12:55922549-55922562-0.9085.2671.510.5400.099NM_020142-1807 NADH:ubiquinone oxidoreductase MLRQ subunit homolog
chr8:25831190-25831203-0.9085.2661.420.5400.099NM_022659127119 early B-cell factor 2 (EBF2), mRNA.
chr1:153209814-153209827-0.9105.2861.310.5380.099NM_183001-188 SHC (Src homology 2 domain containing) transforming
chr1:33602842-33602855+0.9075.2601.380.5370.099NM_19804010939 polyhomeotic-like 2 (Drosophila) (PHC2), transcript
chr12:56157970-56157983-0.9125.3051.030.5370.099NM_00108015625-
chr17:39972665-39972678+0.9135.3121.210.5350.099NM_001466-17686 frizzled homolog 2 (Drosophila) (FZD2), mRNA.
chr17:45635724-45635737+0.9085.2671.340.5350.099NM_000088-1725 collagen, type I, alpha 1 (COL1A1), mRNA.
chr14:50068789-50068802-0.9085.2661.060.5350.099NM_006575337 mitogen-activated protein kinase kinase kinase kinase
chr2:74083931-74083944+0.9085.2661.150.5340.099NM_144993-42927-
chr1:66794909-66794922-0.9135.3121.190.5340.099NM_03229122596 hypothetical protein DKFZp761D221 (DKFZp761D221),
chrX:130984892-130984905+0.9085.2671.640.5340.099NM_01654266 Mst3 and SOK1-related kinase (MST4), mRNA.
chr5:172689323-172689336-0.8034.3851.751.3590.100NM_003714-211 stanniocalcin 2 (STC2), mRNA.
chr5:31521188-31521201-0.9165.3381.110.2140.100NM_01323546737 nuclear RNase III Drosha (RNASE3L), mRNA.
chr1:50662202-50662215+0.9185.3511.500.1880.100NM_032110-473-
chr12:50272084-50272097-0.8244.5582.231.1980.101NM_014191897 sodium channel, voltage gated, type VIII, alpha
chr2:177171498-177171511+0.8184.5052.381.1850.101NM_006554329215 metaxin 2 (MTX2), mRNA.
chr3:39164418-39164431-0.8234.5491.921.1680.101NM_0330275687 AXIN1 up-regulated 1 (AXUD1), mRNA.
chr7:68914810-68914823-0.9155.3241.210.2660.101NM_015570212655 autism susceptibility candidate 2 (AUTS2), mRNA.
chr1:43770563-43770576+0.9155.3241.180.2640.101NM_0028401529 protein tyrosine phosphatase, receptor type, F
chr4:147789353-147789366-0.9165.3381.170.2590.101NM_0045759958 POU domain, class 4, transcription factor 2 (POU4F2),
chr1:199860655-199860668+0.9155.3241.020.2460.101NM_020443-23318 neuron navigator 1 (NAV1), mRNA.
chr11:118965811-118965824+0.9225.3821.060.2440.101NM_203285138834 poliovirus receptor-related 1 (herpesvirus entry
chr17:1912792-1912805+0.9165.3381.120.2440.101NM_0010982026538-
chr4:38431181-38431194+0.9225.3821.300.1300.101NM_00101738829803-
chr1:154741482-154741495+0.8795.0272.140.9240.102NM_005920-4329 MADS box transcription enhancer factor 2, polypeptide
chr3:198509320-198509333-0.8835.0532.260.9190.102NM_001098424524-
chr7:27108171-27108184-0.8754.9882.460.9070.102NM_006735748 homeo box A2 (HOXA2), mRNA.
chr22:38652528-38652541+0.8795.0272.610.9070.102NM_00481025596 GRB2-related adaptor protein 2 (GRAP2), mRNA.
chr5:150932647-150932660+0.8765.0002.390.9060.102NM_001447-3949 FAT tumor suppressor homolog 2 (Drosophila) (FAT2),
chr12:19484683-19484696-0.8945.1491.570.6990.102NM_153207883 AE binding protein 2 (AEBP2), mRNA.
chr2:177785657-177785670-0.8885.0961.260.6990.102NM_19424789 heterogeneous nuclear ribonucleoprotein A3 (HNRPA3),
chr2:19304387-19304400-0.8915.1232.320.6980.102NM_145260117466 odd-skipped homolog (Drosophila) (ODD), mRNA.
chr14:23090229-23090242-0.8945.1491.630.6970.102NM_024328-4742-
chr16:73576301-73576314+0.8945.1491.990.6970.102NM_030581217-
chr17:41219010-41219023-0.8935.1411.400.6960.102NM_0043821661 corticotropin releasing hormone receptor 1 (CRHR1),
chr10:105408217-105408230-0.8885.0961.460.6950.102NM_004210164279 neuralized-like (Drosophila) (NEURL), mRNA.
chr6:17708547-17708560+0.8885.0961.680.6950.102NM_01625582 family with sequence similarity 8, member A1 (FAM8A1),
chr6:22254591-22254604+0.8935.1442.080.6950.102NM_000948151118 prolactin (PRL), mRNA.
chr11:32796010-32796023-0.8915.1231.730.6940.102NM_024081-11955 proline rich Gla (G-carboxyglutamic acid) 4
chr2:200031711-200031724-0.8895.1041.640.6920.102NM_0152651735 SATB family member 2 (SATB2), mRNA.
chr22:28206050-28206063-0.8925.1301.800.6900.102NM_021076-69 neurofilament, heavy polypeptide 200kDa (NEFH), mRNA.
chr12:112058488-112058501+0.8935.1401.570.6900.102NM_004658-84 RAS protein activator like 1 (GAP1 like) (RASAL1),
chr4:24641844-24641857+0.8945.1491.580.6890.102NM_018176-431 leucine-rich repeat LGI family, member 2 (LGI2), mRNA.
chr10:102121127-102121140-0.8945.1491.180.6880.102NM_00506324465 stearoyl-CoA desaturase (delta-9-desaturase) (SCD),
chr2:27047236-27047249+0.8945.1491.540.6870.102NM_012326307 microtubule-associated protein, RP/EB family, member 3
chr6:21704361-21704374-0.8935.1411.670.6830.102NM_0031072510 SRY (sex determining region Y)-box 4 (SOX4), mRNA.
chr16:56393899-56393912-0.8895.1041.540.6820.102NM_00555041 kinesin family member C3 (KIFC3), mRNA.
chr17:16225328-16225341+0.8945.1491.320.6810.102NM_018955336 ubiquitin B (UBB), mRNA.
chr1:36462867-36462880-0.8915.1231.940.6810.102NM_005119333 thyroid hormone receptor associated protein 3
chr9:129557388-129557401+0.8915.1231.540.6800.102NM_00548915984 SH2 domain containing 3C (SH2D3C), mRNA.
chr1:202232480-202232493+0.8935.1442.360.6800.102NM_18257944531 hypothetical protein FLJ40343 (FLJ40343), mRNA.
chr10:98890079-98890092-0.8885.0961.490.6790.102NM_00306145574 slit homolog 1 (Drosophila) (SLIT1), mRNA.
chr2:72224067-72224080-0.8945.1491.620.6790.102NM_0198854404 cytochrome P450, family 26, subfamily B, polypeptide 1
chr2:163403557-163403570+0.8915.1231.510.6770.102NM_173162-71 potassium voltage-gated channel, subfamily H
chr17:44047121-44047134+0.8935.1441.270.6760.102NM_024016179 homeo box B8 (HOXB8), mRNA.
chrX:40162581-40162594+0.8915.1231.880.6740.102NM_005765-162479 ATPase, H+ transporting, lysosomal accessory protein 2
chr14:28759177-28759190-0.8915.1231.960.6720.102NM_005249453239 forkhead box G1B (FOXG1B), mRNA.
chr6:50907641-50907654-0.8885.0961.970.6710.102NM_00322113343 transcription factor AP-2 beta (activating enhancer
chr17:34583868-34583881+0.8915.1231.740.6690.102NM_020405-22570 plexin domain containing 1 (PLXDC1), mRNA.
chr1:32889444-32889457-0.8895.1042.020.6690.102NM_005610133 retinoblastoma binding protein 4 (RBBP4), mRNA.
chr12:56202659-56202672+0.8935.1401.210.6680.102NM_052897-167 methyl-CpG binding domain protein 6 (MBD6), mRNA.
chr8:103493510-103493523+0.8945.1491.420.6680.102NM_015902161 E3 identified by differential display (EDD), mRNA.
chr16:73305529-73305542+0.8795.0271.890.8630.103NM_152649-13239 hypothetical protein FLJ34389 (FLJ34389), mRNA.
chr1:112333501-112333514-0.8795.0192.290.8590.103NM_172198-201 potassium voltage-gated channel, Shal-related
chr11:41438270-41438283-0.8795.0272.330.8550.103NM_020929-1166030 netrin-G1 ligand (NGL-1), mRNA.
chr18:21813634-21813647-0.8815.0392.810.8450.103NM_001007559110975-
chr1:19409106-19409119-0.8754.9881.920.8370.103NM_020765227 retinoblastoma-associated factor 600 (RBAF600), mRNA.
chr18:44756954-44756967+0.8775.0081.920.8370.103NM_005904-25875 SMAD, mothers against DPP homolog 7 (Drosophila)
chr14:92967249-92967262+0.8835.0531.770.8350.103NM_18297184059 cytochrome c oxidase subunit 8C (COX8C), mRNA.
chr6:108410543-108410556+0.8955.1611.150.5290.103NM_007214-24457 SEC63-like (S. cerevisiae) (SEC63), mRNA.
chr19:11233374-11233387-0.8965.1661.260.5270.103NM_020812754 dedicator of cytokinesis 6 (DOCK6), mRNA.
chr2:241860409-241860422+0.8965.1661.070.5260.103NM_203346565 high density lipoprotein binding protein (vigilin)
chr2:176721197-176721210-0.8965.1661.190.5210.103NM_014621-3062 homeo box D4 (HOXD4), mRNA.
chr3:18697701-18697714-0.8955.1611.380.5190.103NM_002971-257357 special AT-rich sequence binding protein 1 (binds to
chr17:45008723-45008736-0.8995.1871.090.5170.103NM_007225345 neurexophilin 3 (NXPH3), mRNA.
chr5:132327290-132327303-0.8955.1581.850.5160.103NM_014423-37 ALL1 fused gene from 5q31 (AF5Q31), mRNA.
chr13:69579890-69579903+0.9035.2221.180.5150.103NM_020866570 kelch-like 1 (Drosophila) (KLHL1), mRNA.
chr15:72343624-72343637+0.8965.1661.360.5120.103NM_02505528004-
chr1:23623000-23623013-0.8975.1751.280.5050.103NM_003196848 transcription elongation factor A (SII), 3 (TCEA3),
chr2:176748223-176748236+0.8234.5492.381.2280.104NM_00689811272 homeo box D3 (HOXD3), mRNA.
chr1:148496147-148496160-0.8574.8352.051.1500.105NM_012113-595 carbonic anhydrase XIV (CA14), mRNA.
chr17:2561271-2561284+0.8574.8392.071.1500.105NM_015229406 KIAA0664 protein (KIAA0664), mRNA.
chr10:22258086-22258099+0.8744.9812.851.1370.105NM_02236574570 DnaJ (Hsp40) homolog, subfamily C, member 1 (DNAJC1),
chr1:26618125-26618138-0.8744.9812.281.1360.105NM_0246748369 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr14:20975376-20975389-0.8744.9812.181.1310.105NM_020920-132-
chr8:28804011-28804024-0.8724.9612.431.1290.105NM_024567-33 hypothetical protein FLJ21616 (FLJ21616), mRNA.
chr11:46882002-46882015-0.8564.8252.141.1240.105NM_00233414747-
chr6:42527682-42527695-0.8614.8681.621.1240.105NM_03350279 transcriptional regulating factor 1 (TRERF1),
chr20:32896238-32896251-0.8744.9822.011.1220.105NM_014071-19144 nuclear receptor coactivator 6 (NCOA6), mRNA.
chr10:105398105-105398118+0.8614.8681.581.1210.105NM_004210154167 neuralized-like (Drosophila) (NEURL), mRNA.
chr12:94491986-94491999+0.8584.8452.181.1210.105NM_032147-22592 ubiquitin specific protease 44 (USP44), mRNA.
chr1:47682432-47682445+0.8734.9691.961.1170.105NM_0044748256 forkhead box D2 (FOXD2), mRNA.
chr2:74408926-74408939+0.8714.9562.291.1110.105NM_021196-13266 solute carrier family 4, sodium bicarbonate
chr16:49061629-49061642+0.8584.8432.341.1080.105NM_033119-78013 naked cuticle homolog 1 (Drosophila) (NKD1), mRNA.
chr1:65305152-65305165+0.8734.9691.831.0910.105NM_203464-80568-
chr10:75230760-75230773-0.8734.9682.711.0870.105NM_00363510588 N-deacetylase/N-sulfotransferase (heparan
chr1:54646067-54646080-0.8744.9812.621.0640.105NM_001009955-1387-
chr1:32488370-32488383-0.8744.9812.311.0600.105NM_005356-957 lymphocyte-specific protein tyrosine kinase (LCK),
chr11:65236560-65236573+0.8664.9161.571.0390.105NM_182710595 HIV-1 Tat interacting protein, 60kDa (HTATIP),
chr17:44423587-44423600+0.8734.9681.861.0380.105NM_006546-6086 IGF-II mRNA-binding protein 1 (IMP-1), mRNA.
chr1:46411951-46411964+0.8724.9611.681.0360.105NM_005727-6748 tetraspan 1 (TSPAN-1), mRNA.
chr10:12124826-12124839-0.8754.9882.170.8980.105NM_015542-12 UPF2 regulator of nonsense transcripts homolog (yeast)
chr3:189123627-189123640+0.8815.0392.220.8960.105NM_001706-177458 B-cell CLL/lymphoma 6 (zinc finger protein 51) (BCL6),
chr13:49553742-49553755-0.8754.9881.840.8930.105NM_19946466451 potassium channel regulator (KCNRG), mRNA.
chr12:50871550-50871563+0.8765.0001.650.8920.105NM_001081492501-
chr14:61231785-61231798+0.8765.0001.790.8900.105NM_001530-107 hypoxia-inducible factor 1, alpha subunit (basic
chr7:129376823-129376836-0.8815.0392.430.8890.105NM_0033443202 ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast)
chr1:52293725-52293738-0.8754.9882.020.8850.105NM_015913-90 endoplasmic reticulum thioredoxin superfamily member,
chr7:134114457-134114470-0.8795.0271.590.8840.105NM_004342-154 caldesmon 1 (CALD1), transcript variant 2, mRNA.
chrX:133142530-133142543-0.8765.0002.570.8840.105NM_032335-192378 PHD finger protein 6 (PHF6), mRNA.
chr7:39079605-39079618-0.8795.0192.250.8760.105NM_00725266772 POU domain, class 6, transcription factor 2 (POU6F2),
chr17:4426968-4426981-0.8795.0192.120.8700.105NM_198501-6975 FLJ42461 protein (FLJ42461), mRNA.
chr4:148757869-148757882-0.9055.2411.090.5330.106NM_018241-77 transmembrane protein 34 (TMEM34), mRNA.
chr15:94704756-94704769+0.9135.3121.590.5330.106NM_02100529906 nuclear receptor subfamily 2, group F, member 2
chr4:38147659-38147672-0.9085.2671.520.5310.106NM_016531-194459 Kruppel-like factor 3 (basic) (KLF3), mRNA.
chr9:97308100-97308113+0.9135.3121.640.5290.106NM_0010836071202-
chr11:6458909-6458922-0.9055.2411.310.5280.106NM_012192-244 fracture callus 1 homolog (rat) (FXC1), mRNA.
chr17:38084797-38084810-0.9135.3121.050.5270.106NM_024927-2302 hypothetical protein FLJ21019 (FLJ21019), mRNA.
chr1:153208914-153208927+0.9135.3121.510.5270.106NM_183001712 SHC (Src homology 2 domain containing) transforming
chr13:78067398-78067411+0.9055.2411.410.5270.106NM_0062378298 POU domain, class 4, transcription factor 1 (POU4F1),
chr1:153559326-153559339-0.9115.2931.040.5260.106NM_0010395171236-
chr11:71429911-71429924+0.9125.3051.390.5260.106NM_00618539310 nuclear mitotic apparatus protein 1 (NUMA1), mRNA.
chr1:59052650-59052663+0.9105.2861.210.5260.106NM_002228-30277 v-jun sarcoma virus 17 oncogene homolog (avian) (JUN),
chr1:859014-859027+0.9135.3121.350.5230.106NM_1524868130 sterile alpha motif domain containing 11 (SAMD11),
chr12:47495617-47495630+0.9115.2931.220.5230.106NM_000725-3062 calcium channel, voltage-dependent, beta 3 subunit
chr1:42371344-42371357-0.9125.3051.190.5230.106NM_007102-20235 guanylate cyclase activator 2B (uroguanylin) (GUCA2B),
chr11:64160446-64160459+0.9135.3121.580.5210.106NM_1387346917 neurexin 2 (NRXN2), transcript variant beta, mRNA.
chr19:11451764-11451777-0.9085.2661.110.5180.106NM_0014201039 ELAV (embryonic lethal, abnormal vision,
chr7:28186955-28186968+0.9085.2671.500.5180.106NM_1750617 juxtaposed with another zinc finger gene 1 (JAZF1),
chr16:51027286-51027299+0.9085.2671.370.5170.106NM_001080430111021-
chr2:33677960-33677973-0.9105.2861.600.5170.106NM_015475-94 DKFZP564F0522 protein (DKFZP564F0522), mRNA.
chr15:24570055-24570068-0.9135.3121.130.5160.106NM_021912-35 gamma-aminobutyric acid (GABA) A receptor, beta 3
chr1:224939649-224939662-0.9105.2861.590.5130.106NM_00222152169 inositol 1,4,5-trisphosphate 3-kinase B (ITPKB), mRNA.
chr14:84463577-84463590-0.9135.3121.320.5110.106NM_013231-602564 fibronectin leucine rich transmembrane protein 2
chr1:24421484-24421497+0.9135.3121.040.5100.106NM_173065-35146 interleukin 28 receptor, alpha (interferon, lambda
chr10:105579743-105579756-0.9075.2601.530.5100.106NM_01463125411-
chr4:146904455-146904468-0.9085.2661.150.5090.106NM_00108053183749-
chr17:43976856-43976869-0.9125.3051.350.5080.106NM_002145536 homeo box B2 (HOXB2), mRNA.
chr21:27139645-27139658-0.9135.3121.390.5080.106NM_006988-46 a disintegrin-like and metalloprotease (reprolysin
chrX:39839936-39839949-0.9135.3121.940.5070.106NM_0177451664 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr15:66509444-66509457-0.9135.3121.470.5040.106NM_0010044392102 integrin, alpha 11 (ITGA11), transcript variant 1,
chr19:44589013-44589026-0.9055.2411.220.5030.106NM_003407-214 zinc finger protein 36, C3H type, homolog (mouse)
chr7:21434127-21434140-0.9085.2671.360.5030.106NM_00311213 Sp4 transcription factor (SP4), mRNA.
chr22:28114622-28114635+0.9105.2861.450.5020.106NM_145730-53 adaptor-related protein complex 1, beta 1 subunit
chr6:148027050-148027063-0.8574.8351.641.0880.107NM_001030060155394-
chr20:45415703-45415716-0.8594.8512.461.0870.107NM_0124083178 protein kinase C binding protein 1 (PRKCBP1),
chr5:73961414-73961427-0.8564.8251.831.0850.107NM_00363310859 ectodermal-neural cortex (with BTB-like domain)
chr15:38516963-38516976+0.8584.8432.231.0840.107NM_014952-3640 bromo adjacent homology domain containing 1 (BAHD1),
chr5:92960347-92960360+0.8604.8632.751.0840.107NM_00565415648 nuclear receptor subfamily 2, group F, member 1
chr11:63775034-63775047+0.8604.8611.941.0670.107NM_000932-564 phospholipase C, beta 3
chr6:74287608-74287621-0.8024.3742.501.1750.108NM_001402-132 eukaryotic translation elongation factor 1 alpha 1
chr18:46976083-46976096-0.7994.3532.411.1680.108NM_0166261605 ring finger and KH domain containing 2 (RKHD2), mRNA.
chr6:74287607-74287620-0.8054.3972.501.1770.109NM_001402-131 eukaryotic translation elongation factor 1 alpha 1
chr19:44586443-44586456-0.8564.8251.931.0650.109NM_003407-2784 zinc finger protein 36, C3H type, homolog (mouse)
chr16:7601667-7601680+0.8634.8911.961.0640.109NM_145893279015 ataxin 2-binding protein 1 (A2BP1), transcript variant
chr16:7601662-7601675+0.8634.8911.961.0640.109NM_145893279010 ataxin 2-binding protein 1 (A2BP1), transcript variant
chr10:102856780-102856793-0.8604.8632.231.0460.109NM_005521-23372 T-cell leukemia, homeobox 1 (TLX1), mRNA.
chr11:46177174-46177187-0.8574.8372.331.0450.109NM_016621-77613 BRAF35/HDAC2 complex (80 kDa) (BHC80), mRNA.
chr7:86619650-86619663+0.8704.9432.040.9950.110NM_021145-110 cyclin D binding myb-like transcription factor 1
chr9:132358940-132358953-0.8744.9821.710.9930.110NM_05401249125 argininosuccinate synthetase (ASS), transcript variant
chr17:7687727-7687740-0.8734.9691.560.9910.110NM_0010804243867-
chr17:35192517-35192530+0.8734.9742.250.9890.110NM_00103000244501-
chr10:105604232-105604245+0.8724.9612.170.9880.110NM_014631922-
chr12:55767498-55767511+0.8734.9681.930.9850.110NM_005967-1346 NGFI-A binding protein 2 (EGR1 binding protein 2)
chr12:47666720-47666733-0.8664.9162.560.9850.110NM_0054308317 wingless-type MMTV integration site family, member 1
chr15:86219785-86219798-0.8744.9811.500.9850.110NM_001012338380880-
chr17:43083144-43083157+0.8704.9432.240.9810.110NM_002265970 karyopherin (importin) beta 1 (KPNB1), mRNA.
chr16:15644574-15644587-0.8664.9171.730.9780.110NM_014647-64 limkain b1 (LKAP), transcript variant 1, mRNA.
chr11:63754571-63754584+0.8724.9621.660.9690.110NM_005528-993 DnaJ (Hsp40) homolog, subfamily C, member 4 (DNAJC4),
chr12:67919602-67919615-0.8664.9171.380.9670.110NM_00700735 cleavage and polyadenylation specific factor 6, 68kDa
chr11:47373053-47373066-0.8835.0532.170.8320.110NM_152264-13605 solute carrier family 39 (zinc transporter), member 13
chr19:47080317-47080330+0.8765.0001.790.8230.110NM_199002131 Rho guanine nucleotide exchange factor (GEF) 1
chr14:36052925-36052938+0.8795.0191.970.8190.110NM_0033175729 thyroid transcription factor 1 (TITF1), mRNA.
chr15:91244399-91244412+0.8795.0272.330.8050.110NM_001042572-56-
chr2:118793573-118793586-0.8795.0271.780.8050.110NM_016133231153 insulin induced gene 2 (INSIG2), mRNA.
chr6:149110128-149110141-0.8775.0071.730.8040.110NM_00571571 uronyl-2-sulfotransferase (UST), mRNA.
chr5:134898071-134898084+0.8795.0271.980.8030.110NM_0061611467 neurogenin 1 (NEUROG1), mRNA.
chr1:36825316-36825329+0.8835.0602.020.8010.110NM_172313-104220 colony stimulating factor 3 receptor (granulocyte)
chr22:49039109-49039122+0.8945.1491.700.6660.110NM_0029693107 mitogen-activated protein kinase 12 (MAPK12), mRNA.
chr4:56107611-56107624-0.8885.0961.490.6650.110NM_004898143 clock homolog (mouse) (CLOCK), mRNA.
chr12:52005299-52005312+0.8885.0961.790.6620.110NM_015665-3651 achalasia, adrenocortical insufficiency, alacrimia
chr17:1749639-1749652-0.8935.1401.810.6610.110NM_00294569644 replication protein A1, 70kDa (RPA1), mRNA.
chr12:54904510-54904523+0.8885.0961.550.6600.110NM_024068-164 hypothetical protein MGC2731 (MGC2731), mRNA.
chr11:75769599-75769612+0.8925.1301.700.6600.110NM_004705-71 protein-kinase, interferon-inducible double stranded
chr7:55999916-55999929+0.8925.1301.220.6580.110NM_001483226 glioblastoma amplified sequence (GBAS), mRNA.
chr18:20394753-20394766+0.8915.1231.830.6580.110NM_021624100262 histamine receptor H4 (HRH4), mRNA.
chr12:119167161-119167174+0.8885.0961.510.6570.110NM_00285920731 paxillin (PXN), mRNA.
chrX:154495770-154495783-0.8945.1491.660.6560.110NM_01819621 trimethyllysine hydroxylase, epsilon (TMLHE), mRNA.
chr11:19219795-19219808-0.8945.1491.370.6560.110NM_024680-712 FLJ23311 protein (FLJ23311), mRNA.
chr12:4260112-4260125+0.8935.1401.960.6550.110NM_0017597013 cyclin D2 (CCND2), mRNA.
chr1:200024438-200024451-0.8885.0962.160.6550.110NM_018085-40373 importin 9 (IPO9), mRNA.
chr12:5343802-5343815-0.8935.1411.660.6550.110NM_002527-129625 neurotrophin 3 (NTF3), mRNA.
chr3:43900430-43900443+0.8885.0961.270.6550.110NM_016006193151 abhydrolase domain containing 5 (ABHD5), mRNA.
chr15:45795495-45795508+0.8915.1232.000.6550.110NM_024966-2383 sema domain, transmembrane domain (TM), and
chr1:181653698-181653711-0.8935.1411.150.6540.110NM_015039662 nicotinamide nucleotide adenylyltransferase 2
chr4:55957417-55957430+0.8945.1491.280.6540.110NM_018475403 TPA regulated locus (TPARL), mRNA.
chr2:161058616-161058629+0.8945.1491.220.6540.110NM_016839-65 RNA binding motif, single stranded interacting protein
chr15:49126799-49126812+0.8885.0961.500.6530.110NM_20738157966 FLJ41287 protein (FLJ41287), mRNA.
chr2:232777508-232777521-0.8885.0961.730.6520.110NM_001632-173984 alkaline phosphatase, placental (Regan isozyme)
chr15:63496391-63496404+0.8945.1491.030.6510.110NM_0209626072 likely ortholog of mouse neighbor of Punc E11 (NOPE),
chr19:14136500-14136513-0.8945.1511.410.6510.110NM_018154-28060 ASF1 anti-silencing function 1 homolog B (S.
chr11:76564838-76564851+0.8945.1511.450.6510.110NM_00026047974 myosin VIIA (Usher syndrome 1B (autosomal recessive,
chr14:102869961-102869974+0.8915.1231.280.6490.110NM_001969-185 eukaryotic translation initiation factor 5 (EIF5),
chr19:12986128-12986141-0.8915.1231.370.6480.110NM_00250118644 nuclear factor I/X (CCAAT-binding transcription
chr6:64404057-64404070-0.8935.1411.750.6460.110NM_015153-10233 PHD finger protein 3 (PHF3), mRNA.
chr3:108725679-108725692+0.8885.0961.310.6440.110NM_0202351299 bobby sox homolog (Drosophila) (BBX), mRNA.
chr19:7930263-7930276-0.8945.1511.690.6420.110NM_006351-15725 translocase of inner mitochondrial membrane 44 homolog
chr19:12758404-12758417+0.8945.1491.190.6400.110NM_002229-4806 jun B proto-oncogene (JUNB), mRNA.
chr2:47449806-47449819+0.8945.1491.300.6400.110NM_002354-65 tumor-associated calcium signal transducer 1
chr19:35707443-35707456-0.8885.0961.640.6400.110NM_014717152375-
chr9:20611201-20611214+0.8915.1231.950.6400.110NM_0045291249 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr12:6921635-6921648-0.8885.0961.150.6390.110NM_138425-1729 likely ortholog of mouse gene rich cluster, C10 gene
chr1:163455167-163455180+0.8885.0961.700.6380.110NM_177399-6031 LIM homeobox transcription factor 1, alpha (LMX1A),
chr1:24767577-24767590+0.8885.0961.300.6370.110NM_00101098012488-
chr1:52828570-52828583+0.8754.9882.050.7960.111NM_015696-11962 glutathione peroxidase 7 (GPX7), mRNA.
chr11:30563703-30563716-0.8795.0191.890.7960.111NM_001584-5087 chromosome 11 open reading frame 8 (C11orf8), mRNA.
chr2:39099373-39099386-0.8795.0191.300.7940.111NM_005633101694 son of sevenless homolog 1 (Drosophila) (SOS1), mRNA.
chr17:46299410-46299423+0.8795.0272.090.7920.111NM_005749-2998 transducer of ERBB2, 1 (TOB1), mRNA.
chr3:129015862-129015875-0.8795.0192.200.7910.111NM_0072838529 monoglyceride lipase (MGLL), transcript variant 1,
chr20:48778736-48778749+0.8815.0392.200.7880.111NM_032521-2652-
chr11:124604040-124604053+0.8815.0391.690.7850.111NM_02206264371 PBX/knotted 1 homeobox 2 (PKNOX2), mRNA.
chr12:109203326-109203339+0.8835.0601.570.7830.111NM_170665-389 ATPase, Ca++ transporting, cardiac muscle, slow twitch
chr1:113734570-113734583+0.8835.0602.140.7830.111NM_020965-224 membrane-associated guanylate kinase-related (MAGI-3)
chr4:113484333-113484346-0.8795.0191.850.7800.111NM_025144-33868 lymphocyte alpha-kinase (LAK), mRNA.
chr10:103864790-103864803-0.8835.0601.790.7740.111NM_003893-98 LIM domain binding 1 (LDB1), mRNA.
chr4:129951557-129951570+0.8795.0191.650.7710.111NM_0249001428 PHD finger protein 17 (PHF17), transcript variant S,
chr17:37813778-37813791-0.8795.0271.840.7700.111NM_01223215022 polymerase I and transcript release factor (PTRF),
chr1:81889171-81889184-0.8714.9561.911.0290.112NM_012302-149399 latrophilin 2 (LPHN2), mRNA.
chr3:34037815-34037828-0.8734.9741.981.0280.112NM_013374223354 programmed cell death 6 interacting protein (PDCD6IP),
chr10:28863009-28863022+0.8744.9812.131.0240.112NM_016628669 WW domain containing adaptor with coiled-coil (WAC),
chr10:103867423-103867436-0.8744.9812.361.0210.112NM_003893-2731 LIM domain binding 1 (LDB1), mRNA.
chr22:43781485-43781498-0.8724.9612.391.0180.112NM_1384152760 hypothetical protein BC012187 (LOC112885), mRNA.
chr12:47740446-47740459-0.8734.9692.461.0170.112NM_003482-5072 myeloid/lymphoid or mixed-lineage leukemia 2 (MLL2),
chr10:74925805-74925818+0.8694.9362.031.0140.112NM_021132-45 protein phosphatase 3 (formerly 2B), catalytic
chr11:45923970-45923983+0.8734.9742.521.0140.112NM_15231224298 glycosyltransferase-like 1B (GYLTL1B), mRNA.
chr7:129933383-129933396-0.8394.6832.011.1490.113NM_00240214309 mesoderm specific transcript homolog (mouse) (MEST),
chr8:38419364-38419377-0.8955.1611.140.4980.113NM_02310526145 fibroblast growth factor receptor 1 (fms-related
chr8:54952755-54952768+0.8965.1661.020.4950.113NM_003702-3263 regulator of G-protein signalling 20 (RGS20), mRNA.
chr1:26892506-26892519-0.8965.1661.470.4950.113NM_139135-2503 AT rich interactive domain 1A (SWI- like) (ARID1A),
chr16:69272332-69272345-0.8975.1721.290.4860.113NM_1383835123 hypothetical protein BC002770 (LOC92154), mRNA.
chr1:9520933-9520946+0.8955.1611.310.4860.113NM_032315-1082 mitochondrial carrier protein (MGC4399), mRNA.
chr1:158354168-158354181+0.8955.1611.870.4810.113NM_0007022096 ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide
chr7:106597186-106597199+0.8975.1751.460.4720.113NM_012257590 HMG-box transcription factor 1 (HBP1), mRNA.
chr17:69616269-69616282-0.8955.1611.170.4690.113NM_000999-95021 ribosomal protein L38 (RPL38), mRNA.
chr5:80885577-80885590-0.8955.1611.190.4670.113NM_130767-159865 cytosolic acetyl-CoA hydrolase (CACH-1), mRNA.
chr7:100019555-100019568-0.8344.6452.301.1460.114NM_0023192157 leucine-rich repeats and calponin homology (CH) domain
chr2:227413113-227413126+0.8254.5662.381.1460.114NM_0322764196 hypothetical protein DKFZp547E052 (DKFZp547E052),
chr12:123473196-123473209+0.8885.0961.200.6320.114NM_006312112906 nuclear receptor co-repressor 2 (NCOR2), mRNA.
chr5:115938719-115938732-0.8855.0771.540.6320.114NM_020796-269 sema domain, transmembrane domain (TM), and
chr10:98582275-98582288-0.8945.1491.180.6310.114NM_032440-352 ligand-dependent corepressor (MLR2), mRNA.
chr12:56200936-56200949+0.8885.0961.620.6300.114NM_004083-369 DNA-damage-inducible transcript 3 (DDIT3), mRNA.
chr1:152459996-152460009+0.8935.1441.340.6300.114NM_015449-99 chromosome 1 open reading frame 43 (C1orf43), mRNA.
chr1:32954977-32954990-0.8945.1491.570.6300.114NM_030786-21517 intermediate filament protein syncoilin (SYNCOILIN),
chr15:65015872-65015885-0.8935.1401.390.6280.114NM_005902-129277 SMAD, mothers against DPP homolog 3 (Drosophila)
chr10:114535070-114535083-0.8885.0961.630.6280.114NM_030756-165031 transcription factor 7-like 2 (T-cell specific,
chr11:57006879-57006892-0.8915.1231.200.6250.114NM_17857022064 reticulon 4 receptor-like 2 (RTN4RL2), mRNA.
chr1:43554016-43554029+0.8885.0961.410.6240.114NM_00542414865 tyrosine kinase with immunoglobulin and epidermal
chr11:118124091-118124104-0.8935.1441.630.6240.114NM_00439742991 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 (DDX6), mRNA.
chr18:71191937-71191950+0.8915.1231.220.6240.114NM_00103733176640-
chr12:50690440-50690453-0.8945.1491.480.6230.114NM_1817113525 GRP1 (general receptor for phosphoinositides
chr1:41073210-41073223-0.8945.1491.680.6230.114NM_13346727395 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr2:231438497-231438510+0.8935.1401.240.6230.114NM_030926732 integral membrane protein 2C (ITM2C), mRNA.
chr1:92187749-92187762-0.8895.1041.750.6220.114NM_207189129 bromodomain, testis-specific (BRDT), transcript
chr16:10227839-10227852+0.8915.1231.460.6220.114NM_000833-43727 glutamate receptor, ionotropic, N-methyl D-aspartate
chr20:60558456-60558469+0.8945.1491.280.6190.114NM_178463451 chromosome 20 open reading frame 166 (C20orf166),
chr11:58103016-58103029+0.8945.1461.370.6190.114NM_053023-47 zinc finger protein 91 homolog (mouse) (ZFP91),
chr10:121346010-121346023+0.8885.0961.410.6190.114NM_001033925521-
chr15:63457487-63457500-0.8945.1491.260.6190.114NM_004884-56 putative neuronal cell adhesion molecule (PUNC), mRNA.
chr19:47503068-47503081-0.8885.0961.190.6180.114NM_002573-4505 platelet-activating factor acetylhydrolase, isoform
chr10:33522679-33522692-0.8935.1401.550.6180.114NM_001024629140777-
chr16:50531196-50531209-0.8935.1411.590.6180.114NM_001080430607111-
chr17:53765754-53765767+0.8945.1491.670.6170.114NM_004758-5277 benzodiazapine receptor (peripheral) associated
chr1:90195564-90195577+0.8895.1041.520.6170.114NM_182976-37604 hypothetical protein FLJ20403 (FLJ20403), transcript
chr10:72557153-72557166+0.8935.1401.380.6160.114NM_170744-85102 unc-5 homolog B (C. elegans) (UNC5B), mRNA.
chr15:41878475-41878488+0.8885.0962.010.6140.114NM_0010335171072-
chr15:39648135-39648148-0.8935.1411.600.6140.114NM_0062939711 TYRO3 protein tyrosine kinase (TYRO3), mRNA.
chr9:85785486-85785499+0.8885.0961.360.6130.114NM_024945129 chromosome 9 open reading frame 76 (C9orf76), mRNA.
chr5:174093078-174093091-0.8885.0961.960.6130.114NM_0024498997 msh homeo box homolog 2 (Drosophila) (MSX2), mRNA.
chr10:44196834-44196847-0.8895.1041.760.6130.114NM_0006093714 chemokine (C-X-C motif) ligand 12 (stromal
chr1:35103707-35103720-0.8915.1232.000.6120.114NM_138428-5775 hypothetical protein BC011880 (LOC113444), mRNA.
chr11:65806293-65806306-0.8945.1491.600.6110.114NM_1825534121 hypothetical protein MGC50896 (MGC50896), mRNA.
chr3:185460300-185460313+0.8925.1301.220.6110.114NM_0332591645 CaM-KII inhibitory protein (CAM-KIIN), mRNA.
chr2:43267803-43267816-0.8915.1231.230.6110.114NM_00688739446 zinc finger protein 36, C3H type-like 2 (ZFP36L2),
chr1:206887944-206887957+0.8945.1491.570.6110.114NM_025179-403656 plexin A2 (PLXNA2), mRNA.
chr18:895766-895779-0.8945.1491.340.6110.114NM_001117569 adenylate cyclase activating polypeptide 1 (pituitary)
chr1:20675739-20675752-0.8945.1491.250.6090.114NM_0185849576 calcium/calmodulin-dependent protein kinase II
chr11:118065661-118065674-0.8895.1041.220.6080.114NM_007180-10070 trehalase (brush-border membrane glycoprotein) (TREH),
chr1:43191832-43191845+0.8945.1491.830.6080.114NM_0065165256 solute carrier family 2 (facilitated glucose
chr11:78637536-78637549-0.8885.0961.460.6070.114NM_001098816-436703-
chr2:72998457-72998470+0.8915.1231.290.6040.114NM_004097445 empty spiracles homolog 1 (Drosophila) (EMX1), mRNA.
chr9:130978231-130978244+0.8885.0961.860.6010.114NM_2034342130 immediate early response 5-like (IER5L), mRNA.
chr1:159396425-159396438+0.8885.0961.830.6000.114NM_012475647 ubiquitin specific protease 21 (USP21), transcript
chr9:129364040-129364053+0.8524.7941.881.1610.115NM_0228337136 chromosome 9 open reading frame 88 (C9orf88), mRNA.
chr12:49080924-49080937+0.8494.7712.061.1450.115NM_199190107 c-Mpl binding protein (LOC113251), transcript variant
chr17:34115622-34115635-0.8294.6051.271.1200.115NM_005937323 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr17:38435824-38435837-0.8334.6382.131.1060.115NM_0054405140 ras homolog gene family, member N (ARHN), mRNA.
chr3:88190552-88190565-0.9115.2931.480.4980.115NM_001008390284-
chr5:124114784-124114797-0.9125.3051.360.4970.115NM_020747-6080-
chr11:78471872-78471885+0.9075.2601.150.4970.115NM_001098816-271039-
chr2:46884026-46884039+0.9135.3121.180.4950.115NM_144949104273 suppressor of cytokine signaling 5 (SOCS5), transcript
chr19:5289729-5289742+0.9085.2661.040.4940.115NM_1308552085 protein tyrosine phosphatase, receptor type, S
chr6:149680437-149680450+0.9055.2411.000.4940.115NM_015093-219 mitogen-activated protein kinase kinase kinase 7
chr6:99194047-99194060-0.9135.3121.250.4940.115NM_005604-195154 POU domain, class 3, transcription factor 2 (POU3F2),
chr10:99249259-99249272+0.9135.3121.220.4930.115NM_024954601 ubiquitin domain containing 1 (UBTD1), mRNA.
chr20:54633493-54633506-0.9085.2661.330.4920.115NM_003222-4172 transcription factor AP-2 gamma (activating enhancer
chr1:20630219-20630232-0.9125.3051.050.4920.115NM_01858455096 calcium/calmodulin-dependent protein kinase II
chr7:19778433-19778446-0.9135.3121.430.4910.115NM_1527741108 hypothetical protein MGC42090 (MGC42090), mRNA.
chr6:37250133-37250146+0.9075.2601.640.4910.115NM_0026484269 pim-1 oncogene (PIM1), mRNA.
chr17:34812322-34812335+0.9135.3121.690.4900.115NM_032875-920 F-box and leucine-rich repeat protein 20 (FBXL20),
chr1:160249214-160249227+0.9075.2601.140.4890.115NM_01544111054 olfactomedin-like 2B (OLFML2B), mRNA.
chr19:45016265-45016278+0.9105.2861.030.4870.115NM_004714416 dual-specificity tyrosine-(Y)-phosphorylation
chr7:28593701-28593714+0.9135.3121.500.4870.115NM_001011666-98445-
chr4:156900165-156900178+0.9135.3121.380.4860.115NM_000857600 guanylate cyclase 1, soluble, beta 3 (GUCY1B3), mRNA.
chr17:40659420-40659433+0.9085.2661.060.4850.115NM_0058924445 formin-like 1 (FMNL1), mRNA.
chr1:22959269-22959282+0.9075.2601.230.4850.115NM_01744949451 EphB2 (EPHB2), transcript variant 1, mRNA.
chr17:34604855-34604868-0.9075.2601.050.4840.115NM_0007232572 calcium channel, voltage-dependent, beta 1 subunit
chrX:152569619-152569632+0.9085.2661.030.4830.115NM_0013958537 dual specificity phosphatase 9 (DUSP9), mRNA.
chr12:56540597-56540610+0.9075.2601.060.4830.115NM_005730-13583 CTD (carboxy-terminal domain, RNA polymerase II,
chr11:12419292-12419305+0.9075.2601.030.4810.115NM_01822263670 parvin, alpha (PARVA), mRNA.
chr1:149210453-149210466-0.9075.2601.060.4800.115NM_0220753611 LAG1 longevity assurance homolog 2 (S. cerevisiae)
chr1:202595234-202595247+0.9135.3121.210.4800.115NM_014935433 pleckstrin homology domain containing, family A member
chr10:111970325-111970338+0.9055.2411.670.4790.115NM_005962-5327 MAX interactor 1 (MXI1), transcript variant 1, mRNA.
chr6:37700993-37701006+0.9105.2861.140.4770.115NM_15348772751 MAM domain containing glycosylphosphatidylinositol
chrX:39853461-39853474-0.9135.3121.040.4760.115NM_020926-11861 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr17:24948020-24948033+0.9085.2661.410.4730.115NM_1523453467 hypothetical protein FLJ25555 (FLJ25555), mRNA.
chr20:43468694-43468707-0.9115.2931.040.4680.115NM_001048224143-
chr15:72343590-72343603+0.9135.3121.210.4680.115NM_02505527970-
chr11:74881022-74881035-0.9075.2601.580.4680.115NM_03079233493 hypothetical protein PP1665 (PP1665), mRNA.
chr1:38800296-38800309+0.9075.2601.130.4680.115NM_022157297631 Ras-related GTP binding C (RRAGC), mRNA.
chr4:153092773-153092786-0.9135.3121.170.4670.115NM_004564-191177 PET112-like (yeast) (PET112L), mRNA.
chr12:53258040-53258053+0.8544.8112.091.1260.116NM_00674110667 protein phosphatase 1, regulatory (inhibitor) subunit
chr2:27358753-27358766-0.8454.7342.531.1220.116NM_032546-251 ring finger protein 30 (RNF30), transcript variant 1,
chr13:30090077-30090090+0.8514.7902.021.1140.116NM_005800257 chromosome 13 open reading frame 22 (C13orf22), mRNA.
chr13:96533981-96533994+0.8604.8631.910.9980.116NM_080818-89376 oxoglutarate (alpha-ketoglutarate) receptor 1 (OXGR1),
chr11:3814788-3814801-0.8594.8511.620.9940.116NM_0016654001 ras homolog gene family, member G (rho G) (RHOG),
chr2:73365227-73365240+0.8574.8352.370.9880.116NM_0019658954 early growth response 4 (EGR4), mRNA.
chr1:152421773-152421786-0.8564.8252.130.9830.116NM_001043351576-
chr8:77748637-77748650+0.8574.8351.520.9760.116NM_024721-7333 zinc finger homeodomain 4 (ZFHX4), mRNA.
chr14:37126875-37126888-0.8574.8352.000.9700.116NM_0044967365 forkhead box A1 (FOXA1), mRNA.
chr6:46246057-46246070+0.8604.8661.520.9680.116NM_021572619 ectonucleotide pyrophosphatase/phosphodiesterase 5
chr18:41388462-41388475+0.8384.6772.281.0840.117NM_007163-60202 solute carrier family 14 (urea transporter), member 2
chrX:70291728-70291741+0.8414.7032.341.0790.117NM_01897710392 neuroligin 3 (NLGN3), mRNA.
chr3:63931454-63931467-0.8594.8562.381.0320.117NM_01481452706 proteasome regulatory particle subunit p44S10
chr19:11437586-11437599+0.8574.8351.411.0210.117NM_00142015217 ELAV (embryonic lethal, abnormal vision,
chr19:47464363-47464376-0.8594.8562.551.0150.117NM_006494-13250 Ets2 repressor factor (ERF), mRNA.
chr1:55644885-55644898-0.8624.8811.851.0140.117NM_015306-191535-
chr9:109085356-109085369+0.8594.8511.651.0120.117NM_00287491 RAD23 homolog B (S. cerevisiae) (RAD23B), mRNA.
chr7:100021712-100021725-0.8584.8462.131.0020.117NM_0023190 leucine-rich repeats and calponin homology (CH) domain
chr15:66134880-66134893+0.8945.1492.000.5970.117NM_0161661354 protein inhibitor of activated STAT, 1 (PIAS1), mRNA.
chr15:34527978-34527991+0.8935.1442.100.5960.117NM_032499-146309 hypothetical protein HH114 (HH114), mRNA.
chr6:64340132-64340145-0.8915.1231.110.5950.117NM_003463353 protein tyrosine phosphatase type IVA, member 1
chr22:31329675-31329688-0.8885.0961.990.5950.117NM_001033024128551-
chr14:62782523-62782536-0.8885.0961.350.5930.117NM_02066341725 ras homolog gene family, member J (RHOJ), mRNA.
chr20:17986123-17986136-0.8945.1491.730.5930.117NM_021220398 zinc finger protein 339 (ZNF339), mRNA.
chr11:65848936-65848949-0.8935.1411.190.5920.117NM_020404-7845 CD164 sialomucin-like 1 (CD164L1), mRNA.
chr3:115789683-115789696+0.8945.1491.410.5920.117NM_173799294218 hypothetical protein FLJ39873 (FLJ39873), mRNA.
chr6:41564601-41564614+0.8885.0961.120.5890.117NM_001012426-57441-
chr21:39612957-39612970-0.8885.0961.510.5870.117NM_001007246-5531-
chr19:12968329-12968342+0.8915.1231.290.5860.117NM_002501845 nuclear factor I/X (CCAAT-binding transcription
chr15:72856998-72857011+0.8945.1491.370.5850.117NM_004383-4670 c-src tyrosine kinase (CSK), mRNA.
chr7:137505727-137505740+0.8945.1491.430.5830.117NM_00598994091 aldo-keto reductase family 1, member D1 (delta
chr14:76077994-76078007+0.8945.1491.260.5820.117NM_004452170615 estrogen-related receptor beta (ESRRB), mRNA.
chr19:59333468-59333481-0.8925.1301.240.5810.117NM_014516307 CCR4-NOT transcription complex, subunit 3 (CNOT3),
chr9:85465395-85465408-0.8945.1511.960.5810.117NM_00100155137709 chromosome 9 open reading frame 103 (C9orf103), mRNA.
chr16:52882551-52882564-0.8945.1491.130.5810.117NM_024336-4672 iroquois homeobox protein 3 (IRX3), mRNA.
chr9:95504293-95504306+0.8935.1441.310.5800.117NM_005392125663 PHD finger protein 2 (PHF2), transcript variant 1,
chr12:96009085-96009098+0.8885.0961.400.5800.117NM_152905183810 neural precursor cell expressed, developmentally
chrX:86659408-86659421+0.8935.1401.510.5790.117NM_01911735 kelch-like 4 (Drosophila) (KLHL4), transcript variant
chrX:70232625-70232638+0.8915.1231.560.5770.117NM_005938-26 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr14:76456174-76456187-0.8945.1491.290.5760.117NM_00108100293644-
chr1:242357908-242357921-0.8935.1441.530.5760.117NM_00635274803 zinc finger protein 238 (ZNF238), transcript variant
chr12:113257944-113257957+0.8945.1491.340.5750.117NM_08071868142 T-box 5 (TBX5), transcript variant 2, mRNA.
chr3:49893530-49893543-0.8945.1492.090.5740.117NM_024046-11157 hypothetical protein MGC8407 (MGC8407), mRNA.
chr17:29907094-29907107+0.8945.1461.360.5740.117NM_20745423407 FLJ44815 protein (FLJ44815), mRNA.
chr16:73590163-73590176-0.8935.1411.230.5730.117NM_032268-153 zinc and ring finger 1 (ZNRF1), mRNA.
chr11:9553655-9553668+0.8935.1401.640.5730.117NM_0033902839 WEE1 homolog (S. pombe) (WEE1), mRNA.
chr18:72345383-72345396-0.8935.1411.050.5730.117NM_014643-41340-
chr12:48304035-48304048-0.8945.1491.050.5710.117NM_012272465 Huntingtin interacting protein C (HYPC), mRNA.
chr14:57835620-57835633-0.8885.0961.320.5710.117NM_002892745 AT rich interactive domain 4A (RBP1-like) (ARID4A),
chr1:180920356-180920369+0.8935.1441.760.5710.117NM_033345-11666 regulator of G-protein signalling 8 (RGS8), mRNA.
chr8:25501515-25501528-0.8885.0961.700.5710.117NM_152562129185 cell division cycle associated 2 (CDCA2), mRNA.
chr17:53515589-53515602-0.8935.1441.050.5700.117NM_080677-109 dynein light chain 2 (Dlc2), mRNA.
chr10:114879128-114879141+0.8885.0962.170.5680.117NM_030756179027 transcription factor 7-like 2 (T-cell specific,
chr14:36795797-36795810-0.8945.1491.260.5670.117NM_13873158990 mirror-image polydactyly 1 (MIPOL1), mRNA.
chr5:142603816-142603829-0.8885.0961.470.5660.118NM_000176159631 nuclear receptor subfamily 3, group C, member 1
chr14:33048969-33048982-0.8945.1492.480.5660.118NM_022073441066 egl nine homolog 3 (C. elegans) (EGLN3), mRNA.
chr19:11452806-11452819-0.8895.1041.970.5640.118NM_032281-3 ELAV (embryonic lethal, abnormal vision,
chr10:102979793-102979806+0.8945.1491.290.5640.118NM_006562-1086 transcription factor similar to D. melanogaster
chr4:110443359-110443372-0.8915.1231.180.5640.118NM_032518-111 collagen, type XXV, alpha 1 (COL25A1), transcript
chr2:20250987-20251000+0.8885.0961.000.5640.118NM_00299737421 syndecan 1 (SDC1), mRNA.
chrX:53297222-53297235-0.8945.1491.100.5630.118NM_004187-25893 Jumonji, AT rich interactive domain 1C (RBP2-like)
chr1:11842474-11842487-0.8885.0961.630.5620.118NM_002521-895 natriuretic peptide precursor B (NPPB), mRNA.
chrX:39259203-39259216-0.8885.0961.730.5600.118NM_017745582397 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr2:42165216-42165229-0.8935.1401.520.5590.118NM_13837036059-
chr11:47246155-47246168+0.8885.0961.680.5580.118NM_130470-1280 MAP-kinase activating death domain (MADD), transcript
chr1:166172724-166172737-0.8945.1491.410.5580.118NM_018442292 IQ motif and WD repeats 1 (IQWD1), mRNA.
chr1:22952737-22952750+0.8885.0961.210.5570.118NM_01744942919 EphB2 (EPHB2), transcript variant 1, mRNA.
chr19:45889108-45889121+0.8945.1511.540.5560.118NM_004756-712 numb homolog (Drosophila)-like (NUMBL), mRNA.
chr16:30911603-30911616+0.8935.1401.600.5550.118NM_0251937670 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and
chr17:67742962-67742975-0.8935.1411.540.5540.118NM_000346114306 SRY (sex determining region Y)-box 9 (campomelic
chr2:26924097-26924110+0.8945.1491.420.5530.118NM_020134-270 dihydropyrimidinase-like 5 (DPYSL5), mRNA.
chr17:76986039-76986052-0.8915.1231.340.5530.118NM_001080519-1422-
chr17:35166302-35166315+0.8935.1401.200.5530.118NM_00103000218286-
chr5:154116003-154116016-0.8945.1491.090.5520.118NM_0335511021-
chr11:61447443-61447456-0.8915.1231.310.5500.118NM_013401-5870 RAB3A interacting protein (rabin3)-like 1 (RAB3IL1),
chr2:104637879-104637892+0.8915.1231.890.5500.118NM_006236-200422 POU domain, class 3, transcription factor 3 (POU3F3),
chr2:60652380-60652393-0.8935.1411.210.5490.118NM_022893-18243 B-cell CLL/lymphoma 11A (zinc finger protein)
chr2:232813976-232813989+0.8885.0961.740.5490.118NM_001632-137516 alkaline phosphatase, placental (Regan isozyme)
chr10:71003310-71003323-0.8915.1231.720.5480.118NM_020999-182 neurogenin 3 (NEUROG3), mRNA.
chr3:16901873-16901886+0.8885.0961.100.5470.118NM_015184-47613 phospholipase C-like 2 (PLCL2), mRNA.
chr19:10538028-10538041-0.8885.0961.250.5460.118NM_023008-326 hypothetical protein FLJ12949 (FLJ12949), transcript
chr15:38986417-38986430+0.8945.1491.470.5460.118NM_02085712597 vacuolar protein sorting protein 18 (VPS18), mRNA.
chr9:136874313-136874326+0.8885.0961.260.5460.118NM_004108-38066 ficolin (collagen/fibrinogen domain containing lectin)
chr8:22590767-22590780+0.8915.1231.230.5450.118NM_018688-8161 bridging integrator 3 (BIN3), mRNA.
chr17:75427267-75427280-0.8935.1441.080.5430.118NM_003655541 chromobox homolog 4 (Pc class homolog, Drosophila)
chr16:69306713-69306726-0.8945.1491.290.5430.118NM_138383-29258 hypothetical protein BC002770 (LOC92154), mRNA.
chr8:144977643-144977656-0.8885.0961.990.5420.118NM_0142815882 fuse-binding protein-interacting repressor (SIAHBP1),
chr11:6632667-6632680-0.8935.1441.020.5420.118NM_003737983 dachsous 1 (Drosophila) (DCHS1), mRNA.
chr18:5286284-5286297+0.8925.1301.180.5410.118NM_003409-2971 zinc finger protein 161 homolog (mouse) (ZFP161),
chr5:85949729-85949742+0.8945.1491.480.5400.118NM_001867289 cytochrome c oxidase subunit VIIc (COX7C), nuclear
chr17:24502679-24502692+0.8885.0961.610.5390.118NM_07847128854 myosin XVIIIA (MYO18A), transcript variant 1, mRNA.
chr1:152206952-152206965+0.8895.1041.030.5380.118NM_13089831 cAMP responsive element binding protein 3-like 4
chrX:150624599-150624612-0.8885.0961.470.5370.118NM_0240827264 proline rich Gla (G-carboxyglutamic acid) 3
chr12:47605616-47605629-0.8885.0961.510.5370.118NM_016594-74 FK506 binding protein 11, 19 kDa (FKBP11), mRNA.
chr1:165208835-165208848-0.8915.1231.820.5370.118NM_1993512350 chromosome 1 open reading frame 32 (C1orf32), mRNA.
chr9:132967518-132967531-0.8945.1491.250.5360.118NM_0314265885 chromosome 9 open reading frame 58 (C9orf58),
chr1:39875826-39875839+0.8945.1491.690.5360.118NM_0145712109 hairy/enhancer-of-split related with YRPW motif-like
chr4:56107433-56107446-0.8885.0961.460.5360.118NM_004898321 clock homolog (mouse) (CLOCK), mRNA.
chr2:66623404-66623417+0.8885.0961.420.5360.118NM_002398107468 Meis1, myeloid ecotropic viral integration site 1
chr17:70496604-70496617+0.8945.1511.090.5350.118NM_0146031382 paraneoplastic antigen (HUMPPA), mRNA.
chr9:97208434-97208447+0.8935.1411.210.5350.118NM_000136-88622 Fanconi anemia, complementation group C (FANCC), mRNA.
chr1:22924845-22924858+0.8885.0961.500.5350.118NM_01744915027 EphB2 (EPHB2), transcript variant 1, mRNA.
chr4:13094937-13094950+0.8915.1231.360.5350.118NM_004249-65 RAB28, member RAS oncogene family (RAB28), mRNA.
chrX:50353258-50353271-0.8895.1041.690.5340.118NM_001013742-122781-
chr17:38435828-38435841-0.8194.5132.131.1290.119NM_0054405144 ras homolog gene family, member N (ARHN), mRNA.
chr10:114605002-114605015-0.8184.5062.191.1130.119NM_030756-95099 transcription factor 7-like 2 (T-cell specific,
chr14:69379427-69379440+0.8775.0082.060.7630.119NM_001034852-36369-
chr17:35016922-35016935-0.8835.0531.630.7630.119NM_006160779 neurogenic differentiation 2 (NEUROD2), mRNA.
chr17:7996524-7996537-0.8805.0331.960.7620.119NM_002616-97 period homolog 1 (Drosophila) (PER1), mRNA.
chr12:54832643-54832656-0.8835.0602.190.7560.119NM_002475141 myosin light chain 1 slow a (MLC1SA), mRNA.
chr16:15644625-15644638+0.8845.0692.040.7560.119NM_014647-115 limkain b1 (LKAP), transcript variant 1, mRNA.
chr7:8441207-8441220-0.8795.0191.960.7560.119NM_1527451197 neurexophilin 1 (NXPH1), mRNA.
chr10:52421656-52421669+0.8795.0271.830.7550.119NM_001098512805-
chr16:78159500-78159513+0.8795.0272.240.7530.119NM_00103180432612-
chr18:9465830-9465843+0.8795.0271.870.7520.119NM_006788400 ralA binding protein 1 (RALBP1), mRNA.
chr3:140146536-140146549-0.8825.0451.700.7520.119NM_0230671955 forkhead box L2 (FOXL2), mRNA.
chr1:112854796-112854809-0.8795.0191.280.7470.119NM_0244941507 wingless-type MMTV integration site family, member 2B
chr6:41963181-41963194+0.8795.0191.710.7440.119NM_0185617896 ubiquitin specific protease 49 (MGC20741), mRNA.
chr17:3992552-3992565-0.8765.0001.730.7420.119NM_015113450 zinc finger, ZZ-type with EF hand domain 1 (ZZEF1),
chr15:39639052-39639065-0.8795.0272.210.7380.119NM_006293628 TYRO3 protein tyrosine kinase (TYRO3), mRNA.
chr1:33538501-33538514-0.8474.7551.851.0870.120NM_00108043820785-
chr5:137974989-137975002-0.8754.9882.200.7330.120NM_004134-35975 heat shock 70kDa protein 9B (mortalin-2) (HSPA9B),
chr17:52030048-52030061-0.8765.0002.200.7330.120NM_0054503874 noggin (NOG), mRNA.
chr17:34157340-34157353+0.8835.0601.780.7320.120NM_007144744 ring finger protein 110 (RNF110), mRNA.
chr8:9798533-9798546+0.8795.0191.580.7290.120NM_012331-150603 methionine sulfoxide reductase A (MSRA), mRNA.
chr1:35108832-35108845-0.8795.0191.490.7190.120NM_138428-10900 hypothetical protein BC011880 (LOC113444), mRNA.
chr12:119608738-119608751+0.8835.0601.740.7170.120NM_014730-494 KIAA0152 gene product (KIAA0152), mRNA.
chr14:23051461-23051474+0.8795.0271.400.7160.120NM_00104263542823-
chr18:18393195-18393208+0.8795.0191.840.7140.120NM_172241-141319 cutaneous T-cell lymphoma-associated antigen 1
chr11:31746987-31747000+0.8815.0392.300.7120.120NM_00028042447 paired box gene 6 (aniridia, keratitis) (PAX6), mRNA.
chr10:103593643-103593656-0.8835.0531.880.7060.120NM_01459124 Kv channel interacting protein 2 (KCNIP2), transcript
chr16:30445434-30445447-0.8835.0601.680.7050.120NM_024671-23 hypothetical protein FLJ23436 (FLJ23436), mRNA.
chr1:10762127-10762140-0.8835.0601.440.7030.120NM_00107984317167-
chrX:66859290-66859303+0.8795.0272.160.7030.120NM_001011645153982-
chr2:44859179-44859192+0.8835.0601.310.7010.120NM_005413-163262 sine oculis homeobox homolog 3 (Drosophila) (SIX3),
chr6:140114159-140114172+0.8334.6381.881.0970.121NM_006079-376681 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr2:74408927-74408940+0.8334.6382.291.0960.121NM_021196-13267 solute carrier family 4, sodium bicarbonate
chr1:209778489-209778502+0.8995.1911.350.4630.122NM_02119440233 solute carrier family 30 (zinc transporter), member 1
chr10:72666138-72666151+0.8955.1611.780.4600.122NM_17074423883 unc-5 homolog B (C. elegans) (UNC5B), mRNA.
chr12:40890562-40890575+0.8955.1611.350.4590.122NM_00574827755 YY1 associated factor 2 (YAF2), mRNA.
chr9:92414903-92414916-0.8955.1611.230.4570.122NM_01759430025 DIRAS family, GTP-binding RAS-like 2 (DIRAS2), mRNA.
chr5:139046930-139046943-0.8975.1751.020.4450.122NM_01646338328 CXXC finger 5 (CXXC5), mRNA.
chr21:40810198-40810211-0.8955.1611.740.4420.122NM_001389330711 Down syndrome cell adhesion molecule (DSCAM),
chr7:150283924-150283937-0.8975.1751.050.4360.122NM_172057-76 potassium voltage-gated channel, subfamily H
chr19:12810255-12810268-0.8154.4871.561.0810.124NM_0149757 microtubule associated serine/threonine kinase 1
chr11:133408834-133408847+0.8154.4871.981.0730.124NM_032801-35096 junctional adhesion molecule 3 (JAM3), mRNA.
chr2:100802130-100802143+0.8214.5312.261.0680.124NM_002518-815 neuronal PAS domain protein 2 (NPAS2), mRNA.
chr1:166173410-166173423-0.8835.0531.470.6960.124NM_018442978 IQ motif and WD repeats 1 (IQWD1), mRNA.
chr1:47467330-47467343-0.8754.9881.290.6950.124NM_003189700 T-cell acute lymphocytic leukemia 1 (TAL1), mRNA.
chr11:86343347-86343360+0.8795.0192.230.6940.124NM_012193734 frizzled homolog 4 (Drosophila) (FZD4), mRNA.
chr5:77364104-77364117-0.8815.0391.580.6940.124NM_004607-256163 tubulin-specific chaperone a (TBCA), mRNA.
chr22:36711744-36711757+0.8795.0271.590.6930.124NM_006941-1259 SRY (sex determining region Y)-box 10 (SOX10), mRNA.
chr6:99389114-99389127+0.8835.0601.450.6920.124NM_005604-87 POU domain, class 3, transcription factor 2 (POU3F2),
chr1:36463057-36463070-0.8754.9881.690.6910.124NM_005119523 thyroid hormone receptor associated protein 3
chr17:58397275-58397288+0.8835.0601.430.6890.124NM_152598-157848 hypothetical protein FLJ35757 (FLJ35757), mRNA.
chr17:34153428-34153441+0.8795.0271.550.6860.124NM_0071444656 ring finger protein 110 (RNF110), mRNA.
chr2:27328262-27328275-0.8795.0191.720.6820.124NM_00345911202 solute carrier family 30 (zinc transporter), member 3
chr12:115045926-115045939-0.8795.0272.400.6800.124NM_015335153600 thyroid hormone receptor associated protein 2
chr8:61987882-61987895+0.8795.0191.870.6780.124NM_017780234089-
chr1:154983473-154983486-0.8754.9882.430.6770.124NM_0044944687 hepatoma-derived growth factor (high-mobility group
chr1:161708628-161708641+0.8795.0191.750.6750.124NM_145697150381 cell division cycle associated 1 (CDCA1), transcript
chr10:31650044-31650057-0.8805.0351.730.6740.124NM_0307511996 transcription factor 8 (represses interleukin 2
chr22:36795688-36795701+0.8795.0191.740.6730.124NM_01240712580 protein kinase C, alpha binding protein (PRKCABP),
chr1:23005714-23005727-0.8765.0001.100.6730.124NM_01744995896 EphB2 (EPHB2), transcript variant 1, mRNA.
chr1:243083110-243083123+0.8754.9881.970.6720.124NM_00450111340 heterogeneous nuclear ribonucleoprotein U (scaffold
chr8:67688174-67688187+0.8775.0082.320.6700.124NM_001080416-445-
chr8:38895702-38895715-0.8915.1232.540.5330.124NM_02162317892-
chr2:233067200-233067213-0.8945.1491.150.5320.124NM_004826-6425 endothelin converting enzyme-like 1 (ECEL1), mRNA.
chr1:94300434-94300447-0.8945.1491.550.5310.124NM_00035058859 ATP-binding cassette, sub-family A (ABC1), member 4
chr15:49702325-49702338+0.8925.1301.460.5310.124NM_015263-66 rabconnectin-3 (RC3), mRNA.
chr2:191854524-191854537-0.8925.1301.340.5310.124NM_01222336249 myosin IB (MYO1B), mRNA.
chr15:49420948-49420961-0.8915.1231.130.5300.124NM_18178943 collomin (COLM), mRNA.
chr1:119345331-119345344-0.8885.0961.620.5290.124NM_152380-11629-
chr16:53527005-53527018+0.8885.0961.180.5290.124NM_0058534493 iroquois homeobox protein 5 (IRX5), mRNA.
chr12:111303791-111303804+0.8945.1491.020.5280.124NM_00097028035 ribosomal protein L6 (RPL6), mRNA.
chr10:77579558-77579571+0.8935.1441.330.5280.124NM_032024367133 chromosome 10 open reading frame 11 (C10orf11), mRNA.
chr15:74984514-74984527-0.8945.1491.870.5260.124NM_020843-21267 zinc finger protein 291 (ZNF291), mRNA.
chr15:68606033-68606046+0.8945.1491.450.5260.124NM_001008224175641-
chr3:182915863-182915876+0.8935.1401.230.5260.124NM_0031063547 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr6:43345701-43345714+0.8945.1511.490.5250.124NM_03253826601-
chrX:39718797-39718810+0.8915.1231.490.5250.124NM_017745122803 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr9:34568377-34568390+0.8945.1491.110.5240.124NM_00184211345 ciliary neurotrophic factor receptor (CNTFR),
chr19:60743972-60743985+0.8945.1491.060.5240.124NM_15260040051 zinc finger protein 579 (ZNF579), mRNA.
chr18:70743962-70743975-0.8895.1041.090.5240.124NM_017757272155 zinc finger protein 407 (ZNF407), mRNA.
chr21:35115936-35115949-0.8885.0961.590.5230.124NM_00100189066921 runt-related transcription factor 1 (acute myeloid
chr2:233075449-233075462-0.8885.0961.800.5220.124NM_004826-14674 endothelin converting enzyme-like 1 (ECEL1), mRNA.
chr1:26820087-26820100+0.8945.1491.390.5220.124NM_139135-74922 AT rich interactive domain 1A (SWI- like) (ARID1A),
chr12:7202750-7202763+0.8885.0961.210.5210.124NM_01471828616 calsyntenin 3 (CLSTN3), mRNA.
chr1:203918903-203918916-0.8885.0961.310.5210.124NM_033102-2650 prostein protein (Prostein), mRNA.
chr1:52116990-52117003-0.8935.1412.140.5200.124NM_00252520 nardilysin (N-arginine dibasic convertase) (NRD1),
chr7:94375936-94375949+0.8915.1231.490.5200.124NM_0176501151-
chr3:54887460-54887473+0.8885.0961.300.5200.124NM_02067849652 HT017 protein (HT017), mRNA.
chr17:45993412-45993425-0.8925.1301.070.5170.124NM_19839664 calcium channel, voltage-dependent, alpha 1G subunit
chr6:37611422-37611435+0.8945.1491.330.5160.124NM_138493-35744-
chr10:73716137-73716150-0.8935.1411.540.5150.124NM_01905812554 DNA-damage-inducible transcript 4 (DDIT4), mRNA.
chr19:43608765-43608778-0.8945.1491.460.5140.124NM_17060420 RAS guanyl releasing protein 4 (RASGRP4), transcript
chr3:36474408-36474421+0.8915.1231.830.5130.124NM_00314977407 SH3 and cysteine rich domain (STAC), mRNA.
chr3:26640033-26640046-0.8945.1491.320.5130.124NM_052953829 leucine rich repeat containing 3B (LRRC3B), mRNA.
chr2:174535215-174535228-0.8935.1411.260.5120.124NM_0010173711978-
chr7:22159806-22159819-0.8915.1231.190.5110.124NM_012294203252 Rap guanine nucleotide exchange factor (GEF) 5
chr10:103984908-103984921-0.8935.1411.940.5100.124NM_0050296313 paired-like homeodomain transcription factor 3
chr10:63450125-63450138-0.8935.1411.830.5090.124NM_032199118776-
chr1:227637124-227637137-0.8945.1491.320.5080.124NM_001100-658 actin, alpha 1, skeletal muscle (ACTA1), mRNA.
chr11:129689880-129689893+0.8885.0961.030.5080.124NM_014155-63 HSPC063 protein (HSPC063), mRNA.
chr1:36822579-36822592-0.8945.1512.010.5080.124NM_172313-101483 colony stimulating factor 3 receptor (granulocyte)
chr15:90737622-90737635-0.8945.1491.180.5080.124NM_006011-422 sialyltransferase 8B (alpha-2, 8-sialyltransferase)
chr3:187407039-187407052+0.8885.0961.510.5060.124NM_004454-97468 ets variant gene 5 (ets-related molecule) (ETV5),
chr11:3907722-3907735-0.8885.0961.250.5060.124NM_00315674313 stromal interaction molecule 1 (STIM1), mRNA.
chr2:159535072-159535085+0.8915.1231.480.5050.124NM_0333941780-
chr11:110475044-110475057+0.8925.1301.640.5040.124NM_198498-156773 Similar to RIKEN cDNA 1810046K07 gene (MGC50104),
chr1:148506823-148506836+0.8885.0961.290.5010.124NM_0010776281333-
chr12:119152838-119152851-0.8945.1491.730.5010.124NM_053275-29441 ribosomal protein, large, P0 (RPLP0), transcript
chr2:210743808-210743821-0.8945.1511.490.5010.124NM_152519488 hypothetical protein FLJ23861 (FLJ23861), mRNA.
chr11:111313524-111313537-0.8945.1491.120.5000.124NM_001037954487-
chr10:80491170-80491183+0.9125.3051.580.4660.125NM_020338-100606 retinoic acid induced 17 (RAI17), mRNA.
chr1:204747419-204747432-0.9085.2671.280.4650.125NM_18266317 Ras association (RalGDS/AF-6) domain family 5
chr7:73379992-73380005+0.9055.2411.180.4650.125NM_00338838351 cytoplasmic linker 2 (CYLN2), transcript variant 1,
chr14:72320359-72320372+0.9125.3051.260.4650.125NM_012074110203 D4, zinc and double PHD fingers, family 3 (DPF3),
chr10:21854705-21854718+0.9125.3051.200.4630.125NM_207371-88 FLJ45187 protein (FLJ45187), mRNA.
chr22:31284895-31284908+0.9105.2861.010.4630.125NM_00103302483771-
chr5:127902417-127902430-0.9085.2661.560.4630.125NM_001999-783 fibrillin 2 (congenital contractural arachnodactyly)
chr2:46697303-46697316-0.9075.2601.210.4620.125NM_014171-409 postsynaptic protein CRIPT (CRIPT), mRNA.
chr2:42135701-42135714-0.9125.3051.440.4620.125NM_1383706544-
chr4:148277184-148277197-0.9135.3121.600.4620.125NM_031956-190700 NYD-SP14 protein (NYD-SP14), mRNA.
chr12:120721836-120721849-0.9085.2671.180.4610.125NM_019034-5859 ras homolog gene family, member F (in filopodia)
chr11:94529627-94529640-0.9135.3121.180.4600.125NM_01503667062-
chr19:10597051-10597064+0.9055.2411.090.4580.125NM_020428-78 CTL2 gene (CTL2), mRNA.
chr10:72663474-72663487+0.9105.2861.380.4570.125NM_17074421219 unc-5 homolog B (C. elegans) (UNC5B), mRNA.
chr2:30308298-30308311+0.9135.3121.060.4570.125NM_030915497 likely ortholog of mouse limb-bud and heart gene
chr1:200516966-200516979+0.9085.2671.190.4560.125NM_01417660741 HSPC150 protein similar to ubiquitin-conjugating
chr11:113452553-113452566-0.9135.3121.060.4550.125NM_00101801116155-
chr15:65884111-65884124+0.9095.2731.520.4550.125NM_001031807-20784-
chr1:27735953-27735966-0.9135.3122.000.4530.125NM_006990-46697 WAS protein family, member 2 (WASF2), mRNA.
chr7:128261278-128261291+0.9075.2601.020.4520.125NM_0014583659 filamin C, gamma (actin binding protein 280) (FLNC),
chr4:5873831-5873844+0.9075.2601.130.4520.125NM_00131367385 collapsin response mediator protein 1 (CRMP1), mRNA.
chrX:133631714-133631727-0.9125.3051.070.4520.125NM_021796-11535 placenta-specific 1 (PLAC1), mRNA.
chr8:93100821-93100834+0.9145.3161.730.4510.125NM_175636-1737 core-binding factor, runt domain, alpha subunit 2;
chr1:18482663-18482676-0.9085.2661.010.4510.125NM_032880175936 hypothetical protein MGC15730 (MGC15730), mRNA.
chr14:53724305-53724318-0.9125.3051.040.4500.125NM_005192-209071 cyclin-dependent kinase inhibitor 3 (CDK2-associated
chr14:73938051-73938064-0.9075.2601.030.4490.125NM_01822853232 chromosome 14 open reading frame 115 (C14orf115),
chr11:86343470-86343483+0.9135.3121.240.4450.125NM_012193611 frizzled homolog 4 (Drosophila) (FZD4), mRNA.
chr9:23811748-23811761-0.9115.2931.020.4440.125NM_0044324315 ELAV (embryonic lethal, abnormal vision,
chr20:3712854-3712867+0.9135.3121.290.4420.125NM_0018102483 centromere protein B, 80kDa (CENPB), mRNA.
chr5:132038745-132038758-0.9075.2601.340.4420.125NM_1723481573 interleukin 4 (IL4), transcript variant 2, mRNA.
chr4:85465045-85465058+0.9095.2731.480.4420.125NM_006168173366 NK6 transcription factor related, locus 1 (Drosophila)
chr11:34029483-34029496-0.9135.3121.150.4410.125NM_005898-223 membrane component, chromosome 11, surface marker 1
chr2:204507143-204507156-0.9075.2601.880.4390.125NM_012092-2505 inducible T-cell co-stimulator (ICOS), mRNA.
chr1:10756050-10756063+0.9105.2861.140.4380.125NM_00107984323244-
chr1:216186540-216186553+0.9075.2601.870.4380.125NM_138796315322 hypothetical protein BC014608 (LOC128153), mRNA.
chr5:176851632-176851645-0.9135.3121.160.4350.125NM_0054515576 PDZ and LIM domain 7 (enigma) (PDLIM7), transcript
chr11:61096162-61096175+0.9055.2411.380.4350.125NM_0042008712 synaptotagmin VII (SYT7), mRNA.
chr17:35766087-35766100-0.9055.2411.250.4340.125NM_1522198384 gap junction protein, chi 1, 31.9kDa (connexin 31.9)
chr1:10661061-10661074+0.9135.3121.410.4340.125NM_001079843118233-
chr11:66242913-66242926+0.8544.8111.601.0610.126NM_0069462533 spectrin, beta, non-erythrocytic 2 (SPTBN2), mRNA.
chrX:39895849-39895862+0.8384.6751.961.0610.126NM_020926-54249 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr13:43258004-43258017+0.8474.7542.131.0590.126NM_14497493822 hypothetical protein FLJ31846 (FLJ31846), mRNA.
chr1:37965196-37965209+0.8404.6902.041.0520.126NM_01810134550 cell division cycle associated 8 (CDCA8), mRNA.
chr6:12817872-12817885+0.8464.7462.181.0500.126NM_030948-7847-
chr11:117551995-117552008-0.8394.6842.001.0370.126NM_004588551 sodium channel, voltage-gated, type II, beta (SCN2B),
chr19:43406511-43406524-0.8464.7481.771.0350.126NM_004647117 D4, zinc and double PHD fingers family 1 (DPF1), mRNA.
chr11:111288655-111288668-0.8694.9362.420.9630.126NM_00154146 heat shock 27kDa protein 2 (HSPB2), mRNA.
chr4:83569147-83569160-0.8734.9762.180.9620.126NM_0313721255 heterogeneous nuclear ribonucleoprotein D-like
chr20:39200044-39200057-0.8724.9622.000.9600.126NM_182811569 phospholipase C, gamma 1 (PLCG1), transcript variant
chr12:52173263-52173276+0.8704.9431.820.9550.126NM_0063016275 mitogen-activated protein kinase kinase kinase 12
chr1:40930176-40930189+0.8734.9762.320.9550.126NM_014223324 nuclear transcription factor Y, gamma (NFYC), mRNA.
chr17:24096707-24096720-0.8664.9161.590.9550.126NM_0042951657 TNF receptor-associated factor 4 (TRAF4), transcript
chr17:41461404-41461417+0.8714.9562.590.9490.126NM_00100753229021-
chr16:65435702-65435715+0.8664.9171.510.9430.126NM_00518219 carbonic anhydrase VII (CA7), mRNA.
chr19:50811662-50811675+0.8734.9681.830.9430.126NM_01215522847 echinoderm microtubule associated protein like 2
chr3:9450976-9450989-0.8664.9162.480.9430.126NM_00108051736673-
chrX:122923578-122923591-0.8734.9742.220.9400.126NM_006603441 stromal antigen 2 (STAG2), mRNA.
chr16:49333551-49333564+0.8734.9742.040.9400.126NM_001042412121-
chr1:39929494-39929507+0.8734.9681.920.9370.126NM_016257182 hippocalcin like 4 (HPCAL4), mRNA.
chr1:45582411-45582424-0.8734.9742.310.9370.126NM_012222-3682 mutY homolog (E. coli) (MUTYH), mRNA.
chr8:72919364-72919377+0.8975.1751.120.4320.126NM_005098-79 musculin (activated B-cell factor-1) (MSC), mRNA.
chr17:38059039-38059052+0.8955.1611.180.4250.126NM_016437-5698 tubulin, gamma 2 (TUBG2), mRNA.
chr19:59105359-59105372+0.8965.1661.450.4240.126NM_031896-2424 calcium channel, voltage-dependent, gamma subunit 7
chr12:12394476-12394489+0.8975.1751.110.4240.126NM_018050-40 MANSC domain containing 1 (MANSC1), mRNA.
chr19:19183993-19184006+0.8965.1661.050.4090.126NM_004386311 chondroitin sulfate proteoglycan 3 (neurocan) (CSPG3),
chr1:1523005-1523018-0.8975.1751.270.4080.126NM_080875-17642 skeletrophin (LOC142678), mRNA.
chr14:102620382-102620395-0.8975.1721.010.4030.126NM_001077594-15752-
chr17:44902687-44902700-0.8564.8252.090.9640.128NM_002507-24879 nerve growth factor receptor (TNFR superfamily, member
chr3:136941309-136941322-0.8574.8352.090.9630.128NM_002718-225848 protein phosphatase 2 (formerly 2A), regulatory
chr1:113045096-113045109-0.8574.8371.920.9610.128NM_0010426796105-
chr5:178976253-178976266-0.8604.8632.280.9610.128NM_0055207023 heterogeneous nuclear ribonucleoprotein H1 (H)
chr5:157948791-157948804+0.8594.8562.700.9580.128NM_024007510556 early B-cell factor (EBF), mRNA.
chr2:216858728-216858741+0.8584.8431.860.9540.128NM_02081486267-
chr1:26671985-26671998-0.8584.8431.750.9530.128NM_005517596 high-mobility group nucleosomal binding domain 2
chr1:33056368-33056381+0.8584.8432.100.9460.128NM_003680-148 tyrosyl-tRNA synthetase (YARS), mRNA.
chr12:44407783-44407796+0.8594.8561.760.9460.128NM_152641-2004-
chr12:62771205-62771218+0.8594.8562.180.9450.128NM_152440131138 hypothetical protein FLJ32549 (FLJ32549), mRNA.
chr4:80351798-80351811-0.8604.8662.490.9450.128NM_032693114397-
chr7:22148915-22148928+0.8584.8432.200.9440.128NM_018719-196884 transcription factor RAM2 (RAM2), mRNA.
chr1:44890152-44890165+0.8584.8461.780.9420.128NM_02458722534 hypothetical protein FLJ22353 (FLJ22353), mRNA.
chr16:74157971-74157984-0.8584.8432.050.9390.128NM_007285321 GABA(A) receptor-associated protein-like 2
chr11:44317330-44317343+0.8584.8462.230.9360.128NM_021926-29038 aristaless-like homeobox 4 (ALX4), mRNA.
chr19:47466739-47466752+0.8334.6382.081.0620.129NM_015125-13818 capicua homolog (Drosophila) (CIC), mRNA.
chr10:102856779-102856792-0.8334.6382.231.0370.129NM_005521-23373 T-cell leukemia, homeobox 1 (TLX1), mRNA.
chrX:84251080-84251093+0.9075.2601.210.4330.129NM_001012980-978-
chr1:93903069-93903082-0.9125.3051.330.4330.129NM_00356716904 breast cancer anti-estrogen resistance 3 (BCAR3),
chr10:130721101-130721114-0.9105.2861.210.4330.129NM_002412-434255 O-6-methylguanine-DNA methyltransferase (MGMT), mRNA.
chr2:161980434-161980447+0.9135.3121.370.4310.129NM_006593-332 T-box, brain, 1 (TBR1), mRNA.
chr2:145139012-145139025+0.9085.2661.190.4300.129NM_014795-144626 zinc finger homeobox 1b (ZFHX1B), mRNA.
chr11:56847776-56847789+0.9095.2731.070.4280.129NM_0333961213 tankyrase 1 binding protein 1, 182kDa (TNKS1BP1),
chr17:45402243-45402256+0.9055.2411.470.4270.129NM_138281780 distal-less homeobox 4 (DLX4), transcript variant 1,
chr1:43860562-43860575+0.9075.2601.830.4270.129NM_014663-27722 jumonji domain containing 2A (JMJD2A), mRNA.
chr12:52676409-52676422-0.9085.2661.540.4250.129NM_006897-3635 homeo box C9 (HOXC9), mRNA.
chrX:40004524-40004537+0.9085.2671.340.4250.129NM_020926-162924 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr13:109237148-109237161-0.9085.2661.150.4250.129NM_003749-233 insulin receptor substrate 2 (IRS2), mRNA.
chr3:138843670-138843683-0.9085.2671.500.4250.129NM_004189-122499 SRY (sex determining region Y)-box 14 (SOX14), mRNA.
chr11:71497652-71497665-0.9135.3121.250.4240.129NM_0140423818 DKFZP564M082 protein (DKFZP564M082), mRNA.
chr14:66777855-66777868+0.9085.2671.000.4240.129NM_022474181 membrane protein, palmitoylated 5 (MAGUK p55 subfamily
chr17:73078969-73078982-0.9125.3051.420.4230.129NM_006640251872 MLL septin-like fusion (MSF), mRNA.
chr19:6432841-6432854-0.9055.2411.340.4220.129NM_024898-43 family with sequence similarity 31, member C (FAM31C),
chr12:106144292-106144305-0.9135.3121.370.4190.129NM_001018072-91935-
chr12:51208830-51208843-0.9055.2411.030.4170.129NM_000424-8320 keratin 5 (epidermolysis bullosa simplex,
chr14:76325122-76325135+0.9105.2861.690.4150.129NM_01530523861 KIAA0759 (KIAA0759), mRNA.
chr10:97793433-97793446+0.9115.2931.230.4150.129NM_019084389 cyclin J (CCNJ), mRNA.
chr17:33974508-33974521+0.9135.3121.290.4150.129NM_02524841201 SNAP25-interacting protein (SNIP), mRNA.
chr16:28213555-28213568-0.9135.3121.110.4140.129NM_0010244012314-
chr3:51361419-51361432-0.9095.2731.120.4140.129NM_006010-36224 arginine-rich, mutated in early stage tumors (ARMET),
chr16:67248356-67248369-0.9125.3051.110.4130.129NM_00179312179 cadherin 3, type 1, P-cadherin (placental) (CDH3),
chr17:44449270-44449283-0.9085.2671.400.4110.129NM_00654619597 IGF-II mRNA-binding protein 1 (IMP-1), mRNA.
chr19:7859531-7859544+0.9135.3121.210.4100.129NM_025061241 hypothetical protein FLJ23420 (FLJ23420), mRNA.
chr12:47897221-47897234+0.9085.2661.010.4100.129NM_006009-28093 tubulin, alpha 3 (TUBA3), mRNA.
chr5:133435293-133435306-0.9135.3121.470.4080.129NM_003202-42908 transcription factor 7 (T-cell specific, HMG-box)
chr6:36856419-36856432-0.9075.2601.120.4060.129NM_02093958779 copine V (CPNE5), mRNA.
chr17:7699841-7699854-0.9055.2411.110.4050.129NM_203411832 similar to RIKEN cDNA 2600017H02 (LOC92162), mRNA.
chr15:65994557-65994570-0.9105.2861.570.4050.129NM_00103180789662-
chr3:137954112-137954125-0.9055.2411.180.4040.129NM_005862-177 stromal antigen 1 (STAG1), mRNA.
chr20:29885934-29885947+0.9085.2661.490.4030.129NM_00411811147 forkhead-like 18 (Drosophila) (FKHL18), mRNA.
chr16:54693827-54693840+0.9075.2601.210.4030.129NM_138736-89722 guanine nucleotide binding protein (G protein), alpha
chr10:14294379-14294392-0.9125.3051.010.4030.129NM_018027118493 FERM domain containing 4A (FRMD4A), mRNA.
chr15:38986402-38986415-0.9085.2671.050.4020.129NM_02085712582 vacuolar protein sorting protein 18 (VPS18), mRNA.
chr6:40674412-40674425-0.9135.3121.180.4010.129NM_020737-11308-
chr15:72906474-72906487+0.9095.2731.280.4000.129NM_001030005570-
chr1:16315174-16315187+0.8795.0271.270.6650.130NM_00443139977 EphA2 (EPHA2), mRNA.
chr2:60186724-60186737-0.8795.0191.650.6640.130NM_018014447413 B-cell CLL/lymphoma 11A (zinc finger protein)
chr6:43705813-43705826+0.8775.0081.670.6610.130NM_001003690656 MAD2L1 binding protein (MAD2L1BP), transcript variant
chr2:73113287-73113300-0.8795.0191.620.6610.130NM_14457939186 sideroflexin 5 (SFXN5), mRNA.
chr6:94186038-94186051+0.8835.0601.880.6610.130NM_004440-45 EphA7 (EPHA7), mRNA.
chr1:27591548-27591561+0.8835.0602.320.6590.130NM_005281-91 G protein-coupled receptor 3 (GPR3), mRNA.
chr11:45875096-45875109+0.8765.0001.480.6580.130NM_00108044610313-
chr6:105512175-105512188+0.8754.9882.280.6540.130NM_001004317659 FLJ16517 protein (FLJ16517), mRNA.
chr3:142569826-142569839+0.8795.0271.440.6520.130NM_00108041244181-
chr2:220111355-220111368+0.8815.0381.490.6500.130NM_0245365327 chondroitin polymerizing factor (CHPF), mRNA.
chr11:63206559-63206572+0.8795.0271.420.6490.130NM_2014301161 reticulon 3 (RTN3), transcript variant 4, mRNA.
chr2:219751614-219751627+0.8835.0601.470.6470.130NM_024293516 chromosome 2 open reading frame 17 (C2orf17), mRNA.
chr14:32847245-32847258-0.8795.0191.810.6450.130NM_173159369071 neuronal PAS domain protein 3 (NPAS3), mRNA.
chr9:130749790-130749803+0.8765.0001.840.6430.130NM_01490843 transmembrane protein 15 (TMEM15), mRNA.
chr1:163545073-163545086-0.8795.0271.470.6420.130NM_17739846568 LIM homeobox transcription factor 1, alpha (LMX1A),
chr6:85044794-85044807+0.8795.0191.420.6400.130NM_014895-50740-
chrX:46938121-46938134+0.8795.0272.360.6380.130NM_003334-18 ubiquitin-activating enzyme E1 (A1S9T and BN75
chr15:89217349-89217362+0.8795.0191.490.6350.130NM_0025694560 furin (paired basic amino acid cleaving enzyme)
chr6:33045754-33045767+0.8955.1611.050.3980.130NM_0051041439 bromodomain containing 2 (BRD2), mRNA.
chr4:183960935-183960948+0.8995.1941.410.3970.130NM_001012732114689-
chr10:102578372-102578385-0.8975.1751.100.3950.130NM_00027883014 paired box gene 2 (PAX2), transcript variant b, mRNA.
chr1:117023691-117023704+0.8955.1611.340.3900.130NM_001542-11854 immunoglobulin superfamily, member 3 (IGSF3), mRNA.
chrX:16875434-16875447-0.8975.1751.040.3870.130NM_004726799 RALBP1 associated Eps domain containing 2 (REPS2),
chr15:81667378-81667391+0.8965.1661.030.3860.130NM_016073-53 hepatoma-derived growth factor, related protein 3
chrX:67635750-67635763+0.8975.1751.390.3840.130NM_173834239 hypothetical protein MGC21416 (MGC21416), mRNA.
chr7:27145455-27145468+0.8975.1751.350.3830.130NM_0191024357 homeo box A5 (HOXA5), mRNA.
chr1:153102327-153102340+0.8975.1751.200.3760.130NM_170782-3365 potassium intermediate/small conductance
chr17:45587611-45587624+0.8975.1751.340.3760.130NM_032595-4735 protein phosphatase 1, regulatory subunit 9B,
chr1:23790733-23790746+0.8955.1611.170.3720.130NM_002167-31861 inhibitor of DNA binding 3, dominant negative
chr20:47532494-47532507+0.8975.1751.300.3720.130NM_00497594 potassium voltage-gated channel, Shab-related
chrX:70504213-70504226+0.8975.1721.730.3710.130NM_1389231474 TAF1 RNA polymerase II, TATA box binding protein
chr12:120722007-120722020+0.8144.4781.991.1570.131NM_019034-6030 ras homolog gene family, member F (in filopodia)
chr3:50169391-50169404+0.8244.5582.351.0440.131NM_0041861639 sema domain, immunoglobulin domain (Ig), short basic
chr8:10491023-10491036+0.8154.4871.561.0380.131NM_17885759004 retinitis pigmentosa 1-like 1 (RP1L1), mRNA.
chrX:128764887-128764900+0.8524.7992.330.9960.131NM_01899023346 chromosome X open reading frame 9 (CXorf9), mRNA.
chr12:52939644-52939657-0.8364.6592.490.9950.131NM_01211720507 chromobox homolog 5 (HP1 alpha homolog, Drosophila)
chr13:108997118-108997131-0.8514.7901.830.9850.131NM_003749239797 insulin receptor substrate 2 (IRS2), mRNA.
chr12:50525769-50525782+0.8394.6832.230.9820.131NM_001013690-23294-
chr7:116099327-116099340+0.8504.7801.320.9800.131NM_000245-268 met proto-oncogene (hepatocyte growth factor receptor)
chr1:109651187-109651200+0.8514.7902.030.9750.131NM_001010985-1-
chr10:59703152-59703165-0.8384.6752.490.9740.131NM_0184644331 chromosome 10 open reading frame 70 (C10orf70), mRNA.
chr4:30327909-30327922+0.8414.7031.780.9670.131NM_032457-3126 BH-protocadherin (brain-heart) (PCDH7), transcript
chr10:131584416-131584429+0.8064.4052.211.0980.132NM_00100546367665-
chr10:131584417-131584430+0.8054.4022.211.0980.132NM_00100546367664-
chrX:110418816-110418829-0.8054.3972.091.0920.132NM_014289-18409 calpain 6 (CAPN6), mRNA.
chrX:136478506-136478519-0.8094.4342.321.0670.132NM_0034132594 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr5:137702296-137702309+0.8364.6592.551.0300.132NM_016605529 chromosome 5 open reading frame 6 (C5orf6), mRNA.
chr3:50613823-50613836+0.8444.7292.531.0250.132NM_14507110384 cytokine inducible SH2-containing protein (CISH),
chr19:40696636-40696649+0.8364.6591.981.0180.132NM_033317-242 dermokine (ZD52F10), mRNA.
chrX:64171344-64171357+0.8404.6941.791.0080.132NM_018684-58283 KIAA1166 (KIAA1166), mRNA.
chr1:38327117-38327130-0.8384.6772.101.0070.132NM_002699-42080 POU domain, class 3, transcription factor 1 (POU3F1),
chr5:180583510-180583523+0.8384.6772.131.0060.132NM_201627698 tripartite motif-containing 41 (TRIM41), transcript
chr2:175420577-175420590+0.8414.7032.281.0060.132NM_001039523-83150-
chr1:142627923-142627936+0.8364.6591.421.0060.132NM_178230447680 cyclophilin-LC (COAS2), mRNA.
chr8:61728707-61728720-0.8544.8161.901.0330.133NM_017780-25086-
chr1:120412648-120412661-0.8534.8061.661.0240.133NM_0244081151 Notch homolog 2 (Drosophila) (NOTCH2), mRNA.
chr7:27137058-27137071-0.8494.7711.721.0210.133NM_002141-134 homeo box A4 (HOXA4), mRNA.
chr2:74588459-74588472-0.8544.8161.991.0190.133NM_032673-130 likely ortholog of mouse nervous system polycomb 1
chr10:114809225-114809238+0.8464.7481.671.0060.133NM_030756109124 transcription factor 7-like 2 (T-cell specific,
chr14:22377810-22377823-0.7994.3532.201.1240.134NM_0049952277 matrix metalloproteinase 14 (membrane-inserted)
chr2:200178857-200178870+0.8024.3742.061.1060.134NM_015265-145411 SATB family member 2 (SATB2), mRNA.
chr17:2443889-2443902-0.8334.6381.870.9900.134NM_000430303 platelet-activating factor acetylhydrolase, isoform
chr9:85512694-85512707-0.8334.6382.090.9870.134NM_053067-6 ubiquilin 1 (UBQLN1), transcript variant 2, mRNA.
chr9:85512695-85512708-0.8254.5662.090.9830.134NM_053067-7 ubiquilin 1 (UBQLN1), transcript variant 2, mRNA.
chr1:48302660-48302673-0.8294.6051.770.9830.134NM_001011547-158231-
chr16:53814042-53814055+0.8324.6302.620.9750.134NM_024335-101830 iroquois homeobox protein 6 (IRX6), mRNA.
chr14:74080682-74080695-0.8765.0001.590.6270.134NM_19427950561 HESB like domain containing 1 (HBLD1), mRNA.
chr17:46348733-46348746+0.8795.0271.390.6260.134NM_005749-52321 transducer of ERBB2, 1 (TOB1), mRNA.
chr17:4351613-4351626-0.8795.0191.730.6200.134NM_01452053780 MYB binding protein (P160) 1a (MYBBP1A), mRNA.
chr19:51170567-51170580-0.8754.9882.340.6180.134NM_002516-2070 neuro-oncological ventral antigen 2 (NOVA2), mRNA.
chr18:44731308-44731321+0.8815.0391.410.6150.134NM_005904-229 SMAD, mothers against DPP homolog 7 (Drosophila)
chr10:63424382-63424395-0.8795.0272.010.6140.134NM_03219993033-
chr8:94822229-94822242-0.8835.0531.750.6110.134NM_203390171 similar to RIKEN cDNA 3000004N20 (LOC389677), mRNA.
chr12:62360162-62360175-0.8754.9881.240.6080.134NM_173812-11541 hypothetical protein FLJ32949 (FLJ32949), mRNA.
chr6:50918567-50918580-0.8825.0451.280.6040.134NM_00322124269 transcription factor AP-2 beta (activating enhancer
chr1:212408207-212408220+0.8754.9881.080.6000.134NM_020197-112892 SET and MYND domain containing 2 (SMYD2), mRNA.
chr20:36219061-36219074-0.9075.2601.040.3990.134NM_0046138053 transglutaminase 2 (C polypeptide,
chr11:56997646-56997659+0.9085.2671.380.3980.134NM_17857012831 reticulon 4 receptor-like 2 (RTN4RL2), mRNA.
chr11:75160564-75160577-0.9075.2601.040.3970.134NM_0325643208 diacylglycerol O-acyltransferase homolog 2 (mouse)
chr6:151753891-151753904-0.9085.2661.000.3970.134NM_020861479 zinc finger and BTB domain containing 2 (ZBTB2), mRNA.
chr5:73962586-73962599-0.9075.2601.200.3970.134NM_0036339687 ectodermal-neural cortex (with BTB-like domain)
chr21:33365391-33365404-0.9055.2411.520.3950.134NM_1389831048 oligodendrocyte transcription factor 1 (OLIG1), mRNA.
chr10:63326815-63326828-0.9075.2601.260.3950.134NM_032199-4534-
chr1:203549547-203549560+0.9125.3051.410.3940.134NM_0309527959 likely ortholog of rat SNF1/AMP-activated protein
chr1:149941627-149941640-0.9135.3121.380.3940.134NM_00718514287 trinucleotide repeat containing 4 (TNRC4), mRNA.
chr14:75197682-75197695+0.9135.3121.110.3940.134NM_015072408 KIAA0998 (KIAA0998), mRNA.
chr14:50322860-50322873+0.9125.3051.430.3930.134NM_01635037246 ninein (GSK3B interacting protein) (NIN), transcript
chr5:106744638-106744651+0.9135.3121.280.3930.134NM_001962289857 ephrin-A5 (EFNA5), mRNA.
chr4:57247677-57247690+0.9075.2601.200.3890.134NM_139212-5355 homeodomain-only protein (HOP), transcript variant 3,
chr11:17931193-17931206-0.9135.3121.380.3890.134NM_01213960020 deafness locus associated putative guanine nucleotide
chr9:129730141-129730154-0.9105.2861.280.3880.134NM_173492-550 phosphatidylinositol-4-phosphate 5-kinase-like 1
chr11:66993305-66993318-0.9085.2671.140.3880.134NM_0010786502-
chr1:158636952-158636965-0.9085.2661.260.3880.134NM_02033561-
chr13:27262607-27262620-0.9135.3121.210.3870.134NM_145657-2073 GS homeobox 1 (GSH1), mRNA.
chr2:104851823-104851836+0.9075.2601.340.3860.134NM_00623613522 POU domain, class 3, transcription factor 3 (POU3F3),
chrX:139459486-139459499-0.9135.3121.300.3860.134NM_005634-44595 SRY (sex determining region Y)-box 3 (SOX3), mRNA.
chr8:34242359-34242372+0.9075.2601.010.3850.134NM_024025-665378 hypothetical protein MGC1136 (MGC1136), mRNA.
chr1:10685356-10685369-0.9105.2861.240.3840.134NM_00107984393938-
chr10:87862343-87862356+0.9135.3121.250.3830.134NM_017551253887-
chr2:45090775-45090788-0.9125.3051.020.3820.134NM_016932-749 sine oculis homeobox homolog 2 (Drosophila) (SIX2),
chr10:49184606-49184619-0.9085.2671.060.3810.134NM_001018071-31883-
chr3:148965050-148965063+0.9125.3051.220.3810.134NM_003412355279 Zic family member 1 (odd-paired homolog, Drosophila)
chr8:109201789-109201802-0.9135.3121.120.3800.134NM_178565-37047 hypothetical protein MGC35555 (MGC35555), mRNA.
chr19:53825361-53825374+0.9055.2411.350.3790.134NM_0013527039 D site of albumin promoter (albumin D-box) binding
chrX:147884712-147884725+0.9135.3121.200.3790.134NM_002025494981 fragile X mental retardation 2 (FMR2), mRNA.
chr15:49761130-49761143-0.9075.2601.070.3780.134NM_013243388 secretogranin III (SCG3), mRNA.
chr11:63030048-63030061+0.9135.3121.710.3770.134NM_03310116 lectin, galactoside-binding, soluble, 12 (galectin 12)
chr4:154114190-154114203-0.9075.2601.010.3770.134NM_03339330705 KIAA1727 protein (KIAA1727), mRNA.
chr12:114102114-114102127+0.9075.2601.010.3770.134NM_016569-495762 T-box 3 (ulnar mammary syndrome) (TBX3), transcript
chr9:33808368-33808381+0.9135.3121.460.3760.134NM_0178111286 ubiquitin-conjugating enzyme E2R 2 (UBE2R2), mRNA.
chr2:56003230-56003243-0.9085.2661.170.3740.134NM_004105630 EGF-containing fibulin-like extracellular matrix
chrX:53608068-53608081-0.9055.2411.380.3730.134NM_03140789708-
chr12:48218941-48218954-0.9085.2671.050.3730.134NM_012284-166 potassium voltage-gated channel, subfamily H
chr22:18105033-18105046-0.9105.2861.070.3720.134NM_00040714067 glycoprotein Ib (platelet), beta polypeptide (GP1BB),
chr19:54299674-54299687-0.9085.2661.140.3720.134NM_022165-9656 lin-7 homolog B (C. elegans) (LIN7B), mRNA.
chr10:118021892-118021905-0.9075.2601.180.3720.134NM_145793-108 GDNF family receptor alpha 1 (GFRA1), transcript
chr7:28188270-28188283+0.9085.2671.060.3700.134NM_175061-1308 juxtaposed with another zinc finger gene 1 (JAZF1),
chr2:233075224-233075237+0.9085.2661.120.3680.134NM_004826-14449 endothelin converting enzyme-like 1 (ECEL1), mRNA.
chr1:25283211-25283224+0.9105.2861.370.3680.134NM_001031680-119123-
chr6:137861068-137861081-0.9135.3121.130.3680.134NM_175747-3844 oligodendrocyte transcription factor 3 (OLIG3), mRNA.
chr11:10836030-10836043+0.9085.2661.500.3680.134NM_001042559-48872-
chr13:40531967-40531980-0.9075.2601.130.3670.134NM_007187-1630 WW domain binding protein 4 (formin binding protein
chr6:56124540-56124553-0.9075.2601.160.3670.134NM_03082095797 collagen, type XXI, alpha 1 (COL21A1), mRNA.
chr9:16857693-16857706-0.9135.3121.300.3670.134NM_0176373093 basonuclin 2 (BNC2), mRNA.
chr5:77388174-77388187-0.8995.1871.030.3660.134NM_003664238110 adaptor-related protein complex 3, beta 1 subunit
chr14:22410870-22410883-0.8965.1661.120.3630.134NM_014045170 low density lipoprotein receptor-related protein 10
chrX:118708941-118708954+0.9005.1991.400.3510.134NM_1458002420 septin 6 (SEPT6), transcript variant III, mRNA.
chr12:22058346-22058359-0.8955.1611.040.3500.134NM_018686-31980 cytidine monophosphate N-acetylneuraminic acid
chr11:118722623-118722636+0.8955.1611.030.3460.134NM_031433-43 membrane frizzled-related protein (MFRP), mRNA.
chr6:41714055-41714068+0.8975.1751.320.3420.134NM_005586-76 MyoD family inhibitor (MDFI), mRNA.
chr10:114701482-114701495-0.8965.1661.080.3350.134NM_0307561381 transcription factor 7-like 2 (T-cell specific,
chr5:158568737-158568750+0.8935.1401.220.4990.135NM_144726-1325 hypothetical protein FLJ31951 (FLJ31951), mRNA.
chr1:199685027-199685040+0.8945.1491.350.4980.135NM_01239619895 pleckstrin homology-like domain, family A, member 3
chr1:26667889-26667902-0.8935.1441.180.4980.135NM_005517-3500 high-mobility group nucleosomal binding domain 2
chr19:51798617-51798630-0.8885.0961.490.4970.135NM_0051842365 calmodulin 3 (phosphorylase kinase, delta) (CALM3),
chr8:37687743-37687756-0.8885.0961.230.4970.135NM_02506915384 hypothetical protein FLJ14299 (FLJ14299), mRNA.
chr4:38289211-38289224+0.8885.0961.430.4950.135NM_016531-52907 Kruppel-like factor 3 (basic) (KLF3), mRNA.
chr7:100077386-100077399+0.8945.1491.340.4940.135NM_003227-277 transferrin receptor 2 (TFR2), mRNA.
chr10:31475594-31475607+0.8885.0961.450.4940.135NM_182755-162233 hypothetical protein LOC220929 (LOC220929), mRNA.
chr1:56788474-56788487-0.8945.1491.800.4940.135NM_00371329371 phosphatidic acid phosphatase type 2B (PPAP2B),
chr3:49434757-49434770-0.8885.0961.190.4930.135NM_000481259 aminomethyltransferase (glycine cleavage system
chr19:4828868-4828881+0.8945.1491.240.4930.135NM_005817-10192 mannose-6-phosphate receptor binding protein 1
chr17:35532344-35532357-0.8935.1441.110.4910.135NM_001012241128-
chr1:202367829-202367842-0.8885.0961.150.4890.135NM_01820819816 ethanolamine kinase 2 (ETNK2), mRNA.
chr17:76973961-76973974-0.8945.1491.720.4880.135NM_001080519-13500-